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Abstract 
Defective mucus barrier function is one of the contributing factors for inflammatory bowel 
disease (IBD) pathogenesis. Understanding the regulation of mucus secretion is essential for 
developing new therapies. Cholinergic signals have been shown to stimulate mucus secretion, 
but the mechanism is not fully understood. The aim of this study was to investigate the 
molecular mechanism of calcium (Ca2+) coupling mucus (MUC2) secretion in colonic goblet 
cells in situ, using an ex-vivo 3D model native human colonic crypt model system. 
Immunohistochemistry revealed the presence of cholinergic neurons in close proximity to 
the basal membrane of the crypts, where the muscarinic receptor (M3AchR) was expressed. 
Fura-2 Ca2+ imaging demonstrated that Carbachol (Cch) evoked Ca2+ signals at the human 
colonic crypt base via M3AchR activation, which then spread to all cell types along the crypt-
axis. Surprisingly, pharmacological inhibition of the canonical 2nd messenger IP3 pathway had 
no major effect on Ca2+ signal generation, and depleting the ER Ca2+ store demonstrated Cch-
induced Ca2+ mobilisation from other intracellular organelles, including lysosomes. Inhibition 
of pathways and 2nd messengers which mobilise Ca2+ from lysosomal stores – including 
chemicals targeting CD38, NOX1, NAADP and TPC – profoundly suppressed Cch-induced Ca2+ 
signals. Furthermore, inhibition of this cholinergic coupled calcium signalling pathway 
prevented MUC2 mucus secretion from colonic crypt goblet cells in situ.  
This is the first study to demonstrate that M3AchR activation mobilises Ca2+ from acidic 
lysosomes in the human colonic epithelium. These findings also implicate NAADP as the key 
2nd messenger which mediates this pathway via activation of two pore channels. Modulation 
of Ca2+ release from acidic stores may serve as a potential target for treating IBD and other 
gastrointestinal pathologies. 
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Chapter 1: General Introduction 
Mucosal barrier in health and diseases  
The gastrointestinal (GI) tracts of vertebrate species are incredibly interesting biological 
systems, which must fulfil a number of contrasting functions. They must be able to digest 
food, without digesting themselves. They also contain billions of bacteria – some commensal, 
some pathogenic, some somewhere in between – and thus must allow the concomitant 
survival and existence of both parties. The intestinal mucosal barrier provides the first line 
of defence against these bacteria and toxins, as well as host-derived digestive enzymes 
(Johansson, et al., 2013). It consists of three protective components: cell junctions, mucus 
layers and anti-microbial peptides (Groschwitz, 2009). The innermost layer of the mucosa is 
composed of a single layer of epithelial cells inwardly facing the lumen of the GI tract. This 
intact epithelial cell layer is sealed by apical junctional complexes including the tight and 
adherens junctions (Figure 1.1 left). Tight junctions form a physical barrier which control the 
paracellular transport across the epithelium; whereas the adherens junctions maintain the 
integrity and polarity of the epithelium (Giepmans, et al., 2009). Coating the epithelial layer 
is the key defence mechanism: the mucus barrier. The colon is protected by two mucus layers: 
the outer layer harbours the commensals, while the inner layer is usually impenetrable to 
bacteria (Figure 1.1 right) (Hansson, et al., 2010). In healthy colonic epithelium, interaction 
with microbes is minimised by the secretion of anti-microbial peptides, primarily defensins, 
and by the functional mucus barrier (Antoni, et al., 2014).  
Intestinal barrier dysfunction – where the physical barrier between luminal bacteria and the 
intestinal mucosa is defective – is emerging as a risk factor for some subsets of inflammatory 
bowel diseases (IBDs) (Antoni, et al., 2014). Defective mucus production has been reported 
in various immune mediated diseases. Insufficient or absent mucus layers allows bacteria to 
come into direct contact with epithelial cells. Mouse models devoid of such layers have been 
shown to develop severe colitis and eventually colon cancer (Velcich, et al., 2002; Van der 
Sluis, et al., 2006; Heazlewood, et al., 2008; Hansson, et al., 2010; Balzola, et al., 2013), which 
resembles the phenotype of human disease. Changes in mucus composition have also been 
shown to affect the makeup of microbial populations (Fritz, et al., 2011). In addition, tight 
junction barrier dysfunction has also been shown to contribute to the development of IBD 
(Hollander, 1988; Groschwitz, et al., 2009; Salim, et al., 2011; Hering, et al., 2012). Thus, the 
mucosal and mucus barriers play an important role in GI defence, with intestinal permeability 
potentially being one of the key factors contributing to colonic diseases such as IBD. 
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Figure 1.1 Colonic defence barrier  
The colonic mucosa is composed of a single layer of epithelial cells (right). Each cell is 
connected by junctional complexes including tight and adherens junctions that control 
paracellular transport and maintain the integrity & polarity of the epithelium respectively 
(left). The key defence mechanism of the colonic epithelium is the surface mucus coatings 
that are produced by colonic goblet cells. The outer mucus layer harbours the commensals, 
while the inner mucus layer is normally sterile. Microbial-epithelial interactions are further 
minimised by the secretion of anti-microbial peptides such as defensins by Paneth-like cells 
(goblet cells) at the colonic crypt base. 
(Figures from Turner, 2009 (Left) and partially adapted from Johansson, et al., 2013 (Right)) 
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IBDs are major health problems in developed countries which can greatly impair the quality 
of life of the patients. IBDs are characterised by chronic or relapsing gastrointestinal 
inflammation (Jawad, et al., 2011; CDC, 2015). Based on their clinical and histopathological 
features, IBDs can be categorised into ulcerative colitis (UC) and Crohn’s disease (CD). CD can 
affect all of the digestive systems (from mouth to anus), whereas the inflammation observed 
in UC is restricted to the colon (Gersemann, et al., 2011). 30-40% of genetic risk loci are 
shared between the diseases despite their phenotypic differences (Zhernakova, et al., 2009; 
Budarf, et al., 2009; Fritz, et al., 2011), and patients with chronic uncontrolled colitis (CD or 
UC) have a significantly higher risk of developing colorectal cancer (Coussens, et al., 2002; 
Sheng, et al., 2011; Jawad, et al., 2011). The risk of UC-associated colorectal cancer elevates 
after seven years of extensive colonic disease (Guagnozzi, et al., 2012). Based on a meta-
analysis of 41 cumulative studies, IBD-associated colorectal cancer in UC patients was 2% at 
10 years, 8% at 20 years, and 18% after 30 years of disease (Eaden, et al., 2001). Although 
colorectal cancer occurs in a minority of IBD patients (1%), it accounts for approximately 20% 
of IBD-related deaths (Basseri, et al., 2011). The worldwide incidence rate of UC varies 
between 2.2-14.3/ 100,000 persons, whereas CD varies between 3.1-14.6/100,000 persons 
(CDC, 2014). While the precise aetiology of the diseases remains unclear, it is believed that 
they are caused by complex interactions between genetic, environmental and immune-
regulatory factors. This would involve: (1) the luminal bacteria and dietary factors; (2) the 
intestinal epithelial barrier; and (3) the innate and adaptive immune systems.   
The vast majority of research into the pathophysiology of UC has mainly concentrated on 
immunological aspects (Cader, et al., 2013; Geremia, et al., 2014). However, the role of 
defects in the production and maintenance of the mucus layer have not been extensively 
addressed. Increased intestinal permeability was reported as early as the 1980s in children 
with active small-bowel CD (Pearson, et al., 1982), a phenomenon that has been suggested 
as a predictor of relapse in CD patients (Wyatt, et al., 1993). More recently, barrier 
dysfunction was also described in UC patients (Arslan, et al., 2001; Welcker, et al., 2004). 
These findings, alongside MUC2 knockout (KO) mouse phenotypes, inform a hypothesis that 
defective mucus layers and tight junction abnormalities might contribute to disease 
progression. However, it remains to be shown whether permeability changes are primary 
events in disease development or secondary effects triggered by inflammation.  
By highlighting disease-associated genetic polymorphisms, genome-wide associated studies 
(GWAS) have implicated a number of genes as potential contributors to IBD susceptibility, 
particularly nucleotide-binding oligomerisation domain-containing protein 2 (NOD2), a 
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regulator of autophagy (Hugot, et al., 2001; Ogura, et al., 2001; Van Limbergen, et al., 2009; 
Fritz, et al., 2011). These genomic data have brought NOD2, autophagy and endoplasmic 
reticulum (ER) stress responses to light as a focus of IBD research for the past few years. For 
example, ER stress and the unfolded protein response (UPR) have recently been shown to be 
involved in the regulation of mucus secretion (Walter et al, 2011).  
The current gold standard treatment for moderate to severe IBD patients consists of anti-
inflammatory therapy (such as anti-tumour necrosis factor, or TNF). However these 
treatments can be considered to be targeting the symptoms rather than the underlying cause 
of the disease, which is typically unknown. Recent studies have implicated the cholinergic 
nervous system in mediating gut immune responses (Pavlov, et al., 2003; Pavlov, et al., 2008). 
Cholinergic signalling has additionally been shown to play a role in cell proliferation (Wessler, 
et al., 2008; Takahashi, et al., 2014), axon guidance (Xu, et al., 2011), muscle contraction 
(Parkman, et al., 1999; Gosens, et al., 2006), fluid secretion (Javed, at al., 1992; O’Malley, et 
al., 1995; Reynolds, et al., 2007) and mucus secretion (Halm and Halm, 2000), and 
cholinergic-mediated MAchR activation has been shown to mobilise intracellular Ca2+ 
(Lindqvist, et al., 1998; Lindqvist, 2000). These findings imply that there are connections 
between cholinergic signals, intracellular Ca2+ mobilisation and mucus secretion; however 
there is no specific evidence thus far regarding the underlying mechanisms of how 
cholinergic signals could mediate Ca2+ signal generation and how this relates to the 
regulation of mucus barrier function. Therefore the research question of this thesis asks what 
are these mechanisms, and how do they function, with the contention that it could 
potentially form the basis of a therapy for treating IBD. 
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1.1 Neuronal-epithelial cells interaction 
1.1.1 Structure and function of the human colon  
The human large intestine consists of the cecum, colon, rectum and anus, in order, totalling 
around one and a half meters in length. The colon is separated into four regions (Figure 1.2): 
the ascending colon (which passes upwards from the cecum on the right), transverse colon 
(the longest section which arches across), descending colon (passing downwards on the left) 
and sigmoid colon (the ‘S’ shaped region connecting to the rectum and anus).  The primary 
function of the large intestine is to absorb water from the remaining indigestible food matter 
(stool) (Grays, 1918; NIH National Cancer Institute). Mucus is secreted by colonic goblet cells 
into the gut lumen where in addition to its protective barrier functions it serves as a lubricant 
for the stool passing through the colon due to peristalsis. The stool is stored in the sigmoid 
colon and it normally takes about 36 hours for the content to be emptied into the rectum 
and passed out the body from the anus.   
 
 (Figure from Colorectal Cancer Association of Canada) 
  
Figure 1.2 Anatomy of the human Colon 
The large intestine consists of the cecum, 
colon, rectum and anus. The colon is 
further separated into four regions: 
ascending, transverse, descending and 
the sigmoid colon. The hepatic flexure 
(adjacent to liver) is a sharp bend 
between ascending and transverse colon. 
The splenic flexure (near spleen) is a 
sharp bend between transverse and 
descending colon. The primary function 
of the colon is to absorb water from the 
remaining indigestible food matter. 
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1.1.2 Mucin distribution along the GI tract 
The major functional components of the colonic barrier are mucin glycoproteins, the 
organisation of which varies along the GI tract (Atuma, et al., 2001). Similar to the large 
intestine, the stomach is protected by a relatively thick sterile firm inner mucus layer, where 
the loose outer layer contains low numbers of bacteria compared to the colon (Figure 1.3). 
This thick inner layer is believed to protect the lining from the acidic digestive enzymes. The 
mucins 5AC (MUC5AC) and MUC6 are the major mucin subtypes produced by stomach goblet 
cells. The MUC2 glycoprotein is the major type of gel-forming mucin found in the small and 
large intestines (Matsuo et al., 1997). In the small intestine, both the inner and outer mucus 
layers are very thin, and the mucins are produced by goblet cells and Paneth cells 
(Stappenbeck, 2009). Both thin mucus layers seem to facilitate the absorption of nutrients 
and minerals from the digested food (Ermund, et al., 2013B). Mucin production in the colon 
comes predominately from goblet cells (McGuckin et al., 2011). The large intestine is also 
protected by two layers of mucus, with the loose outer mucus layer (being the habitat of 
millions of commensals) being the thickest among the entire GI tract (Hansson, et al., 2010) 
(Figure 1.3). These bacteria have several useful functions such as synthesising vitamins (K 
and H), processing food waste (fermenting indigestible dietary fibre for the generation of 
short chain fatty acids) and protecting us from the actions of harmful bacteria. Thus, the 
thickness of the mucus layer correlates with the specific function of the different regions of 
the GI tract. However, the regulation of mucus secretion remains poorly understood. 
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Figure 1.3 Schematic diagram of the gastrointestinal mucosal barrier. 
The diagram shows the thickness of the two translucent mucus layers of the rat GI tract. The 
loose outer mucus layer (light grey) is continuous along the GI tract and can be easily 
removed by careful suction, while the firm inner mucus layer (dark grey) is relatively thicker 
and continuous only in the stomach (antrum) and colon. In the small intestine (duodenum, 
jejunum and ileum), the inner mucus layer (dark grey) is relatively thin, and exhibits a patchy 
distribution (non-continuous) and is absent from some individual villi according to some 
studies.  
(Figure from Atuma, et al., 2001) 
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1.1.3 Anatomy of the intestinal mucosa 
The mucosa is the innermost layer surrounding the lumen of the GI tract. Both the small and 
large gut wall are composed of the following four layers (outer to inner): serosa or adventitia 
(connective tissue), muscularis externa (two layers of smooth muscle, longitudinal and 
circular), submucosa (dense and irregular connective tissue) and mucosa (Figures 1.4 and 
1.6). The mucosa itself is further divided into three layers (inner to outer): epithelium, lamina 
propria (connective tissue), and muscularis mucosae (thin layer of smooth muscle) (Jaladanki, 
et al., 2011). The surface of the small intestinal epithelium has numerous finger-like 
protrusions called villi projecting into the lumen, which increases the surface area for 
absorption. These villi are closely associated with the pocket-like invaginations called Crypts 
of Lieberkϋhn (Figures 1.4 and 1.5). By contrast, villi are absent in the colon and the surface 
lining of the colonic epithelium is flat, pocked with numerous crypts (composed of a single 
layer of epithelial cells) that penetrate into the underlying submucosa (Figures 1.4 and 1.6) 
(Jaladanki, et al., 2011; Simons, et al., 2011a). These epithelial cells are under constant self-
renewal, being replaced every 4-5 days, with the stem cells located at the base of the crypts 
providing the proliferative activity of the crypt (Van der Flier, et al., 2009; Clevers, 2013a and 
b). The study of crypt biology is therefore faced with a number of relative technical 
difficulties, being complex physiological units composed of a heterogeneous mix of rapidly 
dividing cells. Furthermore, despite being highly prevalent – it has been estimated that there 
are about 20 million crypts in the human colon (Potten, et al., 2003) – given their location 
they are relatively inaccessible, which can make data or sample acquisition more difficult. 
  
 9 
 
 
 
 Figure 1.4 Structures of the colonic mucosa. 
The large intestinal wall is composed of four layers (from bottom to top): serosa, muscularis 
externa (longitudinal and circular smooth muscle layers), submucosa and the mucosa. The 
mucosa is further divided into three layers: muscularis mucosae (thin layer of smooth 
muscle), lamina propria (connective tissues) and the single epithelial cell layer folded into 
structures called Crypts of Lieberkϋhn. Openings of crypts face towards the gut lumen that 
are the passageways for fluid and mucus secretion. Goblet cells are one of the epithelial cell 
types embedded in crypts and are responsible for synthesis and secretion of mucus. 
(Figure from Encyclopaedia Britannica) 
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1.1.4 The organisation of human colonic crypt and the importance of stem cell niche 
The four major epithelial cell lineages present in the colonic crypt are: (1) the enterocytes or 
columnar cells, (2) the mucus-secreting goblet cells, (3) peptide hormone-secreting 
enteroendocrine cells and (4) tuft cells (Figure 1.5). Paneth cells and microfold (M) cells 
(other epithelial cell lineages found in the small intestine) are not detected in the colon 
(Cheng, et al., 1974b; Van der Flier, et al., 2009; Gerbe, et al., 2011; Simons, et al., 2011a). 
However, Paneth-like cells (goblet cells expressing the Paneth cell marker cKit) have been 
demonstrated to be present at the mouse colonic crypt base (Rothenberg, et al., 2012). 
These crypt base goblet cells have an intermediate gene signature between goblet and 
Paneth cells, but their functional significance remains uncertain (Date and Sato, 2015). All 
these cell types are terminally differentiated and are derived from the multipotent intestinal 
stem cells (ISCs) located at the bottom of the crypt (Figure 1.5) (Bjerknes, et al., 1981a and 
b; Simons, et al., 2011a and b; Gerbe, et al., 2012).  
The most abundant cell type in the colon are columnar cells, which make up more than 80% 
of intestinal epithelia. These cells are highly polarised and have a basal nucleus and an apical 
brush border, which plays a dual role in absorption and secretion (Cheng, et al., 1974b; Van 
der Flier, et al., 2009). Goblet cells play a major role in mucosal defence by secreting mucins. 
They also secrete other bioactive molecules believed to help protect and repair the 
epithelium and maintain mucosal barrier integrity, such as trefoil factors (TFF), resistin-like 
molecule beta (RELMβ) and Fc-gamma binding proteins (Fcgbp) (Kim, et al., 2010). In addition, 
the proportion of goblet cells increases from the duodenum (~4%) to the descending colon 
(~16%) (Karam, 1999). Enteroendocrine cells are present throughout the intestinal 
epithelium, which represents approximately 1% of all intestinal lineage. They produce 
peptide hormones which are secreted basally in an endocrine or paracrine manner 
(Tsubouchi, et al., 1979). Based on their morphology and specific hormone expression, 15 
different enteroendocrine cell subtypes have been identified (Schonhoff, et al., 2004). Tuft 
cells are very rare cell types identified which constitute roughly 0.4% of total epithelia 
(Bjerknes, et al., 2012; Gerbe, et al., 2012). Their precise function is unknown but is probably 
related to sensing the chemical content of the lumen (Hofer, et al., 1996; Clevers, 2013a and 
b).  All four lineages move up the crypt axis and are shed into the lumen after a few days 
while undergoing apoptosis. In addition, relatively long lived Paneth cells (2-3 months) at the 
base of small intestinal crypts produce lysozymes, antimicrobials, and defensins, which are 
stored in apical granules awaiting secretion, allowing them to play a major role in innate 
immunity in the small intestine (Bjerknes, et al., 1981b; Date and Sato, 2015). During 
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differentiation, Paneth cells move downward to the base of crypt and are suggested to 
regulate the stem cell niche by providing Wnt, Notch and EGF signalling to the stem cells 
(Bjerknes and Cheng, 1981a and b; Abdul khalek, et al., 2010; Sato, et al., 2011; Simons and 
Clevers, 2011a; Date and Sato, 2015). M cells are expressed at the surface of the gut 
associated lymphoid tissue (GALT) in the small intestine, where they transport luminal 
antigens to immune cells such as dendritic cells and macrophages (Neutra, 1998).  
Due to the high turnover of cells there is a strong pressure to maintain homeostasis of the 
intestinal epithelium. The ISCs are Lgr5+ (Barker, et al., 2007) and were first identified as crypt 
base columnar cells (CBCC) undergoing continuous cell cycling by Cheng and Leblond in 1974. 
These ISCs are crucial for the renewal of the differentiated progeny within the intestinal 
epithelial layer (Leblond and Stevens, 1947; Medema, et al., 2011; Clevers, 2013a) and play 
a major role in maintaining the cellular organisation of the mucosa. Briefly, the stem cells 
proliferate and exit the stem cell zone at the base of crypt and start to differentiate into one 
epithelial cell lineage; once committed the lineage will further mature upon migration up 
along the crypt axis (Bjerknes and Cheng, 1981a and b). Moreover, extensive evidence 
demonstrates the importance of Wnt and Notch signalling pathways in maintaining the ISC 
niche and regulating normal crypt dynamics (Pinto, et al., 2003; van Leeuwen, et al., 2009; 
Ogaki, et al., 2013). Furthermore, reactive oxygen species (ROS) has recently emerged as an 
important mediator of stem cell homeostasis in various systems, in particular, Rac1-
dependent ROS has also been shown to drive stem cell proliferation and regeneration in 
mouse model of colorectal cancer (Myant, et al., 2013). 
  
 12 
 
 
Figure 1.5 Characterisation of intestinal epithelial cell lineages in crypt and villus 
The epithelium is composed of a variety of cell types. Intestinal stem cells (ISCs) are Lgr5+ 
and were first identified as crypt base columnar cells (CBCC, red) located at the base of the 
crypt. These stem cells are involved in the generation of progenitor cells (pink) that 
subsequently differentiate into other epithelial cell lineages including enterocytes (green), 
goblet cells (orange), enteroendocrine cells (purple), and Paneth cells (small intestinal crypt 
only, light blue); and they play an important role in the renewal and repair of the epithelium. 
Some studies have suggested the presence of +4 cells (quiescent stem cell population, yellow) 
that function to replenish the active stem cell population after crypt injury. Other newly 
identified epithelial cell lineages including tuft cells and M cells (small intestine only) are not 
shown in this figure. The subepithelial myofibroblast (dark blue, alpha-smooth muscle actin-
positive (α-SMA+) mesenchymal cells in the lamina propria) has also been shown to be 
involved in growth and repair, tumorigenesis and fibrosis of the intestine.  
(Figure from Medema, et al., 2011) 
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1.1.5 Enteric nervous system 
The enteric nervous system (ENS), called the second brain by some, is embedded in the wall 
of the GI tract. It contains 200-600 million neurons which are distributed in many thousands 
of small ganglia. The majority of these ganglia can be found in the myenteric (Auerbach’s) 
plexuses located between the inner and outer layer of the muscularis externa; and in the 
submucosal (Meissner’s) plexuses located in the submucosa (Figure 1.6) (Bowen, R. 2006; 
Furness, J. 2008). Both plexuses receive central nervous system (CNS) signals via the 
parasympathetic and sympathetic systems, which can control the activation and inhibition 
of the gastrointestinal functions respectively. The ENS is also an autonomous system, which 
includes a number of efferent-, afferent- and interneurons (the neural circuits) which make 
the system capable of reflex actions and signal transduction in the absence of the CNS input 
(Furness, et al., 2014). 
The function of the ENS is to control blood flow, motor functions, mucosal transport and 
secretions, and also to modulate immune and endocrine functions. All these events are 
interlinked and are operated in concert by independent enteric neural networks, including 
the muscle motor neurons, secreto-motor neurons, and vasodilator neurons (Costa, et al., 
2000). To perform their functions, the primary afferent (sensory) neurons sense thermal, 
chemical and mechanical stimuli; the signals are then conveyed by interneurons which act 
directly on different effector cells including the smooth muscle, mucosal glands, blood 
vessels and epithelial cells (Costa, et al., 2000).  
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Figure 1.6 Enteric nervous systems.   
The wall of the GI tract is innervated with a few hundred millions of neurons (enteric nervous 
systems) and these neurons are distributed in many thousands of small ganglia. The majority 
of these ganglia are found in the myenteric (Auerbach’s) plexuses located between the two 
layers of the muscularis externa; and in the submucosal (Meissner’s) plexuses located in the 
submucosa. Some nerve (axon) terminals are further extended from the submucosa into the 
mucosa (crypts) (Figures 3.1, 3.2 and 3.4). The functions of the ENS are to control blood flow, 
motility, transport of fluid, secretion of mucus, and also to modulate immune and endocrine 
functions. 
(Figure from McGraw Hill text book Human physiology) 
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1.1.5.1 Cholinergic innervation of the colonic epithelium 
The colonic epithelium is under the neuronal control of the ENS. The neurons that extend 
from the submucosal plexus into the mucosa can be cholinergic and non-cholinergic. These 
cholinergic neuronal networks are the major source of the neurotransmitter Ach in the 
intestine. Other classical neurotransmitters such as dopamine, serotonin and histamine are 
also well known regulators of gut physiology. Cholinergic innervation has been detected by 
vesicular acetylcholine transporter (VAChT) labelling (Schafer, et al., 1998). In particular, the 
release of Ach into the neuro-epithelial junction stimulating ion secretion from intestinal 
mucosa is a well-known phenomenon (Brown, et al., 1997). Chloride (Cl-) secretion in the 
colonic mucosa mediated by cholinergic stimulus has been mostly studied in animal models 
(McCulloch, et al., 1987; Diener, et al., 1989; Javed, et al., 1992; O’Malley, et al., 1995) and 
more recently in humans (Cliff, et al., 1998; Reynolds, et al., 2007; Toumi, et al., 2011). In 
addition, cholinergic agents via the muscarinic receptor signal transduction have also been 
shown to accelerate mucus exocytosis from goblet cells throughout the intestines of rats 
(Neutra, et al., 1982). All these studies strengthen the role of neurotransmitters in regulating 
gastrointestinal functions.  
Ach functions as a neuromodulator in both the CNS and peripheral nervous systems (PNS). It 
is also a major neurotransmitter in the autonomic nervous system. Ach was first identified 
by Henry Hallett Dale in 1915 when he demonstrated its role on heart tissue. It was later 
identified as the first neurotransmitter when Otto Loewi described the function of the 
chemical when it was released from the vagus nerve. Ach is a fast-acting neurotransmitter, 
synthesised by the enzyme choline acetyl transferase (ChAT) from its two immediate 
precursors – choline and acetyl coenzyme A (Figure 1.7) (Tucek, 1983; Wurtman, et al., 2008).  
This event is dependent on the Na+ dependent CHT1 transporter (high-affinity choline 
transporter/SLC5A7 (solute carrier family 5 member 7)) for transferring the Ach precursor 
choline into the cytosol of the cholinergic nerve endings (Ribeiro, et al., 2006). The source of 
this choline is thought to be either hydrolysis by cholinesterase from the released Ach or 
from the breakdown of phosphatidylcholine (Wurtman, et al., 2008). Following synthesis by 
ChAT, Ach is then loaded into synaptic vesicles by vesicular Ach transporter (VAChT / 
SLC18A3) prior to being released by exocytosis (Parsons, et al., 1987; Parsons, 2000). These 
synaptic vesicles accumulate thousands of Ach molecules to form a quantum, in which this 
process is driven by an electrochemical gradient generated by a proton ATPase (Parsons, 
2000) (Figure 1.7). However, VAChT acts very slowly, thus serving as a limiting factor for 
maintaining Ach release (Varoqui and Erickson 1996). Moreover, ChAT and VAChT have been 
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suggested to be co-regulated, as the gene encoding VAChT was discovered to be located 
within an intron of the ChAT gene (Erickson, et al., 1996). Both ChAT and VAChT are required 
for cholinergic neurotransmission. Since ChAT protein expression is concentrated at the 
nerve endings of cholinergic neurons, and VAChT is predominantly expressed in synaptic 
vesicles in the same location (Gilmor, et al., 1996), both ChAT and VAChT proteins have been 
used as markers for cholinergic neurons in immunohistochemical studies (Ichigawa, et al., 
1997).  
 
 
Figure 1.7 Acetylcholine synthesis and secretion at the cholinergic synapse  
A typical neuron consists of complex dendritic arbors that receive electrochemical (synaptic) 
inputs from other neurons, a cell body (containing the nucleus) and an axon that transfers 
signals to postsynaptic cells (neurons or other effector cells) (left). Ca2+ serves multiple 
complex and integrated functions, including the control of dendritic responses to 
neurotransmitters; and the initiation of neurotransmitter Ach release from presynaptic 
cholinergic axon terminals (red box) upon a nerve impulse (right). At nerve endings, ChAT is 
the enzyme responsible for Ach synthesis in the presence of the substrate choline, while 
VAChT is responsible for transferring Ach into secretory vesicles. Upon release, Ach binds to 
cholinergic receptors on the membrane of the postsynaptic cell.  
(Figure from New World Encyclopaedia-Nervous system (Left); figure partially adapted from 
quizlet.com images- cholinergic synapse (Right)) 
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1.1.5.2 Non-neuronal Ach in the regulation of intestinal physiology 
The traditional view of Ach acting solely as a neurotransmitter has been revised after 
significant amount of studies demonstrated the production of Ach in non-neuronal 
cholinergic systems (Keely, 2011; Grando, et al., 2012). It was first observed by Sastry and 
Sadavongvivad in 1979, and subsequently Ach synthesis has been identified in a range of 
non-neuronal cells including lymphocytes (Kawashima, et al., 2000), epithelial cells (Wessler, 
et al., 2003), vascular endothelial cells (Kirkpatrick, et al., 2001), and keratinocytes (Grando, 
et al., 1993). Evidence is mainly provided by ChAT labelling, Ach content (measured by HPLC 
or microdialysis) and muscarinic receptor expression (Wessler, et al., 2008). However, our 
knowledge about the mechanism of the non-neuronal Ach release is still very limited. In the 
airway epithelium, organic cation transporters (OCT) subtypes 1 and 2 have been shown to 
mediate non-neuronal Ach release (Lips, et al., 2005; Kummer, et al., 2006). Since OCTs are 
widely expressed in most cells, they can be considered appropriate candidates for non-
neuronal Ach transport.  
In the intestine, non-neuronal Ach release was first identified by Klapproth et al in 1997 in 
rats and humans, and again in humans by Jönsson et al in 2007.  However, the physiological 
relevance of this regulation is still poorly understood. Recent findings by Yajima et al (2011) 
and Bader et al (2014) provide valuable insights into the non-neuronal Ach regulation of gut 
physiology. They demonstrated that the fatty acid propionate stimulates non-neuronal Ach 
release which coupled to chloride secretion in the rat colon. In addition, they also showed 
the expression of ChAT and OCT transporters in the colonic epithelial cells. These 
observations fully support a model in which synthesis and release of Ach occurs in the colon 
without cholinergic innervation, and that the release of endogenous epithelial Ach in 
response to short chain fatty acids (the contribution of microbiota) could play an important 
role in regulating goblet cell mucus exocytosis and maintaining the barrier function. 
Moreover, by using mouse crypt-villus organoids that lack nerves and immune cells, 
Takahashi and colleagues (2014) demonstrated that endogenously synthesised Ach regulates 
growth and differentiation via muscarinic receptor activation. Thus, Ach is not only a 
neurotransmitter, but can also function as an intercellular messenger that integrates 
different aspects of intestinal physiology. Taken together, these studies open up new insights 
about the non-neuronal regulation of gut physiology and a potential target for developing 
new therapies for colonic diseases.  
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1.1.6 Muscarinic Acetylcholine Receptor signalling 
The two main classes of Ach receptors are the nicotinic (NAchR) and muscarinic receptors 
(MAchR) (Wess, 2003). The concept of these receptors was first described by Dale in 1914, 
and confirmed by Loewi, Dale and others between 1921 and 1934. MAchRs were named 
because they are selectively activated by muscarine, a natural product of the mushroom 
Amanita muscaria which can mimic the actions of parasympathetic neurons. Its action can 
be blocked by atropine, a derivative from the plant Atropa bella-donna (Hulme, et al., 1990). 
MAchRs are expressed in both the CNS and PNS, in particular in the target organs of 
parasympathetic neurons (van koppen, et al., 2003). It has been shown that they modulate 
a variety of physiological functions such as smooth muscle contraction and secretions from 
glands (Caulfield, 1993).  
 
1.1.6.1 G-protein coupled receptor 
MAchR belongs to the seven-transmembrane receptor superfamily, which interact with 
heterotrimeric guanine nucleotide binding regulatory proteins (G proteins) to activate signal 
transduction. G proteins are composed of alpha (α), beta (β) and gamma (γ) subunits. These 
proteins are categorised by their α-subunits into four broad types: Gαs, Gαi, Gαq and Gα12/13 
(Sanders, 1998). In addition, five isotypes of β and at least 12 γ subunits have been identified 
(Sanders, 1998). The α-subunit is critical for normal functioning of the G protein. In its 
inactive state it binds GDP: upon G protein activation, the exchange of bound GDP with GTP 
leads to dissociation of the βγ subunit (figure 1.8). The α-subunit then in turn interacts with 
the effector protein to stimulate or inhibit the release of intracellular second messengers 
(Weiss, et al., 1988). The βγ subunit was originally shown to be required for the GDP-GTP 
exchange at the α subunit of the G protein (Florio, et al., 1989), but more recent studies have 
revealed their role in regulating signal transduction (Katz, et al., 1992). Significant amount of 
studies have shown the existence of G-protein coupled receptor (GPCR) as dimers/ oligomers, 
that appears to be assembled either in the ER or at the cell surface (Devi, 2001). 
Heteromerisation of GPCR has emerged as an important process in recent years for receptor 
function specification that mediate distinct biological responses (Milligan, et al., 2009; Ferre, 
et al., 2014).  
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Figure 1.8 G-protein coupled receptor signal transduction 
GPCR are seven transmembrane receptors that activate intracellular signal transduction. 
Ligand binding causes a conformation change of the receptor, exchanging of GDP to GTP of 
the α-subunit dissociates the βγ subunits. The GTP bound α-subunit then activates 
downstream signal transduction, whereas the βγ subunit has also been shown to activate 
further effector functions.  
(Figure from Belmonte, et al., 2011) 
 
In mammals, five subtypes of MAchR have been identified, termed M1 to M5 (or M1AchR to 
M5AchR) (Bonner, et al., 1987). Each receptor subtype is encoded by a different gene 
(CHRM1-5) (Bonner, et al., 1987; Nathanson, 2000). The odd-numbered receptors (M1, M3 
and M5) are coupled to the pertussis toxin-insensitive Gαq/11 and Gα13 proteins, which 
activate phospholipase A2 (PLA2), phospholipase C (PLC) and phospholipase D (PLD) (Fukada, 
et al., 1987; Wess, et al., 1989); whereas the even numbers (M2 and M4) are coupled to 
pertussis toxin-sensitive Gαi and Gαo proteins, which inhibit adenylyl cyclase (Peralta, et al., 
1988; Caulfield, 1993; Felder,1995; Caulfield and Birdsall, 1998; Rϋmenapp, et al., 2001). 
These different receptor subtypes can couple to a diverse array of signalling pathways via 
these G proteins (Ashkenazi, et al., 1989). With regards to the gut, signalling through M1, M2 
and M3 receptors has been shown to influence intestinal activity such as motility and 
secretion (Cooke, 2000; Harrington, et al., 2010).  
In most model systems, MAchR activation increases intracellular Ca2+ concentration [Ca2+] up 
to 20-fold (Budd, et al., 1999). Activation of different MAchR subtypes can mediate different 
signal transduction pathways. Activation signals via PLA2 catalyses the hydrolysis of 
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membrane phospholipids to form arachidonic acid and lysophospholipids. Arachidonic acid 
is then converted to a variety of eicosanoids (bioactive fatty acid derivatives) such as 
prostaglandins, thromboxanes and leukotrienes, whereas lysophospholipids are recycled 
within the membrane (Felder, 1995). The release of arachidonic acid and eicosanoids upon 
MAchR activation has been shown in a variety of tissues including the heart, muscle and brain 
(Abdel-Latif, 1986). Moreover, activation signals via PLD promotes the hydrolysis of 
phosphatidylcholine (PC) into choline and phosphatidic acid (PA) (Figure 1.9) (Felder, 1995; 
Liscovitch, et al., 2000). In most cells studied, PLC and PLD are stimulated simultaneously 
after agonist induced receptor activation, but through independent processes (Liscovitch, 
1991). 
 
1.1.6.2 Muscarinic receptor mediated intracellular calcium signalling in the ER 
ER is a highly dynamic organelle. In addition to its role in protein synthesis and packaging, it 
is also the major intracellular Ca2+ store within the cell that mediates many signalling 
processes (Berridge, 2002). The ER intraluminal [Ca2+] is about 0.5 mM (Alvarez, et al., 2002). 
Ca2+ homeostasis in the ER is predominantly controlled by three mechanisms: refilling of the 
store is maintained by the continuous activity of the sarco/endoplasmic reticulum Ca2+ 
ATPase (SERCA) pump and capacitive Ca2+ entry (or store-operated Ca2+ entry (SOCE)) 
(Takemura, et al., 1989; Putney, 2001; Putney, 2008), while efflux is mediated through the 
Ca2+-induced Ca2+ release (CICR) response (Berridge, 2002). Inositol 1,4,5 triphosphate 
receptors (IP3Rs) and Ryanodine receptors (RYRs) are the two main Ca2+ channels on the ER 
membrane. 
The most common MAchR signal transduction is via the activation of PLC (Budd, et al., 1999). 
Upon Ach binding, M3AchR activation initiates conformational change of the receptor, 
promoting its association with the heterotrimeric G protein (Gαqβγ). The activation of the G 
protein causes the dissociation of βγ subunits from the α-subunit, freeing the α-subunit to 
travel along the cell membrane and activate additional PLC molecules. PLC in turn initiates 
phosphatidyl-inositol 4, 5 bisphosphate (PIP2) hydrolysis (a drastic decrease of membrane 
PIP2 levels by 75% within seconds of agonist stimulation) to generate diacylglycerol (DAG) 
and inositol 1,4,5 triphosphate (InsP3 or IP3) (Felder, 1995; Budd, et al., 1999). IP3 then 
translocate to the ER where it binds to the IP3R and promotes Ca2+ release from the ER Ca2+ 
store into the cytosol (Felder, 1995; Nahorski, et al., 1997). Increase in cytosolic [Ca2+] in turn 
activates the IP3R and RYR and induce the CICR response (Ca2+ waves) in the entire cell 
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(Figure 1.9) (Taylor and Dale, 2012). This mobilisation of intracellular Ca2+ then initiates a 
variety of physiological responses such as transcription of genes, muscle contraction and 
fluid secretion (Caulfield, 1993; Billington, et al., 2002; Gerthoffer, 2005; Kong and Tobin, 
2011). The ER store depletion mediated by IP3 is then refilled by the SOCE mechanism. The 
magnitude and kinetics of the CICR and SOCE responses in a cell are dependent on the precise 
intracellular channel isoforms and their subcellular localisation in the ER.  Meanwhile, DAG 
binds to and activates PKC (Felder, 1995). While the molecular mechanisms of DAG and PKC 
signalling are not fully understood, and the immediate downstream effects of PKC are 
unclear, PKC has been shown to activate downstream effectors in regulating proliferation, 
differentiation, cell migration, cell death and secretion (Nishizuka, 1989; Kai, et al., 1994). In 
addition, DAG can also be converted to PA by DAG kinase (Kanoh, et al., 2002), which might 
terminate signalling downstream of DAG. MAchR activation has been shown to activate the 
ectoenzyme CD38 (ADP-ribosyl cyclase), causing it to synthesise Cyclic ADP Ribose (cADPR) 
and nicotinic acid adenine dinucleotide phosphate (NAADP) (Higashida, et al., 2001a and b). 
However, it is unclear whether CD38 signalling is downstream of PKC.  
To sum up, Ca2+ release from the ER amplifies cytosolic Ca2+ signals, but there are also 
multiple feedback mechanisms that prevent Ca2+ overload such as mitochondrial Ca2+ uptake 
and extrusion from cell via Na+/Ca2+ exchanger (NCX) on the plasma membrane. The uptake 
of Ca2+ by the mitochondria accelerates the decline in cytosolic [Ca2+], which can influence 
the Ca2+ signal transduction cascade. Because all intracellular Ca2+ channels on the ER 
membrane are governed by different regulatory mechanisms, the control of Ca2+ 
homeostasis in the ER remains relatively complex.  
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Figure 1.9 Schematic diagram of the M3AchR signal transduction pathways upon Ach 
stimulation. 
The binding of Ach to M3AchR triggers the dissociation of βγ subunits from α subunit of the 
G protein. The alpha (α) subunit travels along the plasma membrane and activates 
phospholipase C (PLC). PLC then initiates the hydrolysis of phosphatidyl-inositol 4, 5 
bisphosphate (PIP2) into inositol 1,4,5 triphosphate (IP3) and diacylglycerol (DAG). 
Subsequent translocation of the 2nd messenger IP3 to the ER membrane allows its binding to 
the IP3R and triggers intracellular Ca2+ mobilisation from the ER store. Localised increase in 
cytosolic [Ca2+] further activates IP3 receptor (IP3R) and ryanodine receptor (RYR) on the ER 
membrane and induces Ca2+-induced Ca2+ release (CICR) response. Meanwhile, DAG 
activates the downstream signalling molecule protein kinase C (PKC). It is currently unclear 
whether PKC directly activates CD38 upon M3AchR activation or via some upstream 
signalling molecules potentially phosphatidic acid (PA, converted from DAG) and/ or NADPH 
oxidases (not shown). CD38 is an enzyme synthesising both 2nd messenger Cyclic ADP Ribose 
(cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) that could also trigger 
cytosolic [Ca2+] increase upon binding to RYR and Two pore channel (TPC) respectively. 
Through independent processes, phospholipase D (PLD) can also be activated upon PLC 
activation. PLD then promotes the hydrolysis of phosphatidylcholine (PC) into choline and 
PA, suggesting PA might be an important effector for M3AchR signal transduction pathway.  
 (Partially adapted from Gerthoffer 2005)  
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1.2 Intracellular calcium signalling 
Ca2+ is an important 2nd messenger, which helps control almost every cellular activity. Our 
modern understanding of the role of Ca2+ began with the studies by Sydney Ringer in early 
1880s when he first demonstrated that Ca2+ ions were indispensable for certain physiological 
functions, such as muscle contraction, cell adhesion and the development of fertilized eggs 
(Ringer, 1883- 1894, reviewed by Miller, 2004). In particular, his observation that 
extracellular Ca2+ removal abolishes contraction of the frog heart suggested that the influx 
of Ca2+ ion across the cell membrane might regulate intracellular activity (reviewed by Miller, 
2004). In 2002, Bers suggested that Ringer’s observation was due to depolarisation-triggered 
Ca2+ entry through the plasma membrane, triggering CICR via the RYR in the ER membrane 
(Bers, 2002). Thus, while the extracellular Ca2+ signal was not directly responsible for heart 
contraction, it triggers a huge intracellular release of Ca2+ from the ER store. These studies 
provided the first lines of evidence that regulation of Ca2+ entry is important for physiological 
functions, building on the concept of Ca2+ ion storage within intracellular organelles that was 
established in 1965. Sandow demonstrated that the major source of Ca2+ triggering striated 
muscle contraction was indeed also coming from the sarcoplasmic reticulum (SR) (Sandow, 
1965). Subsequently in 1984, Streb discovered that IP3 stimulates Ca2+ release from non-
mitochondrial Ca2+ store in pancreatic acinar cells (Streb, 1984). Later studies confirmed that 
the ER is the major intracellular source of Ca2+ in most cells (Berridge & Irvine, 1984; Berridge 
& Irvine, 1989). Previous studies had also suggested the possible role for IP3 in releasing Ca2+ 
from other intracellular organelles into the cytosol including the Golgi apparatus (Pinton, et 
al., 1998), nucleus (Gerasimenko, et al., 1995; Marchenko, et al., 2005) and secretory vesicles 
(Gerasimenko, et al., 1996). Our current understanding of the spatiotemporal complexity in 
the regulation of cytosolic [Ca2+] relies mainly on the extracellular Ca2+ (~ 1.2mM) and the 
intracellular Ca2+ stores (>100µM), while the resting cytosolic [Ca2+] is approximately 50-
100nM, which generates a concentration gradient across the plasma and organelles 
membranes (Streb, et al., 1984; Pozzan, et al., 1994). Recent studies have identified several 
other intracellular Ca2+ channels that are unrelated to IP3R and RYR, in mediating Ca2+ signal 
transduction. In particular, Two pore channels (TPCs) have been shown to regulate Ca2+ 
release from intracellular acidic organelles (Brailoiu, et al., 2009; Calcraft, et al., 2009; Zong, 
et al., 2009; Patel, et al., 2010; Zhu, et al., 2010). Finally, the transient receptor potential 
cation (TRPC) channels not only mediate Ca2+ influx through the plasma membrane, but 
several receptor subtypes such as TRPV (vanilloid) and TRPML (mucolipin) may also mediate 
Ca2+ release from intracellular stores (Puertollano, et al., 2009; Gees, et al., 2010). At present, 
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it is widely appreciated that Ca2+ signals generated through different mechanisms act via 
different channels and through different pathways. All such channels do not function alone, 
instead working in concert to maintain intracellular Ca2+ homeostasis.  
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1.2.1 Intracellular calcium homeostasis and physiological responses 
Intracellular Ca2+ homeostasis involves dynamic processes which dictate the balance 
between (1) Ca2+ entry into and extrusion from cells; and (2) Ca2+ uptake into and release 
from organelles (Sneyd, et al., 1995; Brini and Carafoli, 2009). Eukaryotic cells contain various 
Ca2+ transport systems (channels), belonging to a number of different subtypes and 
subcellular locations, which make the transport process relatively complex. These channels 
are mainly localised on the plasma membrane, and the membranes of the intracellular 
organelles including the ER, Golgi, mitochondria and endo-lysosomes. The plasma 
membrane typically contains three Ca2+ transport systems: the plasma membrane Ca2+ 
ATPases (PMCA), Na+/ Ca2+ exchanger (NCX), and the Ca2+ channels (CRAC, TRPC). The first 
two systems are involved in the removal of cytosolic Ca2+ into the extracellular space, while 
the latter one is involved in extracellular Ca2+ entry into cell (Brini and Carafoli, 2009). The ER 
and mitochondria have long been known to be key players in regulating cytosolic [Ca2+], 
whereas the role of the endo-lysosomes has come to our attention more recently, in the late 
2000s. The major intracellular Ca2+ channels (IP3R, RYR), ATPase pump (SERCA) in the ER, and 
endo-lysosomal stores (TPC) will be discussed in the following sections. 
As discussed previously, elevation of cytosolic [Ca2+] mediates certain cellular responses. The 
physiological outcomes are very diverse, ranging from extremely rapid events such as muscle 
contraction and neuro-secretion, to more orchestrated responses such as cell division, 
differentiation and apoptosis (Dupont, et al., 2011). In the human colon, Ca2+ signalling has 
been shown to be important for fluid secretion and tissue renewal of the colonic epithelium 
(Lindqvist, 2000; Reynolds, 2007). Chronic disruptions of Ca2+ homeostasis have also been 
shown to be causative in the development of certain diseases such as neurodegeneration 
(Mattson, et al., 2003), heart failure (Scoote, et al., 2004) and cognitive deficits in senescence 
(Toescu, et al., 2004). Therefore, the balance between the supply and removal of cytosolic 
Ca2+ is key to maintain homeostasis.  
  
 26 
 
1.2.1.1 Spatial and temporal aspects of calcium oscillations 
MAchR induced Ca2+ signals (oscillations or waves) in a cell can vary with respect to time and 
space (Lechleiter, et al., 1991b; Berridge, 1993). The two general properties of Ca2+ 
oscillations are: (1) each Ca2+ spike or oscillation is primarily due to intracellular release-
transient phase. (2)  The oscillations rapidly run down in the absence of extracellular Ca2+, 
indicating the requirement of Ca2+ influx to maintain the system-plateau phase (Thomas, et 
al., 1996; Bird, et al., 2005; Dupont, 2011). Oscillations and waves of cytosolic Ca2+ were first 
described by Prince and Berridge in 1973 and Woods et al in 1987, respectively (Prince and 
Berridge, 1973; Woods, et al., 1987). It is now known to be a common phenomenon in a wide 
range of cell types upon agonist stimulation of second messengers, revealed through a 
number of experimental devices. IP3-dependent release of Ca2+ from ER stores via IP3R is 
considered to be one of the hallmark models of Ca2+ oscillation. By using Ca2+ specific 
fluorescent dye such as Fura-2 AM and Fluo-4 AM, the spatial and temporal dynamics of 
these Ca2+ oscillations in cells can be visualised. Temporal events of Ca2+ oscillations have 
been measured experimentally with photomultipliers as average recordings from whole cells 
or as regions of interest within a cell or structure (Sneyd, et al., 1995). Ca2+ waves are 
transient and repetitive (Berridge, 1990a and b), yet imaging techniques have clearly 
indicated that Ca2+ oscillations are not uniformly distributed, but rather initiated in a specific 
site of the cell and then propagated to other regions of the cell (Sneyd, et al., 1995). Upon 
PLC activation in a restricted region of the cell, newly-generated IP3 is then free to diffuse 
outwards, stimulating Ca2+ release by binding to IP3R on the ER membrane (Rooney, et al., 
1993). The size of the cell can also influence the appearance of such Ca2+ waves. In very large 
cells, such as Xenopus oocytes, the Ca2+ wave can be organised into complex spatiotemporal 
patterns such as rotating spirals or multiple concentric circles (Lechleiter, et al., 1991a).  
Intercellular communication is required for transmitting regulatory signals in multicellular 
organisms (Figure 1.12). Intercellular Ca2+ waves are one form of communication that allows 
a single cell to interact with multiple adjacent cells (Sneyd, et al., 1995). These waves were 
first observed in epithelial and glial cell cultures in response to neurotransmitters, and are 
now commonly observed in many other cell types (Sanderson, et al., 1994). However, these 
spatiotemporal patterns of [Ca2+] are not fully understood. One popular proposed model is 
that IP3 generated by mechanical stimulation in the stimulated/ initiator cell diffuses from 
cell to cell through gap junctions to spread the Ca2+ signals (Sneyd, et al., 1995). 
It has become increasingly clear that periodic discharges and/or entry of Ca2+ is the common 
signalling pattern in both excitable and non-excitable cells. In excitable cells such as 
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myocardium, Ca2+ signals are initiated by the Ca2+ action potential (electrical or nerve impulse) 
on the plasma membrane (Hess, et al., 1986) and then amplified by the release of 
intracellular Ca2+ (Fabiato, 1983). In non-excitable cells such as epithelial cells, Ca2+ signals 
initiate from the discharge of ER stored Ca2+ into the cytosol. However, a study by Bird and 
Putney demonstrated that some non-excitable cells do not require Ca2+ influx to drive 
oscillations, which seems at odds with the original two proposed general properties of Ca2+ 
oscillations (Bird and Putney, 2005). In the human epithelial kidney (HEK293) cell line, 
methacholine (a MAchR agonist) induced Ca2+ oscillation is sustained by SOCE. Bird and 
Putney demonstrated that this Ca2+ oscillation can also be sustained when the cells are 
treated with high concentrations of Gadolinium (III) Chloride (GdCl3, 1mM) that blocks the 
transcellular Ca2+ fluxes across the plasma membrane via the PMCA. These findings suggest 
that the mechanisms underlying Ca2+ oscillations can be intrinsic to the intracellular milieu 
and that Ca2+ entry is not a requirement if Ca2+ ions were prevented from being pumped out 
of the cell (Bird and Putney, 2005). Presently, controversy remains about the precise mode 
of Ca2+ entry associated with Ca2+ oscillations. 
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1.2.2 Intracellular calcium channels 
1.2.2.1 Inositol 1,4,5 triphosphate receptors 
In addition to being one of the major Ca2+ release channels expressed in the ER membranes 
of most cell types, IP3Rs are also expressed in the Golgi apparatus, secretory vesicles and in 
plasma membrane of some specialised cells (Dellis, et al., 2006; Taylor, et al., 2010; Yoo, et 
al., 2010). In mammals, three IP3R isoforms (IP3R1, 2 and 3) have been identified. All these 
IP3Rs are regulated by both IP3 and Ca2+ (Finch, et al., 1991; Marchant and Taylor, 1997; 
Foskett, et al., 2007), albeit with different affinities of IP3 binding. The general consensus of 
the receptor sensitivity hierarchy is that IP3R2 > IP3R1 > IP3R3 (Tu, et al., 2005a; Tu, et al., 
2005b; Iwai, et al., 2007). In addition, expression levels of the receptor (Dellis, 2006), 
subcellular distribution of the receptor (Petersen, et al., 1999), and the presence of accessory 
proteins (Patterson, 2004), can also influence IP3R sensitivity. Opening of IP3Rs upon IP3 
stimulation allows Ca2+ movement across the ER membrane into the cytosol (Foskett, et al., 
2007). Each ten millisecond (10 ms) opening of the IP3R can mediate a large Ca2+ flux 
(approximately 104 Ca2+ ions) into the cytosol (Vais, et al., 2010). Moreover, a single IP3R 
opening may be sufficient to evoke a cellular response (Ca2+ blips). The presence of IP3 causes 
IP3R clustering, and the coordinated opening of several IP3Rs culminates in Ca2+ puffs. With 
sufficient IP3, these individual Ca2+ puffs culminate to form a regenerative Ca2+ wave which 
spreads across the entire cell (Figure 1.10) (Bootman, et al., 1997; Demuro and Parker, 2008).  
Ca2+ regulation of IP3Rs is biphasic. A moderate increase of cytosolic [Ca2+] augments the 
receptor response to IP3, whereas high cytosolic [Ca2+] inhibits the IP3R (Iino, 1987; Finch, 
1991; Marshall and Taylor 1993). This Ca2+ mediated inhibition of IP3R is probably due to 
direct Ca2+ binding to the IP3R or the formation of Ca2+complexes with accessory proteins 
such as calmodulin (CaM) (Hirota, et al, 1999; Nadif, et al., 2002; Taylor and Laude, 2002). 
Previous studies have suggested the presence of essential Ca2+ binding sites on the IP3R. 
Marshall and Taylor (1994) suggested that there are distinct stimulatory and inhibitory Ca2+ 
binding sites on the IP3R, and that the essential role of IP3 is to promote the binding of Ca2+ 
to the stimulatory binding site to mediate opening of the channel (Marshall and Taylor, 1994). 
However, a study by Mak and colleagues revised the initial model of inhibition, by suggesting 
that the absence or presence of IP3 controls the switching of a single Ca2+ binding site from 
being inhibitory to stimulatory respectively (Mak, et al., 2003). This model suggests that IP3 
not only alleviates Ca2+ inhibition but also promotes Ca2+ binding to the IP3R (Marchant and 
Taylor, 1997; Adkins and Taylor, 1999). However, the molecular mechanism of inhibition 
remains unclear. In experimental condition, IP3Rs can be blocked by the non-specific 
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inhibitor 2-amino-ethyl diphenylboronate (2-APB, Bootman, et al., 2002) or the specific 
inhibitor Xestospongin C (Xes C, Gafni, et al., 1997), in which 2-APB has been shown to block 
IP3 mediated Ca2+ release without affecting IP3 binding (Maruyama, et al., 1997). Moreover, 
high concentrations of caffeine have also been shown to inhibit IP3-mediated Ca2+ release 
(Parker and Ivorra, 1991) without affecting IP3 binding (Worley, et al., 1987). Since caffeine 
can also stimulate the RYR (Endo, 1977), it becomes difficult to differentiate Ca2+signals 
released from these two receptors upon activation. 
 
Figure 1.10 Calcium oscillation event evoked by IP3. 
(Top) Single IP3R opening mediated by low [IP3] evokes Ca2+ blips. The presence of IP3 causes 
IP3R clustering which facilitates Ca2+ interaction with IP3-bound IP3Rs. Several IP3-bound 
neighbouring receptors in a cluster open simultaneously and generate the Ca2+ puff. The 
diffusion of Ca2+ from one puff site to another ignites a regenerative Ca2+ wave at 
neighbouring sites.  
(Figure from Taylor and Dale 2012) 
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1.2.2.2 Ryanodine receptors 
RYR are the largest known ion channels (>2MDa) (Takeshima, et al., 1989; Otsu, et al., 1990) 
which are expressed primarily on the sarcoplasmic reticulum (SR) of muscle cells and 
endoplasmic reticulum (ER) of other cell types. In mammals, there are three RYR isoforms 
(RYR1, 2 and 3) which share 66% sequence identity. All three isoforms were first identified 
as expressed in excitable muscle cells (Lanner, et al., 2010), in which RYR1 and RYR2 are 
crucial for excitation contraction (E-C) coupling in skeletal and cardiac muscle respectively 
(Takeshima, et al., 1989; Lai, et al., 1989a; Otsu, et al., 1990; Lewartowski, 2000; Lamb, 2000). 
However, the activation mechanism of RYR in E-C coupling is different between skeletal and 
cardiac muscles. In both scenarios, activation of RYR mediates SR Ca2+ release. In skeletal 
muscle, the depolarisation of transverse tubules (t-tubules) activates RYR via the voltage 
sensor dihydropyridine receptor (DHPR, also known as L-type Ca2+ channels) (Tanabe, et al., 
1990; Nakai, et al., 1998); whereas in cardiac muscle, E-C coupling depends primarily on Ca2+ 
influx through DHPR. (Endo, 1977; Sham, et al., 1995).  
RYRs are homotetramers and their activation can be regulated by caffeine (Endo, 1977) and 
cyclic ADP-Ribose (cADPR, Takasawa, et al., 1993; Ozawa, et al., 1999; Ogunbayo, et al., 2011) 
or by direct interaction with Ca2+ ions (Lanner, et al., 2010). In addition, ryanodine (a plant 
alkaloid), can also regulate RYR function by binding to it with high affinity and specificity, 
hence the receptors’ name. Low, nanomolar concentrations of ryanodine lock the channels 
in an open state (allowing Ca2+ release), whereas high concentrations (> 100 µM) inhibit 
receptor opening (Meissner, et al., 1986; Lai, et al., 1989b; McGrew, et al., 1989). In addition, 
millimolar magnesium (Mg2+) (Meissner, et al., 1997; Laver, et al., 1997) or micromolar 
ruthenium red concentrations (Miyamoto, et al., 1982) have also been shown to inhibit RYR 
activity. 
RYRs are considered to be one of the key players in regulating intracellular Ca2+ release in 
many cell types. In particular, they have been found to regulate anion secretion in non-
excitable rat colonic epithelial cells (Kocks, et al., 2002). However, the activation mechanism 
of RYR has not been clearly elucidated. Similar to IP3R (with which they share an overall 17% 
sequence identity) (Mignery, et al., 1989), RYR mediates Ca2+ release from the ER store. 
Depleted or emptied SR/ER stores are then refilled with Ca2+ via their membranous SERCA. 
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1.2.2.3 Calcium pumps  
SERCA, a P-type II ATPase, is another key player of Ca2+ signalling in the ER. The SERCA pump, 
first discovered in 1961 in a cell fraction derived from skeletal muscle tissue, is involved in 
many aspects of signal transduction and cellular function (Clapham, 2007). This fraction was 
later shown to contain the vesicles of the SR which accumulate Ca2+ at the expense of 
hydrolysing ATP (Ebashi, et al., 1962). Further studies extended the analysis to the ER of all 
cells, revealing SERCA as one of the main control systems of cytoplasmic Ca2+ in all cells. 
In mammals, three SERCA isoforms (SERCA1-3) have been identified which are encoded by 
three highly homologous genes (ATP2A1-3) (Arai, et al., 1994). Diversity within these genes 
is generated by alternative splicing; at least 11 SERCA splice variants have been observed 
(Periasamy, et al., 2007). The main function of the SERCA pump is to transfer cytosolic Ca2+ 
into the ER for storage by utilising ATP, maintaining Ca2+ homeostasis within a cell (Wuytack, 
et al., 2002; Berridge, et al., 2003). Under experimental conditions, these pumps can be 
inhibited with lanthanum ions (La3+) and orthovanadate (Szász, et al., 1978), or more latterly 
with specific small molecule inhibitors such as thapsigargin (Tg) (Thastrup, et al., 1990), now 
the most commonly used pharmacological tool for store-operated pathway. SERCA has been 
shown to play a role in certain human diseases: the loss of SERCA3 expression has been linked 
to the progression of colon carcinogenesis (Brouland, et al., 2005), underlining the 
importance of ER Ca2+ homeostasis in health.  
In response to agonist induced ER store depletion, there is a functional coupling between the 
SERCA pump and SOCE mechanism, in which extensive Ca2+ influx into the cytosol via the 
SOCE mediated Ca2+ release-activated Ca2+ channel (CRAC) is rapidly taken up by SERCA into 
the ER (Takemura, et al., 1989; Thastrup, et.al., 1990). This highly regulated mechanism not 
only avoids Ca2+ overload in the cytoplasm, but also maintains the [Ca2+] gradient for proper 
physiological functions.  
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1.2.2.4 ER Calcium store homeostasis - Store-operated calcium entry  
Ca2+ signalling events are highly coordinated and linked, and it is widely accepted that (1) the 
increase in cytosolic [Ca2+] is mediated by Ca2+ release from intracellular stores and also (2) 
the increase of Ca2+ flux across the plasma membrane (Putney, et al., 2008). As discussed 
previously, intracellular Ca2+ release is mediated by IP3 derived from PLC activation at the 
plasma membrane, whereas Ca2+ entry to the cytosol results from the activation of SOCE 
(capacitive Ca2+ entry) (Putney, 1986; Putney, 2014). Between 1986 and 2005 there were 
several important findings regarding SOCE. By using the fluorescent Ca2+ indicator Fura-2, 
Takemura and colleagues demonstrated for the first time that Ca2+ entry to the cytosol is 
independent of agonist-induced receptor activation of PLC on the plasma membrane 
(Takemura, et al., 1989). The use of Tg provided solid evidence that Ca2+ influx refilling the 
intracellular ER store is not a consequence of receptor activation (Jackson, et al., 1988; 
Takemura, et al., 1989). Tg was subsequently shown to deplete Ca2+ stores by blocking the 
SERCA pump (Thastrup, et al., 1990). Since Tg has no effect on ER permeability, store-
operated Ca2+ influx must occur across the plasma membrane directly into the cytoplasm. If 
this is the case, then there should be an electrical current associated with this process. In 
1992, Marcus Hoth and Reinhold Penner identified the store-operated current Icrac as the 
Ca2+ release-activated Ca2+ channel (CRAC) current (Hoth and Penner, 1992).  
A number of studies have aimed to characterise the store-operated Ca2+ influx channels – 
now commonly known as the CRAC channels – in the plasma membrane. In 1993, Hardie and 
Minke put forth the idea that transient receptor potential cation (TRPC) channels might be 
the store-operated Ca2+ influx channels (Hardie and Minke, 1993). TRPCs were first described 
in Drosophila as light-activated Ca2+ permeable cation channels (Montell, et al., 1989; Hardie 
and Minke, 1992). Seven mammalian genes, designated TRPC1-7, were eventually found to 
encode the canonical TRPC channels (Montell, et al., 2002). Subsequent electrophysiological 
studies of these TRPC channels suggested that they did not likely form the basis of Icrac (Hurst, 
et al., 1998). However, discrepancies in the findings between different laboratories means 
that the question remains unresolved (Cahalan, 2009; Yuan, et al., 2009). TRPC1 protein 
overexpression is however capable of increasing Ca2+ influx following store depletion (Rao, 
et al., 2006), and this effect was demonstrated to be dependent on the CRAC channel subunit 
Orai1 (Kwong, et al., 2008). Therefore, it remains possible that TRPC1 protein may interact 
with or couple to the store-operated CRAC channels for Ca2+ entry. 
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The discovery of the ER Ca2+ sensors-STIM1 (stromal interaction molecule 1) and 2 by Zhang 
and colleagues in 2005 further expanded our current understanding of SOCE (Zhang, et al., 
2005). Both STIM1 and 2 proteins contain a Ca2+ binding EF-hand motif facing the ER lumen, 
which is a key component of STIM for sensing Ca2+ levels. STIM1 is a single transmembrane 
protein residing in both the ER and plasma membranes (Dziadek, et al., 2007). When the ER 
store is full, STIM1 is distributed uniformly on the ER membranes, with the EF-hand motif of 
STIM1 bound to Ca2+ (Zhang, et al., 2005; Liou, et al., 2005). In response to IP3 mediated ER 
store depletion, Ca2+ ions dissociate from the EF-hand motif and trigger oligomerisation of 
STIM1 and migration towards the ER-plasma membrane junction. The concomitant 
relocation of Orai1 within the plasma membrane allows the two proteins to interact and 
induces SOCE (Prakriya, et al., 2006; Navarro-Borelly, et al., 2008; Luik, et al., 2008). Orai has 
been shown to function as pore forming subunits of the CRAC channels (Putney, 2011). 
Opening of the CRAC channels allows rapid Ca2+ influx into the cytosol. Since overexpressing 
Orai1 and STIM1 augments the Icrac current by 50-100 fold, these two proteins fully 
reconstitute the function of the Icrac (Peinelt, et al., 2006; Soboloff, et al., 2006). In addition, 
STIM2 has been shown to be a more sensitive Ca2+ sensor than STIM1, but the efficacy of 
STIM2 activation is lower and its function is less clear (Shim, et al., 2015). A recent study has 
demonstrated the role of STIM2 in promoting the recruitment of STIM1 to the ER-plasma 
membrane junction (Ong, et al., 2015).  In summary, STIM is a true ER [Ca2+] sensor, in that 
it triggers SOCE only in response to a decrease in ER [Ca2+] rather than an increase in cytosolic 
[Ca2+] (Putney, 2011). Therefore, SOCE is identified as a mechanism for refilling the 
intracellular ER Ca2+ store following agonist-receptor dependent or independent depletion.  
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1.2.3 Role of mitochondria in Calcium homeostasis 
Mitochondria were the first intracellular organelles associated with Ca2+ handling (Slater, et 
al., 1953), when the electrochemical gradient (or membrane potential) was found to be the 
driving force for Ca2+ influx into the mitochondria (Scarpa, et al., 1970; Selwyn et al., 1970; 
Rottenberg, et al., 1974). Accumulation of Ca2+ in the mitochondrial matrix requires it to cross 
two membranes: the outer mitochondrial membrane (OMM, permeable to solutes such as 
Ca2+) and the inner mitochondrial membrane (IMM, which is ion-impermeable) (Rizzuto, et 
al., 2012). OMM permeability is dependent on the expression level of the voltage dependent 
anion channels (VDACs), whereas the mitochondrial Ca2+ uniporter (MCU) is involved in 
transporting Ca2+ across the ion impermeable IMM (Rizzuto, et al., 2012). VDACs, also known 
as the mitochondrial porins, are the key players in crosstalk between the mitochondria and 
the rest of the cell (Rizzuto, et al., 2012). Mitochondrial Ca2+ efflux, on the other hand, is 
dependent on the Na+/Ca2+ (NCX) or H+/Ca2+ (HCX) exchangers, or “antiporters” (Crompton, 
et al., 1978; Carafoli, et al., 2012). 2APB, a non-specific IP3R inhibitor, has also been shown 
to block Ca2+ efflux from mitochondria possibly inhibiting the NCX (Prakriya, et al., 2001). 
Moreover, in response to mitochondrial Ca2+ overload and oxidative stress, Ca2+ and other 
small molecules (<1.5kDA) may also escape the mitochondrial matrix through the opening of 
the mitochondrial permeability transition pore (PTP) (Elrod, et al., 2010; Barsukova, et al., 
2011). PTP is a voltage and Ca2+ dependent channel which is also sensitive to cyclosporine A 
(CsA). Their properties have been well defined through extensive research, but uncertainty 
remains about the exact molecular identity of PTP (Halestrap, 2009). Thus, both Ca2+ uptake 
and extrusion mechanisms allow mitochondria to operate as a reversible Ca2+ storage 
compartment in the cytoplasm.  
Mitochondria can move through the cytosol in a Ca2+ dependent manner, which makes the 
relationships between mitochondria and Ca2+ signalling even more dynamic  (Yi, et al., 2004; 
Brough, et al., 2005). This strategic trafficking of mitochondria can keep cytosolic Ca2+ 
signalling to a specific subcellular region. Mitochondria are capable of forming close contacts 
with the ER (Rizzuto, et al.,1998), the Golgi (Dolman, et al., 2005) and also the plasma 
membrane (Frieden, et al., 2005), allowing them to affect their Ca2+ modulatory roles at each 
of these sites. The transfer of Ca2+ from the ER via IP3R to the mitochondrial matrix is also 
crucial for mitochondrial-specific functions, including the regulation of cell survival/death 
(Giorgi, et al., 2008; Harr, et al., 2010).  A substantial number of studies were performed in 
different cell models, and a “two pool” system of Ca2+ in ER-mitochondrial interplay was 
observed: (1) The rapid Ca2+ uptake into mitochondria suppresses local Ca2+ signals and 
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prevents the formation of Ca2+ waves via IP3R and RYR on the ER membrane; (2) ATP and 
reactive oxygen species (ROS) production as a result of Ca2+ uptake induce local Ca2+ 
responses and further sustain CICR in the cytosol (Deluca, et al., 1961; Vasington, et al., 1962). 
Rather than just causing cell damage, ROS have been implicated in physiological cell 
signalling (Goldhaber, et al., 2000; Hidalgo, et al., 2008). However, our understanding of the 
role of ROS in regulating Ca2+ homeostasis in physiological conditions is still unclear. 
Furthermore, ATP depletion has been shown to block Ca2+ release from internal stores and 
also inhibit SOCE (Gamberucci, et al., 1994). Hence, mitochondria seem to be capable of 
regulating numerous components of the Ca2+ signalling cascade, at various levels including 
Ca2+ uptake and extrusion by the mitochondria, Ca2+ release via IP3R and RYR on the ER 
membrane, and Ca2+ influx via store operated channels (Rizzuto, et al., 2012). The 
mitochondrial Ca2+ handling remains complex and unresolved. Our current understanding is 
that mitochondrial Ca2+ uptake not only happens during pathological conditions but also 
during physiological Ca2+ responses.  
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1.2.4 Calcium signalling in the acidic organelles – Lysosomes 
Mobilisation of Ca2+ from intracellular stores is a common signal transduction mechanism in 
both plants and animals. The temporal and spatial aspects of cytoplasmic [Ca2+] can be 
controlled through the interplay between different intracellular organelles through a range 
of Ca2+ channels. The ER, as the major intracellular Ca2+ store, has been the key focus of 
research for decades. Recently, the acidic organelles have also emerged as important Ca2+ 
stores for regulating cellular and physiological functions. These acidic Ca2+ stores are 
organelles with acidic lumens such as the endosomes, lysosomes, secretory vesicles and 
lysosome-related organelles (Morgan, et al., 2011). These acidic organelles not only store 
Ca2+, but also release Ca2+ and evoke downstream  responses  such as cell differentiation 
(Brailoiu, et al., 2006; Aley, et al., 2010; Zhang, et al., 2013), vesicle trafficking (Ruas, et al., 
2010; Ruas, et al., 2014) and exocytosis (Davis, et al., 2012). Lysosomal exocytosis plays an 
important role in secretion and plasma membrane repair. These findings suggested that the 
cell can mobilise additional intracellular source of Ca2+ to drive different cellular processes.  
Ca2+ storage in the lysosomes requires active ion transport across the lysosomal membrane. 
This process is dependent on the transmembrane vacuolar-type proton ATPase (V-type H+ 
ATPase) (Lemons and Thoene, 1991). The H+ ATPase not only promotes the acidification of 
the intracellular compartment via the neighbouring chloride channel, it also mediates the 
uptake of Ca2+ via H+-driven antiporter (Beyenbach, et al., 2006). Loss of protons from a 
lysosome is likely to diminish Ca2+ release due to the incapability to refill the acidic stores. 
The uptake of Ca2+ into the acidic stores can be blocked by vacuolar proton pump inhibitors 
such as bafilomycin (Baf) and also by protonophores such as nigericin which dissipates the 
proton gradient across lysosome membranes (Galione, 2006). 
 
1.2.4.1 NAADP: A new intracellular messenger 
The discovery of NAADP as the 2nd messenger for mobilising acidic Ca2+ stores was based on 
a landmark study in 1987 by Clapper and colleagues, in which they showed that both NAD 
and NADP release sequestered Ca2+ from IP3-desensitised sea urchin egg homogenates (i.e. 
Percoll-purified intracellular vesicles). This finding was remarkable because two 2nd 
messengers, cADPR and NAADP, were later discovered, and these two molecules were 
suggested to target distinct Ca2+ channels (Clapper, et al., 1987). cADPR is a product of the 
enzymatic conversion from NAD (Lee, et al., 1999), whereas NAADP was initially thought to 
be a contaminant in the commercial sources of NADP: the two structures are closely related, 
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with NAADP only different from NADP due to the substitution of a nicotinamide moiety with 
nicotinic acid (Galione, 2006).  
NAADP was later confirmed as a potent Ca2+ mobilising molecule (Lee, et al., 1995), and the 
nature of the NAADP-sensitive Ca2+ store was further investigated by Genazzani and Galione 
in 1996. By using high concentrations of the SERCA inhibitor Tg (which depleted the ER Ca2+ 
store), NAADP was revealed to still be capable of releasing Ca2+ in egg homogenate and in 
intact eggs. CD38 was later identified as the enzyme responsible for synthesising both NAADP 
and cADPR, the latter of which was later shown to be an agonist of RYR (Lee, 1997; Ogunbayo, 
et al., 2011).  
The intracellular actions of NAADP were further explored. In 2002, Churchill and colleagues 
demonstrated that reserve granules (the functional equivalent of a lysosome in the sea 
urchin egg) and lysosome-related organelles are targets of NAADP in sea urchin eggs. 
Disruption of these acidic organelles (by osmotic permeabilisation) using GPN (glycyl-
phenylalanyl-napthylamide) selectively abolished the effects of NAADP. In addition, 
application of Baf prevented organelle acidification and blocked Ca2+ uptake into these stores, 
which also eliminate NAADP mediated Ca2+ mobilisation. Thus, this study identified a novel 
acidic Ca2+ store regulated by NAADP, which was distinguishable from the ER Ca2+ release 
mediated by IP3R and RYR (Churchill, et al., 2002).  
The action of NAADP was further investigated in mammalian cells, starting with mouse 
pancreatic acinar cells being shown to be responsive to NAADP (Galione, 2005). NAADP has 
also been shown to be very potent in these cells, with < 50nM concentrations capable of 
producing a robust Ca2+ current independent of extracellular Ca2+ (Cancela, et al., 1999). 
Moreover, by using both GPN and Baf , the role of NAADP was further confirmed in a variety 
of mammalian cells including pancreatic beta cells (Yamasaki, et al., 2004), smooth muscle 
(Kinnear, et al., 2004), neurons (Brailoiu, et al., 2005), endothelial cells (Brailoiu, G.C. et al., 
2010b) and breast cancer cells (Schrlau, et al., 2008), efforts that were aided through use of 
the antagonist “trans-Ned 19”, which has also been shown to block NAADP signalling (Naylor, 
et al., 2009). These findings further reinforce the concept of NAADP as a mediator of acidic 
store Ca2+ release in both mammalian and non-mammalian species. Subsequent studies have 
revealed the physiological role of NAADP such as in angiogenesis, cardiac function, 
fertilisation, immunology and autophagy (Galione, 2015). Activation of NAADP has been 
shown to be agonist specific. The brain/gut peptide cholecystokinin (CCK but not 
acetylcholine) has been shown to recruit NAADP in pancreatic acinar cells (Yamasaki, et al., 
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2005), which raises the possibility that NAADP might be recruited by other neurotransmitters 
such as Ach in other cell types and systems.  
 
1.2.4.2 NAADP sensitive calcium channels 
The identity of the NAADP receptor (endo-lysosomal ion channel) has been the subject of 
debate. The TRPC family member mucolipins (TRPMLs), of which three mammalian isoforms 
have been identified (TRPML1-3), are one of the best characterised endo-lysosomal ion 
channels (Puertollano, et al., 2009). These TRPML channels have been linked to Ca2+ 
dependent membrane trafficking of the endo-lysosomal system, in which Ca2+ is required for 
the fusion of lysosomes with other acidic organelles (Luzio, et al., 2007) and the plasma 
membrane (Luzio, et al., 2010).  Depletion of TRPML1 from the lysosomes of myocytes using 
siRNA has been shown to reduce NAADP mediated Ca2+ release. This suggests that TRPML1 
is an NAADP receptor (Zhang, et al., 2009). Defects in lysosomal Ca2+ handling due to TRPML1 
mutations have been shown to disrupt membrane trafficking and contribute to the lysosomal 
storage disease mucolipidosis IV (Bargal, et al., 2000). Thus, NAADP extends the role of 
lysosomal Ca2+ signalling as well as membrane trafficking. Several other ion channels such as 
TRPC subfamily members (TRPM2, TRPV2) and P2X purinergic receptor 4 (P2RX4), all located 
within the endo-lysosomal system, have also been touted as potential candidate NAADP 
receptors, but the definitive evidence for their involvement in NAADP mediated signalling 
are lacking (Patel, et al., 2010).   
TPCs are a family of proteins that have gained recognition in recent years as major regulators 
of endosomal-lysosomal Ca2+ release (Figure 1.11) (Morgan, et al., 2015). TPCs were first 
cloned in 2000 by Ishibashi and colleagues (Ishibashi, et al., 2000). The function of TPCs had 
remained mysterious for some time until 2005, when a TPC in the model plant species 
Arabidopsis thaliana was revealed by overexpression and knockdown studies to be a slow 
vacuolar Ca2+ release channel (Peiter, et al., 2005), which mediates long-range Ca2+ waves 
(Choi, et al., 2014).  
In sea urchin egg cell lysate model, NAADP receptors were initially found to be insensitive to 
Ca2+ feedback (Morgan, et al., 2011). However, similar to TRPML channels, growing evidence 
suggests that TPCs are also mediated by Ca2+ to regulate membrane traffic. An initial 
investigation in 2010 confirmed that TPC2 present in lipid bilayers or discrete lysosomes 
functions as a Ca2+ permeable channel (Pitt, et al., 2010, Schieder, et al., 2010). By using Ca2+ 
imaging and electrophysiological techniques, different laboratories have subsequently 
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revealed that TPC1 (Rybalchenko, et al., 2012; Pitt, et al., 2014) and TPC2 (Brailoiu, et al., 
2010a; Schieder, et al., 2010; Pitt, et al., 2010) are Ca2 permeable NAADP target channels 
(Ogunbayo, et al., 2011). In addition, TPCs not only signal in response to Ca2+ flux, but also to 
changes in pH and membrane potential, which might be important for the regulation of 
autophagy (Morgan, et al., 2015). In humans, two TPCs (TPC1 and TPC2) were identified. 
TPC2 is primarily expressed in late-endosomes/lysosomes, while TPC1 appeared to be 
express in endosomes (Brailoiu, et al., 2009; Calcraft, et al., 2009; Ruas, et al., 2010).   
 
Figure 1.11 Predicted transmembrane domain structure of animal TPCs. 
All TPCs share the same membrane topology, which is the two well-defined 6-TM 
(transmembrane) homologous domains. The pore loop is present on the luminal side of the 
receptor between the 5th and 6th TM domains of the 6-TM segment. Positively charged 
residues are present on the 4th TM domain and the tree-like symbol represent the 
glycosylation site of the receptor.  
(Figure from Morgan, et al., 2015) 
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The hypothesis that TPCs are NAADP sensitive channels is supported by a substantial number 
of studies (Calcraft, et al., 2009; Brailoiu, et al., 2009; Zong, et al., 2009). However, these 
findings were recently challenged by two high profile papers in late 2012 which described 
TPCs as lipid-regulated Na+ channels. Both studies concluded that TPCs were NAADP 
insensitive in both wild type mouse cells or in cell lines overexpressing TPCs (Wang, et al., 
2012; Cang, et al., 2013). However, these studies used 2mM of Mg2+ in their assays, while 
cytosolic Mg2+ has recently been shown to potently inhibit TPCs function with an affinity of 
60-130µM (Jha, et al., 2014; Morgan, et al., 2015); which suggests the TPCs in their systems 
were inactive. 
Overexpression of TPCs enhances NAADP dependent responses (Calcraft, et al., 2009; Ruas, 
et al., 2010; Churamani, et al., 2013; Jha, et al., 2014; Lin-Moshier, et al., 2014). Similarly, TPC 
down-regulation by RNA interference attenuates responses to NAADP (Brailoiu, et al., 2009; 
Calcraft, et al., 2009; Zhang, et al., 2013), and similar results have been observed in TPC 
knockout mouse models (Arndt, et al., 2014; Ruas, et al., 2015). NAADP sensitivity was 
restored upon re-expression of wild type TPCs, but not with mutant TPCs that have 
impairment in Ca2+ permeability nor with TRPML1 (mucolipins, Ruas, et al., 2015). Taken 
together, these findings suggest that TPCs are NAADP targets expressed on the membrane 
of acidic organelles. However, it is still unclear whether NAADP binds directly to TPC or via 
an accessory protein (Patel, et al., 2011). For instance, by using [32P] NAADP molecules, 
several studies have suggested the possible indirect interaction of TPC with an unknown low 
molecular weight NAADP binding protein that mediates channel activation (Ruas, et al., 2010; 
Lin-Moshier, et al., 2012; Walseth, et al., 2012). It is now widely appreciated that TPCs 
contribute to both the control of endo-lysosomal trafficking and the regulation of diverse 
cellular activities via Ca2+ release from acidic stores. Upon ER Ca2+ store depletion, TPC2 has 
been shown to modulate SOCE by its association with STIM1 and Orai 1 in human 
megakaryoblastic leukaemia (MEG01) cells (Lopez, et al., 2012).  
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1.2.4.3 Lysosomal-ER interaction via NAADP 
Pancreatic acinar cells were the first whole mammalian cell type used for testing NAADP 
function. In this model, Cancela and colleagues (1999) demonstrated that the NAADP 
mediated Ca2+ response was attenuated in the presence of ER Ca2+ channel inhibition. This 
observation was in contrast to findings in a sea urchin egg homogenate model, which 
suggested that NAADP initiates a small local release of Ca2+ by TPCs that is subsequently 
amplified by the ER through the process of CICR via IP3R and or RYR (Berridge, 1999).  
Lysosomes and the ER are often closely associated (Kinnear, et al., 2008). In HEK293 cells 
overexpressing TPC2, there was a biphasic effect of the Ca2+ transient waves. Pre-treatment 
of cells with Tg and heparin selectively blocked the 2nd large Ca2+ waves, whereas pre-
treatment with Baf eliminated the entire NAADP-stimulated Ca2+ response. Thus, the 2nd 
large Ca2+ waves should be a result of the ER Ca2+ release. These findings suggest that the 
initial phase of Ca2+ release is dependent on the acidic stores, while the 2nd transient was 
triggered by Ca2+ release from the acidic stores (Calcraft, et al., 2009). In order to raise local 
[Ca2+], it is likely that multiple endo-lysosomes act in concert to release Ca2+ at a specific site 
in close proximity to IP3R and RYR (Zhu, et al., 2010). Substantial evidence also suggests that 
TPCs could preferentially interact with IP3R or RYR in different cell types. Hence in HEK cells, 
TPC2 effectively triggers IP3R activation (Brailoiu, et al., 2010a); while in vascular smooth 
muscle cells, TPCs couple selectively to RYR even in the presence of IP3R (Kinnear, et al., 
2004).  Furthermore, not all NAADP evoked Ca2+ signals will be converted to a global CICR, as 
the signal could be removed by mitochondrial uptake. However once IP3R or RYR get 
activated by previous Ca2+ release from acidic stores, it is likely that a regenerative Ca2+ wave 
will be produced throughout the entire cell (Boittin, et al., 2002; Zhu, et al., 2010). Thus, the 
Ca2+ signals were generated by the interplay of multiple Ca2+ stores in which the acidic stores 
provide the initial key signals for subsequent Ca2+ waves. 
However, very little is known about the interactions between these Ca2+ signalling organelles 
and the role of NAADP in the colon, and what its functional significance might be. 
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1.2.5 Cholinergic stimulated calcium signalling in human colonic epithelium 
1.2.5.1 Intercellular communication in polarized epithelium  
As described previously, the epithelial cell surface is linked by cell-cell adhesion junctions. 
The three major connections are the tight junctions, gap junctions and the adherens 
junctions (Figure 1.12). 
Tight junctions are intercellular adhesions which form physical barriers between the 
extracellular space and epithelium. They are normally found at the apical membrane of a cell, 
where they play an important role in maintaining the apical-basal polarity of the epithelium. 
The major function of the tight junction is to restrict paracellular transport (transport of 
substances through the intercellular space between cells) across epithelial cell sheets, and 
to serve as a barrier between the apical and basolateral membrane for intramembrane 
diffusion (Giepmans, et al., 2009). Depletion of extracellular Ca2+ ions has been shown to 
impair the formation of tight junctions (Cereijido, et al., 1993), which suggests an important 
role of Ca2+ in maintaining epithelial cell integrity and polarity.  
Gap (or ‘nexus’) junctions are clusters of channels on the lateral plasma membrane which 
provide direct intercellular communication between epithelial cells through the transmission 
of 2nd messengers such as molecules, ions and electrical impulses (Rose, 1971). In particular, 
both Ca2+ ions and IP3 molecules have been shown to move passively through gap junctions 
(Sanderson, et al., 1990). Gap junction channels are formed by hexameric assemblies of the 
integral membrane proteins ‘connexins’ (Goodenough, et al., 1996). Since multiple connexin 
isoforms are expressed in most cell types, the formation of homomeric or heteromeric 
connexons can be observed (Falk, et al., 1997). The diversity of these channels has been 
shown to correspond to a range of physiological properties including single- or multiple-
channel conductance states (Takens-Kwak and Jongsma, 1992), and selectivity and 
permeability to certain molecules and ions (Veenstra, et al., 1995; Bevans, et al., 1998; Harris, 
2007).  
Adherens junctions are cell-cell microdomains that physically connect neighbouring 
epithelial cells and provide the adherent strength (Fristrom, 1988).  In mammals, these 
adherens junctions are located at the basal side of the tight junctions, which help to define 
each cell’s apical-basal axis. They are composed of proteins including cadherins and catenins, 
while E-cadherin is the most abundant integral membrane protein expressed in the epithelia. 
Interaction of E-cadherin with extracellular Ca2+ has been shown to strengthen the cell-cell 
interaction and integrity of the epithelium (Perez-Moreno, et al., 2003). 
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Figure 1.12 Multiple levels of cell-cell junctions that connect epithelial cells.  
Epithelial cells are connected to each other via junctional complexes. These junctions are 
present on the plasma membrane of the epithelial cells and play various roles. Tight junctions 
form the first line of defence between the epithelia and the extracellular space. Gap 
junctions allow intercellular communication between cells, whereas cell-cell connections 
(integrity) are maintained by adherens junctions and desmosome. The epithelial cell sheet is 
attached to the basal lamina via hemidesmosome.  
 (Figure from Life Science web textbook by University of Tokyo) 
 
  
 44 
 
1.2.5.2 Cholinergic signalling mediated secretion in the colonic epithelium 
Over the past 30 years there have been a considerable number of studies investigating the 
role of cholinergic signalling in mediating secretion in the colonic epithelium. However, most 
of these studies were based on animal models such as guinea pig, rat, mouse and rabbit 
(Bradbury, et al., 1980; Zimmerman, et al., 1982; Camilleri, et al., 1982; Phillips, et al., 1984; 
Kuwahara, et al., 1987; Diener, et al., 1989; Javed, et al., 1992; O’Malley, et al., 1995; 
Haberberger, et al., 2006), which do not necessarily accurately reflect human biology. Since 
the early 1990s, some studies began to be performed using human colon cancer cell lines 
such as HT-29 (Phillips, et al., 1993; Bou- Hanna, et al., 1994; Bertrand, et al., 1999; Stanley, 
et al., 1999; Oprins, et al., 2000; Himmerkus, et al., 2010) and T-84 (Tabcharani, et al., 1994; 
Cliff, et al., 1998; Banks, et al., 2004; Hassan, et al., 2012), which provided evidence of 
cholinergic signalling in a human tissue model. However, the polarity and topology of the 
colonic epithelium is lost in these cell lines, which might affect Ca2+ signal generation 
properties relative to the tissues from which these lines derive. Cholinergic stimulation has 
been shown to mobilise intracellular Ca2+ in all cells, however, the underlying mechanism of 
the Ca2+ signal generation in coupling the physiological function of the human colonic crypts 
has never been shown.  
 
1.2.5.3 Association of intracellular calcium signals and colonic crypt physiology 
A 3-D human colonic crypt culture model has been developed in our lab, which made it 
possible to perform functional studies on the native human colonic epithelium. Using this 
model, cholinergic stimulated Ca2+ mobilisation in the native human colonic epithelium was 
first shown by Susanne Lindqvist. By using Ca2+ sensitive fluorescence imaging, she 
demonstrated that Ach initiated a Ca2+ signal in the base of the crypt (via M3AchR activation), 
which then propagated along the crypt-axis towards the surface epithelium. In conjunction 
with experiments on the HT-29 colon cell line, Lindqvist concluded that there is a 
fundamental role for Ach-induced Ca2+ signals in regulating cellular homeostasis of the 
colonic epithelium (Lindqvist, et al., 1998; Lindqvist, et al., 2002). Subsequent work by Amy 
Reynolds in our lab investigated the cholinergic regulation of fluid secretion and tissue 
renewal in the human colonic epithelium. She demonstrated for the first time that 
internalisation of the Na-K-2Cl co-transporter (NKCC1) attenuates the cholinergic secretory 
response in a Ca2+ dependent manner, identifying NKCC1 as a major modulator of colonic 
crypt fluid secretion. She further observed that cholinergic stimulation of colonic epithelium 
regulates fluid secretion in the short term (minutes to hours), and tissue renewal in the long 
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term (days) (unpublished data). Both of these studies provided important information 
informing this thesis, regarding Ca2+ signalling in the regulation of physiological function in 
human colonic crypt. 
Our lab has repeatedly demonstrated that cholinergic stimulation of MAchR mobilises 
intracellular Ca2+ in the native human colonic epithelium (Lindqvist, 2000; Reynolds, 2007). 
This Ca2+ signal is observed within 30 seconds of cholinergic stimulation. This Ca2+ wave 
appears to initiate at the apical pole of cells at the base of crypt, near the stem cell niche; 
the signal then diffuses to the basal pole of the initiator cell, before it propagates further up 
the entire crypt axis (Figure 1.13). The intercellular communication that permits signal 
transduction is believed to be mediated via gap junctions in the lateral membrane of the 
epithelial cells. However, the mechanism of the regulation remains unclear. Based on 
immunohistochemistry findings, we speculate that Lgr5+ stem cells are the Ca2+ initiator cells 
at the colonic crypt base (Figure 4.2B, unpublished data). This could be due to their close 
proximity with the cholinergic neurons which provide the activation signals. Further study is 
required to confirm this finding, and to discover why specifically stem cells are the initiator 
cells when all epithelial cells express MAchR.  
 
 (Figure is courtesy of Mark Williams) 
  
Figure 1.13 Schematic diagram of Ca2+ 
wave propagation along the colonic 
crypt-axis upon a cholinergic 
stimulation. 
Binding of Ach to M3AchR on the basal 
pole of the crypt triggers Ca2+ 
mobilisation at the crypt base. The Ca2+ 
signal initiates at the apical pole of 
initiator cells and exhibits both 
intracellular propagation to basal pole, 
and intercellular propagation along the 
entire crypt axis via gap junctions.  
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1.3 Mucin secreting goblet cells 
1.3.1 Goblet Cell biology and function 
One of the major known physiological roles of colonic crypts is to produce the mucus which 
forms the protective and lubricative barrier that lines the gut, a feat which is made possible 
by the actions of mucin-secreting goblet cells. Goblet cells were first described in the GI tract 
by Bizzozero in 1892 (reviewed by Cheng, et al., 1974a). They were so-named due to the cup-
like appearance of the cytoplasm that holds mucus granules below the apical membrane 
(Figure 1.15). They are one of the several secretory cell types found in the intestines, 
scattered among the columnar cells in the epithelium (Figure 1.5). Their main function is to 
secrete mucins, trefoil peptides, Fc gamma binding protein (Fcgbp) and RELM-β, which are 
the major components of the mucus barrier layer formed between the gut lumen and the 
epithelial surface (Kim, et al., 2010). Goblet cells are morphologically indistinguishable from 
other epithelial cells in the absence of mucin. Based on studies of rabbit colon, goblet cells 
have been shown to undergo several morphological changes during their life. Once 
propagated from the stem cell niche, immature goblet cells rapidly begin to synthesise and 
secrete mucin granules (Radwan, et al., 1990). These immature cells are large and pyramidal 
in shape due to the shedding of cytoplasm, organelles and mucin granules; this causes their 
cell volume to diminish throughout migration upwards to the colonic surface (Radwan, et al., 
1990). In addition, based on the level of maturation along the crypt axis and the location 
along the GI tract, intestinal goblet cell subpopulations produce and secrete different mucin 
species (Kim, et al., 2010). In the colon, goblet cells synthesise and secrete the mucin MUC2. 
The mucus, with MUC2 being the major component, also contains several abundant proteins 
such as CLCA1, ZG16, FCGBP and AGR2, although their functions remain largely unknown 
(Johansson, et al., 2008; Birchenough, et al., 2015). However, AGR2, an ER protein that is 
secreted into mucus, has been suggested to promote MUC2 folding in the ER by building 
intramolecular disulphide bonds (McGuckin, et al., 2011a).  In addition, AGR2-/- mice have 
less filled goblet cells and a poorly developed inner colon mucus layer. These mice are more 
susceptible to colon inflammation. The high concentration of AGR2 in secreted mucus 
throughout the GI tract suggests they may also play some extracellular role (Bergström, et 
al., 2014). While our current knowledge of goblet cell biology is still very limited, studies from 
the past 10 years suggest that there are several types of goblet cells in the GI tract, which 
function in different ways.  
MUC2 polymers are densely packed into secretory granules due to the low pH and high Ca2+ 
in this compartment. Once secretion takes place, the densely packed MUC2 polymers expand 
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over 1000-fold into large net-like structures (Johansson, et al., 2013). This process is 
dependent on increasing pH and the removal of a single Ca2+ ion (Ridley, et al., 2014). 
Experimentally, bicarbonate has been shown to be an ideal solution for raising pH and 
precipitating Ca2+ (Gustafsson, et al., 2012b). In the small intestine, the enterocytes adjacent 
to goblet cells provide the required bicarbonate for mucin unfolding (Gustafsson, et al., 
2012b), whereas in the large intestine, goblet cells supply their own bicarbonate via the 
bestrophin-2 bicarbonate transporter (Yu, et al., 2010). Regulated granule secretion and 
compound exocytosis are the two major methods of mucus secretion. Regulated mucus 
secretion has been extensively studied in airway goblet cells. In this model, exocytosis of 
vesicles (granules) through fusion with the plasma membrane was shown to be mediated by 
typical exocytosis components such as the SNARE proteins: Syntaxin, VAMP8 and SNAP23 
and the scaffolding protein Munc18 in both basal and stimulated secretion (Adler, et al., 
2013). Although not yet closely studied, mucus secretion in the small and large intestines 
probably follow similar mechanisms. Moreover, compound exocytosis in goblet cells is more 
dramatic in that most mucus theca fused together in the cytoplasm and emptied their mucin 
content all at once that causes a 100-1000 fold expansion in mucin volume. To date, 
molecular studies of goblet cells compound exocytosis are not available, but morphological 
studies demonstrate the explosion of goblet cells during the secretion process (Specian & 
Neutra et al. 1980). Based on mucus turnover and renewal studies (by detecting mucin 
biosynthesis with azide-modified N-acetylgalactosamine, GalNAz), rapid mucin synthesis and 
secretion were observed in goblet cells on colon surface epithelium. In contrast, goblet cells 
at the colonic crypt base accumulate mucus granules over time, and secretion is much slower 
(Johansson, 2012). In addition, mucin biosynthesis and secretion was shown to be faster in 
small intestinal villi goblet cells than crypt goblet cells (Johansson, 2012). Thus, goblet cells 
play a pivotal role in maintaining the homeostasis of the gut microenvironment through the 
production of mucins.  
 
1.3.1.1 Other potential goblet cell functions 
The assumed primary function of intestinal goblet cells is to synthesise and secrete mucus. 
Recent studies have demonstrated that a sub-population of goblet cells exists in the small 
intestine which are capable of acquiring and presenting luminal antigens to CD103+ dendritic 
cells in the lamina propria (McDole, et al., 2012; Howe, et al., 2014), implying a role in gut 
immunity. This antigen uptake was shown to be augmented by cholinergic agonists via 
muscarinic receptor 4 stimulation (Knoop, et al., 2015).  This finding further supports the 
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existence of different goblet cell subsets along the GI tract that is mediated by cholinergic 
signalling. 
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1.3.2 Intestinal goblet cell development 
Goblet cells are one of the principal cell types in the human colon which appear early in 
development, at around 9 to 10 weeks gestation in human foetal small intestines (Kim, et al., 
2010). Previous studies in mouse small intestinal epithelium (Cheng, et al., 1974a and b) 
suggested that goblet cells were derived from some "poorly differentiated” cells called 
oligomucous cells at the crypt base, which contained very few of the mucus granules that 
identify goblet cells. Both oligomucous and mature goblet cells were shown to be present in 
the intestinal epithelium, but they are indistinguishable in the adult tissues. A later study by 
Gordon and colleagues demonstrated that goblet cells arise from multipotent stem cells 
residing at the mouse intestinal crypt base (Gordon, et al., 1992). It is now widely appreciated 
that goblet cells are sequentially derived from the long-lived Lgr5+ ISC and shorter-lived 
secretory progenitor cells (Figure 1.5) (Barker, et al., 2007). Some studies have suggested the 
presence of two stem cell populations in the mouse small intestinal crypt: an active stem cell 
(ASC) population, responsible for proliferation and crypt maintenance, and a quiescent stem 
cell (QSC) population (typified by Bmi1 expression, which is a +4 cell marker) which 
replenishes the ASC population after crypt injury (Potten, et al., 2009; Yan, et al., 2012). This 
theory was later challenged by more recent studies, in which transcriptomic and proteomic 
approaches as well as lineage tracing knock-in mouse models suggested that the proposed 
quiescent stem cell marker Bmi1 is robustly expressed in Lgr5+ stem cells (Muñoz, et al., 2012; 
Itzkovitz, et al., 2012). In addition, the Notch ligand DII1 has been recently used as a marker 
for the early secretory progenitors (van Es, et al., 2012). Thus identifying the definitive ISC 
population remains an active area of investigation (Carulli, et al., 2014).  
Goblet cells form a constantly renewing population of very short lived cells. In mice, it has 
been shown that they migrate from the base to the top of crypt and are sloughed into the 
intestinal lumen within 2-3 days (Merzel and Leblond, 1969). However, the mechanism 
driving intestinal cell death (goblet cells included) during normal homeostasis is not clear. 
One recent study by Eisenhoffer and colleagues suggested that the overcrowding due to 
constant epithelial renewal forces extrusion of live cells, which is important for controlling 
the numbers of epithelial cell and maintaining the cellular organisation of the colonic mucosa 
(Eisenhoffer, et al., 2012).  
ISCs are subject to the control of different molecular pathways and transcription factors to 
maintain intestinal homeostasis. Wnt signalling is important for stem cell establishment and 
crypt development in the intestine. It is required for the proliferation of stem and progenitor 
cells, and has been implicated in regulating epithelial cell differentiation, possibly via a Wnt-
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Notch cross talk mechanism (Crosnier, et al., 2006). In addition, aberrant Wnt signalling has 
been observed in most cases of colorectal and intestinal cancers (White, et al., 2012). Notch 
signalling is involved in determining the cell fate decisions, and thus lineage specification, of 
intestinal cells. However, it is unclear when exactly such signalling occurs, and whether it 
targets progenitor cells or some intermediate (van der Flier and Clevers, 2009). Notch 
signalling has been shown to favour the development of absorptive cell lineages (enterocytes) 
relative to secretory cell lineages including Paneth, goblet and enteroendocrine cells (van Es, 
et al., 2005; Gerbe, et al., 2011). Based on mouse models, colonic goblet cell differentiation 
has been shown to be regulated by the transcription factors Math1 (the mouse homologue 
of human Hath1) and Krüppel-like factor 4 (KLF4), as well as the Notch and Wnt signalling 
pathways (Gregorieff, et al., 2005; Gregorieff, et al., 2009). Other signalling pathways 
including Bone Morphogenetic Proteins (BMP), Hedgehog, Hippo, Eph/ Ephrin and EGF/ Erb 
B have also been shown to play important roles in stem cell function (Crosnier, et al., 2006; 
Vanuytsel, et al., 2013). However, relevant data from humans is very limited due to the 
difficulties in culturing human stem cells. 
Activation of Notch and its downstream target Hes1 blocks the basic Helix Loop Helix 
transcription factor Math1/ATOH1, in which Math1 is an essential determinant of secretory 
lineage commitment (Fre, et al., 2005; Stanger, et al., 2005). In contrast, inhibition of Notch 
pathway (by γ-secretase blockage) causes a rapid differentiation into the secretory cell 
lineages (Yang, et al., 2001; van Es, et al., 2005; Zecchini, et al., 2005; van Es, et al., 2010; 
Reynolds, 2014). Thus Notch signalling regulates epithelial cell fate in a Math1 dependent 
manner. The transcription factor SPDEF (SAM pointed domain ETS factor), which acts 
downstream of Math1, has also been shown to be important for goblet cell differentiation 
and maturation in the intestinal epithelium (Gregorieff, et al., 2009; Noah, et al., 2010). Apart 
from controlling cell fate, Notch signalling is also required for stem cell proliferation and 
survival in a Math1 independent manner (Crosnier, et al., 2005; Fre, et al., 2005; Stanger, et 
al., 2005; VanDussen, et al., 2012). Therefore Notch is capable of regulating distinct aspects 
of epithelial cell homeostasis. Moreover, the activation of KLF4, a zinc-finger transcription 
factor expressed in crypt intestinal goblet cells (Ghaleb, et al., 2011) is also involved in the 
terminal differentiation of goblet cells in mice (Katz, et al., 2002; Yu, et al., 2012). KLF4 has 
been identified as a tumour suppressor gene in colorectal cancer (Zhao, et al., 2004; Zhang, 
et al., 2006), and studies have shown inhibition of KLF4 expression as a result of Notch 
signalling (Ghaleb, et al., 2008; Zheng, et al., 2009). Furthermore, several studies have also 
suggested the involvement of E74-like factor 3 (Elf3) (Ng, et al., 2002; Kwon, et al., 2009) and 
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OASIS (ER stress transducer) (Asada, et al., 2012) in the terminal differentiation of goblet 
cells in mice.  
 
1.3.3 Mucin structure, function and biosynthesis 
Mucin is the major component of the mucus layer. A total of 20 different mucins have been 
described in humans, 15 of which being expressed in some region of the GI tract. Depending 
on their structure and location, mucins are subdivided into membrane-bound and secretory 
forms (Johansson, et al., 2011; MuGuckin et al., 2011b). Membrane-bound mucins are so-
called due to the presence of a transmembrane domain which allows them to anchor to the 
cell membrane. These proteins consist of a large N-terminal extracellular, and a short 
cytoplasmic C-terminal domain (Hattrup, et al., 2008), and are primarily expressed at the 
apical side of epithelial cells. While the function of transmembrane mucins is only partially 
understood, they number a large proportion of known mucins, including: MUC1, MUC3A, 
MUC3B, MUC4, MUC11, MUC12, MUC13, MUC15, MUC16, MUC17, MUC20 and MUC21 
(Imai, et al., 2013). The glycocalyx, a fuzz-like coating covering the surface of the microvilli of 
enterocytes, is composed of these cell surface mucins (Williams, et al., 2001; McGuckin, et 
al., 2011b). This glycocalyx is believed to function as a protective barrier, and is probably 
involved in apical cell surface sensing and signalling (Singh, et al., 2006; Hattrup, et al., 2008). 
Secretory mucins, which can be gel-forming or non-gel-forming, include: MUC2, MUC5AC, 
MUC5B, MUC6, MUC7, MUC8, MUC9 and MUC19. MUC5AC is mainly expressed in tracheal-
bronchial and gastric mucosa. Although lesser amounts of MUC5AC and MUC6 were 
detected in the colon, MUC2 is the major secretory mucin that is constitutively synthesised 
by colonic goblet cells (McGuckin, et al., 2011b). MUC2 molecules are large glycoproteins, 
whose protein core is characterised by multiple tandem repeat sequences with a high 
proportion of proline, theronine and serine residues (forming “PTS domains”) (Figure 1.14 B). 
The protein core is resistant to host proteolytic enzymes due to the high number of intra-
molecular disulphide bonds and the glycan coating that shields the potential cleavage site 
(Johansson, et al., 2011; MuGuckin et al., 2011b). The hydroxyl residues of MUC2 get heavily 
O-glycosylated (Figure 1.14A); these post-translational modifications make up approximately 
80% of the mature MUC2 mass. These O-linked oligosaccharides are densely packed, which 
functions to maintain the integrity of the mucin polymer. They also possess significant water 
holding capacity that provides the gel-like properties of mucins. The N- and C-terminal 
regions of MUC2 are poorly glycosylated, and mostly consist of cysteine residues (Figure 1.14 
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B). Secretory mucins (including MUC2) often contain three N-terminal von Willebrand factor-
like domains (termed D1, D2 and D3), while the C-terminal region contains only one D4 
domain (Figure 1.14 B). Some evidence suggests that glycosylation can be altered in response 
to mucosal infection and inflammation (Johansson, et al., 2011; MuGuckin et al., 2011b).   
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Figure 1.14 The MUC2 mucin network in mucus.  
(A) MUC2 glycosylation sites. MUC2 mucin from human sigmoid colon has a relatively 
uniform O-glycan composition. (B) From bottom to top: MUC2 domain organisation (bottom). 
MUC2 has a central PTS domains that are rich in serine, threonine and proline residues, and 
these domains will subsequently become heavily glycosylated upon post-translational 
modification. The N- and C-terminal regions of MUC2 mostly consist of cysteine residues. 
Three von Willebrand factor-like domains (termed D1, D2 and D3) at the N-terminal, and only 
one D4 domain at the C-terminal region. MUC2 is synthesised in the ER, processed in the 
Golgi (middle), and released into the lumen from goblet cells (top). (C) The firm adherent 
mucus layer is converted to the loose outer layer by proteolytic cleavage of the cysteine 
residues of MUC2, expanded and dispersed to form a net-like structure. 
(Figures from Johansson et al., 2011) 
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1.3.4 MUC2 packaging and secretion in goblet cell 
Newly synthesized MUC2 proteins form homodimers in the ER via their C-termini concurrent 
with N-glycosylation, before subsequent O-glycosylation in the Golgi (Johansson, et al., 2011; 
Johansson, et al., 2013a). These heavily O-glycosylated MUC2 dimers are then densely 
packed into numerous apically-stored secretory vesicles (Figure 1.15). At this stage, the N-
terminal ends of the dimers are coupled together by disulphide bonds into trimeric 
structures which give the native fresh mucus its viscous, sticky and hydrophobic properties 
(Caldara, et al., 2012). Due to the multimerisation, once released from the cell, MUC2 
molecules expand to form large net-like structures (Figures 1.14B top and 1.15) (Johansson, 
et al., 2011; McGuckin et al., 2011b).  
By using sprinkled charcoal, Lena Holm and others demonstrated the two layers of mucus in 
the rat colon (Holm, et al., 2012); the loose outer layer can be readily removed by suction, 
whereas the firm adherent inner layer required scraping to be removed (Atuma, et al., 2001; 
Brownlee, et al., 2003; Hansson, et al., 2010; Johansson, et al., 2011; MuGuckin et al., 2011b). 
The continuous release of MUC2 means that newly released mucins will interact with the 
already present inner mucus layer (Johansson, et al., 2012). This inner layer is about 50µm 
thick in mice and is renewed every 1-2 hours in the distal colon of live animals. In humans, 
the inner layer is around 200µm thick (Johansson, et al., 2012, Johansson, et al., 2013). The 
conversion of inner to outer mucus layers is mediated by proteolytic cleavage of cysteine 
residues of the mucus film (Figure 1.14C), that allow mucin to expand further, up to 3-4 times 
in volume. Because the outer layer pore size is larger, it allows freer movement of bacteria 
(Hansson, et al., 2010).  
Due to the large size of the MUC2 protein, the high number of disulphide bonds and the 
oligomerisation into multimers, there is a relatively increased chance of misfolding during 
their biosynthesis (McGuckin, et al., 2011b). Correct protein folding is mediated by ER 
resident chaperones and enzymes. In normal conditions, the ER chaperone GRP78 (BiP) is 
bound by the transmembrane proteins IRE1, ATF6, and PERK, and thus rendered inactive. 
The accumulation of misfolded or unfolded proteins initiates the ER unfolded protein 
response (UPR) via the association with GRP78 (McGuckin, et al., 2010), which will lead to 
their removal by a process called ER associated degradation (ERAD) (Vembar, et al., 2008). 
Liberation of IRE1 and PERK facilitates the translation of the transcription factor X-box 
binding protein-1 (XBP-1). XBP-1 in turn induces a range of ER UPR-related genes such as 
chaperones and proteins involved in ERAD (Vembar, et al., 2008; Kaser, et al., 2008). Lack of 
XBP1 has been shown to cause accumulation of misfolded mucins, develop ER stress in 
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Paneth and goblet cells and subsequently lead to inflammation (Kaser, et al., 2008). In 
addition, activation of PERK inhibits global protein synthesis; the generation of active ATF6 
also enhances the transcription of XBP-1 and other ER UPR genes. Thus, ER homeostasis is 
maintained by (1) elevating the degradation of misfolded proteins, (2) attenuating protein 
translation, (3) and increasing the protein folding capacity by upregulating the expression of 
ER chaperones (McGuckin, et al., 2011a). 
Mucin granule exocytosis occurs in one of two modes: constitutively (unregulated baseline 
low-level secretion) and in response to extracellular stimuli (accelerated) (McGuckin et al., 
2011a and b). Under normal physiological conditions, goblet cells continuously replenish the 
mucus layer. In the presence of potent secretagogues including hormones (neuropeptides) 
and inflammatory mediators (cytokines and lipids), there is a rapid increase in mucus 
exocytosis, with a maximum rate at 1-3 minutes after stimulation, followed by a much slower 
rate of release (Specian and Neutra, 1980; Phillips, et al., 1984; McGuckin, et al., 2011b; 
Johansson, 2012). However, the mechanisms underlying the formation of these layers are 
still under investigation. Mucus secretion was suggested to be mediated by various 2nd 
messengers that include intracellular Ca2+ (Seidler, et al., 1989; Davis, et al. 2008), cAMP and 
DAG. Current techniques available for detection of mucins included ELISA, dot/ slot blotting, 
Western blotting, use of lectins and antibodies on membranes, additionally 
immunohistochemistry and immunofluorescence on both tissues and cells (Harrop, et al., 
2012).  
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Figure 1.15 MUC2 mucin assembly in goblet cell.  
MUC2 monomers are synthesised in the ER and dimerised via the C-terminals with 
concurrent N-glycosylation. These dimers then translocate to the Golgi where O-
glycosylation occurs. The heavily O-glycosylated MUC2 then densely packed into the apically 
stored secretory granules. At this stage, the N-terminal ends of the dimers are coupled 
together by disulphide bonds into trimeric structures. Once released from cell, MUC2 
multimers expand to form large net-like structures.  
(Figure from Birchenough, et al., 2015) 
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1.3.5 Known mediators of goblet cell mucin secretion 
Mucin secretion in goblet cells can be regulated by various mechanisms. Ach is the most 
studied Ca2+ mobilising agent that has been shown to induce mucus secretion in both the 
small and large intestines of mouse, rat, rabbit and the human colon (Specian & Neutra, 1980; 
Neutra, et al, 1982; Halm & Halm, 2000; Gustafsson, et al., 2012c; Ermund, et al., 2013b). 
Administration of Ach or Carbachol (Cch, non-degradable by cholinesterases) stimulates a 
rapid but transient increase in mucus secretion. Some previous studies have suggested that 
the small intestinal crypt goblet cells are more sensitive to cholinergic stimulation, while the 
villus goblet cells and colonic surface goblet cells are nonresponsive to the stimulus for 
mucus exocytosis (Gustafsson, et al., 2012a; Ermund, et al., 2013a and b). Histamine is 
another inducer that is mainly produced by immune cells such as basophils and mast cells. It 
is involved in local immune responses and can also act as a neurotransmitter. It has been 
shown to mediate mucus secretion in the airways of guinea pigs (Tamaoki, et al., 1997) and 
in the human colon, but not in the small intestine (Neutra, et al., 1982; Halm & Halm, 2000). 
Moreover, the prostaglandin E2 (PGE2) family is composed of lipid compounds that have 
been shown to induce mucus secretion in the rat colon and mouse small intestine, both via 
cAMP and Ca2+ dependent pathways. However, in the human colon PGE2 only appears to 
stimulate fluid secretion (Halm & Halm, 2000).  
Colonic ischemia can be caused by disease or surgery. A recent study by Grootjans and 
colleagues demonstrated that the release of mucus by compound exocytosis prevented 
ischemia-induced tissue damage. Ischemia has been shown to cause the detachment of the 
inner mucus layer, allowing bacteria to penetrate the sterile crypts. Goblet cells seem 
tolerant to ischemia reperfusion injury, and they release mucus when circulation is restored. 
The growth of the newly formed mucus layer then washes off the bacteria from the 
epithelium (Grootjans, et al., 2013). Although the mechanisms for colonic crypt mucus 
compound exocytosis have not yet been identified, this mass release has been shown to be 
triggered by Ach (Neutra, et al., 1982; Plaisancié, et al., 1998).  
 
1.3.6 Immunomodulation of goblet cell function 
Interleukin-10 (IL-10) is an anti-inflammatory cytokine that has been shown to be critical for 
intestinal homeostasis. Bacterial-dependent colitis has been observed in mice deficient for 
IL-10 or its receptor (Kϋhn, et al., 1993; Sellon, et al., 1998). In addition, GWAS have 
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highlighted single nucleotide polymorphisms in the IL-10 loci, as well as IL-10 receptor 
mutations, as associated with IBD (Franke, et al., 2008; Begue, et al., 2011). ER stress is 
emerging as an important contributor to IBD pathogenesis (McGuckin, et al., 2010; Hasnain, 
et al., 2013). Mice lacking IL-10 develop colitis accompanied by ER stress (Shkoda, et al., 
2007). TUDCA (a tertiary bile acid) has been suggested to play a role in resolving ER stress 
response in the small intestinal epithelial cell line Mode-K, that could be a potential drug to 
target IBD pathology (Berger and Haller, 2011). In addition, a study by Hasnain and colleagues 
recently demonstrated the role of IL-10 in modulating the ability of goblet cells to manage 
mucin biosynthesis and misfolding (Hasnain, et al., 2013). In another study, MUC2 
production was shown to be decreased in IL-10 deficient mice (van der Sluis, et al., 2008). 
Thus, these studies demonstrate the role of anti-inflammatory cytokines in mediating goblet 
cell mucin secretion.  
 
1.3.7 Other potential mediators of mucus secretion in goblet cells 
Current studies have suggested that cellular processes including endocytosis, autophagy, 
ROS generation, and inflammasome activity appear to modulate mucin granules 
accumulation and secretion.  For example, a study by Patel, et al demonstrated that the 
accumulation of goblet cell mucin granule in differentiated mouse intestinal cells was a result 
of the inhibition of clathrin-mediated endocytosis (Patel, et al., 2013). Electron microscopy 
revealed the expression of LC3β (an autophagosomal marker) and EEA1 (an endosomal 
marker) double positive vacuole, and this association was abrogated in endocytosis-inhibited 
cells. This finding potentially linked the autophagy and endocytosis pathways to mucus 
secretion. Autophagy is a process that links to immunity and inflammation (Levine, et al., 
2011). Cells lacking autophagy proteins including Atg5, Atg14 and FIP200 also caused mucin 
granule accumulation in goblet cells. Fusion of autophagosomes and endosomes forms an 
intermediate structure called an amphisome (Sanchez-Wandelmer, et al., 2013) which 
closely resembles the LC3β and EEA1 double positive vacuoles (Figure 1.16). These 
amphisomes are the source of ROS (Patel, et al., 2013). Inhibition of endocytosis or knockout 
of autophagy genes have been shown to block NADPH oxidase (NOX) activity in these 
amphisome-like structures and result in a decrease of cellular ROS (Patel, et al., 2013). 
Administration of exogenous ROS mediates mucin secretion, which suggested a role of ROS 
in mucus regulation (Figure 1.16) (Brownlee, et al., 2007; Patel, et al., 2013). 
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Inflammasomes are another potential regulator of goblet cell mucus secretion. They are 
multiprotein complexes which comprise of a subset of NOD-like receptor (NLR) family 
members, and are linked to caspase 1 via the adaptor protein ASC (apoptosis-associated 
speck-like protein containing a CARD). NLRPs function as sensors for various pathogen-
associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). 
Activation of inflammasomes trigger pyroptosis, a proinflammatory and lytic mode of cell 
death (Lamkanfi, et al., 2014). Some NLRP subtypes have been shown to be expressed in 
mucosal epithelial cells which suggests their possible role in intestinal homeostasis (Chen, G. 
et al., 2011; Elinav, et al., 2011; Chen, G.Y. et al., 2014; Wlodarska, et al., 2014). NLRP6 
inflammasomes are highly expressed by colonic goblet cells. Mice lacking NLRP6 displayed 
mucin granule accumulation, and thinner inner mucus layers compared to wild-type mice. 
This phenotype is similar to heterozygous Atg5 knockout mice (Patel, et al., 2013; Wlodarska, 
et al., 2014; Chen, G.Y. et al., 2014). In addition, NLRP6 knockout mice also possess elevated 
numbers of damaged mitochondria, which is a symptom of defective autophagy (Wlodarska, 
et al., 2014). Thus, these findings suggested the functional role of NLRP in intestinal mucin 
exocytosis through activation of autophagy in mice. 
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Figure 1.16 Proposed model of goblet cell mucus secretion mediated by ROS.  
NADPH oxidase 1 (NOX1) is an endosomal enzyme in the colon that mediates the formation 
of ROS outside of the mitochondria. ROS is generated via the activation of NOX1 by forming 
a complex with RAC1 and p22 phox. These ROS were suggested to promote the fusion of LC3+ 
vesicles with endosomes to form amphisome-like organelles. This compartment probably 
enhances the ROS production and in turn increase cytosolic [Ca2+] through an unknown 
mechanism and lead to mucus secretion in goblet cells.   
(Figure from Sanchez-Wandelmer, et al., 2013) 
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1.4 Hypothesis 
Cholinergic stimulation of muscarinic acetylcholine receptor 3 (M3AchR) in native human 
colonic epithelium mobilises intracellular Ca2+ and regulates mucus secretion in colonic 
goblet cells. 
 
 
 
Figure 1.17 Illustration of the hypothesis to be tested.  
(From left to right) Depictions of the neuronal-epithelial cell interactions in the human 
colonic epithelium via M3AchR. It has been well established in the Williams lab that the 
application of the neurotransmitter Ach or Cch stimulates a Ca2+ signal within seconds at the 
base of crypt near the stem cell niche. This Ca2+ signal (wave) appears to initiate at the apical 
pole of initiator cells at the base of crypt, before spreading to the basal pole of the cell and 
propagating further along the entire colonic crypt-axis via intercellular gap junctions. It is 
proposed that the cholinergic stimulated Ca2+ mobilisation from intracellular stores (ER, 
lysosomes) along the crypt-axis coordinates excitation secretion coupling of mucus in the 
human colonic goblet cells.  
 
 
 
 
 
  
Initiator cell Goblet cell 
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1.4.1 Aims of this study 
Previous studies have demonstrated a close correlation between Ca2+ signalling and mucus 
secretion in several models, including: animal GI tracts (Neutra, et al., 1982; Seidler, et al., 
1989; Hamada, et al., 1997; Yang, et al., 2013); human colon cancer cell lines (Mitrovic, et al., 
2013); animal airways (Davis, et al. 2008); human airways (Sebille, et al., 1998; Denning, et 
al., 1998), and animal eyes (Dartt, et al., 2000). Cholinergic stimulated Ca2+ signals have been 
shown to regulate fluid secretion in the native human colonic epithelium (Reynolds, 2007). 
In addition, cholinergic stimulated mucus secretion was first demonstrated by Halm and 
Halm in the isolated human colonic crypt (Halm and Halm, 2000). However, the molecular 
mechanism of the cholinergic mediated Ca2+ signal generation in coupling mucus secretion 
is unclear. Recent advances in the field suggest that the acidic endo-lysosomal Ca2+ stores 
are the initiator of Ca2+ signal generation via the TPC. The intracellular organelles including 
the endosome (EEA1+), lysosomes (LAMP1+) and autophagosomes (LC3+) are closely 
associated with each other. This arrangement suggests a possible cross-talk mechanism 
between Ca2+ and ROS in regulating mucus secretion. 
The aim of the current study is to investigate the role that cholinergic stimulation of the 
muscarinic acetylcholine receptor 3 (M3AchR) and mobilisation of intracellular Ca2+ plays in 
the coordination of excitation-mucus secretion coupling in human colonic crypts. The 
hypothesis will be tested by addressing the following objectives:  
(1) Characterisation of the cellular and molecular machinery of excitation-mucus 
secretion coupling in human colonic crypts 
 
(2) Investigation of cholinergic regulated Ca2+ signal generation 
 
(3) Investigation of Ca2+ excitation-mucus secretion coupling in the human colonic 
crypts 
 
(4) Exploration of the interplay between Ca2+ and ROS in mucus secretion
 63 
 
Chapter 2: Materials and Methods 
 
2.1 Materials  
2.1.1 Chemicals and reagents  
Chemicals, reagents, buffers and medium Supplier 
Agarose Sigma- Aldrich 
Bovine serum albumin (BSA) Sigma- Aldrich 
Calcium chloride (CaCl) BDH Prolabo (VWR International) 
D-Glucose Fisher Scientific 
Dimethyl sulfoxide (DMSO) Sigma- Aldrich 
Disodium hydrogen phosphate (Na2HPO4 ) Fisons Scientific Apparatus 
DMEM Invitrogen 
Donkey serum Sigma 
Ethanol Sigma 
Fluo-4 AM Invitrogen (Molecular Probe) 
Fura-2 AM Invitrogen (Molecular Probe) 
HEPES Fisher Scientific 
Hoechst 33342 solution Life Technologies 
Magnesium chloride (MgCl) Fluka (Sigma-Aldrich) 
Matrigel  BD Biosciences 
Paraformaldehyde (PFA) Sigma- Aldrich 
Phosphate buffered saline (Dulbecco A) 
Tablets 
OXOID 
Potassium chloride (KCl) Fisher Scientific 
ROSstarTM 550 LI-COR 
Sodium bicarbonate (NaHCO3 ) Fisher Scientific 
Sodium chloride (NaCl) Fisher Scientific 
Triton-X 100  Roche 
VECTASHIELD Vector laboratories 
Xylene Sigma 
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2.1.2 Buffers 
Buffer Formula 
HEPES Buffered Saline 
(HBS), pH 7.4 
KCl (5mM), NaCl (140mM), HEPES (10mM), D-glucose 
(5.5mM), Na2HPO4 (1mM), NaHCO3 (10mM), MgCl 
(0.5mM), CaCl (1mM) for 1 litre 
Citrate Buffer, pH 6 Tri-sodium citrate 2.94 g in 1litre of H2O (10mM) 
 
2.1.3 RNA isolation, RT-PCR and PCR reagents 
Name Supplier 
RNA later® Solution Ambion life technologies 
E.Z.N.A total RNA kit 1 OMEGA bio-tek 
SuperScript® II Reverse Transcriptase Invitrogen life technologies 
RNasin® ribonuclease inhibitor Promega 
Oligo(dT) primer Promega 
PCR nucleotide mix  Promega 
GoTaq® G2 polymerase Promega 
Low Molecular Weight DNA Ladder New England Biolabs 
 
2.1.4 Requirement of Bicarbonate in HBS buffer 
Bicarbonate (HCO3-) is a crucial biochemical component of many physiological pH buffering 
systems. HCO3- is secreted into the gut lumen by diffusing into the mucus layers to aid in the 
neutralisation of acid generated by microbial fermentation (Allen, et al., 2005). A previous 
study has demonstrated the increase in diffusivity and hydration of mucus with the presence 
of extracellular (exogenous) HCO3- in airway cells (Chen, et al., 2010), suggesting HCO3- is 
required for decreasing the viscosity and increasing transportability of mucus. In cultured ex-
vivo segments of mouse small intestine the presence or absence of HCO3- had no effect on 
the rate of basal mucus secretion. While HCO3- was shown to enhance mucus secretion when 
stimulated by secretagogues such as PGE2 or 5-hydroxytryptamine (5-HT), and the 
secretagogue-induced mucus secretion was reduced by half in the absence of HCO3- (Garcia, 
et al., 2009). These findings suggest the concurrent HCO3- secretion is a requirement for 
normal mucus secretion. In addition, inhibition or in the absence of HCO3- did not affect fluid 
secretion rates, suggesting the role of HCO3- in mucus secretion was independent of fluid 
secretion (Garcia, et al., 2009). In order to investigate the secretagogue (Cch)-induced mucus 
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secretion in the human colonic epithelium, HCO3- was included in the HBS buffer for all the 
experiments conducted in the current study. 
 
2.2 Methods 
2.2.1 Human colorectal tissue samples 
This study is performed in accordance with the Norfolk and Norwich University Hospital UK 
and approval by the East of England National Research Ethics Committee (LREC 97/124). 
Human colorectal tissue biopsies were obtained with informed consent from patients 
undergoing recto-sigmoid endoscopy and from cancer patients undergoing colectomy (right 
hemi-colon or left hemi-colon or anterior resection). The histologically-normal mucosa 
samples were obtained at least 10cm away from tumour sites, and only used if there was no 
apparent intestinal pathology.  
 
2.2.2 Micro-dissected native human colonic crypts 
Biopsies and surgical tissue samples were fixed with 4% PFA for one hour and then washed 
with PBS. After micro-dissection, single micro-dissected crypts were embedded in Matrigel 
and post-fixed with 4% PFA before further immuno-staining procedures.  
 
2.2.3 Vibratome sectioning of human colonic biopsies 
Human colon biopsies or surgical samples were fixed immediately with 4% PFA for one hour. 
The samples were then washed with PBS 2-3 times. Fixed samples were cut into smaller 
pieces and embedded in 4% low melting temperature agarose gel, in a suitable orientation 
for sectioning. Tissues were sectioned with a Vibratome (Leica VT1000) to produce 70-100 
µm thick sections, and were stored in PBS at 4˚C before further immuno-staining procedures. 
2.2.4 Human colonic crypt isolation and culture 
Human colonic crypts were isolated (as described in Reynolds et al., 2007 and Reynolds et 
al., 2014 supplementary methods), and provided by Dr. Alyson Parris in the Williams 
Laboratory. Briefly, tissues were washed with HBS and then transferred into Ca2+ and Mg2+ 
free HBS containing 1mM Dithiothreitol (DTT) and 1mM Diaminoethane-tetraacetic acid 
(EDTA) for one hour at room temperature. Crypts were then liberated through vigorous 
shaking; sedimented crypts were collected and mixed with Matrigel. A 20µl Matrigel 
suspension containing 50-100 crypts was seeded onto glass coverslips nested inside the wells 
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of a 12-well plate. After polymerisation of Matrigel at 37˚C for 15 min, isolated crypts were 
then flooded and cultured with 0.5ml of human colonic crypt culture medium (hCCCM, 
advanced F12/DMEM culture medium containing penicillin/streptomycin [100U/ml], L-
glutamine [2mM], B27, N2, N-acetylcysteine [1mM], Hepes [10mM], A83-01 [0.5µM], human 
recombinant R-spondin-1 [500ng/ml], human recombinant Wnt 3A [100ng/ml], human 
recombinant Noggin [100ng/ml] or Gremlin-1 [200ng/ml], and human recombinant IGF-1 
[50ng/ml]) at 37˚C with 5% CO2 overnight prior to experimentation (Parris and Williams, 
2015).  
 
2.2.5 Single colonic epithelial cell isolation and culture 
The isolated crypts were collected by centrifugation for 800rpm at 5 mins at 4˚C; and 
dissociated with TrypLE express in the presence of Y-27632 [10µM] and N-acetylcysteine 
[0.5mM] for 8 min at 37˚C with pipetting. After removal of cell clumps with a 20µm cell 
strainer, the dissociated colonic epithelial cells (including goblet cells) were then washed 
with culture medium and collected by centrifugation. 5000 epithelial cells were then re-
suspended in 100µl of Matrigel, and a 20µl of Matrigel droplet was seeded onto glass 
coverslips contained within a 12-well plate. After polymerisation of Matrigel at 37˚C for 15 
min, isolated single cells were then cultured with hCCCM as described above at 37˚C with 5% 
CO2 overnight prior to experimentation. 
 
2.2.6 Immunohistochemistry 
Isolated human colonic crypts (Day1 - Day3 cultures) were used for live experiments. Crypts 
were washed once with PBS before fixation with 4% PFA for one hour on ice. The Vibratome 
sections, micro-dissected crypts or cultured crypts were then ready for immuno-staining 
procedures.  
The samples were incubated with 1% SDS for 5 mins and then permeabilised with 0.5% 
Triton-X 100 for 30-35 minutes followed by a PBS wash. Non-specific binding was blocked 
with 10% donkey serum with 1% bovine serum albumin (BSA) for two hours. Depending on 
the protein of interest, the biopsy samples or cultured colonic crypts were incubated 
overnight with a combination of two to three primary antibodies (1:100 dilution) from 
different origin species at room temperature or 4˚C respectively (full list of antibodies as 
shown below in table 2.2.1). Samples were washed three times with PBS. Alexa fluor 
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conjugated donkey secondary antibodies (as listed in table 2.2.1) at half the concentration 
of the primary antibodies were used to detect the signals. Secondary antibodies were 
incubated for 2 to 5 hours at room temperature or 4˚C respectively. Non-specific labelling 
was determined by using primary antibody-negative controls. Samples were washed with 
PBS and mounted in VECTASHIELD containing Hoechst stain for labelling the cell nuclei. In 
conjunction with confocal microscopy (Zeiss LSM510-meta), the labelling can be visualised 
in thin optical sections (~ 1µm). 
For live cell imaging of organelles, cultured colonic crypts were loaded at 37˚C for 2 hours 
with ER Tracker (5µM), Lyso Tracker (1µM) or Mito Tracker (0.5µM) diluted with serum-free 
DMEM. Samples were then washed twice with HBS and analysed by confocal microscopy. 
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2.2.6.1 Image analysis of immunohistochemistry 
Fluorescent images were analysed by image analysis software including ImageJ (National 
Institutes of Health) and Volocity (Perkin Elmer). Fluorescence intensities of proteins of 
interest were measured by drawing regions of interest (ROI) on fluorescent images of colonic 
crypts. Values were background corrected. Mean readings were calculated for each 
treatment group and normalised to the mean intensity level of the control group as 
described in the equation below. Semi-quantitative analysis was presented using normalised 
mean ± standard error mean (SEM). For example, the MUC2 mucin content (as inferred from 
anti-MUC2 immunofluorescent intensities) in goblet cells was quantified by drawing a region 
of interest around the secretory vacuole of each  goblet cell located at the base of colonic 
crypts using ImageJ. Mean MUC2 immunofluorescent intensities in goblet cells in each 
treatment group were calculated and normalised to the control group, as described above 
and presented as mean ± SEM. 
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Table 2.2.1 Antibodies and Organelle Stains 
Primary Antibody name 
Species 
origin 
Clonality 
Working 
concentration 
Supplier 
anti-MUC2 Rabbit Polyclonal  1:100 Santa Cruz 
anti-MUC2 Mouse Monoclonal 1:100 Abcam 
anti-KDEL Mouse Monoclonal 1:100 Santa Cruz 
anti-LAMP-1 Rabbit Polyclonal  1:100 Abcam 
anti-TPC1 Rabbit Polyclonal 1:100 Abcam 
anti-TPC2 Rabbit Polyclonal 1:100 Abcam 
anti-LC3 Mouse Monoclonal 1:100 MBL 
anti-LAMP-1  
ascities/ concentrate 
Mouse Monoclonal 1:100 DSHB 
anti-E-Cadherin Goat Polyclonal  1:100 R&D systems 
anti-E-Cadherin Mouse  1:100 BD Bioscience 
anti-M1 muscarinic 
receptor (M1AchR) 
Rabbit Polyclonal 1:100 
Research & 
Diagnostic Abs 
anti-M3 muscarinic 
receptor (M3AchR) 
Rabbit Polyclonal  1:100 
Research & 
Diagnostic Abs 
anti-M5 muscarinic 
receptor (M5AchR) 
Rabbit Polyclonal 1:100 
Research & 
Diagnostic Abs 
anti-Choline 
acetyltransferase (CHAT) 
Goat Polyclonal 1:100 Millipore 
anti-Ki67 Mouse Monoclonal 1:100 DAKO 
anti-beta tubulin III (Tuj-1) Mouse Monoclonal 1:100 Neuromics  
anti-Tubulin, beta III 
isoform (TU-20) 
Mouse Monoclonal 1:100 Millipore 
anti-Neurofilament Mouse Monoclonal 1:100 Abcam 
anti-200kD Neurofilament 
Heavy  
Mouse Monoclonal 1:100 Abcam 
anti-Neurofilament Light 
(NF-L) 
Rabbit Polyclonal 1:100 Millipore 
anti-
VesicularAcetylcholine 
Transporter (VAChT) 
Rabbit Polyclonal 1:100 Abcam 
anti-CD38 Rabbit Monoclonal 1:100 Abcam 
anti-CD38 Mouse Monoclonal 1:100 Abcam 
anti-IP3R1 Rabbit Polyclonal 1:100 
Novus 
Biologicals 
anti-IP3R2 Goat Polyclonal 1:100 Santa Cruz 
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anti-IP3R3 Rabbit Polyclonal 1:100 
Novus 
Biologicals 
anti-Ryanodine receptor 
(RYR) 
Rabbit Polyclonal 1:100 Abcam 
anti-SERCA 1/2/3 Rabbit Polyclonal 1:100 Santa Cruz 
anti-DCAMKL-1 Rabbit Polyclonal 1:100 Abcam 
anti-OLFM4 Rabbit Polyclonal 1:100 Abcam 
anti-OLFM4 Rabbit Polyclonal 1:100 
LifeSpan 
BioSciences 
anti-Lgr5 Mouse Monoclonal 1:100 Origene 
anti-Chromogranin A 
(CGA) 
Rabbit Polyclonal 1:100 Abcam 
anti-Chromogranin A 
(CGA) 
Mouse Monoclonal 1:100 Abcam 
anti-C-kit Rabbit Polyclonal 1:100 Abcam 
anti-COX-1 Goat Polyclonal 1:100 Santa Cruz 
     
Secondary Antibody name 
Species 
origin 
 
Working 
concentration 
Supplier 
anti-goat Alexa Fluor 488 Donkey  1:200 Invitrogen 
anti-goat Alexa Fluor 568 Donkey  1:200 Invitrogen 
anti-rabbit Alexa Fluor 488 Donkey  1:200 Invitrogen 
anti-rabbit Alexa Fluor 647 Donkey  1:200 Invitrogen 
anti-mouse Alexa Fluor 488 Donkey  1:200 Invitrogen 
anti-mouse Alexa Fluor 647 Donkey  1:200 Invitrogen 
     
Other stains   
Working 
concentration 
Supplier 
Rhodamine red- Wheat 
germ agglutinin (WGA) 
Lectin  1:200 
Vector 
Laboratories 
Mito Tracker® (Organelle 
Stain) 
  0.5µM Invitrogen 
ER-Tracker™ (Organelle 
Stain) 
  5µM Invitrogen 
Lyso Tracker® (Organelle 
Stain) 
  1µM Invitrogen 
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2.2.7 Gene expression analysis of muscarinic receptors and intracellular calcium 
channels in the human colonic mucosa 
 
2.2.7.1 Isolation of total RNA and generation of cDNA  
Human colon biopsies or freshly isolated colonic crypts were pelleted and placed in 
RNAlater®. Total RNA was isolated using the Omega Bio-tek Easy nucleic acid isolation kit 
according to the manufacturer’s instructions. The concentration and purity of the total RNA 
was then measured by the NanoDrop Spectrophotometer. Purity of RNA samples with 
A260/A280 ratio between 2-2.2 was deemed acceptable for further experiments. RNA was 
then stored at minus 80˚C prior to use. First strand cDNA was prepared from 1 µg of total 
RNA using oligo-dT primers and Superscript II RT according to the manufacturer’s instructions.  
 
2.2.7.2 Conventional PCR 
The presence of expression of the cholinergic neuronal markers (CHAT and VAChT), 
muscarinic acetylcholine receptor subtypes (M1-M5AchRs), intracellular Ca2+ channels (IP3Rs, 
RYRs and TPCs) and Ca2+ ATPase pump (SERCA) were assessed using reverse transcription 
PCR (RT- PCR).  Gene-specific primers were designed to span intron-exon boundaries to avoid 
amplification from potential contaminating genomic DNA; primer sequences are listed below 
in table 2.2.2. Two µl of cDNA from RT reactions (as described above) was amplified using a 
G-Storm thermocycler. The conditions for amplification were as follows: initial denaturation 
for 5 mins at 95˚C followed by 40 cycles of; denaturation for 1 min at 95˚C; annealing for 50 
sec using a touchdown PCR protocol (normally ranged from 55˚C to 65˚C, depending on the 
specific primer pairs), and extension for 1 min at 72˚C, followed by a final extension for 10 
min at 72˚C. The PCR products were electrophoresed in 2.5% agarose gel and post stained 
with ethidium bromide, and then reviewed under UV-light with gel documentation system 
(UVP).   
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Table 2.2.2 Conventional PCR primers 
Gene 
name 
NCBI Reference Primer L sequence Primer R sequence 
Product size 
(bp) 
CHAT NM_020985.3 
GGACAACATCAGATC
GGCCAC 
GAACATCTCCGTGGT
TGTGGG 
300 
Nested 
CHAT 
NM_020985.3 
TTTGTGAGAGCCGTG
ACTGA 
ATCCATGAACATCTC
GGGCA 
195 
SLC18A3 
(VAChT) 
NM_003055.2 
CTGTAACATTCCCCTC
GCCTTC 
GCTGTGTCGACTAGG
GCTATGC 
299 
Nested 
VAChT 
NM_003055.2 
TGGATGAAGCATACG
ATGGC 
GAGGCCGCATAGTG
AGACC 
228 
CHRM1 NM_000738.2 
CAAGTGGCCTTCATTG
GGATCAC 
GCATTGCTGGCCACA
TAGTCC 
260 
CHRM2 NM_000739.2 
GAGCTCCAATGACTCC
ACCTCAG 
GGGAAGGAGGAGGC
TTCTTTTTTG 
298 
CHRM3 NM_000740.2 
CAACCTCGCCTTTGTTT
CCAAAC 
CCAGGATGTTGCCGA
TGATGG 
242 
CHRM4 NM_000741.3 
GGCAGTTTGTGGTGG
GTAAG 
CGCTCTGCTTCATTAG
TGGGC 
248 
CHRM5 NM_012125.3 
GTCTGGCTTGTGACCT
TTGGC 
GGTGGGCTCAGAGA
GAAACTG 
278 
ITPR1 
(IP3R1) 
NM_001099952.2 
TGTCGGAATTAAAGG
ATCAGATGAC 
CTGGTTGTTGTGGGT
TGACATTC 
102 
ITPR2 
(IP3R2) 
NM_002223.3 
GGAGCTCAAGGAGCA
GATGAC 
CAGGCAGGACACTG
ATGAAAG 
150 
ITPR3 
(IP3R3) 
NM_002224.3 
AGCTCAAGGAGCAGA
TGACG 
AGTGATGAGCATCCC
CTGTTG 
123 
RYR1 NM_000540.2 
AGAACACACGGGTCA
GGAGTC 
AGGGGCTTGCTGTGA
GAATAAG 
172 
RYR2 NM_001035.2 
CAGAACACACAGGAC
AGGAATC 
GGGTTTTGGTTTTTA
GAGGTGA 
147 
RYR3 NM_001036.4 
CTGGCCATCATTCAAG
GTCT 
ACCCGTGTGCTCTGTT
TCAT 
231 
ATP2A1 
(SERCA1) 
NM_004320.4 
GGACAACACCCACTTT
GAGG 
GAGGATGAGGAAGT
GCAGGG 
211 
ATP2A2 
(SERCA2) 
NM_001681.3 
GACAATGGCGCTCTCT
GTTC 
CATGAGAATCACGGG
CAAGG 
250 
ATP2A3 
(SERCA3) 
NM_005173.3 
GAAATGTGCAATGCC
CTCAACAG 
GCAGGATGACAGGC
AGAGATATC 
214 
TPCN1 NM_001143819.2 
GCATCACCCTTGAGAA
GGAAATC 
GGCATGCTCCTCATA
CCACTC 
233 
TPCN2 NM_139075.3 
GGCCAACAACTTCGAT
GACTTTG 
TTGACCCAGATGACA
GACGAC 
165 
GAPDH NM_002046.5 
GTCAGTGGTGGACCT
GACCTG 
TGCTGTAGCCAAATT
CGTTG 
245 
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2.2.8 Intracellular calcium imaging in human colonic crypt  
Isolated human colonic crypts (Day 1 to Day 3 cultures) were loaded with Fura-2/AM (5 µM) 
for 2 hours at room temperature in the dark to monitor cytoplasmic Ca2+ levels. Crypts were 
washed twice with HBS and incubated with HBS for at least a further 30 minutes to allow de-
esterification of the dye. The loaded samples were then transferred into a chamber located 
on the stage of an inverted fluorescent microscope (with X40 or X20 objectives) while 
maintained in HBS (200µl). Experimental agonists and antagonists (full list in Table 2.2.3 
below) were diluted with HBS. The experimental solutions (agonist and/or antagonist) were 
administered by replacing the HBS buffer solution. Fura-2 in the loaded crypt was excited 
alternatively at 340 nm and 380 nm and the fluorescence at 510 nm was detected by a cooled 
CCD camera (Quantum, Roper Scientific, UK). The background-corrected F340/F380 ratios 
were calculated and monitored in real time. Fluorescent data were presented as pseudo-
colour images (Figure 2.1) or traces (Figure 2.2). At the beginning of each experiment, regions 
of interest (ROI) were drawn along the crypt axis and the average ratio values (F340nm/ 
F380nm) of those regions were plotted with respect to time (Figure 2.1). 
 
Figure 2.1 Fluorescence image of a Fura-2 loaded crypt. 
Regions of interest (ROI) represented by circles as shown were drawn along the axis of the 
crypt. Each region is represented by a different colour in order to distinguish the signals from 
different regions. 
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2.2.8.1 Calcium imaging analysis 
Since Ca2+ signals were reproducible in response to repeated applications of 10 µM Cch, a 
control Cch response was included in each antagonist experiment to which the experimental 
conditions can be compared. Measurement of the amplitude of the Ca2+ response is 
described in figure 2.2 below.  
 
 
Figure 2.2 Changes of Fura-2 ratio with respect to time in response to Cch stimulation in 
ROI 1. 
Human colonic crypts were loaded with Fura-2 AM to monitor intracellular Ca2+. An increase 
in Fura-2 ratio represents an increase in cytosolic Ca2+ levels upon Cch stimulation. After 
background subtraction, the amplitude of the response was calculated by subtracting the 
baseline ratio from the peak ratio.  
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Table 2.2.3 Chemicals (agonist and antagonist) for live intracellular calcium 
experiments 
Name Function 
Working 
concentration 
Incubation 
time  
Supplier 
Carbachol (Cch) Agonist 10 µM, 100 µM 1-2 min Sigma 
Methacholine Agonist 10 µM 1-2 min Sigma 
U73122 Antagonist 10 µM 1 hr Sigma 
R59-022  
(DAG kinase inhibitor) 
Antagonist 10 µM 1 hr TOCRIS  
Sotrastaurin  
(PKC inhibitor) 
Antagonist 20 µM 1 hr 
AdooQ 
Bioscience 
2AP-B Antagonist 50 µM 1 hr Sigma 
Xestospongin C (XesC) Antagonist 2 µM 1 hr 
Calbiochem
/TOCRIS 
Ryanodine Antagonist 50 µM 1 hr TOCRIS  
8 Bromo cADP ribose Antagonist 30 µM 1 hr Sigma 
Thapsigargin (Tg) Antagonist 1 µM 50 min TOCRIS  
Nicotinamide Antagonist 20 mM 1-2 hrs Sigma 
Trans-Ned19 Antagonist 200 µM  1 hr TOCRIS  
Glycyl-L-phenylalanine-
beta-naphthylamide (GPN) 
Antagonist 200 µM 45 min Sigma 
Diltiazem (DZM) Antagonist 300 µM 1 hr TOCRIS 
Bafilomycin (Baf) Antagonist 2.5 µM 1 hr TOCRIS  
Chloroquine (CHQ) Antagonist 100 µM 1 hr Sigma 
Methyl-beta-cyclodextrin 
(MβC) 
Antagonist 10 mM 1 hr Sigma 
Hydroxy Dynasore Antagonist 100 µM 1 hr Sigma 
BAPTA-AM Antagonist 66 µM 1 hr Sigma 
Diphenyleneiodonium 
(DPI) 
Antagonist 
1 µM, 2.5 µM, 5 
µM 
1 hr Sigma 
VAS2870 Antagonist 56 µM 1 hr Sigma 
NSC 23766 (RAC inhibitor) Antagonist 250 µM 1 hr TOCRIS 
Apocynin Antagonist 100 µM 1 hr TOCRIS 
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2.2.9 Intracellular ROS and calcium imaging in human colonic crypts 
Similar to Fura-2 experiments, isolated human colonic crypts (Day 1 to Day 3 cultures) were 
loaded with both ROSstar 550 (100 µM, Invitrogen) and Fluo-4/AM (5 µM, Invitrogen) in HBS 
for 1.5-2 hours at room temperature in the dark to monitor cytoplasmic reactive oxygen 
species (ROS) and Ca2+ respectively. The crypts were then washed twice with HBS. Agonist 
(10 µM Cch or 10 µM methacholine) was administered by replacing the HBS buffer solution, 
and then changes in intracellular levels of ROS and calcium were monitored in real time by 
confocal microscopy.  
 
2.2.10 Statistical analysis 
Data were expressed as mean ± SEM. N = total number of subjects (i.e. patients), n = number 
of crypts derived from those ‘N’ subjects, and ng = number of goblet cells in each treatment 
group (that were analysed in ‘n’ crypts via analysis of the microscopy data). Differences 
between two groups were determined by paired or unpaired t-tests, while comparisons 
between more than two groups were determined by one-way ANOVA, followed by 
Bonferroni procedures and Tukey’s post hoc analysis. For each test a P value of less than 0.05 
was considered to be statistically significant.  
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Chapter 3 Results: Characterisation of the cellular and molecular 
machinery of excitation-mucus secretion coupling in human colonic 
crypts 
 
3.1 Introduction  
Activation of MAchRs by the neurotransmitter Ach has been shown previously to mobilise 
intracellular Ca2+ in the intestinal epithelium (Satoh, et al., 1995; Lindqvist, et al., 1998; Klaren, 
et al., 2001; Lindqvist, et al., 2002; Hirota & McKay, 2006; Reynolds, et al., 2007). Ach is 
thought to be primarily secreted by the cholinergic neurons of the enteric nervous system. 
However, evidence for cholinergic innervation in the human colonic epithelium remains 
limited. In recent years, some groups have initiated studies into the presence of the non-
neuronal Ach system of the colonic epithelium. Findings by Yajima et al (2011) and Bader et 
al (2014) demonstrated that the fatty acid propionate stimulates non-neuronal Ach release 
which promoted chloride secretion in the rat colon. These observations fully support a model 
in which synthesis and release of Ach occurs in the colon without cholinergic innervation, 
and provides valuable insights into the regulation of gut physiology by neuronal and non-
neuronal Ach. 
A major function of the colon is to absorb water and to secrete fluid and mucus. Cholinergic 
signalling has been shown extensively to regulate electrolyte secretion in the colon 
(Zimmerman, et al., 1982; Javed, et al., 1992; O’Malley, et al., 1995; Cliff, et al., 1998; Banks, 
et al., 2004; Hassan, et al., 2012). Most of these studies were performed in animal models or 
on human colon cancer cell lines such as HT-29 and T-84. However, the polarity and topology 
of the intact colonic epithelium is compromised in these human cell lines, which may affect 
cellular signals generation with respect to the tissues from which these lines derive. A 3-D 
human colonic crypt culture model has therefore been developed in our lab where many 
features of colonic crypt morphology and function are maintained. These cultured crypts are 
proliferative, polarised, intact, and exhibit agonist-stimulated secretion coupling in culture.  
Our lab has repeatedly demonstrated that cholinergic stimulation of M3AchR mobilises 
intracellular Ca2+ in this native human colonic crypt culture model (Lindqvist, et al., 2002; 
Reynolds, et al., 2007). However, the underlying mechanism of Ca2+ signal generation and 
role in coupling mucus secretion in the human colonic epithelium is unknown. Limited 
information is currently available regarding the cellular localisation of functional intracellular 
Ca2+ stores and the respective expression of the Ca2+ release channels in the human colonic 
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epithelium, and specifically in mucus secreting goblet cells. The present study investigated 
the expression patterns and localisation of cholinergic enteric neurons, and the potential for 
a non-neuronal Ach system in the human colonic epithelium. In addition, the colonic MAchR 
subtype expression and localisation has been confirmed. This initial series of experiments 
also aimed to characterise the Ca2+ signalling toolkit in our model, with a focus on goblet cells, 
in order to form the basis for further investigation of the cholinergic regulation of Ca2+ 
coupling mucus secretion. 
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Results 
3.1.1 Neuronal-epithelial cell interactions 
The colonic epithelium is under the control of the ENS. The neurons that extend from the 
submucosal plexus into the mucosa can be both cholinergic and non-cholinergic. In order to 
describe the spatial relationship of the enteric neurons and the colonic epithelium, human 
colon biopsies were fixed and sectioned with a vibratome. Mucosal sections were then 
stained with various neuronal markers including β-III Tubulin (TU-20 or TUJ 1), neurofilament 
light and heavy chain antibodies to visualise the localisation of enteric neurons. 10X 
magnification of the colonic mucosa revealed the presence of neurons surrounding the 
colonic crypts from the base to the surface epithelium (lumen-facing). The neurons were also 
detected in the muscularis mucosae and the submucosa (Figures 3.1). The neuronal network 
(branches) seem relatively dense in the sub-epithelial domain. Higher magnification, at 40X, 
not only revealed the close proximity of the enteric neurons with the crypts, it also 
demonstrated that nerve endings (axonal projections) touch and clasp the membrane of the 
crypt colonocytes (Figure 3.2A). Some of these interactions look invasive, in that they 
penetrate into the crypt. Images of the crypt equatorial layer further revealed and confirmed 
the penetration of some nerve endings into the single epithelial cell layer (Figure 3.2B). These 
nerve endings extended towards the apical membrane of the crypt cells which suggests that 
there is some site of interaction on the apical pole of colonic epithelial cells. 
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Figure 3.1 Enteric neuronal network in the colonic epithelium 
Vibratome sections of human colon tissue biopsies were fixed and stained with anti-β-III 
tubulin (TU-20) antibody, and visualised with Alexa 488 conjugated secondary antibody. 
Images were taken with a Zeiss LSM 510 Meta confocal microscope using a x10 objective. (A) 
Overlay DIC image of the colonic mucosa and the supporting layers (muscularis mucosae and 
submucosa) and β-III tubulin (green); (B) β-III tubulin only (green) labelled colonic mucosa; 
(C) Enlarged image of (B); (D) No primary antibody (negative) control. Images are 
representative of N=2 subjects, n=4 sections derived from 2 subjects. 
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Figure 3.2 Interaction of enteric neurons with the colonic epithelium 
Sections of human colonic mucosa fixed and stained with anti-neurofilament (green) and 
anti-Ecad (red) antibodies; or with anti-β-III tubulin (green) and anti-Ecad (red) antibodies. 
Optical sections (1µm thick) of the colonic mucosa were taken with a Zeiss LSM 510 Meta 
confocal microscope for 20-30µm with a x40 objective to generate the 3D z-stack images. (A) 
3D reconstruction of the z-stack confocal images using the Volocity software (Perkin Elmer). 
Reconstructed image can be rotated through any axis to give a spatial appreciation of the 
neuronal-crypt morphology and interactions. (B) Consecutive z-stack images of the colonic 
mucosa to give an appreciation of the sequence of events from left to right. The nerve 
endings of the enteric neurons not only touch and clasp the surface of the crypt (A middle 
and right), but also penetrate into the epithelial cells (B white arrows). Images are 
representative of N=8 subjects, n≥40 sections derived from 8 subjects. 
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3.1.1.1 Cholinergic innervation of the human colonic epithelium 
A substantial amount of work has demonstrated that the activation of MAchR by Ach – 
primarily secreted by the cholinergic enteric neurons – mobilises intracellular Ca2+ waves in 
the intestinal epithelium (Lindqvist, et al., 1998; Klaren, et al., 2001; Lindqvist, et al., 2002; 
Hirota & McKay, 2006; Reynolds, et al., 2007). Cholinergic neurons, a potential source of Ach, 
were specifically identified by the expression of CHAT and VAChT (see section 1.1.5.1). By 
using reverse transcription-PCR (RT-PCR), CHAT mRNA expression was demonstrated in both 
human colon biopsies and isolated colonic crypts (Figure 3.3), however, the expression level 
was relatively low (i.e. faint bands) with variations between individuals in both samples 
tested. By contrast, VAChT mRNA expression was undetectable during the initial RT-PCR 
reaction. By using nested PCR, a successive round of PCR amplification using another set of 
primers, the expression of both CHAT and VAChT mRNA was detectable in both set of 
samples. The expression and localisation of the cholinergic neurons were confirmed by 
labelling the mucosal sections with CHAT or VAChT antibodies in conjunction with other 
neuronal markers. CHAT positive or VAChT positive neurons are mainly located at the base 
of crypts, in the muscularis mucosae and submucosa (Figure 3.4 and Figure 3.11). X40 
magnification reveals the close proximity of these cholinergic neurons with the colonic crypts, 
which provides a very short distance for Ach diffusion after release from nerve endings.  
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Figure 3.3 Cholinergic neuronal marker mRNA expression in human colon biopsies and 
isolated crypts. 
Agarose gel electrophoresis showing RT-PCR products for CHAT and VAChT genes from 
human colon biopsies and isolated crypts, using specific primers designed to anneal across 
exon-exon boundaries to avoid amplification from potentially contaminating genomic DNA. 
Minimal or no expression was observed during first round PCR amplification of CHAT and 
VAChT respectively. PCR products from first round were further amplified for 40 cycles with 
the second set of primers for both genes (Nested). GAPDH is used as a positive control. No 
PCR product was detected in the no template (H2O) control lanes. The above gels display 
mRNA expression of CHAT and VAChT from five random intact human colon biopsies and 
their corresponding isolated crypt samples.  
  
 84 
 
 
Figure 3.4 Immunolocalisation of neurofilament heavy, VAChT and CHAT in the human 
colonic epithelium. 
Vibratome sections of human colon biopsy samples were fixed and stained with anti-
200kD neurofilament heavy (green), anti-VAChT (pink) and anti-Ecad (red) antibodies 
(top panel); or with anti-200kD neurofilament heavy (green), anti-CHAT (red) and anti-
MUC2 (pink) antibodies (bottom panel). Both Ecad and MUC2 were used to identify the 
location of the crypts. Images were taken simultaneously using the 488nm laser (green), 
the 568nm laser (red) and the 647nm laser designated pink that revealed overlapping 
signals of the cholinergic neuronal markers CHAT or VAChT with the general neuronal 
marker neurofilament heavy in the human colon. Both top and bottom panels show the 
inner layers of the gut wall including the bottom of the crypt (mucosa), the muscularis 
mucosae and the submucosa. White dotted lines mark the boundary of the crypts 
embedded in the lamina propria. Images were taken with a confocal microscope with a 
x40 objective. Images are representative of N=8 subjects, n≥40 sections derived from 8 
subjects. 
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3.1.2 Potential non-neuronal Ach system in the human colon 
The paradigm of Ach acting solely as a neurotransmitter has been revised after a substantial 
number of studies demonstrated the production of Ach in non-neuronal cholinergic systems, 
including the intestinal epithelium (Keely, 2011). CHAT is the enzyme responsible for Ach 
synthesis. As mentioned in the previous section, CHAT mRNA expression was detectable in 
isolated human colonic crypts that were absent of any neurons (Figure 3.3 right panel). The 
most striking observation was the presence of CHAT positive cells in both human colon 
biopsies and micro-dissected crypts (Figure 3.5). Immunohistochemical labelling also 
revealed that expression of CHAT protein on the basal membrane of the crypt, which co-
localised with M3AchR under resting conditions (Figure 3.5B (iii). A previous study by Jönsson 
et al demonstrated the positive labelling of CHAT proteins in the human colonic epithelium: 
however they did not show the existence of these CHAT positive cells along the crypt-axis 
(Jönsson, et al., 2007). In the current study, these cells expressing CHAT were predominantly 
found among those between the base and the mid region of the crypt, where the 
proliferative immature cells reside. CHAT positive cells were also detectable between the 
mid to top region of the crypt but they were less numerous (Figure 3.5A).  
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Figure 3.5 A non-neuronal Ach system in the human colonic epithelium 
Sections of human colon biopsy were stained with anti-CHAT (red) antibody (A). Image was 
taken with a confocal microscope with a x10 objective. Microdissected crypts were labelled 
with anti-CHAT (red) and anti-M3AchR (green) antibodies, cell nuclei were stained with 
Hoechst (blue) B (iii).  DIC image of a microdissected crypt base (B (i)); CHAT labelling (red) 
(B (ii)); A merged image of CHAT (red), M3AchR (green) and Hoechst (blue) (B (iii)). Images 
were taken with a x63 objective and were representative of N≥5 subjects, n≥25 crypts. 
Microdissected crypts were also labelled with anti-CHAT (red) and anti-Ecad (green) 
antibodies (C). The 2X zoom-in image was taken with a x63 objective (white box). 
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These CHAT positive cells represent a currently unknown cell type of epithelial origin 
expressed in the intact colonic epithelium, as confirmed by the Ecad labelling (Figure 3.5C). 
VAChT is a neurotransmitter transporter that is responsible for loading Ach into secretory 
vesicles for secretion. VAChT is predominantly expressed at the cholinergic nerve endings 
(Gilmor, et al., 1996; Parsons, 2000). VAChT positive labelling in the human colonic 
epithelium and in lamina propria cells was first demonstrated by Jönsson and colleagues, 
albeit only at the very top region of the crypt (Jönsson, et al., 2007).  In addition to the 
previous observation that VAChT positive neurons were found near the base of the crypts in 
the muscularis mucosae and the submucosa (Figure 3.4A), they were also detected in the 
nerve fibers embedded in the lamina propria between the crypts (Figure 3.6A white arrows). 
Most importantly, VAChT positive signals were also detected in the human colonic 
epithelium (Figure 3.6A). In summary, CHAT, VAChT and M3AchR proteins are expressed in 
human colonic crypts, which suggests the existence of epithelial self-regulation by Ach in the 
absence of neuronal innervation.   
 
 
Figure 3.6 VAChT expression in the human colonic mucosa 
Vibratome sections of the human colonic epithelium stained with anti-VAChT and anti-Ecad 
antibodies; cell nuclei were labelled with Hoechst. Images were taken with a confocal 
microscope with a x40 objective. (A) VAChT (green), cell nuclei (blue); (B) Ecad (red), cell 
nuclei (blue); and (C) a composite image of all three channels. Images are representative of 
N≥5 subjects, n≥25 sections derived from 5 subjects. 
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Attempts were made to identify the CHAT positive colonic epithelial cell type. Others have 
shown CHAT labelling in enteroendocrine cells (Jönsson, et al., 2007), however these images 
were in black and white and the data did not show double labelling with CHAT and the 
enteroendocrine cell marker, which generates equivocal conclusion. In this study, human 
colonic crypts were co-labelled with chromogranin A, an enteroendocrine cell marker, as well 
as CHAT. Immuno-reactivity of CHAT was observed in chromogranin A positive 
enteroendorcine cells, however there are also some cells that only exhibited CHAT labelling 
(Figure 3.7). In addition, the morphology of these CHAT single positive cells was different 
from the enteroendocrine cells expressing CHAT in that these cells are relatively long in 
shape, with the cytoplasm extended to the apical membrane of the crypt (Figure 3.7A and 
C). Conversely, the enteroendocrine cells exhibit a dense triangular basal domain and a very 
thin tail towards the apical pole of crypt (Figure 3.7B and D). Tuft cells are a newly identified 
epithelial cell type with unknown function (Gerbe, et al., 2012). Since tuft cells have a longer 
cell morphology, the CHAT positive cells were further investigated by staining with the tuft 
cell marker DCAMKL-1 which labels microtubules (Figure 3.8A). Positive labelling of DCAMKL-
1 was detected in some CHAT positive cells (Figure 3.8B), but the staining pattern was 
different from that previously reported (Gerbe, et al., 2012; Westphalen, et al., 2014). There 
were also some CHAT positive cells that lacked DCAMKL-1 expression (Figure 3.8C). Thus, 
these results are inconclusive and further experiments are required to confirm the nature of 
these CHAT positive cells.  
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Figure 3.7 Characterisation of CHAT positive cells in the human colonic crypt 
Human colonic crypts were labelled with anti-chromogranin A (green) and anti-CHAT (red) 
antibodies, cell nuclei were stained with Hoechst (blue).  (A) and (B) are z-stack confocal 
images that show the presence of CHAT positive cells and enteroendocrine cells at different 
planes of focus in the same crypt. Images were taken with a x63 objective. (C) Enlarged zoom-
in images of the yellow box in (A); composite image of the 3 channels (left); and a DIC image 
plus the 3 channels (right) clearly showing the basal and apical membrane of the epithelium. 
(D) Enlarged zoomed-in images of the yellow box in (B); (i) chromogranin A (green) and nuclei 
(blue); (ii) CHAT (red) and nuclei (blue); (iii) composite image of the 3 channels; (iv) DIC image 
overlaid with all three fluorescence channels. Dashed line shows the boundary of the apical 
membrane to the crypt lumen. 
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Figure 3.8 Immunolocalisation of tuft cell marker in CHAT positive cells 
Enlarged epithelial layer was stained with anti-COX-1 (red), anti-DCAMKL-1 (white) and anti-
MUC2 (green) antibodies; cell nuclei were stained with Hoechst (blue) (A). A composite 
image of all four channels: COX-1 (red), DCAMKL1 (white), MUC2 (green) and DNA (blue) 
(top). A merged image of COX1 (red), DCAMKL1 (white) and DNA (blue) (bottom). White 
dashed line shows the boundary of the crypt lumen. Enlarged epithelial layer was stained 
with anti-CHAT (red) and anti-DCAMKL-1 (white) antibodies, cell nuclei were stained with 
Hoechst (blue) (B). A composite image of CHAT (red) and DCAMKL1 (white) (C). All enlarged 
images were taken with a confocal microscope with a x63 objective. 
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3.1.3 MAchR subtype expression and localisation in human colonic crypts 
MAchR expression in tissues of the GI tract or colon cancer cell lines was identified previously 
by RT-PCR and Western blot analysis that lacks information regarding its subcellular location; 
data for MAchR localisation in the human colon is very limited. Jönsson et al demonstrated 
the expression of M2AchR in the human colonic epithelium and in the smooth muscle layers 
(Jönsson, et al., 2007). Our lab demonstrated expression of the M3AchR protein on the basal 
membrane of human colonic crypts (Reynolds, et al., 2007). Furthermore, a recent study by 
Harrington and colleagues demonstrated the localisation of M1AchR, M2AchR and M3AchR 
expression in the human colon. They detected M3AchR but not M1AchR expression on the 
surface of colonic epithelial cells. M3AchR was also detected in myenteric nerve cell bodies. 
Both M2AchR and M3AchR were abundantly expressed in the circular and longitudinal 
muscles, while M1AchR expression was most abundant in myenteric and submucosal nerve 
cells (Harrington, et al., 2010). In this study, RT-PCR and immunohistochemistry were used 
to further characterise and confirm the expression and localisation of the MAchR subtypes 
in the human colonic epithelium.  
M1AchR mRNA expression was detected in most four of the five human colon biopsy samples 
and its corresponding isolated crypt samples (Figure 3.9). The expression level of M1AchR 
was relatively low and varied between individuals. The highest M1AchR mRNA level was 
detected in subject 3 of the isolated crypt samples. M2AchR mRNA expression was only 
detected in two of the colon biopsy samples (subjects 2 and 3), and no expression was 
observed in the isolated crypt samples. Moreover, M3AchR mRNA was detected in all five 
colon biopsy and corresponding isolated crypt samples, with variation of the expression 
observed between individuals. M4AchR mRNA was however undetectable in all five colon 
biopsy samples, yet detected in three of the isolated crypt samples (subjects 3, 4 and 5). 
Finally, M5AchR mRNA was detected in most of the five colon biopsy samples and its 
corresponding isolated crypt samples. The expression level was relatively low in the biopsy 
samples, while three of the isolated crypt samples (subjects 3, 4 and 5) showed a higher level 
of expression. In summary, mRNA for M1AchR, M3AchR and M5AchR was detectable in most 
individuals, with subject 3 expressing the most MAchR subtypes in the colon.  
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Figure 3.9 MAchR subtypes mRNA expression in the human colon biopsy and isolated 
colonic crypts 
Agarose gel electrophoresis showing RT-PCR products from human colon biopsy and isolated 
crypts using specific primers for M1AchR to M5AchR genes designed to anneal across exon-
exon boundaries to avoid amplification from potentially contaminating genomic DNA. 
GAPDH was used as a positive control. No bands were detected in the no template negative 
(H2O) control. N=5 subjects.  
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Previously studies in our lab reported the M3AchR expression gradient along the crypt-axis, 
in which M3AchR protein was predominantly expressed at the crypt base (Lindqvist, et al., 
2002; Reynolds, et al., 2007). Immunohistochemistry and confocal microscopy were used to 
further reveal the localisation of MAchR subtype expression in the colonic epithelium. Since 
M3AchR mRNA was expressed in most individuals, colon biopsies were fixed and stained with 
the primary antibody against M3AchR. Positive labelling was observed on both the basal 
membrane of the crypt and the nerve cell bodies in the lamina propria (Figure 3.10A). Given 
the mRNA data, M1AchR, M3AchR and M5AchR protein expression were targeted for 
immuno-labelling with primary antibodies, in both microdissected crypts from colon biopsy 
and isolated culture crypts. Positive immunofluorescence staining was observed for all three 
receptor subtypes, all of which was localised to the basal membrane at the crypt base (Figure 
3.10B and C). In microdissected crypts, the expression intensity of M1AchR and M5AchR was 
relatively lower than M3AchR. While in isolated culture crypts, similar levels of expression 
were observed for all three receptor subtypes.  
It is important to note that the cholinergic neurons are in close proximity with MAchRs 
expressed on the basal membrane of the crypt cells, which make the receptors accessible to 
Ach (Figure 3.10A and Figure 3.11). Thus, the conventional neuronal-epithelial cell 
interaction has been confirmed in the human colonic mucosa.  
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Figure 3.10 MAchR subtypes protein expression in human colonic epithelium. 
(A) Sections of human colon biopsy were fixed and labelled with anti-M3AchR antibody 
(green) and cell nuclei were stained with Hoechst (blue). Image was taken with a x40 
objective. Image was representative of N=2 subjects. (B) Microdissected crypts were labelled 
separately with anti-M1AchR, anti-M3AchR or anti-M5AchR antibodies (green), cell nuclei 
were labelled with Hoechst (blue). Images were representative of N=2 subjects, n=8 crypts. 
(C) Isolated culture crypts were stained as in (B). Images were representative of N=3 subjects, 
n=10 crypts. Dashed lines show the lumen of colonic crypt. Images of (B) and (C) were taken 
with a x63 objective. 
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Figure 3.11 Cholinergic-epithelial cell interaction in the human colonic epithelium 
Sections of human colon biopsy were stained with anti-β-III tubulin (green), anti-CHAT (red) 
and anti-MUC2 (pink) antibodies. MUC2 labelling was used to identify the location of the 
crypt. Composite image of the 3 channels was shown (A). Images were taken with a confocal 
microscope with a x40 objective. Cholinergic neurons were indicated by white arrows. These 
cholinergic neurons are expressed in the surroundings of the crypt base and in close 
proximity with the crypt. Dashed line shows the boundary between the mucosa and the 
underlying muscularis mucosae. Isolated culture crypts were labelled with anti-M3AchR 
(green) and anti-Ecad (red) antibodies, cell nuclei were stained with Hoechst (blue).  A 
merged image of all three channels was shown (B). Goblet cells expressing M3AchR on their 
basal membrane were highlighted with an asterisk (*). Cholinergic-epithelial cell interaction 
was established with the presence of M3AchR on the basal membrane of the crypt which is 
in close proximity with the cholinergic neurons.  
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3.1.4 Isolated human colonic crypt culture model  
Human colonic crypts were isolated from colorectal tissue biopsies obtained from patients 
undergoing recto-sigmoid endoscopy and from cancer patients undergoing colectomy. 
Samples were only used if there was no apparent intestinal pathology. Isolated crypts were 
embedded in Matrigel, affixed to glass coverslips, and placed in culture overnight prior to 
experimentation (Reynolds, et al., 2007; Reynolds et al., 2014 supplementary methods). This 
native crypt culture model allows us to study the cell biology and physiology of live human 
colonic epithelium. These isolated colonic crypts have similar dimensions to the 
microdissected crypts and the crypts from colon biopsies, and they resemble the intact 
colonic mucosa in many ways. The epithelial cells at the base of the cultured crypt are 
proliferative, which were identified by the immuno-labelling of the proliferation marker Ki67 
(Figure 3.12A middle). Similar staining patterns were also observed in both microdissected 
crypts and vibratome sections of colon biopsies (Figure 3.12 B and C). Thus the hierarchy of 
proliferation at the crypt base is maintained in the culture system.  
 
Figure 3.12 Proliferative potential of the isolated culture human colonic crypts 
The isolated culture crypt (A), the microdissected crypt (B) and the vibratome section of the 
colon biopsy (C) were fixed and stained with anti-Ki67 antibody. Crypts or tissue sections 
were imaged with a Zeiss LSM 510 Meta confocal microscope using a x63 or x40 objective 
respectively. From left to right, DIC images of the respective crypt sample, the proliferative 
nuclei were labelled with anti-Ki67 (green), the cell nuclei were labelled with Hoechst stain 
(blue).  
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In addition, the single cell epithelial layer remained intact and polarised as shown by the Ecad 
labelling and the basal nuclei along the crypt-axis, respectively (Figure 3.13A and B). Cell 
division events were also observed at the lower region of the crypt as shown by Hoechst 
staining of the nuclei (Figure 3.13C white box). The colonic epithelium not only absorbs water, 
but also secretes fluid and mucus. Time-lapse microscopy of cultured human colonic crypts 
revealed particle flow through the crypt lumen in response to the secretagogue Ach (10µM) 
(Figure 3.14), suggesting that the cultured crypt model maintains the ability to secrete 
substances in response to stimuli.  
 
 
Figure 3.13 Proliferation and cell division in the intact human colonic crypt culture model 
An isolated cultured crypt was fixed and labelled with anti-Ki67 (green), anti-MUC2 (pink), 
anti-Ecad (white) antibodies, and cell nuclei were stained with Hoechst (blue). Images were 
taken with a Zeiss LSM 510 Meta confocal microscope with a x63 objective. (A and B) 
Proliferative epithelial cells at the base of crypt were detected by anti-Ki67 staining and can 
be divided into goblet cells (Ki67 and MUC2 labelled, white asterisks), and non-goblet cell 
populations (green arrows). A composite image of all four channels: Ki67 (green), MUC2 
(pink), Ecad (white) and DNA (blue) (A); a merged image of three channels: Ki67 (green), 
MUC2 (pink) and DNA (blue) (B). Colonocytes undergoing mitosis in culture as labelled by 
Hoechst stain (C, white box). White dotted line marks the boundary of the apical membrane 
to the crypt lumen. 
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Figure 3.14 Secretagogue induced particle flow through the cultured crypt lumen. 
Cultured crypts were loaded with ROSstar550 (red) and stimulated with Ach (10µM). Images 
were taken every 10s for 10 mins. Representative images were taken at the indicated time 
point. The dashed line marks the starting point of the particle moving up the crypt lumen. 
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3.1.5 Calcium signalling organelles in the cultured human colonic crypt 
ER is the major intracellular Ca2+ store within a cell that has been the focus of Ca2+ signaling 
research for decades. The acidic lysosomes have recently emerged as other important Ca2+ 
stores for regulating cellular and physiological functions (Morgan, et al., 2011). Mitochondria 
are dynamic intracellular organelles that can operate as a reversible Ca2+ storage 
compartment in the cytoplasm (Rizzuto, et al., 2012). Mitochondrial Ca2+ uptake is capable 
to influence the generation of Ca2+ waves and the subsequent signal transduction (Rizzuto, 
et al., 1998; Brough, et al., 2005). In order to study intracellular Ca2+ signalling in the human 
colonic epithelium, immunofluorescence labelling and confocal microscopy were used to 
reveal the cellular location of these Ca2+ signalling organelles in polarised colonic epithelial 
cells (Figure 3.15).  
As discussed previously, M3AchR is the predominant receptor subtype expressed at the basal 
pole of human colonic crypt cells (Figure 3.15A). The ER, stained against the retention 
peptide sequence KDEL, was localised at the basal pole of crypt cells, surrounding the nuclei 
(Figure 3.15B). Goblet cells are the key epithelial cell type studied in the current project, and 
were identified by the MUC2 mucin antibody labelling (Figure 3.15C). Mucus was detected 
in the ER, as specified by the prominent KDEL staining (Figures 3.15B and C), and in the 
cytoplasmic space of the goblet cells. The mitochondria were labelled with MitoTracker red, 
and the signals were found to be higher at the basal pole of crypt cells surrounding the nuclei 
(Figure 3.15G). This staining pattern strongly resembled the ER labelling, suggesting a close 
association between the two organelles. Moreover, the expression and localisation of the 
lysosomes were revealed by lysosome-associated membrane protein 1 (LAMP-1) antibody 
labelling in fixed tissues and by LysoTracker in live tissues (Figures 3.15E and F). Fluorescent 
signals were detected at the apical pole (towards crypt lumen) of crypt cells in both live and 
fixed tissues. However, low intensity signals were also observed at the basal pole of the crypt 
in the fixed tissue samples. In summary, M3AchRs are expressed at the basal pole of crypt 
cells including goblet cells, and were in close proximity with the ER. The ER major Ca2+ store 
and the acidic lysosomal Ca2+ stores were conversely located at the opposite pole of the 
colonic crypt cells. There was a strong association between the mitochondria and the ER at 
the basal pole of the crypt, however, the diffuse expression of the mitochondria suggested 
that they also interact with other intracellular organelles.  
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Figure 3.15 Localisation of the intracellular Ca2+ signalling organelles in human colonic 
crypts 
Isolated culture crypts were fixed and labelled with the respective antibodies. (A) M3AchR 
immunolabelled (pink) and Hoechst stained cell nuclei (blue); (B) KDEL labelled ER (red); (C) 
MUC2 labelled goblet cells (green); (D) DIC image of a cultured crypt. (E) LysoTracker labelling 
of lysosomes in live crypts (red); (F) LAMP-1 labelled lysosomes in fixed crypt (green), Ecad 
(red) and Hoechst stained nuclei (blue); (G) MitoTracker labelling of the mitochondria (red); 
(H) no primary antibody (negative) control. Images were taken with a confocal microscope 
with a x63 objective. Dashed lines indicate the boundary of the apical membrane and the 
location of the crypt lumen. Images were representative of N≥5 subjects.  
 
 
  
 101 
 
3.1.6 Intracellular calcium channel expression in the cultured human colonic crypt 
Activation of M3AchR has been shown to mobilise intracellular Ca2+ from the ER store via the 
2nd messenger IP3 (Berridge, 1993; Caulfield, 1993; Felder, 1995). Active IP3 translocates to 
the ER where it binds to IP3R (one of the major intracellular Ca2+ channels) on the ER 
membrane, causing the IP3R to open allowing Ca2+ mobilisation into the cytosol (Foskett, et 
al., 2007). The increase in cytosolic [Ca2+] in turn activates IP3R and RYR on the ER membrane 
and induces the CICR response (Taylor and Dale, 2012). These regenerative Ca2+ waves have 
been shown to mediate certain physiological functions including intestinal motility and 
secretion, apoptosis and proliferation (Ehlert, et al., 2011). The depleted ER Ca2+ store is then 
refilled via the SERCA pump to maintain the ER Ca2+ homeostasis (Berridge, et al., 2003). In 
addition, mobilisation of the acidic lysosomal Ca2+ stores by NAADP via TPC have recently 
been appreciated to drive different cellular processes such as vesicle trafficking and 
exocytosis (Ruas, et al., 2010; Davis, et al., 2012). The expression of different intracellular 
Ca2+ channel subtypes and the subcellular location of these channels could influence the Ca2+ 
responses. It is thus important to identify the expression and cellular localisation of these 
intracellular Ca2+ channels in the colonic epithelial cells which control Ca2+ mobilisation. The 
expression of the IP3R and RYR subtypes have been previously characterised in the rat 
colonic epithelium (Siefjediers, et al., 2007; Prinz, et al., 2008), and little colocalisation of the 
two Ca2+ channels were observed. Information regarding the expression of these intracellular 
Ca2+ channels in the human colon is very limited. A recent study by Shibao and colleagues 
evaluated the expression of the IP3R subtypes in human colorectal carcinomas surgically 
resected from 116 patients (Shibao, et al., 2010). By using Western blots and 
immunohistochemistry, they found the expression of IP3R1 and IP3R2 in the normal 
colorectal mucosa and in colorectal cancer tissues, while IP3R3 expression was only observed 
in colorectal cancer. They concluded that the expression level of IP3R3 is directly associated 
with the aggressiveness of the tumour. RYR transcripts have previously been identified in the 
T84 human colon cancer cell line (Verma, et al., 1996). No information is currently available 
for TPC expression in the human colon. 
In the current study, RT-PCR and immunohistochemistry were used to identify the expression 
and localisation of these intracellular Ca2+ channels in the human colonic epithelium. 
Transcripts of all three IP3R subtypes was detected in five isolated human colonic crypt 
samples (Figure 3.16). RYR1 mRNA was detected in four of the five isolated human crypt 
samples (all except subject 3), while RYR2 mRNA was only found in three human crypt 
samples (all donors except subjects 3 and 4). RYR3 transcripts were not investigated in the 
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current study. SERCA1 mRNA was detected in four of the five human crypt samples (once 
again all donors except subject 3), whereas SERCA2 and SERCA3 transcripts were detected in 
all five human crypt samples. In addition, both TPCN1 and TPCN2 mRNA were found to be 
expressed in all five of the isolated human crypt samples. Thus, most human subjects have 
message for at least one subtype of each intracellular Ca2+ channel gene detectable in their 
colon samples.  
Localisation of the intracellular Ca2+ channel proteins in colonic epithelial cells was then 
investigated through immunofluorescence labelling and confocal microscopy (Figure 3.17). 
While strong yet diffuse IP3R1 protein labelling was observed in the human colonic 
epithelium, positive immunostaining was detected on the basal pole of the crypt, in the cell 
nuclei and in the cytoplasm of epithelial cells (Figure 3.17A). A similar staining pattern was 
observed for IP3R2 protein, but at much lower intensity (Figure 3.17B). In non-goblet 
epithelial cells, IP3R2 expression was diffuse; immunofluorescence signals were present near 
the basal and apical membranes of the crypt, in the cell nuclei and in the cytoplasm. In goblet 
cells, a distinctive IP3R2 staining pattern was observed in the cell nuclei. Positive IP3R2 
labelling was also detected at the basal and apical membranes of the goblet cells and in the 
areas associated with the ER, while IP3R3 was mainly localised at the basal membrane of the 
colonic crypt (Figure 3.17C). RYR1 and/or RYR2 protein was also detected at the basal 
membrane of the crypt (Figure 3.17D). Furthermore, a diffuse expression of SERCA1, 2 and 3 
proteins was detected in non-goblet epithelial cells (Figure 3.17F). Positive signals were 
found at the basal membrane, in the cell nuclei and in the cytoplasm. In goblet cells, labelling 
was detected at the basal membrane, in the cell nuclei and also in the area associated with 
the ER as defined by the KDEL labelling (Figure 3.17E).  
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Figure 3.16 Intracellular Ca2+ channels mRNA expression in isolated human colonic crypts 
Agarose gel electrophoresis showing RT-PCR products of the isolated human colonic crypt 
samples. Specific PCR primers for IP3R, RYR, SERCA and TPC transcripts were used that were 
designed to anneal across exon-exon boundaries to avoid amplification from potentially 
contaminating genomic DNA. GAPDH was used as the positive internal control. No bands 
were observed in most of the negative no template control (H2O lane), except for a faint 
band observed in the IP3R1 and IP3R2 negative control lanes.  However, the expression of 
both genes in the five samples is assumed to be real based on the strong intensity PCR 
products in the presence of template. N=5 subjects. Note that samples in lanes 3 and 4 in the 
SERCA1 gel were mistakenly run in the wrong order, and have therefore had the appropriate 
positions switched here for presentation purposes. 
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Figure 3.17 Immunolocalisation of the intracellular Ca2+ channels in the ER of colonic 
epithelial cells. 
Isolated culture crypts were fixed and labelled with antibodies against different intracellular 
Ca2+ channels known to be expressed on the ER. Top row: (A) colonic crypts labelled with 
anti-IP3R1 antibody (green); (B) crypts stained with anti-IP3R2 antibody (green); (C) crypts 
labelled with anti-IP3R3 antibody (green). All cell nuclei were stained with Hoechst (blue). 
Bottom row: (D) crypts labelled with anti-RYR-1/2 antibody (red); (E) ER were stained with 
anti-KDEL antibody (green); and (F) crypts were stained with anti-SERCA antibody (green). 
Cell nuclei were stained with Hoechst (blue). Images were taken with a confocal microscope 
with a x63 objective. Dashed line indicated the location of the crypt lumen. Images were 
representative of N=3 subjects, n≥10 crypts for each antibody labelling.  
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Both TPC1 and TPC2 proteins were detected at the apical pole (towards crypt lumen) of 
colonic crypt cells (Figure 3.18A). TPC1 was previously found to be expressed in endosomes 
and lysosomes, whereas TPC2 was found on late endosomes and lysosomes (Ruas, et al., 
2014). Similar to LAMP-1 labelling, the majority of the TPC2 signals resided at the apical pole 
of crypt cells, while minimal signals were also detected at the basal pole of the crypt (Figure 
3.18B i and ii). Clusters of LAMP-1 and TPC2 labelled acidic organelles were observed 
between the mid-cell regions and the apical membrane of epithelial cells (Figure 3.18B iii). 
The human colonic epithelium is also equipped with the ectoenzyme CD38 which is 
responsible for the production of cADPR and NAADP, which act on RYR and TPC respectively. 
CD38 was found to be localised to both the apical and basal poles of crypts (Figure 3.18C ii), 
and was strongly associated with TPC2 (Figure 3.18C iii).  
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Figure 3.18 Immunolocalisation of TPCs, lysosomes and CD38 in the human colonic 
epithelial cells. 
Top panel: (A) Isolated crypts were stained separately with anti-TPC1 (green) and anti-Ecad 
(red) antibodies (left), or anti-TPC2 (green) and anti-Ecad (red) antibodies (right), all cell 
nuclei were stained with Hoechst (blue). Bottom panel top row: (B) Crypts were labelled with 
anti-TPC2 (green) (i); anti-LAMP-1 (pink) (ii); a composite image of TPC2 (green) and LAMP1 
(pink) (iii). Bottom row: (C) Crypts were stained with anti-TPC2 (green) (i); anti-CD38 (pink) 
(ii); and a composite image of TPC2 (green) and CD38 (pink) (iii). Images were taken with a 
confocal microscope with a x63 objective. Images were representative of N≥5 subjects, n≥10 
crypts. 
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3.1.7 Calcium signalling organelles in human colonic goblet cells 
The following section specifically focused on the expression of the Ca2+ signaling organelles 
in human colonic goblet cells in situ. The major function of the colonic goblet cells is to 
secrete mucus, which is primarily composed of the MUC2 mucin. Mature MUC2 proteins are 
densely packed into the acidic secretory granules (vesicles) before secretion. These mucus 
granules are mainly located at the apical pole of the goblet cells where the acidic lysosomes 
reside. Thus, there is a strong association between the acidic lysosomes and the mucus 
granules in goblet cells. MUC2 labelling not only identifies goblet cells within the colonic 
epithelium, it also demonstrates the quantity of mucus content within each goblet cells.  
Under unstimulated basal conditions, different stages of mucus secretion were observed in 
goblet cells within the same crypt (Figure 3.19A middle), and can be separated into three 
stages: low, medium and high levels of secretion based on the mucus content within goblet 
cells. The amount of LAMP-1 labelled acidic lysosomes within a goblet cell was strongly 
associated with the MUC2 content. Higher LAMP-1 signals were detected in goblet cells with 
low levels of secretion, in which positive signals were detected in the centre of the cell near 
or underneath the ER in 2D view (Figure 3.19A white asterisks). Decreased LAMP-1 signals 
were observed in goblet cells with medium level of mucus secretion (Figure 3.19A pink 
asterisks), with labelling found near the ER and also beneath the lateral membrane, towards 
the apical poles of cells.  Only weak LAMP-1 signals were detected in goblet cells with high 
level of secretion (Figure 3.19A green asterisks). The enlarged images demonstrate the 
expression of LAMP-1 in and around the nucleus, near the ER and in the cytosol of goblet 
cells. The highest intensity of LAMP-1 was detected beneath the lateral membrane towards 
the apical pole of cells (Figure 3.19 B and C). In addition, similar LAMP-1 expression patterns 
were observed in single goblet cells isolated from human colonic epithelium (Figure 3.19 D 
and E).  
A functional crypt is composed of many different epithelial cell types connected to each 
other via cell junctions, including the tight and gap junctions. These cell-cell junctions are 
believed to mediate signal transduction and communication between cells. Development of 
the single cell epithelial model from native colonic tissue provided the opportunity to study 
the response of epithelial cells (including goblet cells) to a stimulus in the absence of 
neighbouring cells.   
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Figure 3.19 Localisation of acidic lysosomes in human colonic goblet cells 
Cultured human colonic crypts were labelled with anti-LAMP-1, anti-MUC2 and anti-Ecad 
antibodies, and cell nuclei were stained with Hoechst (A). Images from left to right show 
representative crypts with the following combinations of stains: LAMP-1 (pink), Ecad (white) 
and Hoechst (blue); MUC2 (green), Ecad (white) and Hoechst (blue); a merged image of all 4 
channels. MUC2 labelling shows the mucus status of goblet cells, characterised as having low 
levels of mucus secretion (white asterisks), medium levels of secretion (pink asterisks) or high 
levels of secretion (green asterisks). Enlarged images of goblet cells in situ (B and C); crypts 
were labelled with LAMP-1 (pink) and cell nuclei (blue). Single goblet cells (D and E) were 
stained with LAMP-1 (pink), MUC2 (green) and cell nuclei (blue). All images were taken with 
a x63 objective. 
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It is now widely accepted that TPCs are the lysosomal Ca2+ release channels. TPC1 was found 
to be expressed on endosomes and lysosomes (Ruas, et al., 2014): the detection of TPC1 
proteins in the cytoplasm of goblet cells (Figure 3.20) therefore allowed the inference the 
location of the endo-lysosomes. These goblet cells were identified by another MUC2 
antibody labelling predominantly the immature MUC2 protein which resides within the ER 
(Figure 3.20B). A 2D view reveals that clustering of the TPC1 and MUC2 signals occur within 
the region of the ER (Figure 3.20B cells highlighted with white asterisks). Similar to LAMP-1 
labelling, TPC1 was localised in the region where the ER resides and beneath the lateral 
membrane towards the apical pole of cells. Moreover, prominent KDEL labelling was 
observed in the ER of goblet cells (Figure 3.21B), resembling the labelling of immature MUC2 
(Figure 3.20B). TPC2 was found to be expressed mainly on late endosomes and lysosomes. 
Similar to TPC1 and LAMP-1 labelling, TPC2 signals were also detected in the cytoplasm of 
the goblet cells (Figure 3.21A white asterisks). Overlapping signals of TPC2 and the ER were 
observed in these mucus secreting goblet cells (Figure 3.21C), suggesting an association 
between the ER Ca2+ store and the TPC2 expressing lysosomal Ca2+ stores, which could 
possibly play a role in Ca2+ mediated mucus granule exocytosis.  
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Figure 3.20 Immunolocalisation of TPC1 in human colonic goblet cells 
Enlarged images of epithelial cell layer stained with anti-TPC1 (green), anti-Ecad (red) and 
anti-MUC2 (pink) antibodies, cell nuclei were stained with Hoechst (blue). A composite image 
of TPC1 (green), Ecad (red) and nuclei (blue) (A). A composite image of TPC1 (green), MUC2 
(pink) and nuclei (blue) (B). White dashed lines mark the cell boundary of goblet cells. 
Asterisks highlight the goblet cells in the epithelial cell layer. All images were taken with a 
x63 objective.  
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Figure 3.21 Immunolocalisation of TPC2 in human colonic goblet cells 
Enlarged images of epithelial cell layer stained with anti-TPC2 (green), anti-Ecad (white) and 
anti-KDEL (pink) antibodies, cell nuclei were stained with Hoechst (blue). A composite image 
of TPC2 (green), Ecad (white), and nuclei (blue) (A); a merged image of KDEL (pink), Ecad 
(white) and nuclei (blue) (B); an overlaid image of all four channels: TPC2 (green), KDEL (pink), 
Ecad (white) and nuclei (blue) (C). Asterisks highlight the goblet cells in the epithelial cell 
layer. All images were taken with a x63 objective.  
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NAADP is the 2nd messenger responsible for mobilisation from lysosomal Ca2+ stores via the 
TPC (Calcraft, et al., 2009). CD38 is responsible for synthesising both NAADP and cADPR, it is 
therefore important to identify expression of the CD38 in goblet cells. CD38 expression was 
detected at the basal-lateral and apical membranes, and in the cytoplasm of the goblet cells 
in 2D view (Figure 3.22). CD38 immunoreactivity was occasionally observed in the nucleus of 
the goblet cells (Figure 3.22A).The basal expression pattern is consistent with the functional 
role of CD38 in synthesising cADPR, which acts on the RYR, which can be detected on the 
basal membrane of the colonic epithelial cells including goblet cells (Figure 3.17D). CD38 
expression on the lateral and apical membranes was in close proximity to the LAMP-1 
positive lysosomes (Figure 3.22A right), which may provide the major source of NAADP to 
act on the TPC. MUC2 labelling confirmed that goblet cells were indeed expressing CD38 
(Figure 3.22B white asterisks). Thus, colonic goblet cells are equipped with all the necessary 
Ca2+ signalling organelles and Ca2+ channels to be capable of responding to cholinergic 
stimulation, even in the absence of neighbouring cells. 
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Figure 3.22 Expression of CD38 in human colonic goblet cells 
Enlarged image of the epithelial layer. Sections were stained with anti-CD38 (green), anti-
LAMP1 (pink) and cell nuclei were labelled with Hoechst (blue) (A). A composite image of 
CD38 (green) and cell nuclei (blue, left). An overlaid image of CD38 (green), LAMP1 (pink) 
and cell nuclei (blue, right). The seemingly hollow cytoplasmic domain is a common 
morphological feature of goblet cells. The base of a cultured crypt stained with anti-CD38 
(green), anti-Ecad (white) and anti-MUC2 (pink) antibodies, with cell nuclei labelled with 
Hoechst (blue) (B). The image on the left is a composite image of 3 channels: CD38 (green), 
Ecad (white) and DNA (blue). The image on the right is a composite image of 4 channels: 
CD38 (green), MUC2 (pink), Ecad (white) and DNA (blue). White asterisks highlight goblet 
cells in the absence of MUC2 labelling. All images were taken with a x63 objective.  
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3.1.8 Discussion 
3.1.8.1 Cholinergic-epithelial cell interactions 
The enteric neurons innervating the colonic mucosa can be either cholinergic or non-
cholinergic. In this study the spatial relationship of the neurons and colonic crypts were 
visualised by immunohistochemical labelling of fixed human colon biopsies. These enteric 
neurons were found to be present at the sub-epithelial layers including the muscularis 
mucosae and the submucosa, and also in the lamina propria surrounding the crypts, from 
the base to the surface epithelium. Nerve fibers were in close proximity with crypt cells 
(Figure 3.1). This observation is consistent with published findings regarding the location of 
enteric neurons in mouse intestinal crypts (Bjerknes & Cheng, 2001) as well as in the human 
colonic epithelium (Reynolds, et al., 2007).  However, both of these studies only 
demonstrated the presence of the enteric neurons in the colonic mucosa with lower 
magnification 2D images, which therefore lack detailed information regarding the enteric 
neurons’ interactions with the colonic epithelial cells. 3D reconstruction of a z-stack of 
images produced via confocal microscopy allows a much greater depth of investigation; 
reconstructed images can be rotated through different axes and angles, providing a better 
spatial appreciation of the neuronal-crypt morphology and sites of interaction (Figure 3.2A). 
The general view is that the enteric neurons lie in close proximity to – but do not penetrate 
– the colonic epithelium (Furness, 2006). Some nerve fibers, which are believed to be sensory, 
have been shown to penetrate the inner layers of stratified epithelium which line the 
oesophagus (Furness, 2006). Higher magnification of the colonic mucosal sections presented 
here not only reveals that some of axonal projections touch the surface of the crypt cells, but 
some were even found to penetrate through the single epithelial cell layer towards crypt 
lumen (Figure 3.2B). These nerve fibers could potentially be mucosal colonic sensory neurons 
responsible for sensing the luminal contents. However, the actual function of these 
penetrable nerve fibers is as yet unknown.  
It has been long appreciated that cholinergic neurons are the major source of Ach in the 
colonic mucosa. CHAT is the enzyme responsible for synthesising Ach, while VAChT is 
responsible for Ach loading into vesicles prior to secretion. Since CHAT and VAChT are 
abundantly expressed in cholinergic nerve endings, both proteins have been used as 
cholinergic neuronal markers in immunohistochemical studies (Ichikawa, et al., 1997). In the 
human colonic mucosa, cholinergic innervation was primarily found at the base of the crypt, 
as well as in the muscularis mucosae and submucosa (Figure 3.4 and Figure 3.11). This 
observation further supports the previous finding that double immune-labelling of both 
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CHAT and neuronal markers was lacking (Reynolds, 2007). Similar to CHAT, VAChT positive 
neurons were found near the base of the crypts in the muscularis mucosae and the 
submucosa, and in the nerve fibers embedded in the lamina propria between the crypts 
(Figure 3.6A white arrows). The close proximity of the cholinergic neurons with the colonic 
epithelium may provide the shortest distance for Ach diffusion.  
CHAT was also detected on the basal membrane of the colonic crypts, colocalised with 
M3AchR (Figure 3.5B iii). The presence of CHAT positive cells in the human colonic epithelium 
suggests the possible existence of a non-neuronal Ach system in the human colon. Jönsson 
and colleagues were the first group to demonstrate the positive immune-labelling of CHAT 
protein within the human colonic epithelium, yet they did not show the expression pattern 
of these cells along the crypt axis (Jönsson, et al., 2007). CHAT-positive cells are here found 
to be intact epithelial cells (Figure 3.5C), mainly present at the base to the mid region of the 
crypt, where the proliferative epithelial cells reside (Figure 3.5A). Most importantly, VAChT 
positive signals were also detected in the human colonic crypts (Figure 3.6A), consistent with 
the previous finding of VAChT expression in the human colon (Jönsson, et al., 2007). Thus, 
the human colonic epithelium is equipped with the machinery for a non-neuronal Ach system 
which strongly suggests the epithelial self-regulation in the absence of neuronal innervation. 
Moreover, recent studies have suggested the involvement of the organic cation transporters 
(OCT) in regulating non-neuronal Ach release in the rat colonic epithelium, in response to 
short chain fatty acids (Yajima, et al., 2011; Bader, et al., 2014). Yajima and colleagues 
demonstrated the role of OCT in Ach release in the absence of VAChT expression; in contrast 
Bader et al demonstrated the expression of VAChT in the rat colonic epithelium, yet VAChT 
blockade was ineffective in blocking the propionate induced short-circuit current and the 
release of Ach into the basolateral compartment. Thus, further experiments are required to 
investigate the functional role of VAChT within the human colonic epithelium; measurement 
of Ach level before and after the treatment with OCT or VAChT inhibitors is underway in our 
laboratory. 
The identity and functions of the CHAT positive cells described here are currently unclear. 
Jönsson and colleagues have demonstrated CHAT labelling in enteroendocrine cells (Jönsson, 
et al., 2007). As enteroendocrine cells are known to be able to secrete hormones into the 
basolateral compartment, it is a reasonable supposition that these CHAT positive cells might 
fulfill a similar function with Ach, basal secretion of which could then bind to MAchR 
expressed on the basal membrane. 
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To confirm their findings, CHAT-positive cells were assessed for expression of the 
enteroendocrine cell marker chromogranin A (Figure 3.7). CHAT was indeed detected in 
enteroendocrine cells (Figure 3.7D), however some cells only exhibited CHAT labelling 
(Figure 3.7D iii white arrow), suggesting that these cells might represent previously 
undescribed epithelial cell types. Tuft cells are a newly identified epithelial cell type with 
unknown functions. Based on the cell morphology of the CHAT positive cells in the current 
study, they were further characterised by the tuft cell marker DCAMKL-1 (Figure 3.8). 
However, the results were inconclusive and further experiments are necessary to confirm 
the identity of these CHAT positive cells in the human colonic epithelium.   
Previous studies have demonstrated the expression of M2AchR (Jönsson, et al., 2007) and 
M3AchR (Lindqvist, et al., 2002; Reynolds, et al., 2007; Harrington, et al., 2010) in the human 
colonic epithelium. However, no study so far has characterised all five MAchR subtypes in 
the human colon. In the current study, expression of all five MAchR mRNA were investigated. 
M3AchR was found to be the predominant subtype expressed in both colon biopsies and 
isolated crypt samples. M1AchR and M5AchR transcripts were also detected in both samples 
albeit at a lower level than M3AchR (Figure 3.9). These results suggest that M1AchR, M3AchR 
and M5AchR are the three major MAchR subtypes expressed in the human colon, which was 
confirmed by detection of all three receptors in microdissected and isolated cultured crypts 
(Figure 3.10). M2AchR mRNA was only detected in two of the five colon biopsy samples, but 
no expression was observed in isolated crypt samples. The explanation for this could be 
either that M2AchR is not expressed in the colonic mucosa, or the expression level was too 
low to be detected by conventional PCR. While M4AchR mRNA was undetectable in the colon 
biopsies, relatively higher expression was observed in three of the five isolated crypt samples 
suggesting that M4AchR transcription might be induced during the isolation processes. In 
addition, the overall mRNA expression level of each subtype was relatively higher in isolated 
crypt samples than in colon biopsy samples. This observation suggests that the receptor 
mRNA was either predominantly expressed in the colonic mucosa, or the isolated crypt 
samples provided a more concentrated mRNA sample for the PCR reaction. One other 
explanation would be the receptor transcripts were induced during the isolation processes. 
Moreover, not every individual showed concomitant expression of M1AchR, M3AchR and 
M5AchR in the colon. Since all three receptors couple to the Gq protein signal transduction 
pathway, it is possible that there is a functional compensation between these three receptor 
subtypes. 
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MAchR subtypes 1, 3 and 5 are expressed on the basal membrane of the cultured crypt model, 
which resembles the expression pattern on the microdissected crypts (Figure 3.10B and C). 
M3AchR expression at the base of the crypt was also consistent with the previous findings in 
our lab (Lindqvist, et al., 2002; Reynolds, et al., 2007). This native human colonic crypt culture 
model maintained many features of the intact colonic mucosa in both morphology and 
function; they are proliferative, polarised and intact, and also exhibit secretion coupling in 
culture in response to agonist stimulation (Figures 3.12, 3.13 and 3.14). This model allows us 
to study the cell biology and physiology of live colonic epithelium that is otherwise not 
possible to achieve in fixed colon biopsy tissues. Our lab has repeatedly demonstrated that 
cholinergic stimulation of M3AchR mobilises intracellular Ca2+ in this model (Lindqvist, et al., 
2002; Reynolds, et al., 2007), and that these Ca2+ signals were shown to mediate fluid 
secretion via the Na-K-Cl cotransporter NKCC1 (Reynolds, et al., 2007). However, the 
intracellular Ca2+ stores responsible for this signal transduction is not known. In order to 
study the intracellular Ca2+ signalling in the live human colonic epithelium, the expression 
and localisation of the intracellular Ca2+ stores and the respective Ca2+ releasing channels 
were investigated in the cultured crypt.  
 
3.1.8.2 Calcium signalling machineries in the human colonic epithelium 
The ER – the major intracellular Ca2+ store within a cell – was found at the basal pole of the 
crypt epithelial cells surrounding the nucleus (Figure 3.15B). The ER is relatively large in size 
within the goblet cells as defined by the prominent KDEL labelling (Figures 3.15B and 3.21B). 
In a 2D equatorial view, the ER is located below the basal membrane and extends towards 
the middle of the cell. This large intracellular compartment is believed to be responsible for 
the continuous synthesis of mucus, protein chaperones and anti-microbial peptides to 
replenish the mucus barrier. In addition, the close proximity between the ER and M3AchR on 
the basal membrane of the crypt provides a short distance for IP3 diffusion and subsequent 
signal transduction. The acidic organelles such as the lysosomes and the secretory vesicles 
have recently emerged as other important cellular Ca2+ stores (Morgan, et al., 2011). 
Lysosomes were mainly located in the cytoplasm towards the apical pole of the cell (Figures 
3.15E and 3.15F). Thus, the two intracellular Ca2+ pools were located at distinct opposite 
poles within the colonic epithelial cells in a 2D view. Low levels of lysosomes were also 
detected at the basal pole of the crypt in 2D view (Figure 3.15F and Figure 3.18B), which 
suggests that the lysosomes are localised in the cytoplasmic space surrounding the nucleus 
and the ER in a 3D view. These results further suggest that there is a close association 
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between the ER and lysosomal Ca2+ stores near the basal membrane and in the mid-region 
of the cell. Mitochondria are another important Ca2+ storage organelle. Ca2+ uptake into the 
mitochondria can influence the initial Ca2+ signal and subsequent transduction (Rizzuto, et 
al., 1998; Brough, et al., 2005; Ruzzuto, et al., 2012). Mitochondria are mainly localised at the 
basal pole of crypt in close association with the ER and the nucleus (Figure 3.15G). The 
transfer of Ca2+ from the ER via IP3R to the mitochondrial matrix has been shown to be crucial 
for mitochondrial-specific functions, including the regulation of cell survival/death (Giorgi, et 
al., 2008; Harr, et al., 2010; Giorgi, et al., 2012). Mitochondria were also found in the 
cytoplasm in close proximity to the region where the lysosomes reside (Figure 3.15G). The 
diffuse pattern of mitochondrial localisation suggests they are interacting with different 
intracellular organelles to monitor Ca2+ mobilisation within a cell. 
Information regarding the expression patterns of the intracellular Ca2+ channels in human 
colonic epithelial cells are limited. In the current study, transcripts for all three IP3R isoforms 
were expressed in the colonic epithelium of all human subjects tested (Figure 3.16). RYR1 
and RYR2 mRNA was also detected in most of the human samples. Lack of expression of both 
RYR isoforms in subject 3 could be a result of an extremely low transcript level of both RYR 
isoforms in this particular individual that could not be detected by conventional PCR, or this 
individual might express the RYR3 isoform which was not measured in the current study. 
Moreover, SERCA1 mRNA was detected in most subjects, while SERCA2 and SERCA3 mRNA 
were detected in all human subjects. The lack of the SERCA1 isoform would not be expected 
to cause a problem to that particular individual, as the function of the channel can be 
compensated by the two other SERCA isoforms. Furthermore, both TPC1 and TPC2 mRNA 
was also detected in all human subjects.  
The expression and localisation of the intracellular Ca2+ channel proteins in the cultured crypt 
model was further confirmed by immunostaining. All IP3R subtypes were expressed in the 
colonic epithelium. Both IP3R1 and IP3R2 have similar patterns of localisation throughout 
the cell (Figure 3.17A and B), while IP3R3 expression was restricted to the basal membrane 
of the crypt (Figure 3.17C). One interesting observation is that the IP3R2 was expressed on 
the apical membranes of the crypt that are disparate from the ER. It is currently unknown 
whether this expression pattern is related to the acidic lysosomes and the secretory vesicles. 
The presence of IP3R3 in the normal colonic mucosa was in contrast with the findings from 
a recent cohort study that only found IP3R3 expression in colorectal cancer tissues (Shibao, 
et al., 2010). This discrepancy could be a result of induced receptor expression in the culture 
system or elevation of IP3R3 expression in the normal mucosa near the tumour tissues of 
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these five random patients. Moreover, both RYR and SERCA proteins were also expressed in 
the colonic epithelium in close proximity to the ER (Figure 3.17D and F). Furthermore, both 
TPC1 and TPC2 proteins were detected in the cytoplasm towards the apical pole of the cell, 
expression patterns which fully resemble the location of the lysosomes (Figure 3.18A). TPC2 
has been found to be expressed primarily on late endosomes and lysosomes (Brailoiu, et al., 
2009; Calcraft, et al., 2009; Ruas, et al., 2010). Double labelling of TPC2 and the lysosomal 
marker LAMP-1 in the same tissue revealed overlapping regions and clustering of the two 
markers, however co-localisation of these two markers was not observed (Figure 3.18B). In 
addition, the colonic epithelium also expressed the ectoenzyme CD38 that is responsible for 
the generation of both 2nd messenger cADPR and NAADP that act on RYR and TPCs 
respectively. CD38 expression was strongly associated with lysosomes and TPC2 labelling 
(Figure 3.18C), that is believed to provide the shortest distance for the diffusion of 2nd 
messengers. Hence, the human colonic crypt culture model is fully equipped with all relevant 
intracellular Ca2+ signalling organelles and channels, which form the basis for the 
investigation of Ca2+ coupling to mucus secretion. 
Goblet cells are the mucus secreting cells embedded in the colonic epithelium. These cells 
normally possess a large round cytoplasmic space, that can be even sometimes be 
distinguished by the naked eye in a bright field image. MUC2 mucin labelling is commonly 
used to identify goblet cell populations in the epithelium, as well as providing information 
about the mucus content of the cell. Double immunostaining of the lysosomes and mucus 
granules revealed a strong association between these two organelles. Under unstimulated 
basal conditions, three levels (low, medium and high) of mucus secretion can be discerned 
in goblet cells. Higher numbers of LAMP-1 positive lysosomes in the cytoplasm of goblet cells 
during low levels of mucus secretion and vice versa (Figure 3.19A), suggests endocytosis and 
exocytosis of these acidic organelles might be important for the secretion of mucus granules. 
In general, almost all the cytoplasmic space of these goblet cells contains mucus granules. In 
comparison with other epithelial cell types, the lysosomal content is relatively low in goblet 
cells (Figure 3.19A left). These lysosomes are mainly located beneath the basolateral 
membranes and in the mid-cell region associated with the ER in 2D view. The strongest 
lysosomal labelling was found in the lateral membrane towards the apical membrane of the 
cell (Figure 3.19B and C), suggesting the mucus granules are flanked by the acidic lysosomes 
in a 2D view. If one were to transform these 2D data into the third dimension, it should 
produce an arrangement in which mucus granules are surrounded closely on all sides by 
acidic lysosomes, which are then poised to provide the Ca2+ signals for mucus exocytosis. 
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In addition, the expression patterns of both TPC1 and TPC2 in goblet cells resemble the 
lysosomal labelling (Figure 3.20 and Figure 3.21). Double immunolabelling of the ER and TPC2 
revealed a close association in the region of the mature mucus granules (Figure 3.21C). In 
addition, goblet cells also express the ectoenzyme CD38 in close proximity to the ER, acidic 
lysosomes and the mucus granules (Figure 3.22), and are believed to be the source of 2nd 
messengers for mobilising Ca2+ from both of the intracellular Ca2+ stores. These goblet cells 
should be capable of responding to agonist stimulation in the absence of neighbouring 
epithelial cells. 
This first results chapter has confirmed the cholinergic-epithelial cell interactions in the 
human colonic epithelium. The spatio-temporal characteristics of the Cch-induced Ca2+ 
waves in this intact and polarised human colonic crypt culture model was firmly established. 
The machinery for non-neuronal Ach systems in the human colonic epithelium were also 
described, although the mechanism of regulation is currently unclear. Most importantly, the 
expression and localisation of the Ca2+ signalling toolkit in human colonic crypt epithelial cells 
(including goblet cells) was identified. This signalling toolkit includes the major intracellular 
Ca2+ stores, 2nd messengers and Ca2+ release channels. The subcellular localisation and the 
complex interactions between these signalling elements generate Ca2+ signals with broad 
spatial and temporal properties. The basal location of the ER, IP3R and RYR, and the apical 
location of lysosomes, TPCs and CD38  in colonic epithelial cells provide a rationale for an 
investigation of the cellular consequences of cholinergic stimulation and the subsequent 
regulation of Ca2+ coupling mucus secretion in the human colonic epithelium. 
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Chapter 4 Results: The underlying mechanisms of the cholinergic 
stimulated calcium signal generation in human colonic crypts 
 
4.1 Introduction 
Ca2+ is an important 2nd messenger that is primarily stored inside the intracellular organelles 
including the ER, mitochondria and lysosomes within a cell (Berridge, 2002; Morgan, et al., 
2011; Rizzuto, et al., 2012). An increase in intracellular [Ca2+] derived from either the influx 
of extracellular Ca2+ or release from intracellular stores triggers a variety of cellular and 
physiological functions (Dupont, et al., 2011). Accordingly, movement of Ca2+ needs to be 
tightly regulated via the specific channels expressed on the plasma and organellar 
membranes. The intracellular Ca2+ channels expressed on the ER membrane include IP3R and 
RYR have been well studied for decades, whereas TPCs that mediate Ca2+ release from the 
acidic lysosomes have been gaining attention in recent years (Taylor and Dale, 2012). 
Cholinergic activated MAchR signalling has an established role in generating the 2nd 
messenger IP3, which binds to its receptor causing the mobilisation of Ca2+ from the ER store 
and the subsequent CICR response (Felder, 1995; Nahorski, et al., 1997). In addition, GPCR 
signalling, including MAchR activation, has also been suggested to upregulate CD38 activity 
(Higashida, et al., 1997a and b; Higashida, et al., 2001a and b); CD38 is an ectoenzyme that 
is responsible for the generation of two Ca2+ mobilising 2nd messengers: cADPR (an agonist 
for RYR) and NAADP (an activator of TPC) (Ogunbayo, et al., 2011). Thus, interactions 
between multiple Ca2+ releasing 2nd messengers and Ca2+ stores generate complexities and 
specificity of the Ca2+ signals (Galione, et al., 2002). Given the cellular and molecular 
characterisation of the colonic crypt Ca2+ signalling toolkit in the previous chapter, it is 
conceivable that in polarised epithelial cells MAchR activation stimulates multiple Ca2+ 
releasing messengers that mobilise Ca2+ from multiple organelles to generate a cholinergic-
specific Ca2+ signature.  
A close correlation between Ca2+ signalling and mucus secretion has been established in 
several model systems including animal GI tracts (Neutra, et al., 1982; Seidler, et al., 1989; 
Hamada, et al., 1997; Yang, et al., 2013) and human colon cancer cell lines (Mitrovic, et al., 
2013). However, the underlying molecular mechanism of the cholinergic-mediated Ca2+ 
signal generation in the human colonic epithelium is yet to be described. This current work 
investigated three levels of interactions, from the intact tissue (i.e. colonic crypt), to single 
polarised epithelial cells, to the intracellular organelle that serve as Ca2+ stores (Figure 4.1). 
In the previous chapter, the cellular and molecular Ca2+ signalling machineries in the human 
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colonic crypt culture model were characterised. In this chapter, the cultured crypt model was 
further utilised to study the underlying mechanism of intracellular Ca2+ signal generation 
upon M3AchR activation in the human colonic crypt. This was achieved by combining 
fluorescence Ca2+ imaging, immunohistochemistry and confocal microscopy.  Since isolated, 
single crypts are no longer embedded in the lamina propria, cholinergic signals were 
mimicked by the addition of Ach or Cch to the in vitro system.  
 
 
 
 
Figure 4.1 Cholinergic mediated signal transduction from the organ colon to individual 
epithelial cells. 
Enteric cholinergic neurons are the major source of the neurotransmitter Ach in the colon 
(left). Ach is secreted at the enteric axon terminals in close proximity with the colonic 
epithelium (crypts, middle). The binding of Ach to the MAchR on the epithelial cell surface 
triggers intracellular Ca2+ signalling in the epithelial cells (right) that subsequently spread 
along the crypt-axis via gap junctional proteins.  
(Figures from McGraw Hill text book Human physiology (left); cram Mm histology 1 epithelia 
flashcards (middle); ETH Zurich, Institute of Biochemistry, Kornmann group research page 
(right))  
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4.1.1 Cholinergic mediated calcium signalling in the human colonic epithelium 
Application of Ach to both rat and human colonic crypts has previously been shown to 
mobilise Ca2+ in a wave-like manner, via the activation of M3AchR. These Ca2+ signals initiated 
at the base of the crypt and then propagated along the entire crypt-axis (Lindqvist, et al., 
1998; Lindqvist, et al., 2002; Reynolds, et al., 2007). In order to investigate the underlying 
molecular mechanism of Ca2+ signal generation upon M3AchR activation, cholinergic 
mediated Ca2+ signals in cultured human colonic crypts were reproduced and the 
spatiotemporal characteristics were confirmed in the current study. Isolated human colonic 
crypts that had been cultured for 16 to 40 hours were loaded with the intracellular Ca2+-
sensitive dye Fura-2/AM (5µM) for 2 hours. In order to avoid the hydrolysis of Ach by 
endogenous cholinesterases, Cch (a cholinesterase-resistant Ach analogue) was used for all 
experiments in the current study. 10µM of Cch has been shown to be sufficient to evoke a 
biphasic Ca2+ response in human colonic crypts (Lindqvist, et al., 2002). Addition of Cch 
(10µM) elicited a significant increase of intracellular Ca2+ at the crypt base, as demonstrated 
in the pseudocolour images in Figure 4.2A (top panel) and the corresponding traces (Figure 
4.2A bottom panel).  
Specifically, the Ca2+ waves begin at the apical pole of the ‘initiator’ cells at the crypt base, 
then spread to the basal pole of cells before further propagating along the entire crypt-axis 
(Figure 4.2Ba). Region of interests (ROIs) drawn along the crypt demonstrate the progressive 
propagation of the Ca2+ signal along the crypt-axis following initiation at the crypt base 
(Figure 4.2A bottom left panel). Intracellular Ca2+ levels at the crypt-base increased to a peak 
level between 30-100 seconds after Cch administration and then plateaued, presumably due 
to ER store-operated or mitochondrial Ca2+ reuptake, and extrusion by plasma membrane 
Ca2+ ATPase. With the continuous presence of Cch, the intracellular [Ca2+] does not return to 
resting levels (Figure 4.4 top Ca2+ trace). However, upon removal of the agonist, the cytosolic 
[Ca2+] returned to baseline within 3-10 mins (Figures 4.3A and 4.4), which indicates some 
variability of the plateau phase persistence after agonist removal between different 
crypts/individuals. Thus sustained M3AchR activation elicits an intracellular [Ca2+] above 
resting levels, and this behavior is maintained over a culture period of at least 3 days (data 
not shown). Also, these Cch-induced Ca2+ waves have previously been shown to exhibit 
similar spatial characteristics regardless of the age and gender of the patients (Lindqvist, 
2000).  
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Figure 4.2A Spatio-temporal characteristics of Cch-induced human colonic crypt Ca2+ 
waves. 
Application of Cch (10µM) to a day-1 cultured human colonic crypt loaded with Fura-2/AM 
(5µM). Upper panel shows the DIC image of the human colonic crypt, and the pseudocolour 
Fura-2 ratio images with respective time (T) of Cch administration (blue pseudocolour = low 
Fura-2 ratio, red pseudocolour = high Fura-2 ratio) . The Ca2+ signal initiates at the apical pole 
of the ‘initiator’ cells at the base of the crypt (0.5s) and then spreads to the basal pole of the 
‘initiator’ cells (6s) before further propagation along the entire crypt-axis in a unidirectional 
manner (10-30s). Bottom panels are traces of the Ca2+ signals that represent the change in 
Fura-2 ratio along the crypt-axis. Region of interests (ROIs, colour dots) were placed along 
the crypt-axis to detect the Fura-2 ratio changes with respect to time (Bottom left panel). 
The Ca2+ signal is progressively registered along the crypt-axis as demonstrated by the red 
ROI at the crypt base, first in the trace, which then spreads to pink, yellow and blue ROIs, 
with the green ROI at the mid region being last in the trace. ROIs were also placed at the 
basal and apical poles at the base and mid region of the crypt (bottom right panel). Ca2+ signal 
at the apical pole (red) at the base of crypt came first in the trace then spread to the basal 
pole (blue); similarly, the Ca2+ signal at the apical pole of mid region of crypt (purple) came 
first in the trace then spread to the basal pole (yellow). Images were taken with a x40 
objective. This figure was provided courtesy of Mark Williams.  
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Figure 4.2B Potential Ca2+ initiator cells 
Application of Cch (10µM) to a day-1 cultured human colonic crypt loaded with Fluo-4/AM 
(5µM). (a) Ca2+ signal initiates at the apical pole of the ‘initiator’ cells at the base of the crypt 
(8s) and then spreads to the basal pole of the ‘initiator’ cells (10-12s) before further 
propagation along the entire crypt-axis (20s). Filled colour arrows show the point of initiation 
in the initiator cells, while the open arrows show the propagation of the signals to the basal 
pole of initiator cells. Each of the red, pink and green arrows pointed to individual initiator 
cells at the base of the crypt. (b) Human colonic crypts were either unstimulated or 
stimulated with Cch (10µM) for 30 min. The samples were then fixed and stained with anti-
CD38 (pink) and anti-LGR5 (green) antibodies, cell nuclei were stained with Hoechst (blue). 
Images were taken with a Zeiss confocal microscope with a x63 objective. (i) control, (ii) Cch 
stimulated for 30 min. Images are representative of N=2 subjects, n=6 crypts. 
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4.1.2 Characteristics of the Cch-induced calcium signals 
The Ca2+ response evoked by repetitive stimulation (duration of 1-2 minutes; interval greater 
than 10 minutes) with Cch (10µM) at the base of the crypts were both reversible and 
reproducible (consistent peak, 0.99 ± 0.03, N= 6 subjects, n= 8 crypts, paired t-test p= 0.85, 
Figure 4.3A), making it possible to investigate the effects of Ca2+ channel blockers using a 
paired experimental design. The crypt to crypt peak amplitude of the response (from 
baseline to peak) ranged from approximately 0.3-1.5 between different crypts and 
individuals, with an average amplitude of approximately 0.5 Fura-2 ratio units observed in 
most crypts (e.g. Figure 4.3A). The variability in amplitude of the response could be a result 
of the different expression levels of the MAchR between individuals and the regions of the 
colon; this was not investigated in the current study. Moreover, a number of features 
associated with the Cch-induced Ca2+ transients were concentration-dependent (Figure 4.3B): 
these included the latency of the response (from point of stimulation to peak), the initial rate 
of increase and the peak amplitude, the persistence of the plateau phase, and the length of 
resolving phase (back to baseline level) of the response. The dose-dependent response of 
Cch has been described previously in our lab (Lindqvist, et al., 2002; Reynolds, et al., 2007). 
In this study, the concentration dependent effect of Cch was briefly investigated. Cch (1µM) 
was insufficient to evoke a regenerative Ca2+ wave (mean amplitude 0.026 ± 0.008, 
normalised to 1 ± 0, N= 2 subjects, n= 3 crypts), while Cch (10µM) is adequate to generate 
the Ca2+ waves along the entire crypt-axis (normalised mean amplitude 6.7 ± 0.86, N= 2 
subjects, n= 3 crypts). In addition, a maximal amplitude of Ca2+ response was observed when 
the crypts were treated with 50µM Cch (normalised mean amplitude 22.6 ± 7.8) and 100µM 
Cch (normalised mean amplitude 15.9 ± 4.4, N= 2 subjects, n= 3 crypts), confirming that the 
Ca2+ response to Cch is concentration-dependent (Figure 4.3Bii). Furthermore, the mean 
amplitude of Ca2+ response to 100µM Cch was lower than that of 50µM Cch, this could 
possibly either be due to the short resting interval (about 10 min) between Cch (50µM) and 
Cch (100µM) treatment to allow refilling the ER store, or M3AchRs becoming desensitised 
after Cch (50µM) treatment. 
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Figure 4.3A Reproducible Ca2+ response to successive pulse of Cch 
(Ai) Representative Ca2+ trace showing response to successive Cch (10µM) treatment 
(duration=black bar). Fura-2 ratio changes along human colonic crypts pulsed with successive 
Cch (10µM), with a greater than 10 min resting interval after the first Cch administration. (Aii) 
The mean amplitude of the first and second Cch responses were calculated, before the mean 
amplitude of the 2nd response was then normalised to the 1st  response and displayed as 
mean ± SE. Results were representative of N= 6 subjects, n= 8 crypts, paired t-test p= 0.85.  
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Figure 4.3B Cch dosage response in human colonic crypts 
(Bi) Traces are Fura-2 ratio changes in response to increasing concentrations of Cch (1µM, 
10µM, 50µM and 100µM) (duration=black bar) along human colonic crypts loaded with Fura-
2/AM (5µM). The crypt exhibited the same resting baseline ratio throughout the experiment. 
Intervals between each Cch administration were ≥ 10 min. (Bii) Concentration dependent 
features of the Cch-induced Ca2+ responses. Mean amplitudes of Ca2+ responses (from 4-5 
ROIs) to each Cch dosage were calculated, then normalised to the lowest Cch (1µM) Ca2+ 
response and displayed as normalised mean values from N=2 subjects, n=3 crypts. 
Significance was assessed using a One-way ANOVA test, F (3, 8) = 8.3, p= 0.008; followed by 
Tukey’s post hoc analysis. Significant difference (p< 0.05) was observed between pairs of 
mean values including (i) Cch (1µM) vs. Cch (50µM), (ii) Cch (1µM) vs. Cch (100µM), (iii) Cch 
(10µM) vs. Cch (50µM).  
  
 129 
 
4.1.3 Cch-induced calcium release from intracellular calcium stores 
In order to confirm whether the increase of intracellular [Ca2+] is a result of Ca2+ release from 
intracellular stores (i.e. not from extracellular influx of Ca2+), human colonic crypts were pre-
incubated with Ca2+-free HBS (supplemented with 1mM EGTA to chelate endogenous Ca2+). 
Similar level Ca2+ transients in response to Cch were observed in the presence and absence 
of extracellular Ca2+ (Figure 4.4). The initial phase of the Ca2+ response (from initiation to 
peak) conducted with Ca2+-free HBS was similar to the control. This phenomenon was 
observed in both the crypts stimulated with either Cch (10µM) or Cch (50µM, not shown). 
Thus, these results further confirmed the mobilisation of Ca2+ from intracellular stores into 
the cytosol upon Cch stimulation.  
 
Figure 4.4 Effects of extracellular Ca2+ on Cch-induced Ca2+ responses 
Traces represent Ca2+ signals in response to Cch (10µM) stimulation (black bar) in the 
presence (top) or absence (bottom) of Ca2+ in the bathing medium. Bottom trace shows 
cultured human colonic crypts pre-incubated with Ca2+-free HBS for at least 5 min before the 
addition of Cch (10µM) prepared with Ca2+-free HBS. The initial phase of the Ca2+ response 
was shown to be independent of extracellular Ca2+ (top and bottom traces). With 
extracellular Ca2+ (top), the Ca2+ response to Cch plateaued (flat red line) and remained high 
while SOCE is activate and continuously refilling the ER store. Upon removal of Cch (black 
arrow), the cytosolic Ca2+ levels gradually returned to baseline. In the absence of extracellular 
Ca2+ (bottom), the initial phase of Ca2+ response gradually decreased (slope red line). Upon 
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removal of Cch (black arrow), the rate at which cytosolic [Ca2+] returned to baseline was 
increased compared to the control.  
 
 
 
 
The relative contribution of different intracellular Ca2+ organelles such as the ER and 
lysosomes to generate the Cch-specific Ca2+ response in the human colonic epithelium is 
unclear. Thapsigargin (Tg) is a non-competitive inhibitor of the SERCA pump that is commonly 
used to deplete the ER Ca2+ store. In order to investigate the importance of the ER Ca2+ store 
in response to Cch induced Ca2+ signal generation, colonic crypts were pre-treated with 
thapsigargin (1µM) for 40 mins to deplete the ER store. In the presence of extracellular Ca2+, 
a gradual increase of intracellular [Ca2+] (high amplitude, 1.44 ± 0.12, N= 4 subjects, n= 4 
crypts) was observed, which is consistent with ER store depletion followed by an activated 
influx of extracellular Ca2+ into the cytosol due to the inability of the SERCA pump to refill the 
depleted ER store (Figure 4.5A). The intracellular [Ca2+] remained elevated and then slowly 
diminished. In the absence of extracellular Ca2+, treatment with thapsigargin caused an 
increase of intracellular [Ca2+], but the intracellular Ca2+ level quickly returned to the baseline 
level (0.2 ± 0.04, N= 2 subjects, n= 4 crypts, Figure 4.5B). Interestingly, the subsequent 
application of Cch (10µM) in the presence of Tg induced a small increase of intracellular [Ca2+] 
in the human colonic crypt in both the presence of extracellular Ca2+  (0.14 ± 0.03, N= 4 
subjects, n= 4 crypts, paired t-test p= 0.017, Figure 4.5A (ii)) and absence of extracellular Ca2+  
(0.1 ± 0.03, N= 2 subjects, n= 4 crypts, paired t-test p=0.012, Figure 4.5B (ii)) as compared to 
Cch alone, suggesting that cholinergic stimulation was able to mobilise Ca2+ from organelles 
other than the ER. 
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Figure 4.5A Effects of SERCA pump inhibition on the Ca2+ responses to Cch 
(Ai) Control Ca2+ waves in response to Cch (10µM) (1st black bar) followed by thapsigargin 
(1µM) treatment to trigger depletion of the ER Ca2+ stores (arrows). In the presence of Ca2+ 
in the bathing medium, the Ca2+ peak contributed by the depletion of ER Ca2+ store is 
maintained by the influx of extracellular Ca2+ into the cytosol. A small Ca2+ response was 
observed when crypts were re-stimulated with Cch (10µM) (2nd black bar). (Aii) Mean 
amplitude of Ca2+ responses to all three treatments were calculated and displayed as mean 
± SE. Representative data of N= 4 subjects and n= 4 crypts. Significant difference of the effect 
of thapsigargin (role of ER Ca2+ store) on Cch-induced Ca2+ response was assessed using One-
way ANOVA test, F (2,9)= 33.53, p= 0.00007, followed by Bonferroni procedure and Tukey’s 
post hoc analysis. Significant difference as indicated by asterisks (**) for p< 0.01 was 
observed between pairs of mean values including (i) Cch vs. Tg + Cch, (ii) Tg vs. Tg + Cch.  
Significant difference as indicated by asterisks (*) for p< 0.05 was observed between Cch vs. 
Tg. 
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Figure 4.5B Role of SOCE to Cch-induced Ca2+ responses 
(Bi) Control Ca2+ waves in response to Cch (10µM) (1st black bar) followed by thapsigargin 
(1µM) treatment to trigger depletion of the ER Ca2+ stores (arrows).  In the absence of Ca2+ 
in the bathing medium, the latency of the Ca2+ signals in response to thapsigargin increased, 
and the Ca2+ peak quickly returned to baseline level. A small Ca2+ response was also observed 
when crypts were re-stimulated with Cch (10µM) (2nd black bar). (Bii) Mean amplitude of Ca2+ 
responses to all three treatments were calculated and displayed as mean ± SE. Data are 
representative of N= 2 subjects and n= 4 crypts. Statistical significant of the effect of 
thapsigargin (role of SOCE) on Cch-induced Ca2+ response was assessed using One-way 
ANOVA test, F (2, 9)= 22.85, p= 0.0003, followed by Bonferroni procedure and Tukey’s post 
hoc analysis. Significant difference as indicated by asterisks (**) for p< 0.01 was observed 
between pairs of mean values including (i)  Cch vs. Tg (Ca2+ free), (ii) Cch vs. Tg + Cch (Ca2+ 
free). No significant difference was observed between Tg (Ca2+ free) vs. Tg + Cch (Ca2+ free).  
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4.1.4 BAPTA abolished the Cch-induced calcium signals 
In order to investigate whether chelation of intracellular Ca2+ blocks Cch-induced Ca2+ signals, 
cultured human colonic crypts were treated with the intracellular Ca2+ chelator BAPTA-AM 
(66µM) for 1 hour prior to the re-administration of Cch (10µM) (Figure 4.6 top panel). BAPTA-
AM is taken up into cells like Fura-2/AM and de-esterified in the cytosol where it acts as a 
Ca2+ chelator which is highly selective for Ca2+ like EGTA. Chelation of intracellular Ca2+ 
decreased Cch-induced Ca2+ signals by greater than 85% (0.153 ± 0.03, N= 3 subjects, n= 10 
crypts, paired t-test p< 0.01, Figure 4.6 bottom panel), and a similar level of inhibition was 
observed in experiments conducted with Ca2+-free HBS (data not shown). These results 
suggested that 66µM of BAPTA-AM is an appropriate dosage for suppressing Cch-induced 
Ca2+ signals in the human colonic crypt. 
 
 
Figure 4.6 Role of BAPTA-AM on cholinergic mediated intracellular Ca2+ signals 
Representative trace of Ca2+ responses (top). A control response to 10µM of Cch (amplitude 
0.7) followed by pre-incubation with BAPTA-AM (66µM) for 1 hr. Crypts were then re-
stimulated with Cch (10µM) with the presence of BAPTA-AM (black bar). The amplitude of 
the control and BAPTA treated Ca2+ responses were calculated and the mean values were 
plotted (bottom). Ca2+ responses were displayed as mean ± SE from N=3 subjects, n=10 crypts. 
Asterisks (**) denote a significant difference compared to the control (paired t-test, p< 0.01).  
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4.2 Characterisation of the calcium signal generation downstream of MAchR 
activation 
A previous study from our laboratory used a range of MAchR antagonists to demonstrate 
that the Ca2+ signal is MAchR dependent, e.g. pre-incubation with atropine completely 
abolished colonic crypt Ca2+ signals stimulated with 10µM Cch (Lindqvist, et al., 2002). In 
keeping with the site of muscarinergic Ca2+ signal initiation at the crypt base, colonocytes at 
the base of the crypt have additionally been shown to be more sensitive to cholinergic 
stimulation and exhibited a higher expression level of M3AchRs (Lindqvist, et al., 2002). 
However, the intracellular molecular mechanism of Ca2+ signal generation at the base of the 
crypt is less well understood.  
The MAchR signalling pathways involved in mobilising ER Ca2+ stores has been well described 
in numerous tissues. Activation of M3AchR by binding Ach (or Cch) promotes its association 
with the heterotrimeric G protein (Gαqβγ). Dissociation of βγ subunits from the α-subunit 
frees the α-subunit to travel along the inner leaflet of the cell membrane and activate PLC 
molecules. PLC in turn catalyses PIP2 hydrolysis to generate DAG and IP3 (Felder, 1995; Budd, 
et al., 1999). IP3 then translocates to the ER where it binds to the IP3R and promotes Ca2+ 
release from the ER Ca2+ store into the cytosol (Felder, 1995; Nahorski, et al., 1997). Increase 
in cytosolic [Ca2+] in turn activates the IP3R and RYR and induce the CICR response (Ca2+ 
waves) in the entire cell (Taylor and Dale, 2012). Meanwhile, DAG binds to and activates PKC 
(Felder, 1995). DAG can also be converted to PA by DAG kinase (Kanoh, et al., 2002). The 
most common MAchR signal transduction pathway is via the activation of PLC (Budd, et al., 
1999), however, PLC and PLD have also been shown to be stimulated simultaneously after 
agonist induced receptor activation, but through independent processes (Liscovitch, 1991). 
In order to determine whether the Ca2+ signals generated upon Cch stimulation are PLC 
dependent, human colonic crypts were pre-treated with the PLC inhibitor U73122 (10µM) 
for 1 hour, prior to re-stimulation with Cch (10µM) (Figure 4.8A). U73122 significantly 
blocked the peak amplitude of the Ca2+ signals by 87% with respect to control (0.13 ± 0.026, 
N= 5 subjects, n= 19 crypts, paired t-test p< 0.01, Figures 4.8A and 4.9 bottom panel). This 
result suggests that the majority of the Ca2+ signals are downstream of the PLC pathway. 
Activation of PLC initiates the hydrolysis of PIP2 into IP3 and DAG. From this point onwards, 
the signals feed into two paths (Figure 4.7); while the IP3 pathway to Ca2+ mobilisation has 
been relatively well studied, signal transduction downstream of DAG and PKC is not yet 
clearly understood (Figure 4.7).   
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Figure 4.7 Schematic of the MAchR signalling pathways.  
Binding of Ach (or Cch) to M3AchR promotes its association with the heterotrimeric G protein 
on the plasma membrane that further activates PLC molecules. PLC in turn catalyses PIP2 
hydrolysis to generate DAG and IP3. IP3 then translocates to the ER where it binds to the 
IP3R and promotes Ca2+ release from the ER Ca2+ store into the cytosol. Meanwhile, DAG 
binds to and activates PKC. The 2nd messenger IP3 is the hallmark ER Ca2+ mobilising agent 
upon M3AchR activation that has been relatively well studied, while signal transduction 
downstream of DAG and PKC is not yet clearly understood as the downstream effector(s) of 
PKC is currently unknown. DAG can also converted to PA by DAG-kinase. It is currently 
unclear which PKC isoforms are activated by DAG or PA or both upon M3AchR activation in 
the human colonic epithelium, and the signalling pathway downstream of PA is also not 
known.  
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Under resting conditions, the activity of DAG kinase is low, which leaves DAG free to fulfill its 
various signalling roles, including activation of PKC (Mérida, et al., 2008). In order to gain an 
insight into the contribution of DAG kinase to cholinergic stimulated Ca2+ signal generation, 
human colonic crypts were treated with the DAG kinase inhibitor R59-022 (10µM) (Figure 
4.8B). DAG kinase inhibition reduced the peak amplitude of the Ca2+ response to Cch by 
approx. 64% of control (0.36 ± 0.045, N= 2 subjects, n= 7 crypts, paired t-test p< 0.01, Figures 
4.8B and 4.9 bottom panel). DAG kinase inhibition would be expected to increase levels of 
DAG by blocking the conversion to PA. The activation of PKC upon binding to DAG has been 
shown to activate downstream effectors involved in regulating proliferation, differentiation 
and secretion (Shearman, et al., 1989; Kikkawa, et al., 1989). Since Cch stimulation might 
activate more than one PKC isoform (and not all PKC isoforms are activated by DAG), the role 
of PKCs in the human colonic crypt Ca2+ signal generation were determined by using the pan-
PKC-specific inhibitor sotrastaurin (20µM) (Figure 4.8C). Ca2+ signals were blocked by 45% in 
the presence of sotrastaurin (0.55 ± 0.06, N= 6 subjects, n= 14 crypts, paired t-test p< 0.01) 
compared to the control Ca2+ response (Figures 4.8C and 4.9 bottom panel), suggesting that 
the PKC pathway contributed to approximately half of the Ca2+ signals generated upon Cch 
stimulation. These observations suggest that PLC-mediated DAG formation can contribute to 
Ca2+ signal generation by activation of PKC and formation of PA. However, the relative 
contribution of PKC and PA, and their interdependency, to Ca2+ signal generation was not 
investigated.  
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Figure 4.8 The roles of PLC, DAG kinase and PKC in Cch-mediated Ca2+ waves in the human 
colonic crypts (previous page) 
Representative traces of the Ca2+ responses upon Cch stimulation of Fura-2 loaded human 
colonic crypts. A control response to 10µM of Cch was conducted in all experiments (first 
Ca2+ peak). Cch administration (duration) was indicated by the black bar. The amplitude of 
the control Cch-mediated Ca2+ responses ranged from 0.6- 1.2, measured from the peak to 
the baseline. After removal of the agonist and [Ca2+] back to resting level, crypts were then 
treated with different inhibitors for 1 hour prior to subsequent re-administration of Cch 
(10µM) in the presence of the respective inhibitors (2nd black bar). (A) U73122 (PLC inhibitor, 
10µM), representative result of N= 5 subjects, n= 19 crypts; (B) R59-022 (DAG kinase inhibitor, 
10µM), representative result of N= 2 subjects, n= 7 crypts; (C) Sotrastaurin (PKC inhibitor, 
20µM), representative result of N= 6 subjects, n= 14 crypts. 
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Figure 4.9 Probing downstream mediators of MAchR-coupled Ca2+ signalling 
pharmacological inhibitors. 
Schematic representation of the MAchR signalling pathways (Top panel). The amplitude of 
the Ca2+ responses in the control group and the inhibitor treated groups as displayed in the 
previous figure (Figure 4.8) were calculated. The mean amplitude of each experimental 
groups were normalised to the control group, and displayed as mean ± SE (bottom panel). 
Significant difference was assessed by One-way ANOVA, F (4, 73) = 209.3, p< 0.00001; 
followed by Bonferroni procedures and Tukey’s post hoc analysis. Significant difference 
between pairs of mean values (i.e control vs. each treatment group) were indicated by 
asterisks (**), p< 0.01. Significant differences (p< 0.01) were also observed between other 
pairs, but no significant difference was observed between U73122 and U73122 + 
Sotrastaurin (p= 0.32). Schematic diagram is courtesy of Mark Williams.  
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4.2.1 Involvement of IP3R-gated calcium release in Cch-induced calcium signals  
IP3R is one of the major Ca2+ release channels expressed on the ER membranes of most cell 
types. Three IP3R isoforms (IP3R1, 2 and 3) have been identified in mammals, and all are 
regulated by both IP3 and Ca2+ (Finch, et al., 1991; Marchant and Taylor, 1997; Foskett, et al., 
2007). In our human colonic crypt culture model, IP3Rs were found to be expressed in the 
ER area and also in the region where the acidic lysosomes reside (Chapter 3, Figure 3.17). 
However, whether they play any role in releasing Ca2+ from other intracellular organelles or 
not is unclear. Given that inhibition of PLC inhibits the Ca2+ response by 90%, while inhibition 
of DAG kinase or PKC inhibits by no more than 60%, it is conceivable IP3 mediated Ca2+ 
release via the IP3R upon Cch stimulation. In order to verify whether IP3 and IP3R are the 
major contributors to the Ca2+ signals in our model, human colonic crypts were pre-treated 
with either a non-specific IP3R inhibitor (2-APB, 50µM) or a specific IP3R inhibitor (Xes C, 
2µM) for 1 hour prior to the re-application of the Cch (10µM) (Figure 4.10A and 4.10B). 2-
APB is a non-specific IP3R antagonist because it can also block the TRP channels on the cell 
membrane. It acts to mobilise store-operated Ca2+ at low concentrations (<10µM), but also 
inhibits it at high concentrations (up to 50µM). At 50µM 2-APB, only 27% of inhibition (0.722 
± 0.085, N= 5 subjects, n= 16 crypts, paired t-test p< 0.01) of the Ca2+ signals was observed 
in comparison to the control (Figures 4.10A and 4.11 bottom panel). The role of IP3R was 
further confirmed by the specific inhibitor Xes C (2µM), however, similar levels of inhibition 
(31% reduction, 0.69 ± 0.036, N= 3 subjects, n= 6 crypts, paired t-test p< 0.01) compared to 
2-APB were observed (Figures 4.10B and 4.11 bottom panel). Surprisingly, these findings 
suggest that the IP3R is not the major intracellular Ca2+ channel contributing to the Ca2+ 
signals upon Cch stimulation in the human colonic epithelium. This leaves the PKC and the 
PA pathways as the two other main possibilities. In order to eliminate one of the possibilities, 
crypts were treated simultaneously with the PKC inhibitor sotrastaurin (20µM) and 2-APB 
(50µM) (Figure 4.10C and Figure 4.11 top panel). The Ca2+ signal was blocked by 45% (0.55 ± 
0.07, N=1 subject, n= 4 crypts, paired t-test p< 0.01) in the presence of these two inhibitors 
(Figure 4.11 bottom panel), but the percentage of inhibition was similar to the sotrastaurin-
only treated groups (0.55 ± 0.06, N= 6 subjects, n= 14 crypts, paired t-test p< 0.01, Figure 4.9 
bottom panel). Since there was no additive effect in the presence of 2-APB, it seems that the 
role of IP3R is dependent on some effectors or 2nd messengers downstream of the PKC or PA 
pathways. Thus, these results suggest that the PA and PKC pathways – as well as potentially 
some other unknown pathways – are the major contributors to Cch-induced Ca2+ signals.   
  
 141 
 
 
  
 142 
 
Figure 4.10 The role of IP3R in the Cch-induced Ca2+ waves in human colonic crypts 
(Previous page) 
Representative traces of the Ca2+ responses upon Cch stimulation in the Fura-2 loaded 
human colonic crypts. A control response to 10µM of Cch was conducted in all experiments 
(first Ca2+ peak). Cch administration was indicated by the black bar. The amplitude of the 
control Ca2+ responses were ranging from 0.5-0.9. Upon removal of the agonist and the 
intracellular [Ca2+] back to baseline, the crypts were then treated with different inhibitors for 
1hr prior to subsequent re-administration of Cch (10µM) in the presence of the respective 
inhibitors (2nd black bar). (A) 2-APB (non-specific IP3R inhibitor, 50µM), representative result 
of N= 5 subjects, n= 16 crypts; (B) Xes C (specific IP3R inhibitor, 2µM), representative result 
of N= 3 subjects, n= 6 crypts; (C) Sotrastaurin (PKC inhibitor, 20µM) + 2-APB (50µM), 
representative result of N= 1 subject, n= 4 crypts. 
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Figure 4.11 Pharmacological inhibition of the IP3Rs  
Schematic representation of the MAchR signalling pathways (Top panel). The amplitude of 
the Ca2+ responses in the control group and the inhibitor treated groups as displayed in the 
previous figure (Figure 4.10) were calculated. The mean amplitude of each experimental 
groups were normalised to the control group, and displayed as mean ± SE (bottom panel). 
Significant difference was assessed by One-way ANOVA, F (3, 38) = 7.27, p= 0.0006; followed 
by Bonferroni procedures and Tukey’s post hoc analysis. Significant difference between pairs 
of mean values (i.e control vs. each treatment group) were indicated by asterisks (**), p< 
0.01. No significant difference were observed between 2-APB (0.722 ± 0.085) and XesC (0.69 
± 0.036), p= 0.82; and between 2-APB (0.722 ± 0.085) and 2-APB + Sotrastaurin (0.55 ± 0.073), 
p= 0.34. Schematic diagram is courtesy of Mark Williams. 
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4.2.2 Role of RYR-gated calcium release in generating Cch-induced calcium waves 
Expressed primarily on the ER of non-muscle cell types, RYRs are other key regulators of 
intracellular Ca2+ release. In our human colonic crypt culture model, RYR1 is expressed on the 
ER near the basal membrane of the crypt (Chapter 3, Figure 3.17d). Although the activation 
mechanism of RYR has not been clearly elucidated, it has been previously demonstrated that 
RYR activation can be regulated by cADPR (Takasawa, et al., 1993; Ozawa, et al., 1999), Ca2+ 
(Lanner, et al., 2010), and pharmacologically by ryanodine. Low concentrations of ryanodine 
allow Ca2+ release from RYR, whereas high concentrations inhibit receptor opening (Meissner, 
et al., 1986; Lai, et al., 1989; McGrew, et al., 1989). In order to investigate the role of RYR in 
Cch-induced Ca2+ signals, crypts were treated with either low (10µM) or high (50µM) 
concentrations of ryanodine for 1 hour prior to re-stimulation with Cch (10µM), along with 
the respective concentration of ryanodine (Figure 4.12A). Low concentration ryanodine 
(10µM) slightly enhanced Ca2+ release in the presence of Cch (10µM), with approximately 12% 
increase in the Ca2+ signal amplitude observed (not significant, 1.125 ± 0.08, N= 5 subjects, 
n= 16 crypts, paired t-test p> 0.05, Figure 4.13 bottom panel). Conversely, high concentration 
ryanodine (50µM) blocked the Ca2+ signals by 36% (0.635 ± 0.04, N= 5 subjects, n= 12 crypts, 
paired t-test p< 0.01) upon Cch-stimulation in comparison to the control (Figures 4.12A and 
4.13 bottom panel). To confirm the role of RYRs, crypts were treated with 8-Bromo-cADPR 
(30µM) for 1 hour prior to re-administration of Cch (10µM) in the presence of the inhibitor 
(Figure 4.12B). 8-Bromo-cADPR is an antagonist of cADPR, which is synthesised by ADP-
ribosyl cyclase (CD38) in the cell. This dosage of 8-Bromo-cADPR only blocked the Ca2+ signals 
by approximately 9% (not significant, 0.91 ± 0.036, N= 4 subjects, n= 13 crypts, paired t-test 
p> 0.05, Figures 4.12B and 4.13 bottom panel). These results suggest two possibilities: (1) 
the dosage of 8-Bromo-cADPR was insufficient to suppress cADPR activity, or (2) cADPR did 
not play a role in the M3AchR mediated Ca2+ signals via the RYRs. Similar to IP3Rs, RYRs were 
also involved in the Cch-induced Ca2+ signal generation.  
Both RYRs and IP3Rs are the major intracellular Ca2+ channels on the ER membrane. To 
determine the concomitant role of both channels on ER Ca2+ release, human colonic crypts 
were treated simultaneously with IP3R and RYR inhibitors (50µM 2-APB and ryanodine) for 
1 hour, prior to re-stimulation with Cch (10µM) in the presence of both inhibitors (Figure 
4.12C and Figure 4.13 top panel) and a 40% reduction (0.59 ± 0.055, N= 3 subjects, n= 11 
crypts, paired t-test p< 0.01) of the Ca2+ signals was observed (Figure 4.13 bottom panel). 
The ER Ca2+ store was one of the major contributor to the Cch-induced Ca2+ signals, neither 
RYRs nor IP3Rs were the key trigger for the M3AchR signalling mediated Ca2+ signal 
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generation. Previous data from thapsigargin implicated other intracellular organelles might 
provide the activation signals to induce CICR response from the ER via RYRs and IP3Rs. 
 
Figure 4.12 The role of RYRs on Cch-induced Ca2+ waves 
Representative traces of the Ca2+ responses upon Cch stimulation in Fura-2 loaded human 
colonic crypts. A control response to 10µM of Cch was conducted in all experiments (first 
Ca2+ peak). Cch administration was indicated by the black bar. The amplitude of the control 
Ca2+ responses ranged from 0.5-1.2. After removal of the agonist and the intracellular [Ca2+] 
returning to baseline, crypts were then treated with different inhibitors for 1 hour prior to 
subsequent re-administration of Cch (10µM) in the presence of the respective inhibitors (2nd 
black bar). (A) Ryanodine (RYR inhibitor, 50µM), representative result of N= 5 subjects, n= 12 
crypts; (B) 8-Bromo-cADPR (cADPR antagonist, 30µM), representative result of N= 4 subjects, 
n= 13 crypts; (C) Ryanodine (50µM) + 2-APB (IP3R inhibitor, 50µM), representative result of 
N= 3 subjects, n= 11 crypts. 
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Figure 4.13 Pharmacological inhibition of the RYRs. 
Schematic representation of the MAchR signalling pathways (Top panel). The amplitude of 
the Ca2+ responses in the control group and the inhibitor treated groups as displayed in the 
previous figure (Figure 4.12) were calculated, along with the results for low concentration 
(10µM) ryanodine, traces of which were not shown (N= 5 subjects, n= 16 crypts). The mean 
amplitude of each experimental groups were normalised to the control group, and displayed 
as mean ± SE (bottom panel). Statistical significance was assessed by One-way ANOVA, F (4, 
63) = 18.12, p< 0.00001; followed by Bonferroni procedures and Tukey’s post hoc analysis. 
Significant difference between pairs of mean values (i.e control vs. each treatment group) 
were indicated by asterisks (**), p< 0.01. Significant difference (p< 0.01) were also observed 
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between Ryanodine (10µM) vs. Ryanodine (50µM), and between Ryanodine (50µM) vs. 8-
Bromo-cADPR. No significant difference were observed between (i) control vs. Ryanodine 
(10µM), p= 0.15, (ii) Ryanodine (50µM) vs. Ryanodine (50µM) + 2-APB, p= 0.53. Schematic 
diagram is courtesy of Mark Williams.  
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4.2.3 CD38 regulates intracellular calcium release upon Cch stimulation 
CD38 was identified as the enzyme responsible for synthesising both cADPR (agonist of RYRs) 
and NAADP (agonist of TPCs) (Lee, 1997), as well as mediating the hydrolysis of cADPR to 
ADPR (Tohgo, et al., 1997). Both the cyclase and hydrolase activities of CD38 have been 
demonstrated in the mouse and human. CD38 expression is not restricted to the plasma 
membrane; in many cell types a soluble form of CD38 also exists which might be the product 
of enzymatic cleavage of the cell surface protein (Mehta, et al., 1996). In the rat brain, CD38 
expression has been found in association with the ER, ribosomes, small vesicles and the 
mitochondria, thus it is spread in such a way that it could participate in many cellular events 
(Yamada, et al., 1997). Accumulating evidence suggests that the up-regulation of CD38 
activity at the cell membrane is activated by GPCRs including MAchR (Higashida, et al., 1997a 
and b; Higashida, et al., 2001a and b). In mouse pancreatic acinar cells, activation of MAchR 
has been shown to cause an increase in the cellular content of cADPR that was not observed 
in CD38 knockout mice (Fukushi, et al., 2001). Activation of CD38 in B cells and human 
Namalwa cells (Burkitt’s lymphoma cell line) has been demonstrated to result in vesicle-
mediated internalisation of the enzyme (Xu, et al., 2013). As the catalytic domain of CD38 is 
localised at the extracellular side of the cell membrane (Tohgo, et al., 1994; Higashida, et al., 
2001a and b), internalisation allows the active site access to the cytosolic substrates (NAD+ 
or NADP+) and hence exert its function intracellularly (Xu, et al., 2013). However, the 
mechanism of CD38 activation upon MAchR activation remains unclear. 
A previous study has demonstrated the expression of CD38 on endosomes in pancreatic 
acinar cells, which appeared to be proximal to – but not co-localised with – the lysosomes 
(Cosker, et al., 2010). In the current study, the expression and localisation of CD38 was 
compared between the control and Cch treated group. Under resting (unstimulated) 
conditions, CD38 expression was detected in the cytoplasmic space of human colonic crypt 
epithelial cells where the acidic lysosomes reside. LAMP1 and CD38 were expressed in close 
proximity to each other, and some level of co-localisation was also observed (Chapter 3, 
Figure 3.18 and Figure 3.22A). CD38 was also in close association with the ER at the mid-cell 
region (Figure 4.14, control). It is still unclear which signals contribute to this CD38 (of a 
presumably endosomal origin) being continually internalised. Upon Cch (10µM) stimulation 
for 30 min, increased intensity of CD38 expression in the apical region of cells was observed 
(Figure 4.2B (b) and Figure 4.14, Cch). In addition, CD38 expression on the basal membrane 
was also increased. Thus, CD38 expression in human colonic epithelial cells is not restricted 
to the plasma membrane; instead, it is localised to the area where the acidic lysosomes and 
 149 
 
mucus granules reside, indicating a possible role in synthesising 2nd messengers in response 
to signals. 
 
 
Figure 4.14 Expression of CD38 in the human colonic crypt in resting and stimulated state 
Cultured human colonic crypts were either untreated or treated with Cch (10µM) for 30 min. 
Samples were fixed, labelled with anti-CD38 (pink) and anti-Ecad (green) antibodies, and 
visualised with Alexa-conjugated secondary antibodies; cell nuclei were stained with Hoechst 
(blue) (A). Representative images were taken with a Zeiss Meta 510 confocal microscope 
using a x63 objective. Left hand column show the overlay images of CD38 (pink) and Ecad 
(green); right hand column show the merged images of CD38 (pink) and cell nuclei (blue). 
White dotted lines show the boundary of the crypt lumen. The intensities of CD38 at the 
basal pole and cytoplasmic space of the crypt were measured by ImageJ software. Mean 
intensities of both regions were calculated and normalised to the control group, and 
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displayed as mean ± SE (B). Results were representative of N= 3 subjects, n= 12 crypts in each 
treatment group. 
 
As mentioned previously, CD38 has been proposed to exert its function when it is 
internalised. Figure 4.14 suggests that there is an association between CD38 internalisation 
and the endocytic pathway in mediating Cch-induced Ca2+ signal generation in the human 
colonic crypt. The role of endocytosis in Cch evoked Ca2+ signal generation was briefly 
investigated. Dynasore, an inhibitor of clathrin mediated endocytosis did not inhibit the 
amplitude of the Cch-induced Ca2+ signal (1.16 ± 0.2, N= 2 subjects, n= 6 crypts, data not 
shown) as compared to the control (1 ± 0). Methyl-beta-cyclodextrin (MbetaC) is a commonly 
used inhibitor of endocytosis via lipid rafts by selectively extracts cholesterol from plasma 
membranes. Human colonic crypts were treated with MbetaC (10mM) for 1 hour prior to re-
stimulation with Cch (10µM) in the presence of the inhibitor. MbetaC (10mM) reduced the 
Cch-induced Ca2+ signals by 56% (0.44 ± 0.09, N= 1 subject, n= 3 crypts, paired t-test p= 0.024, 
data not shown). This result supports the notion that CD38 internalisation upon Cch-
stimulation is important for the downstream signalling cascade. 
Nicotinamide is a compound that blocks CD38 activity. In order to investigate the cyclase 
activities of CD38 and its role in Ca2+ signal generation upon Cch-stimulation, human colonic 
crypts were treated with 20 or 50mM nicotinamide for 1 hour prior to re-stimulation with 
Cch (10µM), in the presence of the respective dose of nicotinamide (Figure 4.15 and Figure 
4.16 top panel). The lower concentration of nicotinamide (20mM) significantly reduced the 
Ca2+ signal by 63% (0.36 ± 0.08, N= 2 subjects, n= 3 crypts, paired t-test p< 0.01), while the 
higher concentration (50mM) reduced the Ca2+ signal by 84% in comparison to the control 
(0.16 ± 0.03, N= 2 subjects, n= 5 crypts, paired t-test p< 0.01, Figures 4.15 and 4.16 bottom 
panel). Further statistical analysis shows no significant difference between Nicotinamide 
(20mM) and (50mM). These results suggest that CD38 plays a major role in the Cch-mediated 
Ca2+ signal generation.   
However, as discussed previously, 8-Bromo-cADPR (a cADPR antagonist) failed to inhibit the 
Ca2+ signal in response to Cch-stimulation (Figure 4.12B), suggesting either that cADPR (one 
of the 2nd messengers synthesised by CD38) might not play any role in the Cch-induced Ca2+ 
response, suggesting that NAADP, also catalysed by CD38 activity, could be a key 2nd 
messenger. NAADP is renowned for mobilising Ca2+ from non-ER Ca2+ stores such as acidic 
endo-lysosomal organelle. 
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Figure 4.15 Effect of nicotinamide on Cch-stimulated Ca2+ waves 
Representative traces of the Ca2+ responses upon Cch stimulation in Fura-2 loaded human 
colonic crypts. A control response to 10µM of Cch was conducted in all experiments (first 
Ca2+ peak). Cch administration was indicated by the black bar. The amplitude of the control 
Ca2+ responses ranged from 0.8-1. After removal of the agonist and return of the intracellular 
[Ca2+] back to baseline, the crypts were then treated with different doses of nicotinamide for 
1 hour prior to subsequent re-administration of Cch (10µM) while maintaining the same 
nicotinamide dose (2nd black bar). (A) Nicotinamide (CD38 inhibitor, 20mM), representative 
result of N= 2 subjects, n= 3 crypts; (B) Nicotinamide (50mM), representative result of N= 2 
subjects, n= 5 crypts. 
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Figure 4.16 Pharmacological inhibition of CD38 and its role in Cch-mediated Ca2+ signals 
Schematic representation of the MAchR signalling pathways (Top panel). The amplitude of 
the Ca2+ responses in the control group and the inhibitor treated groups as displayed in the 
previous figure (Figure 4.15) were calculated. The mean amplitude of each experimental 
groups were normalised to the control group and displayed as mean ± SE (bottom panel). 
Statistical significance was assessed by One-way ANOVA, F (2, 10) = 162.3, p< 0.00001; 
followed by Bonferroni procedures and Tukey’s post hoc analysis. Significant difference 
between pairs of mean values (i.e control vs. each treatment group) were indicated by 
asterisks (**), p< 0.01. No significant difference was observed between Nicotinamide (20mM) 
and Nicotinamide (50mM). Schematic diagram is courtesy of Mark Williams. 
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4.2.4 Pharmacological disruption of lysosomal calcium stores inhibits Cch-induced 
calcium signals 
The acidic lysosomes have recently emerged as important Ca2+ stores for regulating cellular 
and physiological functions (Morgan, et al., 2011). Ca2+ mobilisation from these stores have 
been shown to mediate vesicle trafficking (Ruas, et al., 2010; Ruas, et al., 2014) and 
exocytosis (Davis, et al., 2012). The thapsigargin data presented above implies that M3AchR 
activation mobilises Ca2+ from other intracellular Ca2+ stores (Figures 4.5A and B). In order to 
confirm whether MAchR activation mobilises Ca2+ from the acidic organelles, human colonic 
crypts were treated with different inhibitors targeting the acidic lysosomes in different ways 
(Figure 4.20 top panel). The continuous refilling with Ca2+ mediated by the V-type H+ ATPase 
and a Ca2+/H+ exchanger on the lysosomal membrane is a basic requirement for a functional 
lysosomal store (Lemons and Thoene, 1991). This H+ ATPase also promotes the acidification 
of lysosomal lumens (Beyenbach, et al., 2006). Bafilomycin acts to inhibit the V-type H+ 
ATPase, and blocks Ca2+ refilling of the lysosomal stores (Galione, 2006).  
Human colonic crypts were treated with bafilomycin (2.5µM) for at least 1 hour prior to re-
stimulation with Cch (10µM, plus additional 2.5µM bafilomycin, Figure 4.17A). A significant 
reduction of Cch-induced Ca2+ signals by 65% (0.35 ± 0.1, N= 3 subjects, paired t-test p< 0.01) 
was observed (Figure 4.20 bottom panel). Chloroquine is a lysosomotropic agent that inhibits 
the acidification of the lysosomes by accumulating within the lysosomes and inhibiting the 
enzymes within, rendering the store inactive. Human colonic crypts were treated with 
chloroquine (100µM) for 1 hour prior to re-application of Cch (10µM) plus chloroquine 
(Figure 4.17B). Here Cch-induced Ca2+ signals were reduced even more dramatically than 
seen during bafilomycin treatment, by 94% (0.06 ± 0.03, N= 3 subjects, paired t-test p< 0.01, 
Figure 4.20 bottom panel). These data strongly suggest that the lysosomal Ca2+ stores are the 
key intracellular organelles responsible for the MAchR signal transduction.  
In order to further confirm the role of acidic lysosomal Ca2+ stores, colon crypts were treated 
with glycyl-L-phenylalanine 2-naphthylamide (GPN). GPN is a substrate that is specifically 
hydrolysed by lysosomal cathepsin C; intralysosomal accumulation of its hydrolysis products 
cause 90% of the lysosomes in treated cells to burst under osmotic pressure (Berg, et al., 
1994). Colonic crypts treated with GPN showed an irregular pattern of intracellular Ca2+ 
waves for 20-30 mins (Figure 4.18A), and the subsequent Cch-induced Ca2+ response was 
significantly reduced by an average of 87% (0.13 ± 0.03, N= 4 subjects, n= 8 crypts, paired t-
test p< 0.01, Figure 4.20 bottom panel). Thus, these results further support the model that 
cholinergic activation of the M3AchR signalling pathway mobilises Ca2+ from acidic lysosomal 
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stores. As the acidic lysosomes are localised at the apical pole of the crypt, these findings are 
also in agreement with the observation that colonic crypt Ca2+ signals initiate at the apical 
pole of the initiator cells at the base of the crypt.  
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Figure 4.17 The role of acidic lysosomes on Cch-mediated Ca2+ mobilisation 
Representative traces of Ca2+ responses upon Cch stimulation in Fura-2 loaded human 
colonic crypts. A control response to 10µM of Cch was conducted in all experiments (first 
Ca2+ peak). Cch administration was indicated by the black bar. The amplitude of the control 
Ca2+ responses ranged from 0.4-0.6. After removal of the agonist and return of the 
intracellular [Ca2+] back to baseline, crypts were then treated with different inhibitors for 1 
hour prior to subsequent re-administration of Cch (10µM) in the presence of the respective 
inhibitors (2nd black bar). (A) Bafilomycin (2.5µM); (B) Chloroquine (100µM). Both Ca2+ traces 
are courtesy of Martin loader, a student in the lab who collaborated on this section.  
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As discussed previously, CD38 immuno-localisation at the apical pole and the effects of the 
CD38 inhibitor nicotinamide on Ca2+ signal amplitude suggest that CD38 mediated generation 
of Ca2+ mobilising messengers plays a major role in Cch-mediated Ca2+ signal generation. 
Given that 8-Bromo-cADPR (a cADPR antagonist) failed to inhibit the Ca2+ signal in response 
to Cch-stimulation (Figure 4.12B), cADPR might not play any role in the Cch-induced Ca2+ 
response; however, NAADP could be the key 2nd messenger downstream of the CD38 
pathway upon M3AchR activation.  
It is known that lysosomal Ca2+ release is mediated by TPCs, a family of proteins that have 
gained recognition in recent years as the major regulator/channel of Ca2+ release from acidic 
stores via the 2nd messenger NAADP (Calcraft, et al., 2009; Brailoiu, et al., 2009). To further 
delineate the role of NAADP in mediating Ca2+ release from the acidic stores upon Cch 
stimulation, human colonic crypts were treated with Ned-19 (200µM), an NAADP antagonist, 
for 1 hour prior to re-stimulation with Cch (10µM) in the presence of Ned-19 (Figure 4.18B). 
The Cch-induced Ca2+ signals were drastically reduced by 94% in comparison to the control 
(0.057 ± 0.009, N= 4 subjects, n= 15 crypts, paired t-test p< 0.01, Figure 4.20 bottom panel). 
In addition, experiments conducted in Ca2+ free HBS gave the same results (Figure 4.19), 
suggesting that cholinergic signals mediated Ca2+ mobilisation from intracellular acidic stores, 
without the requirement for extracellular Ca2+. The release of Ca2+ from acidic lysosomes 
seem to be the key trigger for the subsequent CICR response amplified by the ER store. Hence, 
NAADP is the key 2nd messenger in mobilising lysosomal Ca2+ stores upon M3AchR activation.  
Diltiazem (DZM), an L-type Ca2+ channel blocker that has been shown previously to also block 
NAADP receptors/TPCs (Zhang, et al., 2007). Human colonic crypts were treated with DZM 
(100µM) for 1 hour prior to re-administration of Cch (10µM) in the presence of the inhibitor 
(Figure 4.18C). The Cch-induced Ca2+ response was reduced by 79% (0.209 ± 0.028, N=4 
subjects, n= 13 crypts, paired t-test p< 0.01, Figure 4.20 bottom panel). Thus, Cch stimulated 
Ca2+ release from lysosomal stores by NAADP via the TPCs. Since NAADP is synthesised by 
CD38, these results further suggest that CD38 is a requirement for the coupling of MAchR 
activation to NAADP-mediated Ca2+ mobilisation from lysosomal stores in the human colonic 
crypt.  
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Figure 4.18 Role of NAADP and TPCs on Cch-stimulated Ca2+ mobilisation 
Representative traces of the Ca2+ responses observed upon Cch stimulation in Fura-2 loaded 
human colonic crypts. A control response to 10µM of Cch was conducted in all experiments 
(first Ca2+ peak). Cch administration is indicated by the black bar. The amplitude of the control 
Ca2+ responses ranged from 0.6-1.3. After removal of the agonist and return of the 
intracellular [Ca2+] back to baseline, crypts were treated with different inhibitors for 1hr prior 
to subsequent re-administration of Cch (10µM) in the presence of the respective inhibitors 
(2nd black bar). (A) GPN (200µM), representative result of N= 4 subjects, n= 8 crypts; (B) Ned-
19 (200µM), representative result of N= 4 subjects, n= 15 crypts; (C) DZM (100µM), 
representative result of N= 4 subjects, n= 13 crypts. 
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Figure 4.19 Cholinergic stimulation of Ca2+ mobilisation from intracellular acidic organelles 
Cultured human colonic crypts were loaded with Fura-2/AM for 2 hours and then washed 
with Ca2+ free HBS.  (A) The crypt was incubated with Ca2+ free HBS for 40 mins prior to 
stimulation with Cch (10µM) in Ca2+ free HBS (black bar). (B) The crypt was incubated with 
Ned-19 (200µM) in Ca2+ free HBS for 40 mins prior to Cch (10µM) challenge with the presence 
of Ned-19 (200µM) in Ca2+ free HBS (black bar). Intracellular Ca2+ changes were imaged at 
ROIs placed along the crypt-axis (not shown). Ca2+ trace is a representative of 5 ROIs. The 
Ca2+ responses and the level of inhibition were similar to the experiments conducted with 
normal HBS (Figure 4.18B). Data are derived from N= 1 subject, n= 2 crypts. 
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Figure 4.20 Pharmacological inhibition of the lysosomal Ca2+ stores 
Schematic representation of the association between the acidic lysosomes and the mucus 
granules (Top panel). The amplitude of the Ca2+ responses in the control group and the 
inhibitor treated groups as displayed in the previous figures (Figure 4.17 and 4.18) were 
calculated. The mean amplitude of each experimental group was normalised to the control 
groups and displayed as mean ± SE (bottom panel). Significant differences were assessed 
using One-way ANOVA test, F (5, 53) = 495, p< 0.00001; followed by Bonferroni procedures 
and Tukey’s post hoc analysis. Significant difference between pairs of mean values (i.e 
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control vs. each treatment group) were indicated by asterisks (**) for p< 0.01. Significant 
differences (p< 0.01) were also observed in the following pairs: (i) Bafilomycin vs. 
Chloroquine, (ii) Bafilomycin vs. GPN, (iii) Bafilomycin vs. Ned-19, (iv) GPN vs. Ned-19, (v) 
Ned-19 vs. DZM. No significant difference was observed in the following pairs: (i) Chloroquine 
vs. GPN, (ii) Chloroquine vs. Ned-19, (iii) Chloroquine vs. DZM, (iv) Bafilomycin vs. DZM, (v) 
GPN vs. DZM. Schematic diagram is courtesy of Mark Williams. 
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4.3 The interplay of calcium and ROS signalling pathways 
Ca2+ and ROS are two important 2nd messengers that regulate a diverse range of cellular 
functions. Both Ca2+ and ROS signalling are intimately related, such that Ca2+ signals can be 
ROS dependent and vice versa (Yan, et al., 2006). In higher plants, systemic propagation of 
Ca2+ and ROS waves have been suggested to transmit long distance signals via cell-to-cell 
communication mechanisms (Gilroy, et al., 2014). ROS are generated by electron transfer 
reactions from molecular oxygen resulting in the formation of superoxide anion (O2-) and the 
subsequent conversion into hydrogen peroxide (H2O2) by superoxide dismutase (Yan, et al., 
2006; Görlach, et al., 2015). There are various cellular sources of ROS such as the 
mitochondria, receptor activated enzyme NADPH oxidases (nicotinamide adenine 
dinucleotide phosphate-oxidase, NOX), xanthine oxidases and cytochrome P450 (Yan, et al., 
2006). Our current understanding of the ROS and Ca2+ signalling cross talk has primarily been 
produced from studies focusing on mitochondrial derived ROS; the role of NOX-derived ROS 
in mediating intracellular Ca2+ signals remains poorly understood. It has been shown that 
NOX-derived ROS regulates Ca2+ mobilisation in smooth muscle cells in response to thrombin 
(Zimmerman, et al., 2011; Görlach, et al., 2015). In addition, increase in intracellular Ca2+ and 
NADPH oxidase activity has been suggested to be an upstream event of the apoptotic gene 
expression in pancreatic acinar cells in response to cerulein (Ji, H.Y. et al., 2006). Thus further 
support NOX-derived ROS and Ca2+ signalling cross talk mechanism. ROS can readily diffuse 
across the cell but they are relatively short-lived molecules, hence the subcellular localisation 
of NOX has been suggested to determine the downstream signalling cascade (Brown, et al., 
2009). The idea of targeting specific ROS signals to a precise subcellular compartment upon 
receptor activation has been suggested to be mediated via the association of NOX with lipid 
rafts, caveolae and endosomes (reviewed by Ushio-Fukai, 2006a and b).  
 
4.3.1 NADPH oxidase derived ROS 
The NOX family of enzymes are one of the major sources of ROS generation upon receptor 
mediated signal transduction in mammals. These enzymes have gained considerable interest 
in recent years as NOX-derived ROS has been shown to contribute to a variety of cellular 
functions as well as pathophysiological conditions; in particular it plays an essential role in 
modulating inflammation, cell proliferation and migration (Fu, et al., 2014). In mammals, 
NOX can be divided into three subfamilies: (1) NOX1-NOX4, (2) NOX5 and (3) Duox (Fu, et al., 
2014). Transmembrane NOX1-NOX4 isoforms form heterodimers with the p22phox subunit 
of NOX. The NOX1 isoform is highly expressed in the colon (Brown, et al., 2009) and the 
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assembly of the heterodimer (NOX1/p22phox) with the three cytosolic regulatory subunits 
(NOXO1, NOXA1 and a Rho GTPase RAC1) is necessary for its activation (Figure 4.21) (Yu, et 
al., 2006; Fu, et al., 2014; Görlach, et al., 2015). In particular, RAC1 activation has been shown 
to be the key trigger for NOX-dependent ROS generation (Cheng, et al., 2006). These 
transmembrane NOX enzymes have rapid kinetics of activation and inactivation in response 
to receptor activation for the generation of ROS (Yan, et al., 2006).  
Both PA and DAG have previously been shown to be required for optimal activation of NOX 
in a cell free system (Palicz, et al., 2001). Other studies have also suggested the 
phosphorylation of cytosolic subunits of NOX2 by PKC before they translocate to the plasma 
membrane and form a complex with NOX2/p22phox (Görlach, et al., 2015), hence suggesting 
a role of PKC in NOX activation. Moreover, by using confocal microscopy, flow cytometry and 
membrane protein biotinylation assays, Xu and colleagues demonstrated that RAC1-
dependent NOX-derived ROS mediates CD38 internalisation in coronary arterial myocytes 
(Xu, et al., 2013). All these findings suggest that NOX signalling pathway maybe downstream 
of M3AchR activation in human colonic crypts. 
Signalling molecules including GPCR, PKC and NOX have been identified in caveolae and lipid 
rafts (plasma membrane micro-domains). By using immunofluorescence microscopy and 
biochemical fractionation, a previous study demonstrated the recruitment of NOX2 and the 
cytosolic subunits p47phox and RAC1 of NOX into lipid rafts upon Fas ligand stimulation of 
endothelial cells (Ushio-Fukai, 2006a and b). This recruitment facilitates the formation of the 
NOX complex and the subsequent increase of ROS production in endothelial cells. In addition, 
NOX has also been identified in endosomes: previous work by Li and colleagues 
demonstrated endocytosis of the IL1R complex upon activation which subsequently recruits 
RAC1 and NOX2 into the endosomal compartment (Li, et al., 2006). The recruitment of RAC1 
into the endosomes is required for NOX2 translocation from the plasma membrane to the 
endosomal compartment. These endosomes then become the platform or source of NOX-
mediated ROS (Li, et al., 2006; Ushio-Fukai, 2006a and b). Thus, it is feasible that M3AchR 
activation promotes localised ROS production at a specific subcellular compartment within a 
cell that is achieved by the recruitment and translocation of the NOX and RAC subunits to 
the endosomes  
Currently, peptidic inhibitors specifically targeting NOX1 have not yet been developed. Due 
to this limitation, small molecule inhibitors such as Diphenyleneiodonium (DPI) and apocynin 
have been used historically as NOX inhibitors, yet they lack specificity (Cifuentes-Pagano, et 
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al., 2012). The difficulty in developing isoform-specific NOX inhibitors is that the different 
NOX isoforms are highly homologous. Despite these limitations, the currently available NOX 
inhibitors hold potential as pharmacological tools to dissect the role of NOX enzymes but 
their clinical potential is yet to be identified.  
Information regarding the subcellular localisation of NOX1 is limited. However, a weak 
cytosolic and a strong nuclear immuno-labelling of NOX1 has been reported in keratinocytes; 
ER-proximal localisation has also been reported in vascular smooth muscle cells (Bedard, et 
al., 2007). In this study, the expression and localisation of the NOX signalling subunits NOX1 
and RAC1 were investigated in the human colonic crypt model. Attempts have also been 
made to dissect the role of NOX-derived ROS in mobilising intracellular Ca2+ upon M3AchR 
activation. 
 
 
Figure 4.21 NOX1 and its regulatory subunits 
NOX family enzymes generate ROS in response to a wide range of stimuli. NOX1 is the major 
isoform expressed in the colon. NOX1 uses NADPH as an electron donor to generate 
superoxide (O2-) from molecular oxygen. The NOX1 complex consists of the catalytic subunit 
NOX1 and the regulatory subunit p22phox, both are located in the membrane. The other 
regulatory subunits NOXO1, NOXA1 and the small GTPase Rac are normally located in the 
cytoplasm. Upon stimulation with agonists, the cytosolic subunits translocate to the 
membrane-bound complex leading to enzymatic activity. NOXO1 subunit of NOX is used to 
organize the enzyme assembly, while NOXA1 function to activate enzymatic activity. 
 (Figure from Sirker, et al., 2011) 
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4.3.2 Characterisation of NOX1 and RAC1 protein expression in the human colonic 
crypt 
The activation of NOX1 for the generation of ROS is a RAC1 dependent process (Cheng, et al., 
2006; Brandes, et al., 2014). The expression pattern of RAC1 proteins – both inactive and 
active forms – in human colonic crypts is unclear. In this current study, the protein expression 
of total RAC1, NOX1 and active RAC1-GTP were identified and confirmed in human colonic 
crypts. In order to investigate the effect of Cch on total RAC1 and NOX1 recruitment and 
translocation in colonic crypt epithelial cells, crypts were either stimulated with Cch (10µM) 
for 1 min or not (Figure 4.22). Under resting (unstimulated) conditions, total RAC1 was 
detected at the basal pole of the crypt, and in the cytoplasm of non-goblet cells. In goblet 
cells, total RAC1 was mainly detected at the basal pole of cells. After 1 min of Cch stimulation, 
the immune localisation of total RAC1 was increased both at the basal pole and in the 
cytoplasm of colonocytes, while in goblet cells the expression of total RAC1 seems to appear 
near the nuclei and at the lateral membrane towards the apical pole of cell in 2D view (Figure 
4.22A). Compared to total RAC1, NOX1 expression is relatively greater under resting 
conditions. NOX1 is expressed at the basal pole of the crypt and also in the cytoplasm of non-
goblet cells. In goblet cells, NOX1 was mainly detected near the ER area under the nuclei in 
the 2D view. After 1 min of Cch stimulation, the expression of NOX1 decreased at both the 
basal pole and in the cytoplasm of the crypt (Figure 4.22B). These results demonstrate the 
expression of both total RAC1 and NOX1 proteins in human colonic crypts. 
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Figure 4.22 Expression patterns of total RAC1 and NOX1 proteins in human colonic crypts 
Cultured human colonic crypts were separated into control and Cch treatment groups. Crypts 
were stimulated with Cch (10 µM) for 1 min. Both groups were fixed and stained with anti-
total RAC1 (green) and anti-NOX1 (pink) antibodies; cell nuclei were stained with Hoechst 
(blue). White dotted lines show the boundary of the crypt lumen. Representative images 
were taken with a Zeiss Meta 510 confocal microscope using a x63 objective. (A) Composite 
image of total RAC1 (green) and DNA (blue). (B) Composite image of NOX1 (pink) and DNA 
(blue).  
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As discussed in previous sections 4.2.3 and 4.2.4, Cch-stimulated Ca2+ mobilisation from 
acidic organelles is mediated by the activation of CD38 and possibly the RAC1-dependent 
NOX signalling pathways. In order to demonstrate the correlation between the two pathways, 
the expression of both CD38 and total RAC1 proteins was investigated. Both CD38 and total 
RAC1 expression was detected at the basal pole of crypt cells and in the cytoplasm of non-
goblet cells (Figure 4.23 A and B). In goblet cells, both CD38 and total RAC1 were expressed 
near the ER area below the nucleus and also below the lateral membrane towards the apical 
pole of the cell in 2D view. Some level of colocalisation of CD38 and total RAC1 was also 
observed at the basal pole and in the cytoplasm of crypt epithelial cells (Figure 4.23C). These 
results demonstrate the association between total RAC1 and CD38 proteins in human colonic 
crypts. 
 
Figure 4.23 Localisation of CD38 and total RAC1 in human colonic crypts. 
Cultured human colonic crypts were fixed and stained with anti-CD38 (green), anti-total 
RAC1 (pink) and anti-Ecad (red) antibodies; cell nuclei were stained with Hoechst (blue). 
Images were taken with a Zeiss Meta 510 confocal microscope using a x63 objective. Z stack 
confocal images were then reconstructed into 3D images using the Volocity software. White 
dotted lines show the boundary of the crypt lumen. (A) Composite image of CD38 (green), 
Ecad (red) and DNA (blue); (B) Composite image of Total RAC1 (pink) and DNA (blue); (C) 
Composite image of CD38 (green), Total RAC1 (pink) and DNA (blue); (D) Composite image 
of all four channels : CD38 (green); Total RAC1 (pink); Ecad (red) and DNA (blue). Goblet cells 
are highlighted with white asterisk.  
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4.3.3 Role of Cch in active RAC1-GTP and NOX1 recruitment and trafficking in 
human colonic crypts 
RAC1 belongs to the Rho family of GTPases, and its downstream signalling is involved in a 
wide array of cellular responses including transcriptional dynamics, cell polarity and vesicular 
trafficking (Busetlo, et al., 2007). The conversion of inactive RAC1 to its active state is 
mediated by the guanine nucleotide exchange factors (GEFs) that catalyse the exchange of 
GDP with GTP. M3AchR activation has been shown previously to regulate RAC1 activation 
and translocation to cell junctions in Chinese Hamster Ovary (CHO) cells that were stably 
transfected with M3AchR (Ruiz-Velasco, et al., 2002). In this study, the role of Cch in the 
conversion and recruitment of active RAC1-GTP, and the trafficking of NOX1 in human 
colonic crypts were investigated. Cultured crypts were either unstimulated or stimulated 
with Cch (10µM) at different time points (30 sec, 1 min and 5 min). During resting 
(unstimulated) conditions, active RAC1-GTP was detected at the basal pole of the crypt, and 
also in the cytoplasm at the mid-cell region near the ER area of crypt epithelial cells; nuclear 
localisation was also observed in some colonocytes at the base of the crypt (Figure 4.24A i 
and ii). After Cch stimulation for 30 sec, the detection of active RAC1-GTP increased in the 
nuclei of some colonocytes, particularly at the crypt base (Figure 4.24A iii and iv), recruitment 
of active RAC1-GTP to the basal pole increased (by 94%, 1.94 ± 0.105, N= 4 subjects, n= 15 
crypts, paired t-test p< 0.01) and possibly translocation of active RAC1-GTP from the basal 
pole to the apical pole of cells were also observed (intensity at apical pole/ cytoplasmic space 
increased by 82%, 1.82 ± 0.06, N= 4 subjects, n= 15 crypts, paired t-test p< 0.01, Figure 4.25A). 
After 1 min of Cch stimulation, the presence of active RAC1-GTP remained high at the basal 
pole, in particular in the nuclei of most colonocytes at the crypt base, while the amount in 
the cytoplasm was reduced in comparison to Cch 30 sec (0.98 ± 0.03, N= 3 subjects, n= 12 
crypts, paired t-test p< 0.01, Figures 4.24A v and vi and 4.25A). With 5 min of Cch stimulation, 
the amount of active RAC1-GTP at the basal pole and nuclei returned to resting levels (1.005 
± 0.17, N= 4 subjects, n= 18 crypts) as compared to the unstimulated control, while the 
intensity in the cytoplasm slightly increased as compared to Cch 1 min (not significant, 1.19 
± 0.15, N= 4 subjects, n= 18 crypts, p= 0.28, Figures 4.24A vii and viii and 4.25A). Thus these 
results demonstrate the expression and localisation of active RAC1-GTP in human colonic 
crypts upon Cch stimulation; Cch not only increased the conversion of RAC1 to its active form, 
but it also seems to mediate the trafficking of active RAC1 in the cytosol of crypt epithelial 
cells.  
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Similar to active RAC1, the recruitment of NOX1 in colonic crypt epithelial cells was also 
observed upon Cch stimulation. Under resting (unstimulated) conditions, NOX1 protein was 
detected at the basal pole and in the cytosol of the crypt epithelial cells (Figure 4.24B, i and 
ii). Upon Cch stimulation for 30 sec, the intensity of NOX1 staining at the basal pole of crypt 
(1.8 ± 0.5) and in the cytosol of colonocytes (1.45 ± 0.23) slightly increased in comparison to 
the control group (not significant, p= 0.22, Figure 4.24B iii and iv and Figure 4.25B). After 1 
min of Cch stimulation, both basal pole (1.3 ± 0.3) and cytoplasmic (0.98 ± 0.1) detection of 
NOX1 were similar to unstimulated condition (Figures 4.24B v and vi and 4.25B). With 5 min 
of Cch stimulation, NOX1 staining at both basal pole (0.9 ± 0.1) and cytoplasm (1.1 ± 0.2) 
remained similar to unstimulated condition and Cch 1 min treatment (Figure 4.24B vii and 
viii and 4.25B). These results suggest that there are some levels of co-regulation between 
active RAC1-GTP and NOX1 recruitment in the human colonic epithelium, in particular active 
RAC1-GTP trafficking to NOX complex upon Cch stimulation. Further experiments are 
required to confirm these findings and the mechanism of action. 
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Figure 4.24A Expression patterns of active RAC1-GTP upon Cch stimulation in human 
colonic crypts 
Cultured human colonic crypts were separated into control and Cch treatment groups. Crypts 
were stimulated with Cch (10 µM) for 30 sec, 1 min or 5 min. (A) Both treatment groups were 
fixed and stained with anti-active RAC1-GTP (green) antibody, cell nuclei were stained with 
Hoechst (blue). Dotted lines show the boundary of the crypt lumen. Representative images 
were taken with a Zeiss Meta 510 confocal microscope using a x63 objective. Composite 
images of active RAC1-GTP (green) and DNA (blue) (i-viii). Control group (i and ii); Cch 30 sec 
(iii and iv); Cch 1 min (v and vi); Cch 5 min (vii and viii).  
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Figure 4.24B Expression patterns of NOX1 upon Cch stimulation in human colonic crypts 
Cultured human colonic crypts were separated into control and Cch treatment groups. Crypts 
were stimulated with Cch (10 µM) for 30 sec, 1 min or 5 min. (B) Both groups were fixed and 
stained with anti-NOX1 (pink) antibody, cell nuclei were stained with Hoechst (blue). Dotted 
lines show the boundary of the crypt lumen. Representative images were taken with a Zeiss 
Meta 510 confocal microscope using a x63 objective. Composite images of NOX1 (pink) and 
DNA (blue) (i-viii). Control group (i and ii); Cch 30 sec (iii and iv); Cch 1 min (v and vi); Cch 5 
min (vii and viii).  
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Figure 4.25 Intracellular trafficking of active RAC1-GTP and NOX1 upon Cch stimulation in 
human colonic crypts 
Cultured human colonic crypts were separated into control and Cch treatment groups. Crypts 
were stimulated with Cch (10 µM) for 30 sec, 1 min or 5 min;  both groups were then fixed 
and stained with anti-active RAC1-GTP (green) and anti-NOX1 (pink) antibodies, cell nuclei 
were stained with Hoechst (blue) (Figures 4.24A and B). The active RAC1-GTP (A) and NOX1 
(B) intensities at the basal pole and cytoplasmic space of the crypt were quantified by ImageJ 
software. Mean intensities of both regions were calculated and normalised to the control 
group, and displayed as mean ± SE. Significant differences were assessed using One-way 
ANOVA test, [F (3, 11) = 11.1, p= 0.001] for basal active RAC1-GTP and [F (3, 11)= 21.1, p= 
0.00007] for cytoplasmic active RAC1-GTP; followed by Bonferroni procedures and Tukey’s 
post hoc analysis. Significant difference between pairs of mean values (ie. Cch 30 sec vs. each 
of the other group) were indicated by asterisks (**) for p< 0.01. No significant difference 
were observed between other pairs including (i) control vs. Cch 1 min, (ii) control vs. Cch 5 
min, and (iii) Cch 1 min vs. Cch 5 min for both basal and cytoplasmic active RAC1-GTP. No 
significant difference were observed for both basal and cytoplasmic NOX1 upon Cch 
stimulation. Results were representative of N= 4 subjects, n≥ 11 crypts in each group. 
 172 
 
4.3.4 Correlation of RAC1/NOX1 dependent ROS production and calcium signal 
generation at apical pole of crypt epithelial cells 
Cross talk between ROS and Ca2+ signalling pathways has been shown to occur both in the 
plasma membrane and the cytosol (Yan, et al., 2006). In the human colonic epithelium, the 
role of RAC1/NOX1 dependent ROS production in mediating intracellular Ca2+ mobilisation 
or vice versa is unclear. In order to establish a correlation between ROS and Ca2+ signalling, 
the time course of RAC1/NOX1 recruitment or translocation to the apical pole of cells was 
compared to the latency (from the point of stimulation to the peak of response) of the Cch-
induced Ca2+ signals. About 30 sec after Cch administration, there was an increase in active 
RAC1-GTP and NOX1 proteins at the basal pole of the crypt, and also in the cytoplasm 
towards the apical pole of the crypt (Figure 4.26A). The formation of RAC1/NOX1 complexes 
presumably generates ROS in the cytosol in close proximity to the acidic lysosomal Ca2+ stores. 
Coincidentally, the average latency of Cch-induced Ca2+ signals calculated from 15 human 
subjects is about 46 sec (Figure 4.26B). Hence, it is feasible that ROS acts as the second 
messenger that transfers the activation signals from the basal pole to the Ca2+ response at 
the apical pole of crypt cells. Due to the technical difficulties, it was unable to show the 
interactions/ events for less than 30 sec. The role of ROS/ Ca2+ signalling cross talk in the 
human colonic epithelium was then confirmed by pharmacological inhibitors (see section 
4.3.5). As mentioned in section 4.2, M3AchR activation promotes the conversion of DAG into 
PA, while PA has been shown to stimulate NADPH oxidase activity (McPhail, et al., 1995; 
Zhang, Y. et al., 2009). The role of the PA pathway in NOX1 activation (subunit translocation) 
in human colonic crypts was briefly investigated. Crypt samples were treated with R59-022 
(10µM) for 1 hour in order to block the conversion of DAG into PA. Inhibition of PA formation 
reduced the recruitment of active RAC1-GTP to the basal pole of the crypt as compared to 
the control, suggesting a role of the PA pathway in stimulating NOX1 activity in the human 
colonic epithelium upon Cch stimulation (data not shown). No obvious differences were 
observed in cytosolic RAC1-GTP. The initial recruitment of active RAC1-GTP to the basal 
membrane/pole of the crypt might be an important step for the subsequent recruitment or 
translocation of the active RAC1-GTP to the apical pole of crypt cells. In addition, no obvious 
difference were observed in NOX1 expression after treatment with R59-022 (data not 
shown).  
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Figure 4.26 Correlation between active RAC1-GTP & NOX1 recruitment and Ca2+ signal 
generation upon Cch stimulation 
Crypts were stimulated with Cch (10 µM) for 30 sec. (A) Crypts were then fixed and stained 
with anti-active RAC1-GTP (green) and anti-NOX1 (pink) antibodies, cell nuclei were stained 
with Hoechst (blue). Representative images were taken with a Zeiss Meta 510 confocal 
microscope using a x63 objective (Figures 4.24A (iv) & 4.24B (iv)).(a) Composite image of 
active RAC1-GTP (green) and DNA (blue); red dotted lines show the boundary of the crypt 
lumen and also the boundaries of each goblet cell. Goblet cells are highlighted with red 
asterisks. (b) Composite image of NOX1 (pink) and DNA (blue); white dotted lines show the 
boundary of the crypt lumen and also the boundaries of each goblet cell. Goblet cells are 
highlighted with white asterisks. (c) Composite image of all three channels: active RAC1-GTP 
(green), NOX1 (pink) and DNA (blue); white dotted lines show the boundary of the crypt 
lumen and also the boundaries of each goblet cell. Goblet cells are highlighted with red 
asterisks. (B) Mean latency of Cch stimulated Ca2+ responses in human colonic crypts (5-7 
crypts per set of experiment) from 15 subjects. Mean response time is 46 sec.  
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4.3.5 Role of NOX1/RAC1 in Cch-induced calcium signal generation 
NOX family enzymes are one of the major sources of ROS generation in mammals (Brandes, 
et al., 2014). The NOX1 isoform is dominantly expressed in the colon (Szanto, et al., 2005), 
however, the impact of NOX1-derived ROS on colonic physiology and M3AchR activation 
mediated Ca2+ mobilisation remains poorly understood. Due to the limitation and 
unavailability of peptide-based or other specific NOX1 inhibitors, small molecule inhibitors 
that lack specificity were used to investigate the role of NOX1-derived ROS in Cch-induced 
Ca2+ signal generation (Figure 4.28 top panel). Human colonic crypts were treated with a 
potent NOX inhibitor DPI (1µM) for 1 hr prior to re-stimulation with Cch (10µM) in the 
presence of the inhibitor (Figure 4.27A). DPI (1µM) significantly reduced the Cch-induced 
Ca2+ signals by 66% as compared to the control (0.34 ± 0.06, N= 2 subjects, n=6 crypts, paired 
t-test p= 0.0005, Figure 4.28 bottom panel). To test whether there is a dose dependent 
inhibition, human colonic crypts were treated in the same fashion with DPI (5µM) (Figure 
4.27B). 5µM of DPI significantly blocked the Cch-induced Ca2+ signals by 94% (0.059 ± 0.02, 
N= 1 subject, n=2 crypts, paired t-test p= 0.016, Figure 4.28 bottom panel). However, further 
statistical analysis shows no significant difference between DPI (1µM) and DPI (5µM) (Figure 
4.28 bottom panel). These data suggest NOX1-derived ROS contributes to the Cch-induced 
Ca2+ response. However, DPI has also been shown to block mitochondrial and other sources 
of ROS (Li, et al., 1998; Brandes, et al., 2014), therefore the role of NOX1-derived ROS was 
further verified by other inhibitors. Apocynin is a widely used NOX inhibitor; previous work 
in the vascular system has suggested this compound acts as an antioxidant that interferes 
with peroxides, but not superoxide (Heumϋller, et al., 2008). To test the effect of this 
compound in our model system, human colonic crypts were treated with apocynin (100µM) 
for 1 hr prior to re-stimulation with Cch (10µM) + apocynin (Figure 4.27C). The Cch-induced 
Ca2+ signal was blocked by 49% (0.506 ± 0.05, N= 4 subjects, n= 12 crypts, paired t-test p< 
0.00001, Figure 4.28 bottom panel). These results suggest that ROS is involved in generating 
the Cch-induced Ca2+ waves, yet it is still unclear whether these ROS were derived from NOX1 
or other cellular sources.  
The role of NOX1-derived ROS was further investigated with a specific pan-NOX inhibitor 
VAS2870. Human colonic crypts were treated with VAS2870 (56µM) for 1 hr prior to re-
administration of Cch (10µM) in the presence of the inhibitor. The Cch-induced Ca2+ signal 
was blocked by 76% (0.24 ± 0.12, N= 3 subjects, n= 3 crypts, paired t-test p< 0.05, Figure 4.28 
bottom panel). The level of inhibition is comparable to the effect of DPI (1µM), consistent 
with the hypothesis that NOX1-derived ROS is involved in the Ca2+ signal generation upon 
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Cch stimulation. In addition, the role of RAC1 in NOX-dependent ROS generation was further 
explored using the RAC1 activation inhibitor NSC23766. Cultured human colonic crypts were 
treated with NSC23766 (250µM) for 1 hr prior to re-administration of Cch (10µM) with the 
presence of the inhibitor (Figure 4.27D). The RAC1 inhibitor significantly blocked the Cch-
induced Ca2+ signals by 95% (0.05 ± 0.02, N= 4 subjects, n= 10 crypts, paired t-test p< 0.00001) 
as compared to the control Ca2+ waves (Figure 4.28 bottom panel). This level of inhibition is 
comparable to the effect of DPI (5µM). Further statistical analysis shows no significant 
difference among treatments with NADPH oxidase inhibitors including DPI (5µM), VAS2870 
and NSC23766 (Figure 4.28 bottom panel). Thus, these combined results suggest the 
involvement of NOX1-dependent ROS in Cch-mediated Ca2+ signal generation. Having 
established this involvement, the next step was to look into the effects of these inhibitors on 
mucus secretion in the human colonic epithelium. 
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Figure 4.27 The role of NADPH oxidase inhibitors in Cch-induced Ca2+ signals in human 
colonic crypts 
Representative traces of the Ca2+ response upon Cch stimulation in Fura-2 loaded human 
colonic crypts. A control response to 10µM of Cch was conducted in all experiments (first 
Ca2+ peak). Cch administration is indicated by the black bar (duration). The amplitude of the 
control Ca2+ responses ranged from 0.7-1.1. After removal of the agonist and return of the 
intracellular [Ca2+] back to baseline, crypts were then treated with different inhibitors for 1 
hour prior to subsequent re-administration of Cch (10µM) in the presence of the respective 
inhibitors (2nd black bar). (A) DPI (1µM), representative result of N= 2 subjects, n= 6 crypts; 
(B) DPI (5µM), result derived from N= 1 subjects, n= 2 crypts; (C) Apocynin (100µM), 
representative result of N= 4 subject, n= 12 crypts; (D) RAC1 inhibitor (NSC23766, 250µM), 
representative result of N= 4 subjects, n= 10 crypts. 
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Figure 4.28 Pharmacological inhibition of NADPH oxidase 1 and RAC1 
Schematic representation of the MAchR signalling pathways (top panel). The amplitude of 
the Ca2+ responses in the control group and the inhibitor treated groups as displayed in the 
previous figure (Figure 4.27) were calculated. The mean amplitude of each experimental 
group was normalised to the control group, and displayed as mean ± SE (bottom panel). 
Significant differences were assessed by One-way ANOVA test, F (5, 38) = 91.3, p< 0.00001; 
followed by Bonferroni procedures and Tukey’s post hoc analysis. Significant difference 
between pairs of mean values (i.e control vs. each treatment group) were indicated by 
asterisks (**) for p< 0.01. Significant difference (p< 0.01) was also observed in the following 
pairs: (i) DPI (1µM) vs. NSC23766, (ii) DPI (5µM) vs. Apocynin, (iii) Apocynin vs. NSC23766. 
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No significant difference was observed in the following pairs: (i) DPI (1µM) vs. DPI (5µM), (ii) 
VAS2870 vs. NSC23766, (iii) Apocynin vs. VAS2870. (iv) DPI (1µM) vs. Apocynin, (v) DPI (1µM) 
vs. VAS2870, (vi) DPI (5µM) vs. VAS2870, (vii) DPI (5µM) vs. NSC23766. Schematic diagram is 
courtesy of Mark Williams. Ca2+ data for VAS2870 is courtesy of George Russam, a student in 
the lab who collaborated on this section. 
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4.4 Discussion 
Ach is one of the many neurotransmitters that is synthesised and released by cholinergic 
neurons. In general, activation of MAchRs by Ach or Cch has been shown to trigger 
downstream signalling pathways. Generation of the 2nd messenger IP3 downstream of this 
signalling has been well established, which then causes release of Ca2+ from the ER store via 
the IP3R. The initial increase in intracellular [Ca2+] can trigger the CICR response within the 
cell (Felder, 1995; Budd, et al., 1999). A link between MAchR activation and Ca2+ signal 
generation has been demonstrated previously in rat and human colonic crypts (Lindqvist, et 
al., 1998; Lindqvist, et al., 2002; Reynolds, et al., 2007). However, the underlying mechanism 
of the cholinergic mediated Ca2+ signal generation in the human colonic epithelium has never 
been demonstrated. In this part of the study, inhibitors of the MAchR signalling components 
and intracellular Ca2+ channels were used to delineate the key intracellular Ca2+ release 
channel and the Ca2+ store responsible for the generation of the Ca2+ signals upon Cch 
stimulation. In keeping with the topology and polarity of colonic crypt Ca2+ waves, and the 
expression characteristics of the colonic crypt Ca2+ signalling toolkit, the current data set 
indicate that mobilisation of acidic endolysosomal Ca2+ stores via a 
RAC1/NOX/CD38/NAADP/TPC pathway is instrumental in orchestrating human colonic crypt 
Ca2+ signals.  
 
4.4.1 Cholinergic mediated calcium signalling in the human colonic crypt 
Application of Ach to the human colonic crypt has repeatedly been shown extensively in our 
lab to mobilise Ca2+ in a wave-like manner via the activation of M3AchR. In order to avoid the 
hydrolysis of Ach by endogenous cholinesterases, Cch (a chemical analogue of Ach) was used 
for all of the experiments in this current study. Administration of 10µM Cch stimulates a Ca2+ 
response that is comparable to the Ach stimulated Ca2+ waves and dynamics as 
demonstrated from previous studies in our lab (Lindqvist, et al., 1998; Lindqvist, et al., 2002; 
Reynolds, et al., 2007). Specifically, these Ca2+ waves initiate at the apical pole of initiator 
cells located at the crypt base (Figure 4.2B (a)). It is currently unclear exactly which cell type 
(or types) make up the initiator cell population, however preliminary data from 
immunohistochemical labelling and Fluo-4 Ca2+ imaging suggests that the LGR5+ stem cells at 
the base of crypt might be Ca2+ initiator cells (Figure 4.2B (b)). As the Ca2+ signals were 
initiated at the apical pole of crypt cells, this observation also suggests that some source of 
Ca2+ localised at the apical pole provides the initiation signal, and these Ca2+ signals then 
spread to neighbouring cells along the crypt-axis via gap junctional proteins or via a paracrine 
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route. In this current study, immunohistochemical labelling demonstrated the presence of 
the ER at the basal pole, whereas the acidic lysosomes are localised at the apical pole of the 
polarised colonic epithelial cells (Chapter 3, Figure 3.15). Hence, these findings strongly 
implicate the acidic lysosomes as having a pivotal role in Cch-induced Ca2+ signal generation. 
However, it is still unclear how the signals transfer to the apical pole when the M3AchRs are 
expressed on the basal membrane of the crypt (Chapter 3, Figures 3.10 and 3.15). One of the 
possibilities is the generation of another 2nd messenger upon M3AchR activation that spreads 
the signals to the other side of the cell. As the Ca2+ signals peaked between 30-100 seconds 
after Cch administration, this 2nd messenger must form very quickly and should be strongly 
associated with the Ca2+ signalling (see below section 4.4.6). 
In this study, Cch-induced Ca2+ mobilisation from intracellular Ca2+ stores was also confirmed 
by conducting experiments in Ca2+-free HBS buffer (Figure 4.4). The initial phase of the Ca2+ 
response (from initiation to peak) was similar to the control in both concentration of Cch 
(10µM and 50µM) tested. When the ER store was depleted with thapsigargin (Tg, 1µM), the 
SERCA pump is no longer capable to refill the depleted ER store. The differences in the Ca2+ 
response observed in the presence or absence of extracellular Ca2+ suggests that the SOCE 
(including the CRAC channels, ORAI1 and STIM1 proteins) are functional and operational in 
human colonic epithelial cells (Figures 4.5A and 4.5B). In addition, a small Ca2+ response 
observed after ER store depletion in both the control and Ca2+-free conditions further 
suggests the M3AchR signalling might potentially induce Ca2+ release from additional 
intracellular Ca2+ stores (Figures 4.5A and 4.5B). Moreover, it also implies that global CICR 
Ca2+ signals are dependent on the ER store, as only minimal Ca2+ signals were observed when 
the ER store is depleted. These observations in human colonic epithelial cells are very similar 
to those in pancreatic acinar cells in a previous study which examined the requirement of 
acidic stores for the generation of local Ca2+ spikes upon IP3, cADPR or NAADP stimulation. 
Menteyne and colleagues demonstrated that both IP3- and NAADP-induced Ca2+ spikes were 
inhibited by bafilomycin A1 (150nM); while cADPR evoked Ca2+ spikes that were not inhibited 
by bafilomycin A1, which instead transformed hugely amplified the Ca2+ spike into a large 
response (Menteyne, et al., 2006). These results suggest that acidic stores are required for 
IP3- and NAADP-induced Ca2+ response in addition to the ER store in pancreatic acinar cells. 
Although acidic stores seem to play a role in cADPR-induced Ca2+ response but the level of 
regulation was unclear. Thus, Menteyne et al suggested Ca2+ spikes evoked by different 
agonists all require a different proportion of interactions between acidic lysosomal Ca2+ 
stores and the ER store (Menteyne, et al., 2006). In this thesis, based on the subcellular 
 182 
 
localisation of the lysosomes, the initiation signals at the apical pole of the crypt, and the 
minimal Ca2+ signals evoked by Cch after ER store depletion, we can infer a strong link 
between the acidic lysosomal Ca2+ stores and the ER store during the M3AchR signal 
transduction pathways. However, the exact mechanisms of these interactions are as yet 
unclear.  
 
4.4.2 Characterisation of the calcium signal generation downstream of M3AchR 
activation 
The M3AchR signalling pathways which mobilise the ER Ca2+ stores via IP3R have been well 
established for decades (Felder, 1995; Nahorski, et al., 1997). However, the role of M3AchR 
signals in mobilising Ca2+ from other intracellular organelles is less clear. A study by Aley and 
colleagues have previously demonstrated a transient increase in NAADP levels upon Cch 
stimulation, and these NAADP were shown to increase intracellular [Ca2+]. Inhibition of 
NAADP by Ned-19 suppressed intracellular Ca2+ mobilisation and blocked tracheal smooth 
muscle contraction (Aley, et al., 2013). These findings further support a role of MAchR 
activation in mobilising acidic lysosomal Ca2+ stores, however, the mechanism of regulation 
remains unclear. The most common MAchR signal transduction pathway operates via the 
activation of PLC (Budd, et al., 1999), however, simultaneous activation of PLC and PLD 
pathways have also been shown in most cells studied after receptor activation (Liscovitch, 
1991). In this thesis, PLC was the dominant pathway upon M3AchR activation in human 
colonic crypts as demonstrated by the effect of the PLC inhibitor U73122 that blocked the 
Cch-induced Ca2+ signals (by 87%, Figure 4.8A). Activation of PLC initiates the hydrolysis of 
PIP2 into IP3 and DAG (Felder, 1995; Budd, et al., 1999), at which the signals diverge. DAG 
can be converted to PA by DAG kinase (Kanoh, et al., 2002). Under resting (unstimulated) 
conditions, the activity of DAG kinase is low, allowing DAG to exert its functions (e.g. PKC 
activation). Upon receptor activation of the PIP2 pathway, the increased activity of DAG 
kinase drives the conversion of DAG to PA, terminating signalling downstream of DAG 
(Mérida, et al., 2008). Given these findings, we would expect the effectors downstream of 
M3AchR activation should be IP3 and PA. In order to investigate the contribution of DAG, 
human colonic crypts were treated with the DAG kinase inhibitor R59-022, which blocks the 
conversion of DAG into PA. However, the DAG/PKC pathway only contributed to 36% of the 
Ca2+ signals as compared to the control (Figure 4.8B), suggesting some DAG dependent PKC 
isoforms are involved in the Cch-induced Ca2+ signal generation. Expressed in other terms, 
this means that blockade of the PA pathway reduced Cch-induced Ca2+ signals by 64%. PA 
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has also been shown to activate some isoforms of PKC including -zeta (DAG independent) 
and PKC-alpha (DAG dependent) in the absence and presence of Ca2+ respectively (Limatola, 
et al., 1994). Thus, it suggests that some effectors (including PKC) or 2nd messengers 
downstream of the PA pathway might play an important role in the generation of Cch-
induced Ca2+ signals in the human colonic epithelium.  
The PKC family of proteins consists of 15 isoforms in humans (Mellor, et al., 1998). They are 
divided into three subfamilies: conventional, novel, and atypical, based on their requirement 
for DAG and Ca2+ for activation (Shearman, et al., 1989; Kikkawa, et al., 1989). PKC isoforms 
including PKC-alpha (α), -beta (β), -delta (δ), -epsilon (ε), -zeta (ζ) and –eta (η) have previously 
been reported to be expressed in the human colonic mucosa (Davidson, et al., 1994). PKC-α, 
-β, and –ζ were found to be expressed predominantly in the cytosolic fraction, while PKC-δ, 
-ε and –η were detected in the membrane-associated fraction. It is speculated that more 
than one PKC isoform might be activated by Cch stimulation, and not all PKC isoforms are 
activated by DAG. In this study, the role of PKCs in Ca2+ signal generation was determined by 
the selective PKC inhibitor sotrastaurin, that blocked the Cch-induced Ca2+ signals (by 45%) 
relative to control Ca2+ waves (Figure 4.8C), suggesting that both DAG-dependent and -
independent PKC isoforms are downstream of the M3AchR signal transduction which 
contribute to the Ca2+ signal generated upon Cch stimulation. As the expression of the 
different PKC isoforms was not measured in the current study, we are unable to determine 
which isoforms are involved in the signal transduction. Moreover, a previous study in the 
kidneys of diabetic rats demonstrated that some DAG-dependent PKC isoforms such as PKC-
δ and PKC-ε can be sensitively regulated by oxidative stress (Ha, et al., 2001), suggesting 
another level of PKC regulation by ROS in the absence of DAG activation.  
As discussed previously, blockade of the conversion of DAG into PA reduced Cch-induced 
Ca2+ signals by 64% (Figure 4.8B). In addition to activation of some PKC isoforms, PA has also 
been shown to regulate the activity of NADPH oxidases (NOXs) in plant cells (Zhang, Y. et al., 
2009), and also mediate the phosphorylation of the neutrophil NOX component p47-phox in 
a cell free system (cytosolic and membrane fractions from neutrophils) (Waite, et al., 1997). 
This suggests that M3AchR activation may lead to activation of the NOX pathway via PA. 
NOX1 is the predominant NOX isoform expressed in the colon (Szanto, et al., 2005), and is 
involved in the generation of superoxide anion (O2-). The superoxide is then converted to 
hydrogen peroxide (H2O2) by superoxide dismutase (Yan, et al., 2006; Bedard, et al., 2007; 
Görlach, et al., 2015). Logically, if NOX is indeed activated upon cholinergic stimulation, it 
follows that ROS production might as well, necessitating an investigation of the role of ROS 
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in the Ca2+ signal generation upon Cch stimulation (See later section 4.4.6). PA can also be 
generated by the activation of PLD. PLD catalyses the hydrolysis of phosphatidylcholine 
producing PA and choline (Felder, 1995; Liscovitch, et al., 2000). Choline is the precursor of 
Ach, hence M3AchR-linked PLD activation might be important for the generation of 
endogenous (non-neuronal) Ach in the colonic epithelium.  
 
4.4.3 Involvement of IP3R-gated and RYR-gated calcium release in generating Cch-
induced calcium signals 
IP3Rs are one of the types of Ca2+ release channel expressed on the ER membrane. They were 
also found to be expressed on the Golgi apparatus and secretory vesicles (Taylor, et al., 2009). 
In this current study, IP3Rs were indeed found in the ER area as well as in the area where the 
acidic lysosomes reside (Chapter 3, Figures 3.17A and B). However, it is still unclear whether 
IP3Rs play any role in releasing Ca2+ from other intracellular organelles. As discussed 
previously, if M3AchR activation of PIP2 promotes the conversion of DAG into PA by DAG 
kinase, the effectors downstream of this pathway should be IP3 and PA. The role of IP3/IP3R 
in Cch-induced Ca2+ signals in human colonic crypts was then investigated with a non-specific 
IP3R inhibitor (2-APB) and a specific IP3R inhibitor (Xes C). Surprisingly, both compounds 
were only observed to inhibit approximately 30% of the Ca2+ signals, in comparison to 
untreated controls (Figures 4.10A and B), suggesting that IP3/IP3R is not the key 2nd 
messenger/Ca2+ release channel. This observation is quite unusual as it has been well 
established that M3AchR activation generates IP3, then IP3 mobilises Ca2+ from the ER store 
and subsequently induces CICR responses. These findings prompted our speculation that the 
PA pathway or some other pathways upstream of IP3 might be the key trigger for Cch-
induced Ca2+ signals. As discussed previously, PA has been shown to activate the NOX 
pathway, and inhibition of PKC blocked the Cch-induced Ca2+ signals by 45%. The role of PA 
and the unknown (presumably NOX) pathways were further investigated with the application 
of both sotrastaurin (20µM) and 2-APB (50µM), the combination of which blocked the Ca2+ 
signal by 45% (Figure 4.10C). The lack of an additive effect of 2-APB suggests the role of IP3R 
in mediating Ca2+ release from the ER is probably downstream of PKC, and as R59-022 
inhibited the Cch-induced Ca2+ signals by 64% (Figure 4.8B), the implication is that that PKC 
is activated by PA and/or NOX pathways that are downstream of M3AchR signal transduction 
upon Cch stimulation.   
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RYRs are other key players involved in regulating ER Ca2+ release. In this current study, the 
role of RYRs in Cch-induced Ca2+ signals were investigated by the application of ryanodine 
(50µM), which blocked the Cch evoked Ca2+ signal by 36% (Figure 4.12A). This level of 
inhibition was very similar that seen during IP3R blockade (27% reduction) (Figure 4.10A), 
suggesting that neither IP3Rs nor RYRs are the key intracellular Ca2+ channels mediating the 
Cch-stimulated Ca2+ signals. The role of RYR was further confirmed with the application of 8-
Bromo-cADPR, which inhibits cADPR. 8-Bromo-cADPR only blocked the Ca2+ signals by 
approximately 9% (Figure 4.12B), these results suggest that M3AchR activation might not 
influence or regulate cADPR synthesis by CD38 in the human colonic epithelium; although 
coupling of MAchR to CD38 has been shown to regulate cADPR formation in neuronal cells 
(Higashida, et al., 1997b). An alternative explanation would be that cADPR did not get 
internalised and thus could not exert its function intracellularly via the RYR. As a previous 
study by Menteyne and colleagues demonstrated the lack of effect of bafilomycin on cADPR 
induced Ca2+ spikes (Menteyne, et al., 2006), it also implies that cADPR is not a part of the 
same pathway as NAADP.  
In this current study, the role of the ER during Cch stimulation and the concomitant role of 
IP3Rs and RYRs in mediating ER Ca2+ release were further confirmed with the simultaneous 
application of 2-APB and ryanodine. However, the level of inhibition with the presence of 
two inhibitors was only 40% compared to 36% with the presence of RYR inhibitors alone 
(Figure 4.12C). This observation implies that the RYRs are probably more sensitive in 
triggering the Ca2+ signal from the ER upon Cch stimulation than IP3Rs, although both RYRs 
and IP3Rs are involved in ER Ca2+ release to generate the CICR response upon M3AchR 
activation. 
 
4.4.4 CD38 regulation of Cch-induced calcium signals 
CD38 is an enzyme that is responsible for the synthesis of two Ca2+ mobilising agents: cADPR 
(agonist of RYRs) and NAADP (agonist of TPCs) (Lee, 1997). In pancreatic acinar cells, a 
previous study demonstrated the expression of CD38 on endosomes, which appeared to be 
in close proximity to the lysosomes (Cosker, et al., 2010). In this thesis, CD38 expression was 
also detected in the cytoplasmic space where the acidic lysosomes and mucus granules 
reside (Chapter 3, Figures 3.18 and 3.22). In addition, CD38 was occasionally detected in the 
nuclei of colonic epithelial cells in 2D view (Chapter 3, Figure 3.22A). These expression 
patterns of CD38 are in line with those observed in rat brains that they are in primer positions 
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to theoretically participate in many cellular events (Yamada, et al., 1997). However, it is still 
unclear which signals contribute to endosomal CD38 constantly being internalised into the 
cytosol in the absence of external stimulation. MAchR activation has been suggested to up-
regulate CD38 activity at the cell membrane (Higashida, et al., 1997b; Higashida, et al., 2001a 
and b). In this thesis, CD38 expression at the apical region and basal pole of the crypt was 
increased upon Cch (10µM) stimulation (Figure 4.2B (bii) and Figure 4.14 Cch), suggesting 
that M3AchR activation might enhance CD38 endocytosis and recycling.  
Both exocytosis and endocytosis are Ca2+ dependent events. CD38 internalisation upon 
agonist-receptor activation has been suggested to be critical for its activity (Zocchi, et al., 
1999). In this current study, MbetaC (10mM) significantly reduced the Cch-induced Ca2+ 
signals by approximately half (data not shown), and this level of inhibition is comparable to 
the inhibition of CD38 by nicotinamide (discussed below). Hence, there is a strong correlation 
between CD38 internalisation and the endocytic pathway in regulating Cch-induced Ca2+ 
signals. A previous study in platelets suggests that CD38 internalisation is mediated by PKC 
(Mushtaq, et al., 2011), while another study in diabetic kidney cells implicates NOX1 in the 
activation of PKC (Zhu, K. et al., 2015). Thus, it is feasible that RAC1/NOX1 activation in turn 
activates PKC, which could then mediate CD38 internalisation upon Cch stimulation. 
Coincidentally, a recent study has also suggested a role for NOX-derived ROS in the mediation 
of CD38 internalisation in coronary arterial myocytes (Xu, et al., 2013); all these findings 
suggest that the NOX signalling pathway is possibly downstream of the M3AchR activation 
and might possibly be involved in Cch-induced Ca2+ signal generation (see section 4.4.6). 
Current knowledge regarding CD38 is mainly focused on the role of cADPR, yet CD38 is also 
responsible for the synthesis of NAADP in the acidic environment; information is still lacking 
about its pathways and significance in vivo. As the catalytic domain of membranous CD38 is 
located on the extracellular side of the cell membrane (Tohgo, et al., 1994; Higashida, et al., 
2001a and b), two hypotheses have been proposed: the expression of membrane 
transporters (channels) or agonist mediated endocytosis that explain how the active site is 
rendered accessible to the intracellular substrate for the subsequent conversion into cADPR 
or NAADP. The first proposal is that the transporter connexin 43 hemichannel, which 
transfers intracellular NAD+ to extracellular spaces in a Ca2+ dependent manner, pumps the 
substrate from the cell making it accessible to the CD38 active site (Bruzzone, et al., 2001). 
The cADPR would then need to transfer back into the cell via CD38 or some nucleoside 
transporters to be able to elevate intracellular [Ca2+] (Guida, et al., 2002; Wei, et al., 2014). 
The increase in cytosolic [Ca2+] induces a negative feedback mechanism that was shown to 
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be regulated by PKC, which limits NAD+ transport out of the cell (Bruzzone, et al., 2001). 
Hence, it seems there are some intracellular regulatory mechanisms between CD38 and PKC 
pathways, both of which are activated upon MAchR activation. The second hypothesis, 
proposed by Zocchi and colleagues, is that CD38 undergoes vesicle-mediated internalisation 
upon activation (Zocchi, et al., 1999), for which supporting evidence has been demonstrated 
in B cells and human Namalwa cells (Burkitt’s lymphoma cell line) (Xu, et al., 2013). 
Internalisation of CD38 provides the active site exposure to the intracellular substrates (NAD+ 
and NADP+), which could be shuttled into the endocytic vesicles by transmembrane 
transporters for the subsequent conversion into cADPR (Zocchi, et al., 1999); CD38 can then 
mediate the efflux of cADPR from the endosomal vesicles to the cytoplasm (Bruzzone, et al., 
2001). Alternatively the conversion of NADP+ into NAADP by CD38 could potentially occur 
when endosomes fused with lysosomes. However, many questions still remain regarding the 
CD38/NAADP pathway in vivo. For instance, a previous study has suggested that CD38 is not 
required for NAADP production in the myometrial cells (Soares, et al., 2007). In addition, the 
mechanism of CD38 activation upon MAchR activation still remains unclear.  
In this current study, the cyclase activity of CD38 and its role in the Ca2+ signal generation 
upon Cch-stimulation in human colonic crypts was investigated with nicotinamide. Although 
no statistical significance were observed between the effects of 20mM and 50mM 
nicotinamide, significant level of inhibition of CD38 activity  was observed suggests that CD38 
plays a major role in Cch-mediated Ca2+ signal generation (average inhibition is 74%, Figure 
4.15). However, based on this data, it is unclear whether the Ca2+ signals are mediated by 
cADPR or NAADP. Based on the current available knowledge, nicotinamide acts to reverse 
the cyclase activity of CD38 by forcing the conversion of cADPR back to NAD+ (Aarhus, et al., 
1995; Graeff, et al., 2002). One logical explanation for the above findings would be that 
cADPR is the key 2nd messenger for the Cch-induced Ca2+ signals. However 8-Bromo-cADPR 
failed to suppress the Cch-induced Ca2+ signals, suggesting that cholinergic stimulation 
preferentially promotes the synthesis of NAADP as opposed to cADPR via CD38 
internalisation in the human colonic epithelium; while NAADP is well-known in mobilising 
acidic lysosomal Ca2+ stores. 
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4.4.5 Cch-induced calcium signals are highly dependent on lysosomal calcium 
stores 
As discussed in previous sections, M3AchR activation seems to mobilise Ca2+ from other 
intracellular Ca2+ stores that was observed after the depletion of the ER store. The acidic 
lysosomes have recently emerged as important Ca2+ stores involved in regulating various 
cellular and physiological functions (Morgan, et al., 2011). Ca2+ release from these endo-
lysosomes has been shown to be regulated by the 2nd messenger NAADP (Churchill, et al., 
2002). NAADP is synthesised by the ectoenzyme CD38, and inhibition of CD38 pathways also 
block the Cch-induced Ca2+ signals in human colonic crypts, thus prompting our investigations 
into the role of CD38/NAADP in Cch-induced Ca2+ signal generation.  
In this current study, the role of the acidic organelles in the Cch-induced Ca2+ mobilisation 
upon M3AchR activation were investigated in human colonic crypts with different inhibitors 
which target the acidic lysosomes in different ways (Figure 4.20 top panel). Pharmacological 
agents such as bafilomycin that block the refilling of the stores or chloroquine that disrupt 
the lysosomal pH, both of which significantly reduced the Cch-induced Ca2+ signal generation 
(Figure 4.17). In addition, induction of lysosomal osmotic burst by GPN also suppressed the 
Cch-induced Ca2+ signals by nearly 90% (Figure 4.20 bottom panel). Thus, these results 
further support the model wherein cholinergic activation of the M3AchR signalling pathway 
mobilises Ca2+ from the acidic lysosomal stores; this initial Ca2+ signal (trigger) from the acidic 
lysosomes further activates the RYRs and IP3Rs on the ER store to trigger the CICR response. 
Furthermore, these findings are also consistent with the initial observation that the Ca2+ 
signals initiate at the apical pole of the initiator cells where the acidic lysosomes reside 
(Figure 4.2A top panel and Figure 4.2B (a)).  
The role of NAADP in the generation of Cch-induced Ca2+ signal was further delineated in 
human colonic crypts through the application of the NAADP antagonist Ned-19. Ned-19 
drastically reduced the Cch-induced Ca2+ signals by 94% (Figure 4.18B and Figure 4.20 bottom 
panel). To further support these findings, DZM was employed to test the role of the NAADP 
receptors (TPCs). DZM (100µM) significantly reduced the Cch-induced Ca2+ signal by 79% 
(Figure 4.18C and Figure 4.20 bottom panel). Hence, from these data we can infer that 
NAADP is the key 2nd messenger responsible for mobilising lysosomal Ca2+ stores via TPC 
upon M3AchR activation. These findings are very similar to those observed in the sea urchin 
egg homogenate model (Churchill, et al., 2002), in HEK293 cells overexpressing TPC2 
(Calcraft, et al., 2009); and in pancreatic acinar cells (Gerasimenko, J.V. et al., 2015). As 
NAADP is synthesised by CD38, these results suggest that CD38 is a requirement for the 
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coupling of M3AchR activation to NAADP-mediated Ca2+ mobilisation from lysosomal stores 
in human colonic crypts. The current findings in the human colonic epithelium is in contrast 
to the findings in pancreatic acinar cells, as Menteyne and colleagues suggested that 
inhibition of the acidic stores failed to suppress the cADPR induced Ca2+ waves (Menteyne, 
et al., 2006). Data presented in the current study suggests cADPR might not play any role in 
the Cch-induced Ca2+ signal generation, while inhibition of the acidic stores almost 
completely suppressed the Cch-induced Ca2+ signals. In addition, Menteyne, et al also 
suggested the acidic stores are required for the IP3-induced Ca2+ waves, while inhibition of 
IP3R in the current study only showed about 30% of inhibition, suggests  IP3 mediated Ca2+ 
release is downstream of the Ca2+ release from acidic stores.   
 
4.4.6 The role of RAC1/NOX1/ROS in Cch-induced calcium signal generation 
The expression of NOX1 has been shown previously in human colonic epithelial cells: in 
particular, high levels of NOX1 mRNA were detected within the crypts and on the luminal 
surface (Szanto, et al., 2005). Another study also noted the NOX1 protein expression towards 
the apical pole of crypt colonocytes (Laurent, et al., 2008); while the expression of RAC1 in 
the human colonic epithelium is currently unclear. In this current study, both total RAC1 
(regulatory subunit) and NOX1 (catalytic subunit) of NOX were detected at the basal pole 
and in the cytoplasm towards the apical pole of crypt epithelial cells (Figures 4.22A and 4.22B 
control). This cytosolic expression pattern of NOX1 is in support from previous findings 
(Laurent, et al., 2008), and it seems there is a strong association between NOX1 and RAC1 
localisation within the colonic epithelium. In human pancreatic islet cells, NOX2 protein was 
found to be localised to the membranes of the insulin granules and endo-lysosomes (Li, N. 
et al., 2012). These expression patterns are very similar to the expression of NOX1 in our 
human colonic crypt culture model, in that NOX1 was localised in the area where the acidic 
lysosomes and mucus granules reside (Figure 4.22B control and Figure 4.24B, i and ii), hence, 
suggesting their role in ROS production between mid-cell region to apical pole of crypt cells. 
In addition, a study by Patel and colleagues have demonstrated the localisation of p22phox 
subunit of NOX in LC3+ autophagosomes. By using p22phox mutant mouse model, they 
demonstrated a greater level of mucin granules retention in mutant goblet cells as compared 
to the control, and they concluded that the LC3-associated NOX-derived ROS is critical for 
the regulation of mucus granule exocytosis (Patel, K.K. et al., 2013). Hence, these findings 
further support a role of NOX-derived ROS in mucus secretion; and the role of ROS in colonic 
goblet cell mucus secretion will be discussed in the next chapter.  
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The production of ROS is dependent on the assembly of the regulatory subunits in the cytosol 
with the catalytic subunit on the membrane. Upon agonist stimulation, the regulatory 
subunits (NOXO1, NOXA1 and RAC1) in the cytosol translocate to the membrane-bound 
complex (NOX1/p22phox) leading to the formation of ROS (Yu, et al., 2006; Fu, et al., 2014; 
Görlach, et al., 2015). In this current study, increased detection of total RAC1 protein was 
observed upon 1 min of Cch stimulation, both at the basal pole and in the cytoplasm towards 
the apical pole of crypt colonocytes (Figure 4.22A Cch). These results suggest that more total 
RAC1 proteins (in both inactive and active forms) were recruited to the basal pole of the 
crypt, and possibly translocate to other target sites in the cytosol upon M3AchR activation. 
In order to activate NOX1, inactive form of RAC1 is required to convert to its active state 
“RAC1-GTP”. In this current study, the active RAC1-GTP immune-labelling was detected in 
the human colonic epithelium during unstimulated condition, and the expression of active 
RAC1 matched with the total RAC1 patterns except for the nuclear localisation of active 
RAC1-GTP in some colonocytes at the crypt base (Figure 4.24A i and ii). GTPases such as RAC1 
contain a c-terminal polybasic region that resemble a nuclear localisation signal sequence; 
and the accumulation of RAC1 in the nucleus has been suggested to be enhanced by RAC1 
activation (Lanning, et al., 2003).  Data presented in the current study suggests there are 
some regulatory signals that target active RAC1-GTP to the nucleus in the absence of 
exogenous stimulation. However, it is currently unclear which signals mediate active RAC1 
translocation to the nucleus in the human colonic epithelium in resting condition. To further 
dissect the role of cholinergic signals in NOX-derived ROS generation, the kinetics of active 
RAC1-GTP and NOX1 trafficking upon Cch stimulation was investigated in the current study. 
With 30 seconds of Cch stimulation, intensive labelling of active RAC1-GTP was observed at 
the basal pole and the apical pole of crypt colonocytes (Figure 4.24A iii and iv and Figure 
4.25A). The expression of NOX1 at the basal pole of the crypt and in the cytosol of 
colonocytes was also slightly increased, but no significant difference were observed as 
compared to the control group (Figure 4.24B iii and iv and Figure 4.25B). This could possibly 
be due to the incapability of the antibody to detect NOX1 protein conformational change 
upon the formation of a complex with RAC1-GTP after 30s of Cch stimulation. In support of 
a previous study in CHO cells, activation of the MAchR has been shown to regulate RAC1 
activation and translocation to cell junctions (Ruiz-Velasco, et al., 2002). Data presented in 
this study suggests the activation, recruitment and possibly translocation of active RAC1-GTP 
to the basal pole and also target sites (NOX1 expression sites) in the cytosol of the crypt upon 
M3AchR activation. It is currently unclear why the intensities of both active RAC1-GTP and 
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NOX1 proteins increased shortly after M3AchR activation. Gene expression analyses and 
time-lapse experiments are required to confirm these findings. RAC1 dependent ROS has 
also been shown to increase cyclin D1 expression, which drives hyper-proliferation and 
induces DNA damage in human tumours and cell lines (Daugaard, et al., 2013). In this current 
study, elevation of active RAC1-GTP levels was detected in the nucleus of some colonocytes 
at the crypt base upon Cch stimulation (Figure 4.24A iii and iv). These results suggest 
activation of M3AchR seems to increase the expression or translocation of active RAC1-GTP 
into the nuclei of proliferative colonocytes at the base of the crypt; further suggest the role 
of cholinergic signalling in proliferation by mediating the transcription of certain genes 
(possibly cyclin D1) in the human colonic epithelium.  
Moreover, after 1 min of Cch stimulation, active RAC1-GTP levels remained high at the basal 
pole and in the nuclei of most colonocytes at the crypt base, and the expression in the 
cytoplasm was much reduced (Figure 4.24A v and vi); while NOX1 expression at both the 
basal pole and cytoplasm was also decreased that the level was similar to unstimulated 
condition (Figure 4.24B v and vi). These results suggest that both active RAC1-GTP and NOX1 
were utilised for the generation of ROS in the cytosol, however, the mechanism of regulation 
in the human colonic epithelium is unclear. Previous studies have suggested that the 
deactivation of RAC1 protein by ubiquitylation and turn over by proteolytic degradation is 
necessary upon RAC1-induced ROS formation (Kovacic, et al., 2001). In addition, deactivation 
of RAC1 has been suggested to be the disassembly signal for the NOX complex, before the 
NOX complex then undergoes dissociation or degradation via proteolysis when it is no longer 
required (Yin, et al., 2013). This feedback mechanism presumably controls ROS production 
in cells, preventing aberrant oxidation. In human aortic endothelial cells, DPI (a potent NOX 
inhibitor) has been shown to decrease proteolytic degradation of RAC1, hence, suggesting 
the role of DPI in blocking the interactions between RAC1-GTP and NOX1 (Kovacic, et al., 
2001). Furthermore, after 5 min of Cch stimulation, the intensities of active RAC1-GTP and 
NOX1 proteins returned to resting levels as compared to the control (Figure 4.24A vii and viii 
and Figure 4.24B vii and viii). These observations suggest a strong association between the 
catalytic (NOX1) and regulatory (RAC1) subunits of NOX in the cytosol following Cch 
stimulation. Thus, Cch seems to mediate the conversion of RAC1 to its active form, and the 
recruitment and translocation of active RAC1-GTP and NOX1 in the colonic crypt epithelial 
cells. It seems the recruitment patterns of active RAC1-GTP are dependent on the expression 
of NOX1 in the human colonic epithelium upon Cch stimulation.  
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In vascular endothelium, the increase in ROS production by NOX has been shown to regulate 
intracellular [Ca2+] in the vasculature via the activation of IP3R, blockade of SERCA pumps, 
and stimulation of extracellular Ca2+ influx (Touyz, 2005). The functional role of NOX1-derived 
ROS in intracellular Ca2+ mobilisation or vice versa in the human colonic epithelium is unclear. 
Data presented in this study suggests: (1) both active RAC1-GTP and NOX1 were recruited to 
the apical pole of crypt cells upon 30 sec of Cch stimulation, (2) active RAC1-GTP was 
recruited to the NOX1 expression sites in the cytosol upon 30 sec of Cch stimulation, while 
the average latency of Cch-induced Ca2+ signals was about 46 sec (Figure 4.26); implicating a 
role of NOX-derived ROS in mediating Ca2+ mobilisation in the human colonic epithelium 
upon Cch stimulation. This is in compliment to the cytosolic CD38 and RAC1 expression in 
colonic crypt epithelial cells (Figure 4.23 A and B). However, the current study was unable to 
demonstrate the early event (less than 30 sec) for NOX1/ RAC1-GTP recruitment upon Cch 
stimulation due to technical difficulties. The role of NOX1-derived ROS in Ca2+ signal 
generation were further investigated by a range of NOX and RAC1 inhibitors. Both DPI (non-
specific NOX inhibitor) and VAS2870 (pan-specific NOX inhibitor) significantly reduced the 
Cch-induced Ca2+ signals (Figure 4.28 bottom panel), and the level of inhibition were 
comparable to the inhibition of NAADP by Ned-19 (Figure 4.18B), suggesting NOX might be 
upstream of NAADP in the mediation of Ca2+ signal generation upon M3AchR activation. The 
role of NOX-derived ROS was further confirmed by the RAC1 activation inhibitor (NSC23766), 
and the level of inhibition was comparable to DPI treatment that further suggest the role of 
RAC1-dependent NOX1-derived ROS in Cch mediated Ca2+ mobilisation in the human colonic 
epithelium (Figure 4.28 bottom panel). However, due to the lack of specificity of both NOX1 
inhibitors, further experiments including the use of siRNA silencing of NOX1 is required to 
confirm the current findings. In addition, NSC23766 has recently reported to be a 
competitive antagonist of MAchRs (Levay, et al., 2013), hence, the use of another RAC1 
inhibitor such as W56 or siRNA silencing of RAC1 are required to confirm the role of RAC1 
upon M3AchR activation. Other experiments including the measurement of ROS levels 
before and after Cch stimulation; the use of co-immunoprecipitation and western blotting to 
identify the physical interactions of NOX1 and active RAC1-GTP before and after Cch 
stimulation; and the quantification of NOX1 and RAC1 mRNA expression by quantitative real 
time PCR before and after Cch stimulation, etc. can be done to further confirm the role of 
cholinergic signals in the regulation of NOX-derived ROS generation in the human colonic 
epithelium. 
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In summary, the initial kinetic observations of the Cch-induced Ca2+ signals imply a strong 
link between the acidic lysosomal Ca2+ stores and the ER Ca2+ store. This is supported by the 
Ca2+ initiation signals beginning at the apical pole of initiator cells, the apical localisation of 
the lysosomes, and the effects of thapsigargin that revealed the interactions of the two 
intracellular organelles upon M3AchR activation. Inhibition of PLC downstream of M3AchR 
abolished the Cch-induced Ca2+ signals, which suggests that the signal transduction occurs 
predominantly via the PLC pathway. Surprisingly, the second messenger IP3 generated upon 
PLC activation in the conventional pathway did not show any dominant role in the generation 
of the Ca2+ signals via the IP3R. Intriguingly, signalling downstream of PA and the CD38 
signalling pathways seem to play a major role in the Cch-induced Ca2+ signal generation. The 
PA pathway could possibly activate some PKC isoforms directly or via NOX1 and bypass the 
role of DAG. Inhibition of both IP3Rs and RYRs revealed that the role of the ER store is 
secondary to the initial signals but remained the major source of Ca2+ in response to Cch 
stimulation as demonstrated by using thapsigargin to deplete the ER store. In addition, RYRs 
might be more sensitive to the initiation Ca2+ signal than IP3R for the generation of CICR 
response upon Cch stimulation. Inhibition of the CD38 pathway by nicotinamide and 
blockade of endocytosis by MbetaC revealed the important role of CD38 in the Ca2+ signal 
generation upon Cch stimulation; and that CD38 could possibly be activated by PKC or the 
NOX signalling pathways. Pharmacological disruption of acidic lysosomal Ca2+ stores and 
inhibition of NAADP and TPCs blocked the Cch-induced Ca2+ signal generation, indicating 
lysosomal Ca2+ release mediated by NAADP is the key trigger for the subsequent CICR 
response generated by the ER Ca2+ release. Thus, CD38 is a requirement for the coupling of 
M3AchR activation to NAADP-mediated Ca2+ mobilisation from lysosomal stores via TPCs. 
NOX1-derived ROS has been suggested previously to mediate CD38 internalisation, while PA 
has been shown to activate NOX activity. Inhibition of the PA pathway seems to reduce the 
recruitment of active RAC1 to the basal pole of crypt that further suggests the NOX signalling 
pathway is downstream of M3AchR and PA. In addition, similar levels of inhibition of the Cch-
induced Ca2+ signals were observed between inhibition of ROS by apocynin and inhibition of 
PKC by sotrastaurin, suggesting that PKC might be downstream of PA/NOX1 signalling. 
Furthermore, inhibition of NOX1 and RAC1 significantly reduced the Cch-evoked Ca2+ signals, 
suggesting that RAC1, NOX1 and O2- play an important role in Cch-induced Ca2+ signal 
generation, possibly by direct activation of CD38 or indirectly via PKC.  
This results chapter details the experiments which were used to construct the proposed 
model for the mechanisms underlying Ca2+ signal generation in response to M3AchR 
 194 
 
activation (Figure 4.29). The next step would be looking at how these intracellular Ca2+ signals 
couple mucus granule exocytosis in human colonic crypt goblet cells. 
 
 
Figure 4.29 Proposed mechanisms of intracellular Ca2+ mobilisation upon M3AchR 
activation 
M3AchR activation transduces its signal via the PLC pathway; activation of PLC in turn 
initiates PIP2 hydrolysis to generate DAG and IP3. Activation of PIP2 enhances DAG kinase 
activity that promotes the conversion of DAG into PA. PA then activates NOX1 by recruiting 
RAC1 to the plasma membrane or to vesicular membranes in the cytosol expressing NOX1. 
The RAC1/NOX1/ROS system possibly mediates CD38 internalisation or directly activates the 
CD38 on endosomes; alternatively RAC1/NOX1/ROS might mediate CD38 activity indirectly 
via PKC activation. CD38 then generates NAADP that mediates Ca2+ mobilisation from acidic 
lysosomes via the TPCs. This initial Ca2+ release triggers the IP3Rs and RYRs on the ER 
membrane and induces the CICR response within the cell. 
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Chapter 5 Results: Cholinergic regulation of calcium excitation-mucus 
secretion coupling in human colonic crypts 
 
5.1 Introduction 
The mucus barrier plays an important role in GI defence. The colon is normally protected by 
two layers of mucus that prevent the bacteria which inhabit the lumen, as well any host-
derived digestive enzymes, from making contact with the epithelium (Johansson, et al., 2013). 
This mucus layer is continually being worn away by mechanical forces as the stool passes 
through. Thus, there is a requirement for the continuous replenishment of the mucus layers 
by goblet cells. Increased intestinal permeability due to a defective mucus barrier has been 
suggested as one of the contributing factors for IBD pathogenesis (Antoni, et al., 2014). The 
vast majority of current research into the pathophysiology of UC has mainly concentrated on 
the immunological aspects (Cader, et al., 2013; Geremia, et al., 2014). However, the role of 
defects in the production and maintenance of the mucus layer have not been extensively 
addressed. Anti-inflammatory therapy is currently the gold standard for treating IBD patients. 
Cholinergic signalling has been recently shown to mediate gut immune responses (Dhawan, 
et al., 2012), meaning that alternative therapies targeting cholinergic signalling pathways 
might feasibly be used to suppress abnormal inflammation in the GI tract (Pavlov, et al., 
2008).  
The link between cholinergic mediated MAchR activation and Ca2+ signal generation has been 
previously demonstrated in rat and human colonic crypts (Lindqvist, et al., 1998; Lindqvist, 
et al., 2002). These cholinergic stimulated Ca2+ signals have also been shown to regulate fluid 
secretion in the model of native human colonic epithelium (Reynolds, 2007). In addition, a 
close correlation between Ca2+ signalling and mucus secretion has been established in 
several model systems including animal GI tracts (Neutra, et al., 1982; Seidler, et al., 1989; 
Hamada, et al., 1997) and human colon cancer cell lines (Mitrovic, et al., 2013). Cholinergic 
stimulated mucus secretion was first demonstrated by Halm and Halm in isolated human 
colonic crypts (Halm and Halm, 2000). However, there are no specific reports targeting the 
underlying mechanism of cholinergic signal-mediated Ca2+ mobilisation in regulating mucus 
barrier function in the human colon published thus far.   
In the previous chapter, a proposed mechanism of intracellular Ca2+ mobilisation upon 
M3AchR activation was established. M3AchR activation was shown to transduce its signal via 
the PLC pathway; activation of PLC in turn initiates PIP2 hydrolysis to generate DAG and IP3. 
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Activation of PIP2 enhances DAG kinase activity which promotes the conversion of DAG into 
PA. PA probably activates NOX1 by recruiting RAC1 to the plasma membrane or to NOX1-
expressing vesicular membranes in the cytosol. The RAC1/NOX1/ROS system possibly 
mediates CD38 internalisation or directly activates CD38 on endosomes; alternatively 
RAC1/NOX1/ROS might mediate CD38 activity indirectly via PKC activation. CD38 then 
generates NAADP that mediates Ca2+ mobilisation from acidic lysosomes via the TPCs. This 
initial Ca2+ release from acidic lysosomes triggers the IP3Rs and RYRs on the ER membrane 
and induces the CICR response within the cell (Figure 4.29). In this chapter, the focus is to 
explore the coupling of the Ca2+ excitation to mucus secretion in the human colonic 
epithelium. In particular, the correlation between lysosomal Ca2+ release and mucus granule 
exocytosis will be established (Figure 5.1). Immunofluorescence labelling and confocal 
microscopy will be used to explore the specific role of the CD38/NAADP pathway and the 
potential upstream RAC1/ NOX1/ ROS pathway in the regulation of mucus granule exocytosis 
in human colonic crypt goblet cells.  
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Figure 5.1 Proposed role for CD38/NAADP mediated lysosomal Ca2+ release in coupling 
mucus granule exocytosis in human colonic crypt goblet cells 
Cch-stimulated lysosomal Ca2+ release has been shown to be regulated by the 
CD38/NAADP/TPC pathway. This initial Ca2+ spike further triggers the IP3R and RYR on the ER 
membrane and induces the CICR response. The increase in intracellular [Ca2+] is proposed to 
couple exocytosis of mucus granules (MG) in goblet cells. Schematic diagram is courtesy of 
Mark Williams. 
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5.2 Cch-stimulated mucus secretion is dependent on intracellular calcium 
mobilisation 
As discussed in the previous chapter, BAPTA-AM significantly reduced Cch-stimulated Ca2+ 
signals. The hypothesis that BAPTA-AM will decrease mucus secretion was then tested in 
human colonic crypts. Samples were separated into four groups: (1) untreated (control), (2) 
Cch treated, (3) BAPTA treated, and (4) treated with BAPTA and Cch. For Cch treated groups, 
colonic crypts were treated with Cch (10µM) for 30 min. For BAPTA treated groups, cultured 
crypts were pre-incubated with BAPTA-AM (66µM) for 1.5 hours or with BAPTA-AM (66µM) 
for 1 hour, subsequently treated with Cch (10µM) in the presence of BAPTA (66µM) for 
another 30 min. A significant depletion of intracellular MUC2 immuno-labelling, indicative of 
granule secretion, was observed in human colonic crypt goblet cells treated with 10µM Cch 
(0.49 ± 0.03), relative to untreated controls (1 ± 0, N= 4 subjects, ng≥ 181 goblet cells per 
group, paired t-test p< 0.01, Figures 5.2A and B). Pre-incubation with BAPTA-AM prevented 
Cch-stimulated mucus granule secretion, as evidenced by MUC2 retention in goblet cells at 
the crypt base, which displayed an approximate 106% increase (1.55 ± 0.19) compared to 
Cch alone (0.49 ± 0.03, N= 4 subjects, ng≥ 181 goblet cells per group, paired t-test p= 0.012, 
Figures 5.2A and B). Interestingly, there was a concomitant accumulation of immature MUC2 
proteins (as detected by a mouse monoclonal antibody) detected in the perinuclear ER 
region of goblet cells when pre-treated with BAPTA-AM (66µM) (data not shown). Thus, 
these results further confirmed that cholinergic mediated intracellular Ca2+ signals play an 
important role in mucus secretion in human colonic crypt goblet cells. 
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Figure 5.2 Effects of BAPTA-AM on colonic goblet cell mucus granules depletion 
Cultured human colonic crypts were separated into four treatment groups, control untreated, 
Cch or BAPTA single-treated, and dual-treated. Crypts in the Cch group were stimulated with 
Cch (10µM) for 30 min. For BAPTA-AM treated groups, crypts were either pre-incubated with 
BAPTA (66µM) alone for 1.5 hr, or with BAPTA (66µM) for 1 hr, then with BAPTA (66µM) + 
Cch (10µM) for another 30 min. Samples were fixed and labelled with anti-MUC2 (green) and 
anti-Ecad (red) antibodies, and visualised with Alexa-conjugated secondary antibodies; cell 
nuclei were stained with Hoechst (blue) (A). Representative images taken with a Zeiss Meta 
510 confocal microscope using a x63 objective. The amount of MUC2 mucin granule (i.e. 
immunofluorescence intensities) in goblet cells were measured from 3-5 slices of z-stack 
images using ImageJ software. Mean MUC2 intensities in goblet cells were calculated and 
normalised to the control group, and displayed as mean ± SE (B). Results were representative 
of N= 4 subjects, n≥ 13 crypts and ng≥ 181 goblet cells in each treatment group. Significance 
was assessed using a One-way ANOVA test, F (3, 54) = 12.8, p< 0.0001; followed by 
Bonferroni procedures and Tukey’s post hoc analysis. Significant difference as indicated by 
asterisks (**) for p< 0.01 was observed between pairs of mean values including (i) control vs. 
Cch, (ii) Cch vs. BAPTA, (iii) Cch vs. BAPTA + Cch, (iv) control vs. BAPTA + Cch. No significant 
difference was observed between the following pairs: (i) Control vs. BAPTA, (ii) BAPTA vs. 
BAPTA + Cch.  
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5.3 CD38 has an essential role in Cch-mediated calcium coupling mucus 
secretion in human colonic crypts 
As discussed in the previous chapter, nicotinamide (20mM) inhibits Cch-induced Ca2+ signal 
generation, suggesting an important role for CD38 upon M3AchR activation. The hypothesis 
that CD38 plays a role in Cch-mediated Ca2+ coupling mucus secretion was then tested; crypts 
were separated into four groups: (1) untreated (control), (2) Cch treated, (3) nicotinamide 
treated, and (4) treated with both nicotinamide and Cch. For the Cch treated group, colon 
crypts were stimulated with Cch (10µM) for 30 min. For nicotinamide treated groups, 
cultured crypts were pre-incubated with nicotinamide (20mM) for 2.5 hours or with 
nicotinamide (20mM) for 2 hours, then subsequently with Cch (10µM) in the presence of 
nicotinamide (20mM) for 30 min. Cch (10µM) induced significant levels of mucus depletion 
from colonic crypt goblet cells, an approximate 49% reduction (0.49 ± 0.03) of MUC2 
immunofluorescence intensity in goblet cells as compared to the control (1 ± 0, N= 4 subjects, 
ng≥ 95 goblet cells per group, paired t-test p< 0.01, Figures 5.3A and B). During constitutive 
basal secretion, nicotinamide (20mM) showed no obvious effect on the retention of mucus 
granules (1.02 ± 0.07, N= 4 subjects, ng≥ 95 goblet cells per group) as the average mucus 
content in goblet cells was similar to those in the control (Figure 5.3B). In the presence of 
Cch (10µM), nicotinamide (20mM) counteracted the effect of Cch-stimulated (accelerated) 
mucus secretion (1.16 ± 0.09, N= 4 subjects, ng≥ 95 goblet cells per group, paired t-test p< 
0.01) as compared to crypts treated only with 10µM Cch. Although mucus retention was 
more obvious in goblet cells at the base of the crypt (Figure 5.3A), the average mucus content 
(intensity) was similar to the control group (Figure 5.3B). These results confirm that Cch 
(10µM) induces or accelerates mucus granule exocytosis in human colonic crypt goblet cells, 
and this was counteracted by nicotinamide, an inhibitor of CD38 mediated Ca2+ mobilisation. 
This suggests mucus secretion in crypt goblet cells might be dependent on the CD38 pathway.  
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Figure 5.3 Effect of nicotinamide in Cch-mediated mucus secretion 
Cultured human colonic crypts were separated into four treatment groups, control untreated, 
Cch treated, nicotinamide treated, and nicotinamide plus Cch treated. Colonic crypts in the 
Cch group were stimulated with Cch (10µM) for 30 min. For the nicotinamide treated group, 
crypts were either pre-incubated with nicotinamide (20mM) alone for 2.5 hours, or with 
nicotinamide (20mM) for 2 hours, then with nicotinamide (20mM) + Cch (10µM) for another 
30 min. Samples were fixed and labelled with anti-MUC2 (green) and anti-Ecad (red) 
antibodies, and visualised with Alexa-conjugated secondary antibodies; cell nuclei were 
stained with Hoechst (blue) (A). Representative images were taken with a Zeiss Meta 510 
confocal microscope using a x63 objective. The MUC2 mucin content (intensities) in goblet 
cells was measured from 3-5 slices of z-stack images using ImageJ. Mean MUC2 intensities in 
goblet cells were calculated and normalised to the control group, and displayed as mean ± 
SE (B). Results were representative of N= 4 subjects, n≥ 9 crypts and ng≥ 95 goblet cells in 
each group. Significant differences were assessed using One-way ANOVA tests, F (3, 12) = 
23.31, p< 0.0001; followed by Bonferroni procedures and Tukey’s post hoc analysis. 
Significant difference as indicated by asterisks (**) for p< 0.01 was observed between pairs 
of mean values including (i) control vs. Cch, (ii) Cch vs. Nic, (iii) Cch vs. Nic + Cch. No significant 
difference was observed in the following pairs: (i) control vs. Nic, (ii) control vs. Nic + Cch, (iii) 
Nic vs. Nic + Cch.  
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5.4 Cholinergic stimulated calcium mobilisation from acidic lysosomal stores 
couple mucus granule exocytosis in human colonic crypt goblet cells 
Lysosomes are acidic organelles within a cell that are primarily expressed at the apical pole 
of the human colonic crypt (Chapter 3, Figures 3.15E and F). Use of the live tissue LysoTracker 
and fixed tissue LAMP1 antibody labelling reveals abundant expression of lysosomes in the 
mucus-granule storing region of goblet cells (Chapter 3, Figure 3.19A and Figure 5.4), which 
implies a potential role for these lysosomal Ca2+ stores in mucus granule exocytosis. Co-
localisation of mucus granules and acidic lysosomes were also observed at the apical/ 
cytosolic region of goblet cells (Figure 5.4D iii and iv). As discussed in the previous chapter, 
Ned-19 not only inhibits Ca2+ mobilisation from lysosomes upon Cch stimulation, it also 
fluorescently labels the NAADP receptors on lysosomal membranes (Figure 5.5). This is 
consistent with the fixed tissue labelling with TPCs antibodies (Chapter 3, Figure 3.18). 
 
 
Figure 5.4 Correlation of acidic lysosomes and mucus granules in colonic crypt goblet cells  
Human colonic crypts were labelled with LysoTracker (1µM), allowing the use of live cell 
imaging to reveal the expression and localisation of acidic lysosomes at the apical pole of 
crypt. Images were taken with a Zeiss Meta 510 confocal microscope using a x63 objective. 
(A) DIC image of a human colonic crypt; (B) LysoTracker labelling of the same crypt in (A). 
Images are representative of N= 3 subjects, n≥ 6 crypts. The expression of the lysosomes 
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were also detected by antibody labelling in fixed tissues. (C) Human colonic crypts were fixed 
and labelled with anti-LAMP1 (green), anti-Ecad (red) antibodies, cell nuclei were stained 
with Hoechst (blue). Image was taken with a Zeiss confocal microscope with a x63 objective. 
Representative image of N≥ 3 subjects, n≥ 10 crypts. (D) Enlarged images of human colonic 
epithelial cell layer stained with anti-MUC2 (green), anti-LAMP1 (red) and anti-Ecad (white) 
antibodies, cell nuclei were stained with Hoechst (blue). D(i) composite image of MUC2 
(green), Ecad (white) and cell nuclei (blue), D (ii) merged image of LAMP1 (red), Ecad (white) 
and cell nuclei (blue), D (iii) overlay image of MUC2 (green), LAMP1 (red) and cell nuclei (blue), 
D (iv) composite image of all 4 channels. Asterisks (*) indicate goblet cells in situ. D (iii) shows 
co-localisation of mucus granules and lysosomes in yellow. Images are representative of N≥ 
2 subjects, n≥ 6 crypts. 
 
 
Figure 5.5 Colocalisation of NAADP receptors with lysosomes in the human colonic crypt 
Human colonic crypts were loaded with LysoTracker (1µM) and Ned-19 (0.5mM) for 2 hours, 
live cell imaging revealed the colocalisation of NAADP receptor with lysosomes. Images were 
taken with the confocal microscope with a x63 objective. (A) Lysosomes labelled with 
LysoTracker (red); (B) NAADP receptors labelled with Ned-19 (blue); (C) merged image of 
LysoTracker (lysosomes, red) and Ned-19 (NAADP receptor, blue). Images are derived from 
N=1 subject, n=5 crypts. 
 
 
M3AchR activation mobilising Ca2+ from acidic lysosomes was discussed extensively in the 
previous chapter. This effect can be significantly blocked by the NAADP antagonist Ned-19 
or by pharmacological disruption of the lysosomal Ca2+ stores. Mucus granule exocytosis has 
been shown to be stimulated by Ach (Specian and Neutra, 1980). I then tested the hypothesis 
that Ned-19 blocks Cch-induced MUC2 mucin secretion in goblet cells; human colonic crypts 
were treated with Ned-19 (200µM) for 1.5 hours, or with Ned-19 (200µM) for 1 hour, then 
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with Cch (10µM) in the presence of the inhibitor for 30 min. Mucus secretion as 
demonstrated by reduced intensity of mucus staining relative to untreated control was 
observed in goblet cells upon Cch (10µM) stimulation (reduced by 48%, 0.52 ± 0.07, N= 4 
subjects, ng≥ 228 goblet cells, paired t-test p< 0.01, Figures 5.6A and B). The level of mucus 
retained in goblet cells increased when crypts were pretreated with Ned-19 (200µM) as 
compared to the control group (an approximate 41% increase, 1.41 ± 0.14, N= 4 subjects, 
ng≥ 228 goblet cells, paired t-test p= 0.059). Ned-19 also inhibited the Cch-stimulated mucus 
depletion in goblet cells relative to the control group (an approximate 74% increase, 1.74 ± 
0.09,  N= 4 subjects, ng≥ 228 goblet cells, paired t-test p< 0.01) or the Cch only treated group 
(an approximate 123% increase, 1.74 ± 0.09, N= 4 subjects, ng≥ 228 goblet cells, paired t-test 
p< 0.01, Figures 5.6A and B). As antagonising CD38 and NAADP binding to its receptor block 
the majority of the phenotype, we can infer that NAADP is the key 2nd messenger in 
mediating Ca2+ coupling mucus secretion in human colonic crypt goblet cells.  
In order to determine whether individual goblet cells can respond to the stimulus without a 
requirement for neighbouring signals, our lab is developing a single cell culture model, in 
which epithelial cells are isolated from human colonic crypts. Single epithelial cells were 
stimulated with Cch (10µM) for 30 min. The MUC2 content of goblet cells was then 
determined by antibody labelling (Figure 5.7A). Cch (10µM) significantly reduced the MUC2 
intensity in single goblet cells by 50% (0.48 ± 0.06, N= 3 subjects, ng= 11 goblet cells, paired 
t-test p< 0.05, Figure 5.7B), suggesting that goblet cells were capable of responding to 
cholinergic signals in coupling mucus secretion in the absence of Ca2+ signals generated from 
neighbouring cells. The effect of Ned-19 on single goblet cells was briefly investigated. 
Preliminary data show the retention of mucus in single goblet cells that were pre-treated 
with Ned-19 (200µM) in both constitutive basal and Cch-stimulated conditions as compared 
to the control (data not shown), suggesting single goblet cells are responsive to Ned-19 
treatment. Further experiments are required to confirm this finding.  
With the addition of these mucus data, the proposed model can be expanded. First, MAchR 
activation from cholinergic stimulation mediates Ca2+ mobilisation from the lysosomal Ca2+ 
stores at the apical pole of the initiator cells; this initial increase in Ca2+ waves will then 
spread towards the basal pole and further activate the RYR and IP3R on the ER membrane 
and induce the CICR response in starting cells, before further spreading to the neighbouring 
cells via gap junctions. The induction of global Ca2+ waves along the crypt-axis will 
subsequently couple mucus granule exocytosis in goblet cells.  
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Figure 5.6 Role of lysosomal Ca2+ stores on MUC2 mucin secretion in human colonic crypt 
Cultured human colonic crypts were separated into four treatment groups: control untreated 
crypts, singly treated with either Cch or Ned-19, or simultaneously treated with both. Colonic 
crypts in the Cch group were stimulated with Cch (10µM) for 30 min. For Ned-19 treated 
groups, crypts were either pre-incubated with Ned-19 (200µM) alone for 1.5 hour, or with 
Ned-19 (200µM) for 1 hour, then with Ned-19 (200µM) + Cch (10µM) for another 30 min. 
Samples were fixed and labelled with anti-MUC2 (green) and anti-Ecad (red) antibodies, cell 
nuclei were stained with Hoechst (blue) (A). Representative images taken with a confocal 
microscope using a x63 objective. The MUC2 intensities in goblet cells were measured from 
3-5 slices of z-stack images using ImageJ. Mean MUC2 intensities in goblet cells were 
calculated and normalised to the control group, and displayed as mean ± SE (B). Results were 
representative of N= 4 subjects, n≥ 13 crypts and ng≥ 228 goblet cells in each treatment 
group. Significance differences were assessed using One-way ANOVA tests, F (3, 49) = 18, p< 
0.0001; followed by Bonferroni procedures and Tukey’s post hoc analysis. Significant 
difference as indicated by asterisks (**) for p< 0.01 was observed between pairs of mean 
values including (i) control vs. Cch, (ii) Cch vs. Ned-19, (iii) Cch vs. Ned-19 + Cch, (iv) control 
vs. Ned-19 + Cch. No significant difference was observed between (i) control vs. Ned-19, (ii) 
Ned-19 vs. Ned-19 + Cch. 
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Figure 5.7 Goblet cell responsiveness to Cch stimulation in the absence of neighbouring 
signals 
Single human colonic crypt epithelial cells (including goblet cells) were stimulated with Cch 
(10µM) for 30 min. The cells were then fixed and labelled with anti-MUC2 (green) and anti-
LAMP1 (pink) antibodies, and cell nuclei were stained with Hoechst (blue). Enlarged images 
were taken with Zeiss LSM 510 Meta confocal microscope with a x63 objective. (A) Images 
are 3D reconstructed z-stack confocal images of single goblet cells, different channels were 
displayed separately with the respective treatment group. (B) MUC2 content (intensities) in 
single goblet cells were measured by Volocity 3D image analysis software. Mean MUC2 
intensities in goblet cells were calculated and normalised to the control group, and displayed 
as mean ± SE. Results were representative of N= 3 subjects, ng=11 goblet cells derived from 
3 subjects in each treatment group. Asterisks (*) denotes a significant difference compared 
to the control (paired t-test, p< 0.05). 
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5.5 Role of NOX1/RAC1/ROS in mucus granule exocytosis in human colonic 
crypts 
As CD38 is the enzyme responsible for the synthesis of NAADP, it serves an important 
intermediate role in the signal transduction pathway downstream of M3AchR activation and 
upstream of NAADP. The synthesis of the two 2nd messengers cADPR and NAADP requires 
the availability of the substrates NAD+ and NADP+ respectively in the cytosol for the 
enzymatic reaction to occur. Intriguingly, both substrates of CD38 are side products of 
NADPH oxidase (NOX) (Xu, et al., 2013), hence establishing a link between CD38 and NOX 
signalling pathways.  
Previous findings by Zocchi et al and Xu et al further support a role of NOX in regulating CD38 
activity, which therefore merits investigation of the effect of CD38 modulation on mucus 
secretion in goblet cells (Zocchi, et al., 1999; Xu, et al., 2013). In addition, ROS derived from 
NOX enzymes on LC3+ vacuoles has been suggested to regulate mucus granule accumulation 
in mouse colonic goblet cells; 60% of these LC3+ vacuoles were shown to be co-localised with 
the NOX subunit p22phox (Patel, et al., 2013). In this thesis, the expression and localisation 
of LC3+ autophagosomes in human colonic crypts were briefly investigated. LC3+ 
autophagosomes were primarily detected at the basal pole of the crypt, at mid cell region 
near the ER, and also in the cytosol towards the apical pole of crypt epithelial cells (Figure 
5.8A ii), while LAMP1+ lysosomes were primarily localised at the basal and apical poles. Both 
LC3 and LAMP1 are in close proximity with each other at the mid-cell region but no co-
localisation was observed (Figure 5.8A iii). In addition, NOX1 was detected in the cytosol at 
the apical pole of the crypt (Figure 5.8B i). Both NOX1 and LC3 are in close proximity with 
each other but no co-localisation was observed (Figure 5.8B iii). These results suggest the 
source of ROS is in close proximity to endosomal CD38 (Chapter 3, Figure 3.22) and the 
lysosomal Ca2+ stores at the apical pole of crypt cells.  
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Figure 5.8 The expression and localisation of LC3+ autophagosomes and NOX1 in human 
colonic crypt 
Human colonic crypts were fixed and stained with anti-LAMP1 (lysosomes, green) and anti-
LC3 (autophagosomes, pink) antibodies, cell nuclei were stained with Hoechst (blue) (A). (i) 
Overlay image of LAMP1 (green) and DNA (blue); (ii) overlay image of LC3 (pink) and DNA 
(blue); (iii) merged image of all three channels: LAMP1 (green); LC3 (pink) and DNA (blue). 
To identify the association of NOX1 with LC3+ vacuoles, colon crypts were fixed and labelled 
with anti-NOX1 (green) and anti-LC3 (pink) antibodies, cell nuclei were stained with Hoechst 
(blue) (B). (i) Overlay image of NOX1 (green) and DNA (blue); (ii) overlay image of LC3 (pink) 
and DNA (blue); (iii) merged image of all three channels: NOX1 (green), LC3 (pink) and DNA 
(blue). Images were taken with a Zeiss confocal microscope with a x63 objective. White 
dotted lines show the boundary of the crypt lumen. Asterisks (*) denote goblet cells in situ. 
Images were derived from N=1 subject, n=3 crypts. 
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The role of NOX1-derived ROS in mucus granule exocytosis or retention in goblet cells was 
further investigated through the application of NOX inhibitors. Cultured human colonic 
crypts were treated with DPI (2.5µM) for 2.5 hours, or with DPI (2.5µM) for 2 hour then with 
DPI (2.5µM) + Cch (10µM) for another 30 min (Figure 5.9). During constitutive basal secretion, 
DPI (2.5µM) caused goblet cells to retain significantly more mucus (an approximate 100% 
increase, 2.07 ± 0.35, N= 4 subjects, ng≥ 187 goblet cells, paired t-test p= 0.05) when 
compared to the control group (1 ± 0, Figure 5.9B). In the presence of Cch (10µM), significant 
levels of mucus retention in goblet cells were still observed when crypts were pretreated 
with 2.5µM DPI (an approximate 115% increase, 2.15 ± 0.31, N= 4 subjects, ng≥ 187 goblet 
cells, paired t-test p= 0.034), in comparison to the control group and to the Cch only (0.53 ± 
0.04) treated group (an approximate 162% increase, 2.15 ± 0.31, N= 4 subjects, ng≥ 187 
goblet cells, paired t-test p= 0.01, Figure 5.9B). Hence, these results suggest that the 
availability of ROS can have profound quantitative effects on mucus granule exocytosis and 
accumulation under both resting (unstimulated) and Cch-stimulated conditions. As DPI has 
been shown to block mitochondrial and other sources of ROS (Wind, et al., 2010), the current 
data is unable to determine the specific source of ROS that was playing a role in mucus 
granule release.  
The role of NOX-derived ROS in mucus secretion was further investigated using VAS2870, a 
specific pan-NOX inhibitor (Wingler, et al., 2012). Human colonic crypts were treated with 
VAS2870 (56µM) for 2.5 hours, or with VAS2870 (56µM) for 2 hours and then with VAS2870 
(56µM) + Cch (10µM) for another 30 min (Figure 5.10A). During constitutive basal secretion, 
very little difference was observed in the amount of mucus retained in goblet cells of crypts 
pretreated with 56µM VAS2870 (1.3 ± 0.09, N= 2 subjects, ng≥ 85 goblet cells, paired t-test 
p= 0.19) or not (control, 1 ± 0, Figure 5.10B). In the presence of Cch (10µM), VAS2870 (56µM) 
failed to cause mucus granule retention in goblet cells as compared to the control group 
(0.712 ± 0.14, N= 2 subjects, ng≥ 85 goblet cells, paired t-test p= 0.29) or the Cch only (0.72 
± 0.13) treated group (0.712 ± 0.14, N= 2 subjects, ng≥ 85 goblet cells, paired t-test p= 0.98, 
Figure 5.10B). The current result of VAS2870 in human colonic crypts remained inconclusive 
as this dosage was sufficient to block Cch-induced Ca2+ signal generation. Hence, these 
findings seem to suggest that NOX1-derived ROS does not play a role in mucus granules 
retention in goblet cells. Further experiments including the use of ROSstar and MitoSOX are 
required to confirm the sources of ROS generated in response to Cch stimulation. 
  
 210 
 
 
 
Figure 5.9 The role of NADPH oxidase in MUC2 mucin secretion in human colonic crypts 
Cultured human colonic crypts were separated into four treatment groups as labelled above. 
Colonic crypts in the Cch group were stimulated with Cch (10µM) for 30 min. For DPI treated 
groups, crypts were either pre-incubated with DPI (2.5µM) alone for 2.5 hours, or with DPI 
(2.5µM) for 2 hours followed with DPI (2.5µM) + Cch (10µM) for another 30 min. (A) Samples 
were fixed and labelled with anti-MUC2 (green) and anti-Ecad (red) antibodies, and 
visualised with Alexa-conjugated secondary antibodies; cell nuclei were stained with Hoechst 
(blue). Representative images were taken with a Zeiss Meta 510 confocal microscope using 
a x63 objective. (B) The MUC2 mucin content (intensities) in goblet cells was measured from 
3-5 slices of z-stack images using ImageJ. Mean MUC2 intensities in goblet cells were 
calculated and normalised to the control group, and displayed as mean ± SE. Results were 
representative of N= 4 subjects, n≥ 12 crypts and ng≥ 187 goblet cells in each treatment 
group. Significant difference was assessed by One-way ANOVA, F (3, 49) = 74.3, p< 0.0001; 
followed by Bonferroni procedures and Tukey’s post hoc analysis. Significant difference as 
indicated by asterisks (**) for p< 0.01 was observed between pairs of mean values including 
(i) control vs. Cch, (ii) control vs. DPI, (iii) control vs. DPI + Cch, (iv) Cch vs. DPI, (v) Cch vs. DPI 
+ Cch. No significant difference was observed between DPI vs. DPI + Cch.  
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Figure 5.10 Effects of VAS2870 in MUC2 mucin secretion in human colonic crypts 
Cultured human colonic crypts were separated into four treatment groups as labelled above. 
Colonic crypts in the Cch group were stimulated with Cch (10µM) for 30 min. For VAS2870 
treated groups, crypts were either pre-incubated with VAS2870 (56µM) alone for 2.5 hours, 
or with VAS2870 (56µM) for 2 hours, then with VAS2870 (56µM) + Cch (10µM) for another 
30 min. (A) Samples were fixed and labelled with anti-MUC2 (green) and anti-Ecad (red) 
antibodies, and visualised with Alexa-conjugated secondary antibodies; cell nuclei were 
stained with Hoechst (blue). Representative images were taken with a Zeiss Meta 510 
confocal microscope using a x63 objective. (B) The MUC2 mucin content (intensities) in 
goblet cells was measured from 3-5 slices of z-stack images using ImageJ. Mean MUC2 
intensities in goblet cells were calculated and normalised to the control group, and displayed 
as mean ± SE. Results were representative of N= 2 subjects, n≥ 6 crypts and ng≥ 85 goblet 
cells in each treatment group. Significant differences were assessed using One-way ANOVA 
tests, F (3, 25) = 5.2, p= 0.0063; followed by Bonferroni procedures and Tukey’s post hoc 
analysis. Significant difference as indicated by asterisks (**) for p< 0.01 was observed 
between pairs of mean values including (i) Cch vs.VAS2870, (ii) VAS2870 vs. VAS2870 + Cch. 
No significant difference was observed between other pairs.   
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As is the case with NOX2, RAC1 is required for NOX1 activation (Ueyama, et al., 2006) and 
NOX1 dependent ROS formation (Cheng, et al., 2006). The role of RAC1-dependent NOX1-
derived ROS in mucus secretion was further investigated using the RAC1 activation inhibitor 
NSC23766. Human colonic crypts were treated with NSC23766 (250µM) for 1.5 hour, or with 
NSC23766 (250µM) for 1 hour then with NSC23766 (250µM) + Cch (10µM) for another 30 
min (Figure 5.11). During constitutive basal secretion, the level of mucus granules retained 
in goblet cells in NSC23766 treated crypts (1.08 ± 0.22) was similar to the control group (1 ± 
0, N= 4 subjects, ng≥ 211 goblet cells, Figure 5.11B). In the presence of Cch (10µM), a 
significant level of mucus retention in goblet cells was observed when crypts were pre-
incubated with NSC23766 (250µM) as compared to the control group (an approximate 100% 
increase, 1.99 ± 0.28, N= 4 subjects, ng≥ 211 goblet cells, paired t-test p= 0.038) and to the 
Cch only (0.54 ± 0.09) treated group (an approximate 146 % increase, 1.99 ± 0.28, N= 4 
subjects, ng≥ 211 goblet cells, paired t-test  p= 0.013, Figure 5.11B). These results imply that 
RAC1 is activated only upon Cch stimulation, as no obvious effect was seen in NSC23766-only 
treated group compared to the control group. Hence, the possible role of NOX1-derived ROS 
in mediating mucus granules exocytosis/retention seems likely, given the effects of DPI (NOX 
inhibitor) and NSC23766 (RAC1 inhibitor).  
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Figure 5.11 Role of RAC1 in MUC2 mucin secretion in human colonic crypts 
Cultured human colonic crypts were separated into four treatment groups as labelled above. 
Colonic crypts in the Cch group were stimulated with Cch (10µM) for 30 min. For NSC23766 
(RAC1 inhibitor) treated groups, crypts were either pre-incubated with NSC23766 (250µM) 
alone for 1.5 hours, or with NSC23766 (250µM) for 1 hour, then with NSC23766 (250µM) + 
Cch (10µM) for another 30 min. (A) Samples were fixed and labelled with anti-MUC2 (green) 
and anti-Ecad (red) antibodies, cell nuclei were stained with Hoechst (blue). Representative 
images were taken with a confocal microscope using a x63 objective. (B) The MUC2 mucin 
content (intensities) in goblet cells was measured from 3-5 slices of z-stack images using 
ImageJ. Mean MUC2 intensities in goblet cells were calculated and normalised to the control 
group and displayed as mean ± SE. Results were representative of N= 4 subjects, n≥ 12 crypts 
and ng≥ 211 goblet cells in each treatment group. Significance was assessed using One-way 
ANOVAs, F (3, 51) = 12.7, p< 0.0001; followed by Bonferroni procedures and Tukey’s post 
hoc analysis. Significant difference as indicated by asterisks (**) for p< 0.01 was observed 
between pairs of mean values including (i) control vs. Cch, (ii) Cch vs. NSC23766, (iii) Cch vs. 
NSC23766 + Cch, (iv) control vs. NSC23766 + Cch, (v) NSC23766 vs. NSC23766 + Cch. No 
significant difference was observed between control vs. NSC23766.  
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5.6 Discussion 
In the human GI tract, cholinergic signals have been shown to regulate intestinal ion 
transport (Kuwahara, et al., 1989; Mall, et al., 1998; Reynolds, et al., 2007) and gastric 
motility (Parkman, et al., 1999). In addition, Ach (or its analogue Cch) has been shown to 
regulate mucus secretion in rabbit colonic crypt goblet cells (Specian and Neutra, 1980), in 
the rat GI tract (Rubinstein, et al., 1994), and in the human colonic crypt goblet cells (Halm 
& Halm, 2000). All of these studies have demonstrated the effects of Ach in the acceleration 
of mucus granule exocytosis, reduction of goblet cell content, elevation of mucus thickness, 
and enhancement of mucus secretion rate. However, the mechanism of how Ach exerts its 
function is unclear.  
MAchR is one of the Ach receptors that is expressed in the human colonic epithelium, of 
which M3AchR was found to be the predominant subtype expressed in human colonic crypts 
(Figure 3.10). Activation of M3AchR by Ach or Cch has been shown to trigger downstream 
signalling pathways, in particular the generation of the 2nd messenger IP3. IP3 releases Ca2+ 
from the ER store via the IP3R. The initial increase in intracellular [Ca2+] triggers the CICR 
response within the cell (Felder, 1995; Budd, et al., 1999). Elevation of intracellular [Ca2+] by 
cholinergic stimulation has been shown previously in coupling mucus secretion in rabbit 
gastric mucous cells, and the secretory response was blocked by the application of the 
intracellular Ca2+ chelator BAPTA (Seidler, et al., 1991), suggesting mucus secretion is a Ca2+ 
dependent process. In addition, the link between MAchR activation and Ca2+ signal 
generation was also demonstrated previously in the rat and human colonic crypts (Lindqvist, 
et al., 1998; Lindqvist, et al., 2002; Reynolds, et al., 2007). However, the underlying 
mechanism of cholinergic-mediated Ca2+ signal generation in coupling mucus secretion in the 
human colonic epithelium has never been shown.  
In the previous chapter, BAPTA was shown to block Cch-induced Ca2+ signal generation 
(Figure 4.6). The hypothesis that mucus secretion is dependent on intracellular Ca2+ 
mobilisation was then tested by the application of the intracellular Ca2+ chelator BAPTA. 
BAPTA (66µM) significantly attenuated mucus secretion in human colonic crypt goblet cells 
at the base of the crypt upon Cch stimulation (approximately 100% increase of MUC2 content 
in goblet cells, Figure 5.2), suggests that mucus granule exocytosis in colonic crypt goblet 
cells are dependent on intracellular Ca2+ signal transduction. Intense labelling of immature 
MUC2 proteins was also detected in the ER/Golgi area in goblet cells when treated with 
BAPTA-AM (data not shown). These results suggest that newly synthesised MUC2 mucin 
protein, after all the glycosylation (maturation) processes in the ER and Golgi, was unable to 
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package into secretory vesicles due to the lack of Ca2+ ion in the environment.  In support 
from previous findings in rabbit gastric mucous cells (Seidler, et al., 1991) and rat gastric 
epithelial cells (Tani, et al., 2002), the effect of BAPTA here confirmed that cholinergic 
mediated mucus secretion in human colonic crypts is dependent on intracellular Ca2+ 
mobilisation. 
 
5.6.1 The essential role of CD38 in calcium coupling mucus secretion in human 
colonic crypts 
In the previous chapter, CD38 is identified as one of the key players in Cch-evoked Ca2+ signal 
generation. In this chapter, the role of CD38 in regulating mucus secretion in human colonic 
crypt goblet cells was further investigated with the application of nicotinamide. 
Nicotinamide acts to reverse the cyclase activity of CD38 by forcing the conversion of cADPR 
back to NAD+ (Aarhus, et al., 1995; Graeff, et al., 2002). Nicotinamide (20mM) has no obvious 
effect on mucus granule retention under constitutive basal condition but significantly 
retained mucus granules in Cch stimulated condition. The average mucus content in goblet 
cells in both nicotinamide only and nicotinamide + Cch treated groups were similar to the 
control group (Figure 5.3B). These results suggest that inhibition of cADPR has no obvious 
effect on either Cch-induced Ca2+ signal generation (Figure 4.12B) or mucus granule retention 
(Figure 5.3) in human colonic crypt goblet cells. However nicotinamide counteracts the Cch 
induced acceleration of mucus secretion as compared to the Cch only treated group (Figure 
5.3B), these results further implicate the CD38/NAADP axis in mediating Ca2+ coupling mucus 
secretion in the human colonic epithelium. 
CD38 has been shown to play a role in glucose-induced insulin secretion in pancreatic islet 
cells (Mehta, et al., 1996). One previous study reported that nicotinamide had no effect on 
insulin secretion and glucose kinetics in healthy human subjects, whereas nicotinic acid, a 
structurally similar compound, increased insulin secretion (Bingley, et al., 1993). Nicotinic 
acid is a substrate for CD38 for the generation of NAADP. The current model for the (acidic 
pH favoured) base-exchange reaction is: nicotinic acid + NADP  NAADP + nicotinamide 
(Cosker, et al., 2010; Lee, et al., 2012), suggests the acidic organelles might be a site of NAADP 
synthesis in vivo. Thus, these findings are consistent with our model system that further 
imply a role for NAADP as the key 2nd messenger in Ca2+ coupling mucus secretion. However 
the mechanism of non-base-exchange NAADP synthesis is currently sparse; and whether 
CD38 is required for in vivo NAADP synthesis is unclear. A previous report has suggested that 
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both CD38 and base-exchange reaction are not required for in vivo NAADP synthesis in 
myometrial cells (Soares, et al., 2007). Hence, many questions still remain regarding the role 
of CD38/NAADP pathway in vivo.  
Endocytosis has been suggested to modulate mucin granule accumulation and secretion. In 
differentiated mouse intestinal cells, a study by Patel and colleagues demonstrated the 
inhibition of clathrin-mediated endocytosis causes mucin granule accumulation in goblet 
cells (Patel, et al., 2013). Additionally CD38 activity has been suggested to be regulated by its 
internalisation (Zocchi, et al., 1999), which raises the possibility of a link between CD38 
activation and endocytosis. As was briefly mentioned in the previous chapter, inhibition of 
endocytosis by MbetaC (10mM) reduced Cch evoked Ca2+ signals. Attempts have also been 
made to determine the role of endocytosis on mucus secretion in colonic crypt goblet cells, 
however, the viability of crypt cells decreased after a short period of incubation (30 min or 2 
hours) with MbetaC (10mM). This finding is consistent with a previous study which reported 
that MbetaC significantly decreased the viability of some cell lines including Vero and HuH-7 
cells, even after a short period of incubation with a dosage that is routinely used to inhibit 
endocytosis (Vercauteren, et al., 2010). Thus, the reduction of Cch evoked Ca2+ signals by 
MbetaC could be a false positive result due to decreased viability of the colonic epithelial 
cells. This technical barrier means that it is currently infeasible to show the specificity of this 
agent in inhibiting the endocytosis pathway and whether it causes the accumulation of 
mucus granules in human colonic crypt goblet cells. Further experiments using other 
endocytosis inhibitors such as chloroquine and pitstop 2 would be required to confirm these 
findings.  
 
5.6.2 NAADP is the key 2nd messenger in mediating calcium coupling mucus 
secretion upon M3AchR activation 
The results of this thesis demonstrate that in this model nicotinamide counteracts the effect 
of accelerated mucus secretion observed during Cch stimulation (Figure 5.3B), suggesting 
that the CD38/NAADP pathway plays a role in mediating mucus secretion in human colonic 
crypts. Similarly, the NAADP antagonist Ned-19 was able to inhibit Cch-induced Ca2+ signal 
generation and increase mucus retention inside goblet cells during both basal and stimulated 
conditions, blocking the majority of the phenotype when treated with Cch (Figures 4.18B and 
5.6). Moreover, fluorescent staining of NAADP receptors reveals them to be localised to 
acidic lysosomes (Figure 5.5). These data thus suggest a model in which NAADP is the key 2nd 
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messenger responsible for mediating lysosomal Ca2+ coupling mucus secretion in human 
colonic crypt goblet cells. 
Goblet cells are of course not alone in the crypt, and neighbouring colonic epithelial cells are 
interlinked via junctional proteins which provide a means of direct cellular communication. 
In a tissue explant model such as has been deployed here, it is therefore difficult to tell 
whether goblet cells (in particular those at the base of crypt) on their own are responsible 
for the response to cholinergic stimulation. In order to address this problem, our group is 
developing a colonic crypt derived single cell epithelial culture model, the preliminary data 
of which suggests that single goblet cells are indeed capable of responding to cholinergic 
stimulation even in the absence of signals from neighbouring cells (Figure 5.7), in a Ned-19 
blockable manner (data not shown). This is consistent with the observation from chapter 3 
that goblet cells are equipped with all of the necessary components required for Ca2+ 
signalling. The pitfall of this single cell model is that it cannot currently distinguish goblet 
cells derived from the crypt base from the mature goblet cells at the surface epithelium in a 
mixed population of epithelial cells. This presents a confounder, as previous studies have 
suggested that the colonic surface goblet cells are non-responsive to cholinergic stimulation 
(Gustafsson, et al., 2012a; Ermund, et al., 2013b), potentially as a result of the described 
decreasing MAchR expression along the crypt axis (Lindqvist, et al., 2002). Bereft of their 
ordered tissue structure it becomes difficult to identify goblet cells based on their 
morphology; MUC2 labelling is strictly required to distinguish them from other epithelial cell 
types. Hence, those goblet cells that were responsive to Cch stimulation in these experiments 
are likely to be from the base to mid region of the crypt. In future experiments it might be 
advantageous to use a concentrated pool of phenotyped goblet cells by using cell sorting, 
although this will require the identification of markers for immature and mature goblet cells. 
In addition, laser microdissection would possibly be another way to pick individual goblet 
cells from specific regions of crypts.  
 
5.6.3 The potential role of NOX1, RAC1 and ROS in mucus secretion upon M3AchR 
activation 
CD38 is the ectoenzyme responsible for the synthesis of the 2nd messengers cADPR and 
NAADP (Lee, et al., 1997). Synthesis of both compounds requires the availability of the 
substrates NAD+ and NADP+ (for the production of cADPR and NAADP respectively) in the 
cytosol for the enzymatic reaction to occur. Interestingly, both substrates are produced by 
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NADPH oxidase (NOX) (Xu, et al., 2013), which raises the possibility of NOX (and therefore 
CD38) signalling lying downstream of MAchR activation. Previous studies have demonstrated 
the role of NAD+ (Zocchi, et al., 1996) and NOX (Xu, et al., 2013) in mediating membrane 
CD38 activation via its internalisation. These findings further support a role of NOX in 
regulating CD38 activity and mucus secretion in goblet cells.  
ROS derived from LC3+ vacuole-associated NOX has been suggested to regulate mucus 
granule accumulation in mouse colonic goblet cells (Patel, et al., 2013). In this thesis, LC3+ 
autophagosomes were detected at the apical pole of crypt epithelial cells (among other 
places), in close proximity to – but not precisely co-localised with – NOX1 (Figure 5.8B iii). 
NOX1 is known to form a heterodimer with the p22phox NOX complex subunit (Bedard, et 
al., 2007), which has been demonstrated previously to co-localise with LC3+ vacuoles in 
mouse intestinal epithelial cells in a manner that was suggested to enhance the formation of 
these LC3+ vacuoles (Patel, et al., 2013). There are several scenarios which might explain this 
discrepancy between our data and theirs. One is that the images analysed in Figure 5.8 were 
acquired at a greater resolution than in the Patel et al. data, allowing us to resolve separate 
LC3 and NOX1-p22phox proteins. However this scenario seems unlikely given they have used 
similar and greater resolution technologies in their image acquisition. The second possibility 
is that there is a difference in the underlying biology between the two models. The most 
likely scenarios in that case would likely be either that NOX1 and p22phox do not form stable 
heterodimers in human crypts, or NOX1-p22phox heterodimers do not associate with LC3+ 
vacuoles in human cells. Given that the association between NOX1 and p22phox is 
reasonably well established (Sirker, et al., 2011) it seems unlikely that the first of these 
options is true: were the second option to be the case it might be possible that the NOX 
complex might be associating with LC3-negative organelles instead. 
The role of NOX1-derived ROS in mucus granule exocytosis in goblet cells was further 
investigated through the application of different NOX-targeting small-molecule inhibitors. 
Pre-incubation with DPI – one of the small-molecule inhibitors often used to inhibit NOX-
derived ROS production (Li, et al., 1998) –caused significant levels of mucus retention in 
goblet cells in both constitutive basal and Cch-stimulated conditions (Figure 5.9B). These 
results suggest that ROS is required for typical mucus secretion from both unstimulated or 
agonist stimulated colonic crypts. However a number of reports contest the specificity of DPI, 
with some suggestion that it can also block mitochondrial and other sources of ROS (Wind, 
et al., 2010). However, there appears to be a dose-dependent effect, with DPI preferentially 
blocking NOX enzymes over mitochondrial oxidative phosphorylation, even at high doses: 
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the effects of DPI are commonly attributed to NOX inhibition up to and above 10µM 
(Hancock and Jones, 1987; Bulua, et al., 2011). One study in HT-29 human colon cancer cell 
lines found that 10µM DPI blocked NOX-dependent ROS production and cell migration to a 
similar degree as NOX1 siRNA (Sadok, et al., 2008), suggesting DPI at these concentrations is 
specific in its NOX1-derived ROS blockade. Below this concentration, DPI as low as 0.5µM 
and 5µM has been shown to block mitochondrial ROS in monocytes/macrophages and in rat 
skeletal muscle respectively (Li, et al., 1998; Lambert, et al., 2008). Thus it appears that for 
certain concentrations of DPI, we can expect there to be reasonable NOX-specificity. In this 
current study, 2.5µM DPI caused significant mucus granule retention in human colonic crypt 
goblet cells during unstimulated and Cch-stimulated conditions. Therefore, it is still 
reasonable to interpret these data as suggesting that NOX-derived ROS plays a role in mucus 
secretion in human colonic crypt goblet cells. Future experiments including exogenous 
application of ROS and siRNA silencing of NOX1 gene are required to test the role or NOX1-
derived ROS on mucus secretion in colonic goblet cells.  
The role of NOX-derived ROS in mucus secretion was further investigated using the 
purportedly specific pan-NOX inhibitor VAS2870 (Wingler, et al., 2012). However, there was 
no significant difference in the level of mucus retention observed in goblet cells pretreated 
with VAS2870, during either constitutive basal or Cch stimulated secretion (Figure 5.10B). 
Contrary to the DPI and other data, these findings seem to suggest that NOX1-derived ROS 
does not play a role in mucus granules retention in goblet cells. Although the effectiveness 
of VAS2870 has been reported in multiple cell models, including neutrophils, smooth muscle 
and endothelial cells (Wingler, et al., 2012; Cifuentes-Pagano, et al., 2012), its mechanism of 
action and specificity towards NOX1 (among the various NOX isoforms) is unclear. It is 
possible that the effect of VAS2870 might be cell type or tissues specific, or below some 
dosage or other threshold for activity in this model. To illustrate this principle, we can 
consider a previous study which postulated that NOX is involved in influenza virus-induced 
ROS production and virus replication (Amatore, et al., 2015). In this study, while incubation 
with either DPI or VAS2870 significantly reduced viral load in infected cells, the effect of DPI 
was far more potent than VAS2870. The VAS2870 results shown in Figure 5.10B in human 
colonic crypts therefore remain inconclusive. Thus, further experiments including the use of 
MitoSOX and ROSstar in conjunction with time lapse imaging to identify and map the sources 
of ROS generation before and after Cch stimulation and/or NOX1 inhibition are required to 
confirm the effect of VAS2870 in NOX-derived ROS generation and mucus secretion.  
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RAC1 has been shown to be required for NOX1 activation (Ueyama, et al., 2006) and NOX1-
dependent ROS formation (Cheng, et al., 2006). The small-molecule RAC1 activation inhibitor 
NSC23766 therefore provides another means of investigating the role of NOX1-derived ROS 
formation in mucus secretion. NSC23766 selectively inhibits the RAC1-GEF interaction, 
blocking the conversion of RAC1 to its active form RAC1-GTP, preventing the subsequent 
activation of the NOX1 complex. Incubation with NSC23766 had no obvious effect on mucus 
retention when observing constitutive basal secretion; however, it lead to a significantly 
greater amount of MUC2 being retained in goblet cells that were then stimulated with Cch 
(Figure 5.11B). This suggests that the effect of RAC1 might possibly lie downstream of 
M3AchR activation, and further supports the notion that NOX-derived ROS production is an 
important factor involved in MUC2 secretion. NSC23766 has been used for a decade as an 
antagonist of RAC1 activation since it was first reported by Gao et al in 2004 (Gao, et al., 
2004). However, a recent report by Levay and colleagues suggested this compound also acts 
as a competitive MAchR antagonist (Levay, et al., 2013). NSC23766 was shown to bind to 
both M2AchR and M3AchR, and that the concentration ranges commonly used to block RAC1 
activation also blocked MAchR activation. These findings were discovered after having done 
the above experiments. However, in the absence of ligand binding data in the Levay study, 
an alternative, and attractive, interpretation of their findings is that (i) NSC23766 is a specific 
inhibitor of RAC, (ii) NSC23766 blocks MAChR activated pathways by blocking downstream 
RAC1, and that (iii) some other GPCR functions are not blocked by NSC23766 because they 
are not coupled to RAC1. Further experiments using alternative RAC1 inhibitors such as W56 
or siRNA silencing of RAC1 expression are required to confirm the coupling of MAChR to RAC1 
and its role in Ca2+-mediated mucus secretion. 
To the best of our knowledge, there is no NOX1-specific inhibitor which could be used to 
support the current findings. Due to the lack of specificity of the small-molecule inhibitors, 
future work would benefit from the use of MitoSOX that targets mitochondrial superoxide 
in live cells, and also NOX1-specific siRNA to confirm the source of ROS in mediating mucus 
secretion. In addition, exogenous application of ROS and overexpression of NOX1 gene in 
laser microdissected goblet cells from crypt base provide another way to investigate the role 
of ROS/ NOX1-derived ROS in mucus secretion.  
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Chapter 6: General Discussion and future work 
 
Ach is one of the many neurotransmitters that is synthesised by cholinergic neurons in the 
enteric nervous system (Furness, 2000). Activation of MAchRs by Ach or Cch has been shown 
to trigger various downstream signalling pathways. The generation of the 2nd messenger IP3 
and the release of Ca2+ from the ER store via IP3R is a well-established example of such a 
pathway. The initial increase in intracellular [Ca2+] further triggers the CICR response within 
the cell (Felder, 1995; Nahorski, et al., 1997; Budd, et al., 1999). The link between cholinergic 
mediated MAchR activation and Ca2+ signal generation has been demonstrated previously by 
our lab in both rat and human colonic crypts (Lindqvist, et al., 1998; Lindqvist, et al., 2002), 
while cholinergic stimulated mucus secretion has been demonstrated by others in isolated 
human colonic crypts (Halm and Halm, 2000), yet the underlying mechanism of cholinergic 
signal-mediated Ca2+ mobilisation and the expression of the Ca2+ signalling toolkit in 
regulating mucus barrier function in the human colon has not been published thus far. This 
thesis investigated the molecular and cellular basis of excitation-mucus secretion coupling in 
human colonic crypts – the intact unitary tissue structure of the polarised human colonic 
epithelium. This study has produced a number of findings, including descriptions of the 
arrangement of neuronal-epithelial cells, cholinergic receptors and polarised distribution of 
acidic Ca2+ storage organelles, and the discovery that their associated two pore Ca2+ channels 
trigger intracellular and intercellular colonic crypt Ca2+ waves throughout the intestinal stem 
cell niche. In goblet cells, these elevated Ca2+ levels stimulate mucus granule secretion into 
the colonic crypt lumen. This study identifies a novel neuronal-epithelial signal transduction 
pathway that orchestrates the highly complex release of mucus granules that is required to 
keep the luminal microflora at bay and maintain the barrier function of the intestinal 
epithelium. This study paves the way to investigate the status of this pathway in 
inflammatory bowel disease and cancer, which may lead to novel strategies for prevention 
and treatment.   
 
6.1 Neuronal-epithelial cell interactions in the human colon 
Both cholinergic and non-cholinergic neurons extend from the submucosal plexus into the 
mucosa (Furness, 2000). In this study, enteric neurons were found to be present at the sub-
epithelial layers and also in the lamina propria surrounding the crypts. This observation is 
consistent with published findings regarding the location of enteric neurons in mouse 
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intestinal crypts (Bjerknes & Cheng, 2001) as well as in the human colonic epithelium 
(Reynolds, et al., 2007). These axonal projections are in close proximity with colonic crypts: 
3D reconstructed images of colonic mucosal sections revealed that some axonal projections 
actually touch and clasp the surface of crypt cells. Given that there are gastric endocrine cells 
secreting gastrin under the control of vagal motor neurons (Furness, 2000), one might expect 
that these colonic axons represent motor neurons responsible for innervation of comparable 
enteroendocrine cell hormone secretion. In addition, some of these axon terminals were 
found to penetrate through the single epithelial cell layer towards the crypt lumen. This 
observation is in sharp contrast to the currently accepted view of enteric neurons, in which 
they are thought to lie in close proximity to – but do not penetrate – the colonic epithelium 
(Furness, 2006). Some nerve fibers, believed to be sensory, have been shown to penetrate 
the inner layers of stratified epithelium which line the oesophagus (Furness, 2006), thus 
these trans-epithelial colonic nerve fibers could potentially be sensory neurons responsible 
for sensing the luminal contents. Colon sensory neurons have been reported to detect 
extracellular acidosis via the transient receptor potential vanilloid receptor 1 in mice (Sugiura, 
et al., 2007). However, the actual function of these penetrating nerve fibers in the human 
colonic epithelium is as yet unknown, which presents an opportunity for the generation and 
testing of novel hypotheses regarding their functional roles. For instance, investigation into 
a similar neuronal-epithelial interaction revealed that neurons can play a role in the 
proliferation of epithelial cells and angiogenesis in the sub-epithelial layer – to the extent 
that these interactions were proposed to enhance cancer cell proliferation and neurogenesis 
in tumors (Garcia, et al., 2014). Viewed together with the findings of this thesis and similar 
studies, one might expect that a wide breadth of possible biological functions might fall 
under the control of such neuronal-epithelial cell communications. 
The mechanisms underlying the production of these neuronal-epithelial interactions are also 
currently largely unknown. The field of neurology has identified a number of systems that 
govern the growth and orientation of developing axons, describing the interaction of axonal 
‘growth cones’ which alter growth paths in response to a variety of guidance cues including 
physical interactions and chemical attractants, such as BMP, Wnt, neurotransmitters 
(Bovolenta, 2005; Tamariz, et al., 2015) and RAC1-dependent ROS (Zhang, et al., 2009). 
Future experiments co-culturing neurons and colonic crypts whilst modulating these neuron-
targeting pathways might serve to investigate how neurons interact with the colonic 
epithelium and confirm whether the axon terminals extend and penetrate into the epithelial 
layer.  
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6.1.1 Neuronal and non-neuronal Ach system in the human colonic epithelium 
Ach is primarily secreted by the cholinergic neurons of the enteric nervous system (Wessler, 
et al., 2008). In this thesis, cholinergic innervation was primarily found at the base of the 
crypt, as well as in the muscularis mucosae and submucosa. This observation further 
confirms the neuronal-epithelial interactions in the human colonic epithelium. The close 
proximity of cholinergic neurons to the colonic epithelium presumably provides the shortest 
distance for Ach diffusion. Epithelial cells from the skin and airways have been shown 
previously to express components of cholinergic systems that lack neuronal innervation. In 
the human placenta, CHAT was detected in multiple subcellular compartments such as the 
cell membrane, endosomes, cytoskeleton, mitochondria and the nucleus (Wessler, et al., 
2003). This non-neuronally produced Ach is proposed to act as a local cellular signalling 
molecule due to its involvement in various nerve-independent cell functions such as 
proliferation, differentiation, cell trafficking and secretion, which are different from Ach 
functioning as a neurotransmitter (Wessler, et al., 2003). While data regarding the cellular 
localisation of non-neuronal Ach is increasing, knowledge of the biological significance of the 
system remains limited. Jönsson and colleagues were the first group to demonstrate the 
possible existence of a non-neuronal Ach system in the human colon (Jönsson, et al., 2007). 
In this thesis, the expression of CHAT-positive cells, the basal expression of M3AchR and 
CHAT proteins, and the cytoplasmic expression of VAChT further confirmed the existence of 
colonic epithelial self-regulation in the absence of neuronal innervation. In agreement with 
the findings of Jönsson, et al, CHAT-positive signals were detected in enteroendocrine cells 
in this study. Because MAchR subtypes 1, 3 and 5 were found to be expressed on the basal 
membrane of the crypt, it is a reasonable supposition that these CHAT-positive 
enteroendocrine cells synthesise and secrete Ach into the basolateral compartment where 
it can bind to MAchR in an autocrine or paracrine manner. In mouse models, CHAT positive 
cells which were identified in the intestinal epithelium have been proposed to have 
chemosensory traits, through which they might participate in protective reflexes by 
paracrine Ach signalling (Schutz, et al., 2015); it is therefore possible that the CHAT-positive 
cells identified in this thesis might have comparable functions. 
In neurons, Ach is stored in vesicles in the nerve terminals and released when required for 
effective neurotransmission. Non-neuronal cells described so far do not appear to be 
endowed with storage organelles, and the mechanism of non-neuronal Ach release is 
currently unknown (Wessler, et al., 2003). Recent studies on rat colonic epithelium have 
suggested the involvement of organic cation transporters (OCT) in regulating non-neuronal 
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Ach release in the rat colon (Yajima, et al., 2011; Bader, et al., 2014). This hypothesis is 
further supported by observations from human placenta that non-neuronal Ach is released 
via OCT (subtypes 1 and 3) (Wessler, et al., 2003), and from human skin, in which OCTs have 
been shown to contribute to non-neuronal Ach release (albeit in a non-dominant role) 
(Schlereth, et al., 2006). During the work of this thesis, detection of VAChT expression was 
used to identify colonic crypt-associated neurons; staining for this protein however also 
revealed the presence of non-neuronal VAChT expression in epithelial crypt cells. Given the 
literature cited above, it is currently unclear whether this VAChT has any functional role in 
non-neuronal Ach release in the human colon, which makes this observation difficult to 
interpret. As non-neuronal Ach release was not the focus of this project, OCT gene expression 
was not assessed, although we might expect this family to be responsible for mediating such 
release. OCTN2 (a recently described member of the OCT family) has been found to be highly 
expressed in human intestines, from the jejunum to the colon (Terada, et al., 2005; Liu, et 
al., 2013), making the hypothesis that it could be mediating non-neuronal Ach release 
feasible. Two functional variants of the OCTN genes have also been identified to be 
associated with Crohn’s diseases (Peltekova, et al., 2004), suggesting an important role for 
OCTNs in colon physiology. Further research is required to identify the mechanism of non-
neuronal Ach release and the functional role of VAChT and OCTN in the human colonic 
epithelium. Experiments that could be conducted include (1) measurement of crypt Ach 
content before and after inhibition of VAChT and OCTN2 expression by siRNA; (2) 
measurement of Ach content in the presence or absence of pharmacological inhibitors, such 
as quinine or omeprazole for OCTN2 inhibition and inhibition of VAChT by vesamicol, or (3) 
study the effect of these inhibitors on Ca2+ signal generation and their functional role in 
mucus secretion in the absence of exogenous stimulation (such as Ach or other MAchR 
agonists). 
 
6.2 Cch-induced colonic crypt calcium signals upon MAchR activation 
In this study, immunohistochemical analysis demonstrated the protein expression of MAchR 
subtypes 1, 3 and 5 at the basal pole of human colonic crypts, with M3AchR being the 
predominant subtype. Exogenous application of Cch induced coordinated Ca2+ signals in the 
3D human colonic crypt culture model, the pattern of which being consistent with the 
application of Ach in previous studies in the same model (Lindqvist, et al., 2002; Reynolds, et 
al., 2007). Specifically, Ca2+ signals initiate at the apical pole of initiator cells at the base of 
the crypt, before spreading to the basal pole of those cell and then further propagating along 
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the crypt axis by intercellular communication via the gap junctional proteins. Preliminary 
data in this study suggests that the Ca2+ initiator cells at the base of the crypt are LGR5+ stem 
cells, whose increased Ca2+ signal sensitivity could be due to the higher intensity of MAchR 
expression in this region (Lindqvist, et al., 2002). These unidirectional Ca2+ waves along the 
crypt axis have previously been shown in our lab to impact both short term and long term 
physiological consequences in the colonic epithelium, such as fluid secretion and epithelial 
homeostasis respectively (Lindqvist, et al., 2002; Reynolds, et al., 2007). This current study 
focusses on the short term process of mucus secretion following Cch stimulation, and aimed 
to delineate the molecular mechanism of the Ca2+ signal generation.  
 
Immunohistochemical data presented here demonstrate the polarised location of the 
intracellular Ca2+ stores, with ER at the basal pole of crypt cells, while the acidic lysosomes at 
the apical poles. The subcellular localisation of these acidic lysosomes coincide with the 
initiation site of the Cch-induced Ca2+ signals, which led to the speculation that these acidic 
Ca2+ stores might play an important role in Ca2+ signal generation. The typically accepted 
major role of these lysosomes is to degrade and recycle macromolecules (Appelqvist, et al., 
2013), however recent studies have increasingly shown the importance of the Ca2+ signals 
released from these acidic organelles. NAADP has been shown to be the key 2nd messenger 
responsible for mobilising acidic Ca2+ stores via TPCs (Galione, 2010); these lysosomal Ca2+ 
signals have been shown to regulate diverse cellular functions such as cell differentiation 
(Brailoiu, et al., 2006; Aley, et al., 2010; Zhang, et al., 2013), vesicle trafficking (Ruas, et al., 
2010; Ruas, et al., 2014), exocytosis (Davis, et al., 2012) and autophagy (Medina, et al., 2015). 
The role of NAADP in recruiting Ca2+ from different sources has been studied previously in 
various models, including arterial smooth muscle cells (Boittin, et al., 2002), pancreatic acinar 
cells (Cancela, et al., 1999; Menteyne, et al., 2006) and Jurkat T cells (Steen, et al., 2007). In 
smooth muscle cells, depletion of sarcoplasmic reticulum (SR) Ca2+ stores with thapsigargin 
or inhibition of RYR with ryanodine selectively blocked NAADP mediated global Ca2+ waves 
(Boittin, et al., 2002), suggesting that the NAADP mediated initial phase of Ca2+ release from 
other intracellular organelles triggers global Ca2+ release from the ER, while in pancreatic 
acinar cells or T cells, thapsigargin-depletion of the ER store abolished NAADP evoked Ca2+ 
signals (Menteyne, et al., 2006; Steen, et al., 2007). Thus the role of NAADP in recruiting 
intracellular Ca2+ seems to be cell type specific. In this study, depletion of ER Ca2+ stores with 
thapsigargin did not abolish Cch-induced Ca2+ signals in human colonic crypts: instead a small 
Ca2+ wave was observed, suggesting that M3AchR activation mobilises Ca2+ from other 
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intracellular organelles (in line with the findings in smooth muscle cells but in contrast to 
pancreatic acinar cell and T cell data). In tracheal smooth muscle cells, Cch has been shown 
to induce a rapid and transient elevation of NAADP levels (Aley, et al., 2013), which provides 
a line of reasoning to question whether MAchR activation by Cch induces NAADP-mediated 
Ca2+ mobilisation from acidic stores in human colonic crypts, which has never been reported 
previously. In addition to the activation of PLC and the subsequent generation of the 2nd 
messenger IP3 in mediating ER store Ca2+ release via the IP3R, MAchR activation has been 
shown to regulate CD38 activity by an unknown mechanism in airway smooth muscle cells 
(Gosens, et al., 2006). Activation of M3AchR has also been shown to lead to cADPR 
generation by CD38 (Higashida, et al., 1997a and b). These findings suggest a potential 
involvement of CD38 pathways in the regulation of Ca2+ signal generation upon MAchR 
activation in the human colonic epithelium, and generate a level of complexity regarding how 
intracellular Ca2+ stores interact in the presence of multiple Ca2+ releasing messengers to 
generate the cholinergic-specific Ca2+ signature in the human colonic epithelium.  
  
6.2.1 Molecular mechanism of calcium signal generation upon M3AchR activation 
Activation of each of the three MAchR subtypes detected here in the human colonic 
epithelium could be expected to simultaneously activate both PLC and PLD pathways 
(Liscovitch, 1991). The subsequent PLC pathway is then well described: activated PLC initiates 
the hydrolysis of PIP2 into IP3 and DAG; IP3 then mediates ER Ca2+ release via the IP3R, while 
DAG binds to and activates PKC (Felder, 1995; Budd, et al., 1999). Inhibition experiments in 
this thesis demonstrated that PLC is the major signal transduction pathway responsible for 
generating Ca2+ signals upon M3AchR activation in the human colonic epithelium, thus we 
expected these signals to be transduced via the subsequent generation of IP3 and DAG. 
Surprisingly, inhibition of IP3R did not have any significant effect on Cch-induced Ca2+ waves, 
suggesting that IP3 was not the key 2nd messenger for the Ca2+ signal generation.  
In addition to activating PKC, DAG can be converted to PA by DAG kinase (Kanoh, et al., 2002). 
The activity of DAG kinase remains low during unstimulated condition, allowing DAG to exert 
its function (i.e. contribute to the activation of PKC). Elevation of DAG kinase activity upon 
receptor activation of the PIP2 pathway drives the conversion of DAG to PA, which 
terminates signalling downstream of DAG (Mérida, et al., 2008). In rabbit neutrophils, 
inhibition of DAG kinase activity using the compound R59-022 has been shown to potentiate 
superoxide production, a phenotype which can be blocked by PKC inhibitors, suggesting a 
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role for PKC in ROS generation (Gomez-Cambronero, et al., 1987). In this thesis, inhibition of 
PA formation using R59-022 significantly reduced Cch-induced Ca2+ signal generation by 
more than 60%, suggesting a dominant role for PA (or some member of its downstream 
signalling pathways) in Ca2+ signal generation upon M3AchR activation in human colonic 
epithelium. PA has also been shown to activate some isoforms of PKC in COS cells including 
PKC-zeta (which is DAG-insensitive) and PKC-alpha in the absence and presence of Ca2+ 
respectively (Limatola, et al., 1994). These findings collectively suggest that PKC isoforms can 
be activated either by DAG or PA or both. As the expression of PKC isoforms was not 
addressed in the current study, we are unable to determine which isoforms were activated 
in response to M3AchR activation; inhibition of PKC suppressed approximately half of the 
Cch-induced Ca2+ signals; considered with the observation that R59-022 did not completely 
abolish Cch-induced Ca2+ signals, we can infer that both DAG-sensitive and -insensitive PKC 
isoforms were involved in the Ca2+ signal generation in the human colonic epithelium.  
Having established the importance of PA in signal transduction between cholinergic 
stimulation and production of Ca2+ waves, the target molecules mediating further signalling 
needed to be established. As discussed in Section 6.2, CD38 is responsible for the production 
of two 2nd messengers which are known to mediate Ca2+ secretion, which makes it an 
attractive potential target. In this study, inhibition of CD38 activity by nicotinamide 
significantly reduced Cch-induced Ca2+ signals in human colonic crypts, to a similar degree as 
observed during R59-022 treatment, demonstrating that CD38 does indeed play a role, in a 
manner which is consistent with a model in which CD38 activity lies downstream of PA. 
However the mechanism of CD38 activation upon M3AchR activation remains unclear.  
 
Identification of the steps in the pathway of M3AchR activation between PA generation and 
CD38 activation requires some speculation. The major possibility considered here involves 
the NADPH oxidase (NOX) family of enzymes, which are responsible for the generation of 
superoxide and the subsequent conversion into ROS. The activity of NOX enzymes has been 
shown to be stimulated by PA in various models; in terms of mammalian NOX such studies 
are largely confined to the study of neutrophils, in which NOX-produced reactive oxygen 
compounds serves a microbicidal role (McPhail, et al., 1995; Erickson, et al., 1999; Zhang, Y. 
et al., 2009). As mentioned previously, inhibition of PA formation in rabbit neutrophils 
potentiates superoxide production, an effect which could be blocked by PKC inhibitors, 
suggesting a role for DAG or PKC in ROS generation (Gomez-Cambronero, et al., 1987), a 
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finding which might be argued to run counter to the role that PA plays in stimulating NOX. 
Another report has suggested a synergistic role for PA and DAG in the activation of NOX in 
human neutrophils (Qualliotine-Mann, et al., 1993), while Erickson et al suggested that the 
activity of DAG in the activation of NOX is dependent on its conversion into PA but not via 
PKC (Erickson, et al., 1999). However, a study by Fontayne and colleagues demonstrated the 
phosphorylation of p47phox subunit of NOX by PKC isoforms including α, βII, δ and ζ in 
human neutrophils (Fontayne, et al., 2002). Therefore while some details require clarification, 
PA seems to be the key regulator of neutrophil NOX activation. However it is currently 
unclear (1) whether PA activates NOX in other cell systems, such as the human colonic 
epithelium upon Cch stimulation, (2) whether NOX activation is dependent or independent 
of PKC activation, and (3) whether DAG and Ca2+ dependent or independent PKC isoforms 
are involved in the process. It has been previously reported that high levels of glucose-
induced ROS production occur via PKC-dependent NOX activation in vascular smooth muscle 
and endothelial cells, and that the increase in ROS production can be blocked by both PKC 
and NOX inhibitors, however the specific PKC isoforms involved in the process were not 
identified (Inoguchi, et al., 2000). In this thesis, inhibition of ROS with apocynin significantly 
reduced the Cch-induced Ca2+ signals in human colonic crypts, to a level of inhibition similar 
to that observed during blockade of PKC. These findings not only demonstrate a role for ROS 
in the Ca2+ signal generation downstream of M3AchR activation, but also suggest a link 
between NOX activity and PKC. The NOX1 isoform is highly expressed in the colon (Brown, et 
al., 2009), and the assembly of the transmembrane heterodimer (NOX1/p22phox) with three 
cytosolic regulatory subunits (NOXO1, NOXA1 and a Rho GTPase RAC1) is necessary for NOX 
activation (Yu, et al., 2006; Fu, et al., 2014; Görlach, et al., 2015), with activation of the 
cytosolic RAC1 subunit being the key trigger for NOX-dependent ROS generation (Cheng, et 
al., 2006). Preliminary data in this thesis demonstrated that the DAG kinase inhibiting 
chemical R59-022 blocked the recruitment of active RAC1-GTP to the basal pole of crypts 
(where NOX1 is expressed), suggesting a role for PA in mediating NOX assembly and 
activation. This supports previous findings that DAG kinase alpha mediates RAC activation by 
recruiting PKC zeta (which is DAG and Ca2+ independent), that dissociate RAC from the 
inhibitory complex with RhoGDI (Chianale, et al., 2010). Another study also suggested that 
inhibition of PKC zeta blocks NOX-derived ROS production in cultured neurons (Brennan, et 
al., 2009). However, the role of different PKC isoforms in NOX activation in the human colonic 
epithelium remains unclear. Because data presented in this study suggest a dominant role 
for the PA pathway in Ca2+ signal generation, NOX is most likely to be activated by the DAG-
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insensitive PKC isoforms. There is currently no direct evidence to suggest the activation of 
NOX in plant and animal cells is mediated by the PKC-RAC pathway in a Ca2+ manner (Jiang, 
et al., 2011). As PA has been shown to activate PKC-zeta (Limatola, et al., 1994), one possible 
configuration of the signalling pathway for ROS production in the human colonic epithelium 
would be M3AchR PA  PKC (DAG and Ca2+ independent) NOX  ROS. Further 
experiments are required to compare the level of ROS production before and after the 
application of DAG kinase inhibitor. PKC and NOX inhibitors could also be employed following 
M3AchR activation in the human colonic epithelium to confirm the role of PKC and the 
upstream pathway for ROS generation.   
 
The role of NOX-derived ROS in mediating intracellular Ca2+ signals remains poorly 
understood, although one study has previously demonstrated that NOX1-derived ROS 
regulates Ca2+ mobilisation in smooth muscle cells in response to thrombin (Zimmerman, et 
al., 2011). In this thesis, inhibition of NOX1 by two commonly used NOX inhibitors (DPI and 
VAS2870), and inhibition of RAC1 activation (by NSC23766) potently blocked the Cch-induced 
Ca2+ signals in the human colonic epithelium by more than 70%. These results further support 
a potential role of NOX-derived ROS in mediating intracellular Ca2+ mobilisation in the human 
colonic epithelium upon M3AchR activation. However, due to the lack of specificity of these 
small molecule inhibitors, further research using more specific techniques, such as siRNAs 
directed against NOX1 and RAC1, is required to confirm these findings. A recent study by Xu 
and colleagues suggested that NOX-derived ROS mediates CD38 internalisation and 
activation in coronary arterial myocytes upon MAchR agonist stimulation (Xu, et al., 2013). 
This is consistent with the data discussed earlier in this section that CD38 activation possibly 
exists downstream of PA upon M3AchR activation in the human colonic epithelium, as 
demonstrated by the similar level of Ca2+ signal inhibition seen during either DAG kinase or 
CD38 inhibition. CD38 function has been suggested to be regulated by its internalisation, and 
ligand-induced CD38 internalisation (endocytosis) has been shown to mediate intracellular 
Ca2+ mobilisation (Zocchi, et al., 1999). Preliminary data in this thesis demonstrated that the 
inhibition of endocytosis reduced the Cch-induced Ca2+ signal by half, suggesting endocytosis 
is important for Ca2+ signal generation in the human colonic epithelium. The level of Ca2+ 
signal inhibition observed during endocytosis blockade is comparable to the inhibition of PKC 
and ROS, which again provide suggests that a link between NOX-derived ROS and CD38 
endocytosis is plausible. Combined, these data can be summarised in the following proposed 
signalling pathway: M3AchR  PA  RAC1  NOX  ROS  CD38.   
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ROS are relatively short-lived molecules but they are readily diffusible through the cytoplasm, 
hence the subcellular localisation of NOX has been suggested to determine the downstream 
signalling cascade (Brown, et al., 2009). The idea of targeting specific ROS signals to a precise 
subcellular compartment upon receptor activation has been suggested to occur via the 
association of NOX with lipid rafts, caveolae and endosomes (reviewed by Ushio-Fukai, 2006a 
and b). In this thesis, expression of both NOX1 and active RAC1-GTP protein was detected in 
the cytoplasm of human colonic crypt epithelial cells. After 30 sec of Cch stimulation, there 
was an increase in both staining intensity and translocation towards the apical pole of cells 
where the acidic lysosomes reside (also the Ca2+ initiation sites) observed for both proteins. 
As there was translocation of NOX occurs within the first 30 seconds of a Cch response and 
the average latency of the induced Ca2+ signal was about 46 sec, it is feasible that NOX-
derived ROS acts as the second messenger that transfers the M3AchR-mediated activation 
signals from the basal pole to the response at the apical pole of crypt cells, and that CD38 
should be the key regulator of the Ca2+ signal generation at the apical pole of cells. As with 
NOX1, CD38 expression was detected in the cytoplasmic space of human colonic crypt 
epithelial cells, where the acidic lysosomes reside. This finding is in line with the previous 
report in pancreatic acinar cells that CD38 expression was detected on endosomes which are 
in close proximity with the lysosomes (Cosker, et al., 2010). Data presented in this thesis also 
showed an increase in CD38 expression in the apical region of cells after a prolonged Cch 
incubation (30 min) in human colonic crypts, possibly representing Cch-mediated CD38 
internalisation over a period of time. However, the early events of NOX-dependent CD38 
internalisation in the human colonic crypt remain unclear. In the absence of neuronal 
innervation and the lack of exogenous stimulation with Cch, one possible explanation for the 
continued endosomal CD38 expression in the cytoplasm of crypt epithelial cells might be that 
the non-neuronal Ach system is mediating CD38 internalisation via NOX, although such a 
form of regulation is currently not known. Non-neuronal Ach can be negatively regulated by 
endogenous cholinesterase, which we would expect to present in these epithelial cells 
(Montenegro, et al., 2005), which could possibly explain why there wasn’t excessive 
accumulation of endosomal CD38 in the cytoplasm of crypt epithelial cells as compared to 
the effect of prolonged Cch incubation.  
CD38 is responsible for the synthesis of both cADPR and NAADP (Lee, 1997). Data presented 
in chapter 4 showed that Cch-induced Ca2+ signals were reduced when CD38 activity is 
blocked by nicotinamide, however this finding cannot differentiate between whether the 
effect was mediated by cADPR or NAADP. The cADPR antagonist 8-bromo-cADPR had no 
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obvious effect on blocking Cch-induced Ca2+ signals, suggesting that cADPR might not play 
any role in Cch mediated Ca2+ signal generation: it is possible that cADPR in these cells does 
not get transported into the cytoplasm and hence cannot exert its function via the RYR on 
the ER. Thus our inference that NAADP is likely the CD38-produced messenger responsible 
for Ca2+ signal generation (although it is also possible that the 8-bromo-cADPR inhibitor 
treatment suffered from some technical flaw such as an incorrect dosage, and that cADPR 
might play some role). In guinea pig tracheal smooth muscle cells, Cch has been shown to 
induce a transient increase in NAADP levels, and NAADP was also shown to elevate cytosolic 
[Ca2+ ] following microinjection into cells (Aley, et al., 2013), findings which further support 
the role of CD38/NAADP pathway in mediating Ca2+ mobilisation upon M3AchR activation in 
the human colonic epithelium. In this thesis, some level of co-localisation between LAMP1 
lysosomes and CD38 was observed, suggesting that these could be feasible sites of NAADP 
production. This is in support of previous findings that NAADP synthesis is favoured at an 
acidic pH (Lee, 1999). However, information is still lacking about how NAADP is generated in 
vivo. A previous report has suggested that CD38 is not a requirement for NAADP production 
in myometrial cells (Soares, et al., 2007), while another showed that pancreatic acinar cells 
derived from CD38 knockout mice produced no NAADP in response to CCK stimulation, in 
contrast to wild type mice, demonstrating that it was required (Cosker, et al., 2010). 
Development of protocols for the measurement of intracellular NAADP levels is underway in 
our lab to allow direct investigation of the effect of Cch in NAADP synthesis in the human 
colonic crypt.  
 
Since NAADP was first discovered in sea urchin egg homogenates it has been shown to 
potently mobilise Ca2+ from acidic stores in a wide range of cell types (Galione, 2006). 
Functional coupling between different Ca2+ releasing 2nd messengers such as IP3, cADPR and 
NAADP has also been reported previously (Patel, S. et al., 2001; Menteyne, et al., 2006). 
Notably, one previous study suggested that NAADP mediated Ca2+ released from acidic stores 
may further trigger Ca2+ release from the ER store via IP3Rs and RYRs (Patel, S. et al., 2001). 
In this thesis, inhibition of both IP3R and RYR revealed that the ER Ca2+ store was indeed 
involved in Cch-induced Ca2+ signal generation in the human colonic epithelium, but was not 
the key trigger for the process. This finding is entirely complementary with the thapsigargin 
data, in which depletion of the ER store did not abolish the Cch-induced Ca2+ signals, but 
reduce it to a small Ca2+ wave, suggesting that the initial M3AchR signal mobilises Ca2+ from 
other intracellular organelles (see section 6.2). The role of acidic lysosomes was investigated 
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with the NAADP antagonist Ned-19, which potently suppressed Cch-induced Ca2+ signals. The 
importance of NAADP was further confirmed by targeting the NAADP receptor (TPC) with 
diltiazem (DZM), which caused strong inhibition of the Ca2+ signals. These results further 
support the role of NAADP as the key 2nd messenger responsible for mobilising acidic 
lysosomal Ca2+ stores upon M3AchR activation. Several other drugs such as bafilomycin, 
chloroquine and GPN were also employed to confirm the importance of the acidic lysosomes. 
Because the level of inhibition by these inhibitors were more profound than the inhibition of 
IP3R and RYR on the ER, these observation further suggests the initial increase in local [Ca2+] 
from acidic stores is the key trigger that further activates RYRs and IP3Rs on the ER 
membrane to initiate the CICR response in human colonic crypt epithelial cells. These 
findings are very similar to those experiments in the sea urchin egg homogenate model 
(Churchill, et al., 2002), in HEK293 cells overexpressing TPC2 (Calcraft, et al., 2009), and in 
pancreatic acinar cells (Gerasimenko, et al., 2015). All of these findings further confirm the 
important role of acidic lysosomes in M3AchR signal transduction via a CD38-NAADP-TPC 
pathway in the human colonic epithelium, although further experiments such as siRNA 
knockdown of CD38 and TPC genes would be useful in confirming these findings. 
Incorporating the information from this section, the updated proposed pathway is: 
M3AchR PA RAC1NOX CD38 NAADPTPC Ca2+. 
 
6.3 Cholinergic regulation of mucus secretion in human colonic crypt goblet 
cells 
The role of Ca2+ signalling in the regulation of GI tract mucus secretion has been reported 
from as early as in the 1980s in several animal models (Neutra, et al., 1982; Seidler, et al., 
1989; Hamada, et al., 1997; Yang, et al., 2013). The link between cholinergic signalling and 
intracellular Ca2+ mobilisation has been demonstrated previously in our lab (Lindqvist, et al., 
2002; Reynolds, et al., 2007). Cholinergic regulation of mucus secretion was first reported in 
the airway epithelium in 1990 (Rogers, et al., 1990; Widdicombe, et al., 1991), and then in 
isolated human colonic crypt in 2000 (Halm and Halm, 2000). In this thesis, the role of 
cholinergic-mediated Ca2+ coupling mucus secretion was demonstrated in human colonic 
crypts. Due to the higher intensity of M3AchR expression at the crypt base, this region of the 
crypt has been suggested to be more sensitive to cholinergic signals (Lindqvist, et al., 2002). 
Data presented in chapter 5 confirmed that intracellular Ca2+ mobilisation upon M3AchR 
activation is a requirement for mucus granule exocytosis in human colonic crypt goblet cells, 
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as the application of the intracellular Ca2+ chelator BAPTA caused significant retention of 
mucus granules in goblet cells at the base of the crypt. The effect of BAPTA in blocking Cch-
induced mucus secretion supports previous findings in rabbit gastric mucous cells (Seidler, 
et al., 1989) and in rat gastric epithelial cells (Tani, et al., 2002).  
 
As discussed previously in section 6.2.1, the lysosomal Ca2+ stores play an important role in 
the generation of Cch-induced Ca2+ signals, leading to the proposal that Ca2+ mobilisation 
from these acidic stores couple mucus granule exocytosis in human colonic crypt goblet cells. 
To confirm this hypothesis, inhibitors targeting NOX, CD38 and NAADP were employed to 
investigate how these transitional mediators regulate mucus granule secretion in goblet cells. 
Both DPI (NOX1 inhibitor) and NSC23766 (RAC1 activation inhibitor) caused significant 
upregulation of mucus granule retention in goblet cells upon Cch stimulation, which suggests 
a potential role for NOX-derived ROS in the upstream pathway controlling Ca2+ signal 
generation and thus mucus secretion. This is consistent with previous studies which 
suggested NOX1 and DUOX2 are the predominant sources of ROS in the GI tract which play 
important roles in limiting bacterial pathogenicity and enforcing barrier integrity (Patel, et 
al., 2013; Hayes, et al., 2015). In addition, Hayes et al has also identified novel missense 
variants in the NOX1 and DUOX2 genes that are associated with very early onset IBD 
(VEOIBD). Patients possessing certain variants of both genes showed abnormal Paneth cell 
metaplasia, reduced ROS production, and impaired resistance to Campylobacter jejuni 
infection (Hayes, et al., 2015). However, DPI has been shown to block other sources of ROS 
(Wind, et al., 2010), while NSC23766 was shown to act as a competitive MAchR antagonist 
(Levay, et al., 2013), hence the data presented here remain inconclusive due to the lack of 
specificity of these agents. Yet, other reports have suggested that DPI is less potent in 
blocking mitochondrial oxidative phosphorylation than NOX enzymes (Hancock and Jones, 
1987; Bulua, et al., 2011). Due to this complexity, NOX-derived ROS was further investigated 
by a pan-NOX inhibitor called VAS2870, (Wingler, et al., 2012). In this thesis, both DPI and 
VAS2870 showed similar levels of inhibition of the Cch-induced Ca2+ signals, but VAS2870 
failed to retain mucus granules in goblet cells upon Cch stimulation. It is currently unclear 
about its mechanism of action and its specificity towards NOX1 in the human colonic 
epithelium. However, in a study of MDCK cells infected with H3N2 viruses, the effect of DPI 
is far more effective in reducing viral load than VAS2870 (Amatore, et al., 2015), which 
suggests DPI might be a more potent NOX inhibitor. There is currently no NOX1-specific 
inhibitor which could be used to confirm the current findings, hence future work including 
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the use of MitoSOX (which specifically targets mitochondrial superoxide in live cells) as well 
as NOX1 and RAC1 specific siRNAs are required to confirm the source of ROS in mediating 
mucus secretion in human colonic crypt goblet cells upon M3AchR activation.  
In this study, inhibition of CD38 by nicotinamide has no obvious effect on mucus granule 
retention under constitutive basal condition but significantly retained mucus granules in Cch 
stimulated condition. As nicotinamide acts to block cADPR generation, one logical 
explanation is that inhibition of cADPR has no effect on mucus granules retention. However 
nicotinamide does prevent the observed acceleration in mucus secretion which occurs 
following Cch stimulation. These results further implicate the CD38-NAADP axis in mediating 
Ca2+ coupling mucus secretion in the human colonic epithelium. These observations are 
consistent with the findings in a clinical trial on healthy human subjects, in which 
nicotinamide was shown to have no effect on insulin secretion rates and glucose kinetics, 
whereas nicotinic acid – a structurally similar compound to nicotinamide that is the substrate 
for NAADP (Cosker, et al., 2010; Lee, et al., 2012) – increased insulin secretion (Bingley, et al., 
1993). The role of NAADP in mucus secretion was further confirmed using Ned-19, which 
behaved as predicted and lead to significantly more mucus granules being retained in goblet 
cells upon Cch stimulation. Thus, NAADP is the key 2nd messenger in mediating Ca2+ coupling 
mucus secretion in human colonic crypt goblet cells (Figure 6.1). Further experiments such 
as siRNA silencing of CD38 and TPC would help to confirm these findings. 
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6.4 IBD treatment and therapy 
The colon is normally protected by two layers of mucus which play an important role in GI 
defence (Johansson, et al., 2013). The mucus layer is continually being worn away as the 
stool passes through. Thus, there is strong need for the continuous replenishment of the 
mucus layers by goblet cells. One of the major contributing factors for IBD pathogenesis is a 
defective mucus barrier (Antoni, et al., 2014). The vast majority of current research into the 
pathophysiology of UC has mainly concentrated on immunological aspects (Cader, et al., 
2013; Geremia, et al., 2014), and anti-inflammatory therapy is currently the gold standard 
for treating IBD patients. However, the role of defects in the production and maintenance of 
the mucus layer have not been extensively addressed, and there is no specific report thus far 
targeting the underlying mechanism of cholinergic signal mediated Ca2+ mobilisation in 
regulating mucus barrier function in the human colon. This thesis offers a novel therapeutic 
target for treating IBD. Both cADPR and NAADP have been shown to regulate Ca2+ mediated 
secretion coupling in pancreatic β cells (Takasawa, et al., 1993b; Takasawa, et al., 1998; 
Johnson, et al., 2002; Arredouani, et al., 2015), while both diltiazem (Fehmann, et al., 1988) 
and Ned-19 (Arredouani, et al., 2015) have been shown to inhibit glucose induced insulin 
secretion in the pancreas. In this thesis, inhibition of NAADP significantly blocked Cch 
induced Ca2+ coupling mucus secretion. Thus, NAADP not only acts as a 2nd messenger for 
mobilising lysosomal Ca2+ that couples mucus secretion, its pathway could also be a potential 
target for treating IBD.  
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Figure 6.1 Summary diagram of the consequences of cholinergic stimulation 
(Scenario 1, pg 236) Binding of Ach (or Cch) to M3AchR at the basal pole of crypt/ initiator 
cell promotes its association with the heterotrimeric G protein on the plasma membrane 
that further activates PLC molecules. PLC in turn initiates PIP2 hydrolysis to generate DAG 
and IP3. Activation of PIP2 enhances DAG kinase activity that promotes the conversion of 
DAG into PA. PA then activates NOX1 by recruiting RAC1 to the plasma membrane or to 
vesicular membranes in the cytosol (amphisome) expressing NOX1/p22phox complex. The 
RAC1/NOX1/ROS system possibly mediates CD38 internalisation or directly activates the 
CD38 on endosomes; alternatively RAC1/NOX1/ROS might mediate CD38 activity indirectly 
via PKC activation. CD38 then generates NAADP (presumably in acidic endo-lysosome) that 
mediates Ca2+ mobilisation from acidic lysosomes via the TPCs. These initial Ca2+ release from 
lysosome triggers the IP3Rs and RYRs on the ER membrane and induces the CICR response 
within the cell. Both Ca2+ and NAADP could potentially translocate to the neighbouring goblet 
cell via Gap junctional protein and subsequently activate the IP3Rs and RYRs on the ER 
membrane and TPCs on lysosomes respectively. The induction of CICR response in goblet cell 
mediates the exocytosis of mucus granules. These regenerative Ca2+ waves from the Ca2+ 
initiator cells at the base of crypt then propagate to all cell types along the crypt axis, and 
further mediates mucus granule exocytosis in goblet cells. 
(Scenario 2, pg 237) Binding of Ach (or Cch) to M3AchR at the basal pole of goblet cell 
promotes its association with the heterotrimeric G protein on the plasma membrane that 
further activates PLC molecules. PLC in turn initiates PIP2 hydrolysis to generate DAG and IP3. 
Activation of PIP2 enhances DAG kinase activity that promotes the conversion of DAG into 
PA. PA then activates NOX1 by recruiting RAC1 to the plasma membrane or to vesicular 
membranes in the cytosol (amphisome) expressing NOX1/p22phox complex. The 
RAC1/NOX1/ROS system possibly mediates CD38 internalisation or directly activates the 
CD38 on endosomes; alternatively RAC1/NOX1/ROS might mediate CD38 activity indirectly 
via PKC activation. CD38 then generates NAADP (presumably in acidic endo-lysosome) that 
mediates Ca2+ mobilisation from acidic lysosomes via the TPCs. These initial Ca2+ release from 
lysosome triggers the IP3Rs and RYRs on the ER membrane and induces the CICR response 
within the cell, followed by mucus granule exocytosis.   
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6.5 Limitations of the current study 
The mucosal samples used in the current study were derived from histologically healthy 
tissues, and the spatial characteristics of the Cch induced Ca2+ signals were similar regardless 
of the age and sex of the donor patient. However there might still be some patient bias could 
theoretically impact on the general applicability of the current findings: clinical history and 
demographic data such as medication and family history, sex, ethnicity, age, social status and 
life style (which might include various disease risk-factors, e.g. diet or smoking) were not 
collected or considered in the current study. The fact that these colonic mucosal samples 
were obtained from patients for whom there was a suspected need to undergo a surgical 
resection or colonoscopy could be used to argue that they may be derived from a pool 
enriched for certain demographics that do not represent the majority and thus could bias 
the current results.  
There is also of course the possibility that explanted colon tissue might not behave the same 
way as native, in situ colonic crypts. Surgical removal of colon tissue causes ischemia and 
basal inflammation in the mucosa, which is known to alter gene expression and cause tissue 
damage (Huang, et al., 2001; Santos, et al., 2015). Although explants were immediately kept 
on ice, both for rapid transit to the lab and throughout the isolation process, it is entirely 
feasible that the extraction and culture conditions (which uses various supplements and 
growth factors) might alter the transcriptional profile of certain genes and affect 
physiological responses. Whether or not the extraction process itself unduly affects crypts 
must remain a philosophical question, as we are unable to assay human crypts in vivo. The 
expression profiles of the genes of interest were not compared before and after crypt culture 
in this thesis due to the technical difficulties involved in collecting sufficient crypts from 
Matrigel for further RNA isolation.  
Another consideration is that native colonic crypts are constantly under physical and 
mechanical forces and strains, including compression, shear stress and pressure resulting 
from peristalsis and passing stool, which is not currently replicated or simulated in our 
culture model. As the intestinal mucosal cells respond differently to the type of forces that 
might influence proliferation, differentiation and motility, the lack of such mechanical forces 
may affect the biology of these cells (Gayer, et al., 2009). It is possible that a flow based 
culture system could be used to address whether this is an important consideration. 
A major technical limitation was the inability to directly measure NAADP or ROS, which 
means that many effects need to be measured indirectly. Protocols for the measurement of 
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the intracellular levels of these chemicals before and after Cch treatment are currently being 
developed in our laboratory, which should provide means to more directly investigate the 
findings of this thesis.  
 
6.6 Future work 
The data described in this thesis details how cholinergic signals in human colonic crypts can 
translate into mucus secretion via Ca2+ signalling. While these results are of interest in 
untangling molecular pathways and providing insights into the basic biology and physiology 
of this system, as yet they do not provide much in the way of clinical or translational insight. 
Therefore the next steps in this body of work would be geared towards using the 
methodologies and discoveries of this thesis to explore how the systems described here are 
perturbed in human pathologies. This would best be achieved by conducting a comparative 
study of mucus excitation secretion coupling in the colonic crypts of healthy and IBD subjects. 
Such a study would necessarily involve characterisation of the intracellular Ca2+ signalling 
machinery in crypts from IBD patients, and response to cholinergic stimulation. Similarly 
calcium-mediated excitation-mucus secretion coupling would need to be investigated in IBD 
crypts. Crucially, pharmacological or genetic modulation of components of the signalling 
pathway identified here would allow determination of the functional role of Ca2+ signalling 
in rescuing mucus secretion in IBD crypts. 
There are a number of techniques that could be employed to further investigate and expand 
upon the current findings. Techniques such as proteomics and other molecule sensing 
technologies could be used to identify other molecular changes upon cholinergic stimulation. 
This might identify the currently unknown intermediate signalling molecules downstream of 
MAchR activation. Metabolomics may be used to measure the generation of NAD and NADP 
(substrate of CD38) by NOX upon cholinergic stimulation, and similarly the generation of 
cADPR and NAADP by CD38, which may provide more accurate quantification of signalling 
responses.  Phosphoproteomics and glycoproteomics could be used to try to identify the 
effect of Ach on RAC1 activation and MUC2 maturation respectively. Mass spectrometry can 
be used to measure non-neuronal Ach release before and after the application of the OCT or 
VAChT inhibitors. Genome-wide transcriptomics may identify larger or unanticipated 
transcriptional changes before and after cholinergic stimulation in the human colonic 
epithelium. It might also be instructive to develop or adopt an assay to measure the mucus 
content of stool, which should be easily extractable using standard centrifugation and 
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filtration equipment (White, et al., 2009). Rectal mucus discharge is one of the most common 
symptoms of patients suffering from irritable bowel syndrome (IBS). Similarly, patients with 
IBD have defective mucus barriers, hence sufferers might be expected to have less mucus in 
their stool. Such an assay might have use as a prognostic tool to identify candidates who 
have these or similar gut pathologies. The crypt culture model can also be employed to 
investigate other gut phenotypes and pathologies such as IBS, coeliac disease, diverticulitis 
and colon cancer.  
Acetylcholine has been shown to play a variety of physiological and cellular functions such 
as colonic epithelial cell proliferation (Takahashi, et al., 2014), axon guidance (Xu, et al., 2011), 
muscle contraction (intestinal motility) (Furness, 2000), fluid secretion (Reynolds, et al., 2007) 
and mucus granule exocytosis (Halm and Halm, 2000); suggesting an important role for this 
neurotransmitter in gut health. The binding of Ach to the MAchR causes intracellular Ca2+ 
mobilisation, and interfering with the generation of these Ca2+ signals also has an impact on 
cellular events, which suggests an inter-relationship between cholinergic and Ca2+ signalling 
systems. Cholinergic-mediated mucus secretion has been shown previously in the human 
colonic epithelium (Halm and Halm, 2000), and understanding of the molecular mechanism 
of both the cholinergic and Ca2+ signalling system could enhance our knowledge on how 
mucus secretion is regulated. This thesis identifies a novel cholinergic-mediated Ca2+ signal 
transduction pathway that orchestrates the highly complex release of mucus granules. 
Perturbation of these pathways is therefore likely to lead to either gut inefficiencies or even 
pathologies, making their constituents potential therapeutic targets. Perturbation of mucus 
production may influence the microbiota compositions, which is increasingly reported to 
have wide impacts on gut health (Manichanh, et al., 2012; Guinane, et al., 2013; Ohkusa, et 
al., 2015; Li, H. et al., 2015), and hence it might be instructive to assess gut microbial contents 
in people who have variation in their cholinergic-epithelial secretion systems. The possibility 
of therapeutically targeting perturbed neuronal-epithelial secretion systems which are 
causing gut pathologies may also even be relevant to the treatment of other diseases which 
involve a similar interface, such as chronic obstructive pulmonary disease (COPD). As in 
human bronchial epithelial cells, exposure to titanium dioxide (TiO2) nanoparticles have been 
shown to evoke Ca2+ coupling mucus secretion and led to mucus hypersecretion (Chen, E.Y.T. 
et al., 2011). Finally, I believe that this thesis demonstrates the need for interdisciplinary 
investigations, as they might yield results of translational significance that are less likely to 
be produced from fields which focus on one biological system alone. 
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Mobilisation from endo/lysosomal calcium stores is fundamental to the cellular polarity 
and tissue topology of human colonic crypt calcium signals 
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The human large intestinal epithelium comprises millions of invaginations called colonic 
crypts, which are highly innervated by cholinergic neurons. Spatiotemporal characteristics of 
cholinergic induced calcium waves along the human colonic crypt-axis suggest that calcium 
signals play a central role in co-ordinating the physiological function and perpetual renewal 
of the human colonic epithelium. However, the mechanism of colonic crypt calcium signalling 
is unknown. The aim of the current study was to characterise the cellular and molecular basis 
of human colonic crypt calcium signal generation. Methods: Human colonic crypts were 
isolated from colorectal biopsy samples (NRES approval) and placed in a 3D culture system. 
Intracellular calcium was monitored by Fura-2 ratio imaging. mRNA expression was assessed 
by real-time RT-PCR and protein localisation was visualised by fluorescence immunolabelling 
and confocal microscopy. Results: Application of carbachol (10μM) initiated calcium signals 
at the apical pole of M3AChR-positive cells located in the stem cell niche at the colonic crypt-
base. Calcium signals spread from the apical to basal pole of initiator cells and from initiator 
cells to all neighbouring cell types (e.g. goblet cells) along the crypt-axis. The absence of 
extracellular calcium attenuated the duration of the biphasic calcium response at the crypt-
base, but did not alter the initial peak amplitude (n=5). Thapsigargin pre-treatment did not 
abolish the carbachol-induced calcium signal at the apical pole of crypt cells (n=14). 
Immunolabelling revealed the presence of ER (anti-Kdel) at the basal pole and lysosomes 
(anti-LAMP1) at the apical pole of polarised crypt cells (n=16). Lysosomal lysis by GPN (200 
μM) invoked a calcium increase at the apical pole and abolished subsequent responses to 
carbachol stimulation (n=5), as did pre-treatment with other lysosomotropic agents, 
chloroquine (100μM, n=4) and bafilomycin (5μM, n=4). Colonic crypts expressed mRNA for 
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InsP3R1-3, RyR1&2 and TPC1&2 intracellular calcium channels (N=5 subjects). Carbachol 
induced calcium signals were profoundly inhibited (peak amplitude inhibition >80%, P<0.05) 
by the PLC inhibitor U73122 (10μM, n=15) or the NAADP antagonist NED-19 (20-200μM, 
n=10) and partially inhibited (peak amplitude inhibition <40%, P<0.05) by InsP3R 
(Xestospongin C, n=5; 2-APB, n=10) or RyR (ryanodine, n=10; 8-bromo cADP ribose, n=10) 
antagonists. Conclusions: Cholinergic stimulation of M3AChR mobilises calcium from 
lysosomes located at the apical pole of cells within the colonic crypt stem cell niche. The 
effects of pharmacological agents suggest that dynamic interplay between NAADP-, InsP3- 
and cADP ribose-sensitive stores determines the spatiotemporal characteristics, and the 
physiological outcomes, of colonic crypt calcium signalling. 
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Inhibition of CD38-NAADP-TPC-induced calcium signalling blocks cholinergic excitation-
mucus secretion coupling in native human colonic crypt goblet cells 
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The lumen of the large intestine houses approximately 1013 -1014 microorganisms. In order 
to defend itself, the intestinal epithelium secretes a protective coating of mucus, the major 
component of which is Muc2 mucin protein. There is much interest in the mechanism of 
excitation-mucus secretion coupling because compromised mucus layer formation in Muc2 
knock-out mice and human disease is associated with direct contact of bacteria with the 
epithelium, inflammation, bloody diarrhoea and colon cancer. Previously, cholinergic 
stimulation has been shown to promote mucus secretion, but the mechanism for excitation-
mucus secretion coupling is not fully understood. The aim of the current study was to 
elucidate the mechanism of calcium (Ca2+) signal generation in native human colonic crypt 
goblet cells in situ and determine the role of Ca2+ signalling in Muc2 protein secretion. 
Methods: Human colonic crypts were isolated from colorectal tissue samples obtained at 
surgical resection (NRES approval) and placed in a 3D culture system. Intracellular Ca2+ was 
monitored by Fura-2/Fluo-4 imaging. To complement previous qRT-PCR mRNA expression 
analyses, localisation of M3AChR, CD38 (which catalyses NAADP synthesis), TPC1&2 (i.e. Ca2+ 
channels stimulated by NAADP) and endolysosomes (LAMP-1 positive puncta) within Muc2+ 
goblet cells was visualised by fluorescence immunolabelling and confocal microscopy. Ca2+ 
signal generation and Muc2 depletion from goblet cells was assessed following stimulation 
with carbachol (Cch,10μM) in the presence and absence of nicotinamide (20mM, an inhibitor 
of CD38-mediated NAADP synthesis) or NED-19 (200μM, an NAADP receptor inhibitor). 
Results: Application of Cch evoked a Ca2+ signal at the human colonic crypt base which spread 
to all cell types located along the human colonic crypt-axis, including goblet cells. Muc2+ 
goblet cells expressed: M3AChRs on the basal membrane; CD38 in the cytoplasm and nucleus; 
cytoplasmic TPC1&2 associated with apical LAMP-1 positive intracellular puncta. Cch-
induced colonic crypt Ca2+ signals were suppressed by pre-treatment with nicotinamide 
(64.5±5% reduction, N=2 subjects, n=5 crypts) and were inhibited profoundly by pre-
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incubation with NED-19 (85±5% reduction, N=5 subjects, n=15 crypts). Goblet cell Muc2 
immunofluorescence was dramatically reduced following a 30 minute exposure to Cch 
(44±4.7 % reduction, N=4 subjects, n=4 crypts) and this was inhibited by NED-19 (150±45%, 
N=4 subjects, n=4 crypts). Conclusions: Goblets cells in the human large intestine express the 
molecular machinery to synthesise NAADP. Inhibition of the CD38-NAADP-TPC pathway 
suppressed Ca2+ signal generation and Muc2 depletion. The CD38-NAADP-TPC-calcium 
pathway plays a central role in cholinergic excitation-mucus secretion coupling in human 
colonic crypt goblet cells in situ. 
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Spatiotemporal characteristics of cholinergic-induced calcium waves along the human 
colonic crypt-axis suggest that calcium signals play a central role in coordinating the 
physiological function and perpetual renewal of the human colonic epithelium. One aim of 
the work in our lab is to characterise the cellular and molecular basis of human colonic crypt 
calcium signal generation and ascertain their influence on the intestinal stem cell niche. 
Methods: Human colonic crypts were isolated from tissue biopsy samples obtained at 
sigmoidoscopy (NRES approval) and placed in a 3D culture system. Intracellular calcium was 
monitored by Fura-2/Fluo-4 fluorescence imaging. mRNA expression was assessed by RT-PCR 
and protein localisation was visualised by fluorescence immunolabelling and confocal 
microscopy. Results: Methacholine initiated calcium signals at the apical pole of M3AChR-
positive, LGR5-positive, intestinal stem cells at the colonic crypt-base.  Calcium signals spread 
from the apical to basal pole of initiator stem cells and from initiator cells to all neighbouring 
cell types (e.g. goblet cells) along the crypt-axis. RT-PCR and immunofluorescence analyses 
confirmed the expression of InsP3R, RyR and TPC subtypes. TPCs were expressed at the apical 
pole on endolysosomes. Accordingly, NED-19, a blocker of NAADP/TPC-mediated calcium 
release, inhibited the calcium signal amplitude by ~90%. NED-19 also inhibited cholinergic-
induced mucus secretion from goblet cells and colonic crypt cell proliferation in the intestinal 
stem cell niche. Conclusions: Cholinergic-induced calcium signals maintain the fitness of the 
human intestinal stem cell niche. 
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